Name	Gene(s)	Condition(s)	Clinical significance (Last reviewed)	Review status	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	
der(15)t(5:15)(q23.2;q15.1)	MGA|NUTM1	Spindle cell sarcoma	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter					585331	576380
PIK3CA, ARG115PRO	PIK3CA	MACRODACTYLY, SOMATIC|CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH, SOMATIC	Pathogenic(Last reviewed: Oct 10, 2018)	no assertion criteria provided					585022	576074
NM_175629.2:c.2645G>A	DNMT3A	Acute myeloid leukemia|Tatton-Brown-rahman syndrome	Pathogenic(Last reviewed: May 8, 2018)	no assertion criteria provided					496736	488182
LRG_310t1:c.1821+51A>T	PIK3CA	Sarcoma	not provided	no assertion provided					132966	136715
NM_001002295.1:c.1482-5C>T	GATA3	Familial cancer of breast	not provided	no assertion provided					132962	136711
LRG_517:g.5168-?_5303+?(2)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided					126815	132325
LRG_517:g.166501C>G	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided					126802	132312
LRG_517:g.1662319T>A	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided					126799	132309
LRG_517:g.154289dup	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided					126787	132297
U43746.1:n.8560_8860del301	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Feb 20, 2013)	no assertion criteria provided					126175	131713
NM_007294.3:c.4987_5277del	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Feb 20, 2013)	no assertion criteria provided					125750	131288
FGFR3, FGFR3/IGH FUSION	FGFR3	Multiple myeloma	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided					16343	31382
FLT3, INTERNAL TANDEM DUP	FLT3	Leukemia, acute myeloid, reduced survival in	Pathogenic(Last reviewed: Sep 17, 2009)	no assertion criteria provided					16270	31309
chr11:g.(LOH11A_HBB)del	HBB	Thalassemia intermedia	Pathogenic(Last reviewed: Jan 12, 2002)	no assertion criteria provided					15594	30633
KIT, 15-BP DEL AND LYS550ILE	KIT	Gastrointestinal stroma tumor	Pathogenic(Last reviewed: Jan 23, 1998)	no assertion criteria provided					13855	28894
RB1, IVS20, A-G, -2	RB1	Bladder cancer, somatic	Pathogenic(Last reviewed: Jan 29, 2018)	no assertion criteria provided					13077	28116
PDGFB, PDGFB/COL1A1 FUSION	PDGFB	Dermatofibrosarcoma protuberans	Pathogenic(Last reviewed: May 24, 2001)	no assertion criteria provided					12599	27638
PIGA, IVS5DS, G-A, +1, SOMATIC	PIGA	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided					9965	25004
PTCH1, PRO-SER, 451C-T	PTCH1	Basal cell carcinoma, somatic	Pathogenic(Last reviewed: Sep 1, 1996)	no assertion criteria provided					8219	23258
SMARCB1, 19-BP DEL	SMARCB1	Malignant rhabdoid tumor, somatic	Pathogenic(Last reviewed: Jul 9, 1998)	no assertion criteria provided					8023	23062
PARK2, DEL	PRKN	Neoplasm of ovary	Pathogenic(Last reviewed: May 13, 2003)	no assertion criteria provided					7039	22078
NM_002555.5(SLC22A18):c.864_865insNC_000011.10:g.2919738_2919848	SLC22A18	Breast cancer, somatic|Breast adenocarcinoma	Pathogenic(Last reviewed: Mar 31, 1998)	no assertion criteria provided					6976	22015
PDGRL, 2-BP DEL	PDGFRL	Liver cancer|Hepatocellular carcinoma	Pathogenic(Last reviewed: Mar 2, 1995)	no assertion criteria provided					5469	20508
ARHGAP26, 74-BP INS	ARHGAP26	Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided					5054	20093
ARHGAP26, 52-BP INS	ARHGAP26	Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided					5053	20092
FLCN, 2-BP DEL, 1284TC AND 2-BP INS, 1284AC	FLCN	Chromophobe renal cell carcinoma	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided					3368	18407
APC, 1-BP DEL, 3720T	APC	Desmoid tumor, somatic	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided					838	15877
chr1:909238-16736132 complex variant	RERE|CA6|CASP9|TNFRSF8|CDK11B|CLCN6|CLCNKA|CLCNKB|CORT|DFFA|DFFB|DVL1|MEGF6|EPHA2|ENO1|MTOR|GABRD|GNB1|ZBTB48|TNFRSF9|MTHFR|NPPA|NPPB|PEX10|PEX14|PGD|PIK3CD|PLOD1|EXOSC10|PRKCZ|RPL22|RSC1A1|SCNN1D|SKI|SLC2A5|SRM|TNFRSF1B|TP73|TNFRSF4|ZBTB17|PRDM2|MMP23B|KCNAB2|TNFRSF25|TNFRSF14|TNFRSF18|PER3|DHRS3|VAMP3|H6PD|ISG15|PLCH2|CEP104|KLHL21|SLC35E2A|MFN2|ANGPTL7|UBE4B|MAD2L2|PDPN|MASP2|UTS2|RER1|PARK7|CTRC|ACOT7|CLSTN1|SPEN|KIF1B|PLEKHM2|KAZN|CAMTA1|DNAJC16|TARDBP|ICMT|CHD5|SZRD1|FBXO2|FBXO6|HSPB7|ARHGEF16|SSU72|UBIAD1|WRAP73|SLC45A1|CELA2B|SDF4|ERRFI1|FBXO42|MXRA8|HES2|FBLIM1|CASZ1|INTS11|C1orf159|AURKAIP1|MRPL20|TMEM51|VPS13D|ATAD3A|PANK4|DNAJC11|AJAP1|CTNNBIP1|AGTRAP|PLEKHG5|LRRC47|DISP3|HES4|MIIP|CELA2A|PRDM16|NMNAT1|VWA1|PRAMEF1|PRAMEF2|NADK|EFHD2|MMEL1|CPLANE2|NOL9|AGMAT|MORN1|GPR157|SPSB1|CPTP|TAS1R1|CCNL2|ESPN|TAS1R3|ATAD3B|PLEKHN1|SLC25A33|DDI2|LZIC|CFAP74|KIAA2013|THAP3|C1orf158|FBXO44|FHAD1|RBP7|ACAP3|UBE2J2|LRRC38|AADACL3|PUSL1|B3GALT6|TPRG1L|PRXL2B|ARHGEF19|ACTRT2|MIB2|C1orf127|PHF13|CCDC27|SRARP|SLC2A7|CALML6|TMEM201|FAAP20|ATAD3C|TTLL10|NPHP4|C1orf167|SLC25A34|C1orf174|TMEM240|TMEM52|AADACL4|PRAMEF5|HNRNPCL1|PRAMEF9|PRAMEF10|FAM131C|DRAXIN|SPATA21|AGRN|CENPS|GPR153|C1QTNF12|HES5|SMIM1|RNF207|TMEM82|HES3|PRAMEF12|PRAMEF8|PRAMEF18|PRAMEF17|PRAMEF4|PRAMEF13|RNF223|MIR200A|MIR200B|MIR34A|PRAMEF11|PRAMEF6|HNRNPCL2|ANKRD65|PRAMEF7|MIR429|TMEM88B|FNDC10|PRAMEF19|PRAMEF20|PRAMEF22|PRAMEF15|PRAMEF16|MIR551A|CDK11A|SLC35E2B|TTC34|ENO1-AS1|CENPS-CORT	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	909238 - 16736132			221357	223086
Single allele	ALPL|RERE|C1QA|C1QB|C1QC|CA6|CAPZB|CASP9|TNFRSF8|CDA|CDK11B|CDC42|CLCN6|CLCNKA|CLCNKB|CNR2|CORT|DDOST|DFFA|DFFB|DVL1|E2F2|ECE1|MEGF6|EPHA2|ENO1|EPHA8|EPHB2|MTOR|FUCA1|GABRD|GALE|GNB1|ZBTB48|HMGCL|HSPG2|HTR1D|HTR6|ID3|TNFRSF9|MFAP2|MTHFR|NBL1|NPPA|NPPB|PAX7|PEX10|PEX14|PGD|PIK3CD|PLA2G2A|PLA2G5|PLOD1|EXOSC10|PRKCZ|RAP1GAP|RNU1-4|RPL11|RPL22|RSC1A1|SCNN1D|SDHB|SKI|SLC2A5|SRM|TCEA3|ELOA|TNFRSF1B|TP73|TRE-TTC3-1|TRNAG1|TNFRSF4|ZBTB17|LUZP1|PRDM2|MMP23B|KCNAB2|AKR7A2|ALDH4A1|EIF4G3|TNFRSF25|TNFRSF14|TNFRSF18|PER3|DHRS3|VAMP3|H6PD|ISG15|PLCH2|CROCC|CEP104|KLHL21|SLC35E2A|ZBTB40|MFN2|CELA3A|ANGPTL7|HNRNPR|UBE4B|MAD2L2|PDPN|MASP2|SRSF10|UTS2|RER1|MST1L|PADI2|LYPLA2|PARK7|CTRC|ACOT7|CLSTN1|AKR7A3|SPEN|KDM1A|EMC1|KIF1B|PLEKHM2|OTUD3|KAZN|CAMTA1|DNAJC16|UBR4|ATP13A2|TARDBP|CELA3B|ICMT|PADI4|CHD5|SZRD1|FBXO2|FBXO6|PLA2G2D|HSPB7|ARHGEF16|SSU72|UBIAD1|PADI1|PLA2G2E|WRAP73|SLC45A1|HP1BP3|CELA2B|SDF4|MRTO4|PADI3|ERRFI1|WNT4|FBXO42|RNF186|MXRA8|HES2|FBLIM1|PQLC2|CASZ1|INTS11|C1orf159|AURKAIP1|MRPL20|TMEM51|ARHGEF10L|VPS13D|ATAD3A|PANK4|CAMK2N1|ASAP3|PNRC2|NBPF1|NECAP2|DNAJC11|RCC2|AJAP1|CTNNBIP1|AGTRAP|PITHD1|PLEKHG5|LRRC47|DISP3|KIF17|HES4|GRHL3|IL22RA1|MIIP|CELA2A|PRDM16|PLA2G2F|NMNAT1|VWA1|PINK1|PRAMEF1|PRAMEF2|NADK|EFHD2|MMEL1|CPLANE2|MUL1|NOL9|AGMAT|MORN1|GPR157|SPSB1|CPTP|ZNF436|TAS1R2|TAS1R1|ACTL8|CCNL2|ESPN|TAS1R3|ATAD3B|PLEKHN1|USP48|NBPF3|SLC25A33|DDI2|LZIC|IGSF21|CFAP74|KIAA2013|THAP3|STPG1|C1orf158|FBXO44|FHAD1|RBP7|ACAP3|UBE2J2|LRRC38|AADACL3|PUSL1|B3GALT6|IFFO2|TPRG1L|PRXL2B|MYOM3|KLHDC7A|VWA5B1|UBXN10|ARHGEF19|ACTRT2|MIB2|C1orf127|PHF13|CCDC27|SRARP|SLC2A7|CALML6|IFNLR1|FAM43B|TMEM201|FAAP20|ATAD3C|AKR7L|TTLL10|TMCO4|MDS2|NPHP4|C1orf167|SLC25A34|C1orf174|TMEM240|TMEM52|AADACL4|PRAMEF5|HNRNPCL1|PRAMEF9|PRAMEF10|FAM131C|PADI6|DRAXIN|SPATA21|AGRN|CENPS|GPR153|C1QTNF12|HES5|SMIM1|RNF207|TMEM82|HES3|PRAMEF12|PRAMEF8|PRAMEF18|PRAMEF17|PLA2G2C|PRAMEF4|PRAMEF13|SH2D5|RNF223|LDLRAD2|MIR200A|MIR200B|MIR34A|PRAMEF11|PRAMEF6|HNRNPCL2|MICOS10|ANKRD65|PRAMEF7|MIR429|TMEM88B|FNDC10|PRAMEF19|PRAMEF20|LACTBL1|PRAMEF22|PRAMEF15|PRAMEF16|MIR551A|CDK11A|SLC35E2B|TEX46|LINC01783|TRQ-CTG14-1|TTC34|ENO1-AS1|CENPS-CORT|MICOS10-NBL1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	909238 - 24706269			221334	223063
NM_002074.4(GNB1):c.239T>A (p.Ile80Asn)	GNB1	Acute lymphoid leukemia|Global developmental delay|Seizures|Failure to thrive|Feeding difficulties|Focal seizures with impairment of consciousness or awareness|Growth delay|Cortical visual impairment|Global developmental delay|Growth delay|Limb hypertonia|Infantile muscular hypotonia|Multifocal epileptiform discharges|Muscular hypotonia|Muscular hypotonia|Mental retardation, autosomal dominant 42|hypotonia|Neurodevelopmental Disability	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	1	1737942	1	1806503	224715	226498
NM_002074.4(GNB1):c.239T>C (p.Ile80Thr)	GNB1	Myelodysplastic syndrome|Dystonia|Global developmental delay|Expressive language delay|Seizures|Failure to thrive|Growth delay|Hypothyroidism|Nystagmus|not provided|Strabismus|Intellectual disability|Global developmental delay|Growth delay|Developmental regression|Limb hypertonia|Inability to walk|Infantile axial hypotonia|Multifocal epileptiform discharges|EEG with generalized epileptiform discharges|Upper limb hypertonia|Muscular hypotonia|Inborn genetic diseases|Muscular hypotonia|Cleft palate|Mental retardation, autosomal dominant 42|hypotonia|Neurodevelopmental Disability	Pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, multiple submitters, no conflicts	1	1737942	1	1806503	208722	205216
NM_002074.4(GNB1):c.227A>G (p.Asp76Gly)	GNB1	Acute lymphoid leukemia|Global developmental delay|Seizures|Intellectual disability|Global developmental delay|Infantile muscular hypotonia|Muscular hypotonia|Muscular hypotonia|Mental retardation, autosomal dominant 42|hypotonia|Neurodevelopmental Disability	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	1	1737954	1	1806515	224711	226502
NM_003820.3(TNFRSF14):c.558C>G (p.Ser186Arg)	TNFRSF14	not provided	Uncertain significance	no assertion criteria provided	1	2493118	1	2561679	91954	97432
NM_001324309.1(KLHL21):c.501G>C (p.Glu167Asp)	KLHL21	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	1	6662377	1	6602317	487795	480802
NM_004958.3(MTOR):c.7514G>C (p.Arg2505Pro)	MTOR	Kidney Carcinoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	1	11169361	1	11109304	376127	363006
NM_004958.3(MTOR):c.7500T>G (p.Ile2500Met)	MTOR	Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	1	11169375	1	11109318	376455	363334
NM_004958.3(MTOR):c.7498A>T (p.Ile2500Phe)	MTOR	Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	1	11169377	1	11109320	376456	363335
NM_004958.3(MTOR):c.7280T>A (p.Leu2427Gln)	MTOR	Focal cortical dysplasia type II	Pathogenic(Last reviewed: Apr 11, 2017)	no assertion criteria provided	1	11174395	1	11114338	417724	404625
NM_004958.3(MTOR):c.7280T>C (p.Leu2427Pro)	MTOR	Focal cortical dysplasia type II	Pathogenic(Last reviewed: Apr 11, 2017)	no assertion criteria provided	1	11174395	1	11114338	417723	404624
NM_004958.3(MTOR):c.7255G>A (p.Glu2419Lys)	MTOR	not provided|Transitional cell carcinoma of the bladder	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	1	11174420	1	11114363	156709	166569
NM_004958.3(MTOR):c.6667C>A (p.Gln2223Lys)	MTOR	Kidney Carcinoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	1	11182179	1	11122122	376128	363007
NM_004958.3(MTOR):c.6644C>A (p.Ser2215Tyr)	MTOR	Malignant melanoma of skin|Focal cortical dysplasia type II|Renal cell carcinoma, papillary, 1|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Malignant neoplasm of body of uterus|Kidney Carcinoma	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2018)	no assertion criteria provided	1	11184573	1	11124516	376129	363008
NM_004958.3(MTOR):c.6644C>T (p.Ser2215Phe)	MTOR	Malignant melanoma of skin|Focal cortical dysplasia type II|Renal cell carcinoma, papillary, 1|not provided|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2018)	no assertion criteria provided	1	11184573	1	11124516	156703	166563
NM_004958.3(MTOR):c.6643T>A (p.Ser2215Thr)	MTOR	Malignant melanoma of skin|Renal cell carcinoma, papillary, 1|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	1	11184574	1	11124517	376457	363336
NM_004958.3(MTOR):c.6637C>T (p.Pro2213Ser)	MTOR	Cutaneous melanoma	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	1	11184580	1	11124523	376358	363237
NM_004958.3(MTOR):c.6625C>G (p.Leu2209Val)	MTOR	Metastatic pancreatic neuroendocrine tumours	Likely pathogenic(Last reviewed: Nov 1, 2017)	no assertion criteria provided	1	11184592	1	11124535	446276	439682
NM_004958.3(MTOR):c.6040G>A (p.Glu2014Lys)	MTOR	Transitional cell carcinoma of the bladder	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	1	11187857	1	11127800	376131	363010
NM_004958.3(MTOR):c.5902C>T (p.His1968Tyr)	MTOR	Cutaneous melanoma	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	1	11188519	1	11128462	376357	363236
NM_004958.3(MTOR):c.4449C>G (p.Cys1483Trp)	MTOR	Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Glioblastoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	1	11217229	1	11157172	376454	363333
NM_004958.3(MTOR):c.4448G>A (p.Cys1483Tyr)	MTOR	Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Glioblastoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	1	11217230	1	11157173	376453	363332
NM_004958.3(MTOR):c.4448G>T (p.Cys1483Phe)	MTOR	Renal cell carcinoma, papillary, 1|not provided|Neoplasm of the breast|Glioblastoma|Smith-Kingsmore syndrome	Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	1	11217230	1	11157173	190121	187953
NM_004958.3(MTOR):c.4447T>C (p.Cys1483Arg)	MTOR	Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Glioblastoma|Hemimegalencephaly	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	1	11217231	1	11157174	374796	361700
NM_004958.3(MTOR):c.4379T>C (p.Leu1460Pro)	MTOR	Focal cortical dysplasia type II|Kidney Carcinoma	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2017)	no assertion criteria provided	1	11217299	1	11157242	376130	363009
NM_004958.3(MTOR):c.4366T>G (p.Trp1456Gly)	MTOR	Focal cortical dysplasia type II	Pathogenic(Last reviewed: Apr 11, 2017)	no assertion criteria provided	1	11217312	1	11157255	417727	404628
NM_005957.4(MTHFR):c.1739delT (p.Phe580Serfs)	MTHFR	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	11851277	1	11791220	161642	171293
NM_005957.4(MTHFR):c.665C>T (p.Ala222Val)	MTHFR	Gastrointestinal stroma tumor|Neural tube defects, folate-sensitive|MTHFR deficiency, thermolabile type|Neoplasm of stomach|not specified|not provided|carboplatin response - Efficacy|cyclophosphamide response - Toxicity/ADR|methotrexate response - Dosage, Efficacy, Toxicity/ADR	drug response(Last reviewed: May 14, 2018)	reviewed by expert panel	1	11856378	1	11796321	3520	18559
GRCh37/hg19 1p36.22(chr1:11850846-11867218)x3	CLCN6|MTHFR	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	11850846 - 11867218			221409	223138
NM_014874.3(MFN2):c.1143_1145delGGC (p.Ala383del)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B	Uncertain significance(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	1	12062143 - 12062145	1	12002086 - 12002088	446368	439809
NM_001243.4(TNFRSF8):c.271G>T (p.Asp91Tyr)	TNFRSF8	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	12164438	1	12104381	161578	171294
GRCh38/hg38 1p36.21(chr1:13272807-13275727)x1	PRAMEF16	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	12780917 - 13910449	1	13272807 - 13275727	221372	223101
NM_015001.2(SPEN):c.6997_7012del16 (p.Gln2333Hisfs)	SPEN	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	16259732 - 16259747	1	15933237 - 15933252	221330	223059
NM_004431.4(EPHA2):c.2162G>A (p.Arg721Gln)	EPHA2	Cataract 6, age-related cortical|Age-related cortical cataract|Cortical senile cataract	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	16458722	1	16132227	13262	28301
NM_004431.4(EPHA2):c.1171G>C (p.Gly391Arg)	EPHA2	Squamous cell lung carcinoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	1	16464489	1	16137994	376146	363025
NM_004431.4(EPHA2):c.1171G>A (p.Gly391Arg)	EPHA2	Cataract 6, multiple types|Squamous cell lung carcinoma|not specified|Age-related cortical cataract	Benign(Last reviewed: May 15, 2017)	criteria provided, multiple submitters, no conflicts	1	16464489	1	16137994	259386	249482
NM_001145277.1(NECAP2):c.462G>T (p.Glu154Asp)	NECAP2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	16775669	1	16449174	161534	171305
GRCh37/hg19 1p36.13(chr1:16782351-17359598)x1	MFAP2|RNU1-4|SDHB|TRE-TTC3-1|TRNAG1|CROCC|MST1L|ATP13A2|NBPF1|NECAP2|LINC01783|TRQ-CTG14-1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	16782351 - 17359598			221373	223102
chr1:16902894-17264939 complex variant	RNU1-4|TRE-TTC3-1|CROCC|MST1L|NBPF1|TRQ-CTG14-1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	16902894 - 17264939			221358	223087
NM_022089.3(ATP13A2):c.237C>G (p.Pro79=)	ATP13A2	not provided	Uncertain significance	no assertion criteria provided	1	17331920	1	17005425	92011	97489
NM_003000.2(SDHB):c.299C>T (p.Ser100Phe)	SDHB	Pheochromocytoma	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	1	17355219	1	17028724	12788	27827
NM_018715.3(RCC2):c.782G>C (p.Cys261Ser)	RCC2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	17747287	1	17420791	219300	220989
chr1:17555508-24706269 complex variant	ALPL|C1QA|C1QB|C1QC|CAPZB|CDA|CDC42|CNR2|DDOST|E2F2|ECE1|EPHA8|EPHB2|FUCA1|GALE|HMGCL|HSPG2|HTR1D|HTR6|ID3|NBL1|PAX7|PLA2G2A|PLA2G5|RAP1GAP|RPL11|TCEA3|ELOA|LUZP1|AKR7A2|ALDH4A1|EIF4G3|ZBTB40|CELA3A|HNRNPR|SRSF10|LYPLA2|AKR7A3|KDM1A|EMC1|OTUD3|UBR4|CELA3B|PADI4|PLA2G2D|PADI1|PLA2G2E|HP1BP3|MRTO4|PADI3|WNT4|RNF186|PQLC2|ARHGEF10L|CAMK2N1|ASAP3|PNRC2|RCC2|PITHD1|KIF17|GRHL3|IL22RA1|PLA2G2F|PINK1|MUL1|ZNF436|TAS1R2|ACTL8|USP48|NBPF3|IGSF21|STPG1|IFFO2|MYOM3|KLHDC7A|VWA5B1|UBXN10|IFNLR1|FAM43B|AKR7L|TMCO4|MDS2|PADI6|PLA2G2C|SH2D5|LDLRAD2|MICOS10|LACTBL1|TEX46|MICOS10-NBL1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	17555508 - 24706269			221359	223088
NM_032409.2(PINK1):c.799C>T (p.Gln267Ter)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	not provided	no assertion provided	1	20971005	1	20644512	183259	181392
GRCh38/hg38 1p36.12(chr1:20810811-20829210)x0	EIF4G3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	21137304 - 21155703	1	20810811 - 20829210	221374	223103
NM_001198801.1(EIF4G3):c.2650G>T (p.Asp884Tyr)	EIF4G3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	21191668	1	20865175	161563	171314
NM_000478.5(ALPL):c.648+1G>A	ALPL	Infantile hypophosphatasia|Hypophosphatasia, perinatal lethal	Pathogenic(Last reviewed: Jan 2, 2017)	criteria provided, single submitter	1	21890710	1	21564217	13678	28717
NM_032236.7(USP48):c.1243A>G (p.Met415Val)	USP48	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	22056254	1	21729761	161781	171317
NM_004442.7(EPHB2):c.835G>T (p.Ala279Ser)	EPHB2	Prostate cancer/brain cancer susceptibility	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	1	23189553	1	22863060	8533	23572
NM_004442.7(EPHB2):c.2035G>A (p.Asp679Asn)	EPHB2	Prostate cancer/brain cancer susceptibility	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	1	23233346	1	22906853	8534	23573
NM_004442.7(EPHB2):c.2167C>T (p.Gln723Ter)	EPHB2	Prostate cancer/brain cancer susceptibility	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	1	23234473	1	22907980	8532	23571
NM_004442.7(EPHB2):c.2359G>A (p.Gly787Arg)	EPHB2	Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	1	23235518	1	22909025	376739	363618
NM_001309193.1(EPHB2):c.3055A>T (p.Lys1019Ter)	EPHB2	Prostate cancer/brain cancer susceptibility	risk factor(Last reviewed: Jun 1, 2006)	no assertion criteria provided	1	23240250	1	22913757	8535	23574
NM_001004434.2(SLC30A2):c.655G>A (p.Ala219Thr)	SLC30A2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	26369117	1	26042626	219312	221001
GRCh38/hg38 1p36.11(chr1:26519018-26520365)x0		Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	26801111 - 26856444	1	26519018 - 26520365	221375	223104
NM_006015.5(ARID1A):c.60_62dup (p.Pro21_Ser22insPro)	ARID1A	not specified|Astrocytoma	Conflicting interpretations of pathogenicity(Last reviewed: Apr 25, 2016)	criteria provided, conflicting interpretations	1	27022954 - 27022956	1	26696463 - 26696465	434329	427762
NM_006015.4(ARID1A):c.1113delG (p.Gln372Serfs)	ARID1A	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Mar 9, 2017)	no assertion criteria provided	1	27024007	1	26697516	225843	227657
NM_006015.5(ARID1A):c.1653C>G (p.Tyr551Ter)	ARID1A	Colorectal cancer	association	no assertion criteria provided	1	27057945	1	26731454	523633	514281
NM_006015.5(ARID1A):c.2732G>T (p.Arg911Met)	ARID1A	Medulloblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	1	27089776	1	26763285	438751	432392
NM_006015.4(ARID1A):c.3679G>T (p.Glu1227Ter)	ARID1A	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Mar 9, 2017)	no assertion criteria provided	1	27099442	1	26772951	225844	227658
NM_006015.5(ARID1A):c.4480C>T (p.Gln1494Ter)	ARID1A	AKT1 Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	1	27101198	1	26774707	523173	513781
NM_006015.4(ARID1A):c.5965C>T (p.Arg1989Ter)	ARID1A	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	1	27106354	1	26779863	225842	227656
NM_006015.5(ARID1A):c.6259G>A (p.Gly2087Arg)	ARID1A	Hepatoblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	1	27106648	1	26780157	438750	432391
NM_052896.4(CSMD2):c.7814G>T (p.Arg2605Leu)	CSMD2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	34037281	1	33571681	161791	171323
NM_156039.3(CSF3R):c.1853C>T (p.Thr618Ile)	CSF3R	Chronic myelogenous leukemia|Acute myeloid leukemia|Early T cell progenitor acute lymphoblastic leukemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	1	36933434	1	36467833	208339	204572
NM_156039.3(CSF3R):c.1843A>G (p.Thr615Ala)	CSF3R	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	1	36933444	1	36467843	376125	363004
NM_012090.5(MACF1):c.1523G>C (p.Arg508Thr)	MACF1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	39751430	1	39285758	161658	171324
NM_012090.5(MACF1):c.6753-2_6754delAGAG	MACF1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	39835700 - 39835703	1	39370028 - 39370031	161659	171325
NM_005373.2(MPL):c.1513A>T (p.Ser505Cys)	MPL	Myeloproliferative Neoplasm	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	1	43814978	1	43349307	376029	362908
NM_005373.2(MPL):c.1514G>A (p.Ser505Asn)	MPL	Essential thrombocythemia|Myelofibrosis|Thrombocytosis, benign familial microcytic|Myeloproliferative Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	1	43814979	1	43349308	14163	29202
NM_005373.2(MPL):c.1543_1544delTGinsAA (p.Trp515Lys)	MPL	Myelofibrosis with myeloid metaplasia, somatic|Myelofibrosis with myeloid metaplasia	Pathogenic(Last reviewed: Nov 15, 2006)	no assertion criteria provided	1	43815008 - 43815009	1	43349337 - 43349338	14165	29204
NM_005373.2(MPL):c.1544G>T (p.Trp515Leu)	MPL	Congenital amegakaryocytic thrombocytopenia|Myelofibrosis with myeloid metaplasia, somatic|Myelofibrosis with myeloid metaplasia|Thrombocythemia 2, somatic|Hematologic neoplasm	Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	1	43815009	1	43349338	14164	29203
NM_201649.3(SLC6A9):c.796G>A (p.Glu266Lys)	SLC6A9	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	44474038	1	44008366	161857	171326
NM_003738.4(PTCH2):c.3357+5C>T	PTCH2	Basal cell carcinoma, somatic	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	1	45288736	1	44823064	6146	21185
NM_001166292.1(PTCH2):c.1172_1173delCT (p.Ser391Terfs)	PTCH2	Gorlin syndrome|Medulloblastoma	Likely pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	1	45295116 - 45295117	1	44829444 - 44829445	6145	21184
NM_001128425.1(MUTYH):c.1241A>G (p.Gln414Arg)	MUTYH	Neoplasm of stomach	Pathogenic(Last reviewed: Sep 2, 2004)	no assertion criteria provided	1	45797174	1	45331502	5299	20338
NM_001128425.1(MUTYH):c.1213C>T (p.Pro405Ser)	MUTYH	Neoplasm of stomach	Pathogenic(Last reviewed: Sep 2, 2004)	no assertion criteria provided	1	45797202	1	45331530	5298	20337
NM_015506.2(MMACHC):c.649G>T (p.Glu217Ter)	MMACHC	not provided	Uncertain significance	no assertion criteria provided	1	45974687	1	45509015	100863	106723
NM_001142548.1(RAD54L):c.188C>A (p.Pro63His)	RAD54L	Adenocarcinoma of the colon	Pathogenic(Last reviewed: Jun 3, 1999)	no assertion criteria provided	1	46715769	1	46250097	6191	21230
NM_001142548.1(RAD54L):c.1331T>A (p.Val444Glu)	RAD54L	Non-Hodgkin lymphoma	Pathogenic(Last reviewed: Jun 3, 1999)	no assertion criteria provided	1	46738430	1	46272758	6192	21231
NM_024603.3(BEND5):c.1210A>G (p.Ile404Val)	BEND5|AGBL4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	49193614	1	48727942	161769	171327
NM_001199080.2(PODN):c.1147G>T (p.Ala383Ser)	PODN	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	53544242	1	53078570	161564	171328
GRCh37/hg19 1p31.3(chr1:61543299-61548462)x7	NFIA	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	61543299 - 61548462			221410	223139
NM_002227.3(JAK1):c.1972G>T (p.Val658Phe)	JAK1	Leukemia, acute, ?X-linked|Lymphoblastic leukemia, acute, with lymphomatous features|Polycythemia vera|Acute myeloid leukemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	1	65312347	1	64846664	376030	362909
NM_002227.3(JAK1):c.1937C>T (p.Ser646Phe)	JAK1	Lymphoblastic leukemia, acute, with lymphomatous features	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	1	65312382	1	64846699	376099	362978
NM_002227.3(JAK1):c.1901C>A (p.Ala634Asp)	JAK1	Lymphoblastic leukemia, acute, with lymphomatous features|Inborn genetic diseases	Likely pathogenic	criteria provided, single submitter	1	65312418	1	64846735	225075	226887
NM_001256865.1(DNAJC6):c.244C>T (p.Arg82Ter)	DNAJC6	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	65831790	1	65366107	219301	220990
GRCh37/hg19 1p31.3(chr1:67327908-67519596)x3	SLC35D1|MIER1|WDR78	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	67327908 - 67519596			221411	223140
NM_003902.4(FUBP1):c.1611G>A (p.Trp537Ter)	FUBP1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	78422351	1	77956666	221322	223051
GRCh37/hg19 1p31.1(chr1:84610138-84650825)x6	PRKACB	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	84610138 - 84650825			221412	223141
GRCh37/hg19 1p31.1-22.3(chr1:84662362-85035719)x3	CTBS|GNG5|PRKACB|DNASE2B|RPF1|SAMD13|SPATA1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	84662362 - 85035719			221413	223142
NM_003921.4(BCL10):c.635_637delAAG (p.Glu212del)	BCL10	Follicular lymphoma|Follicular lymphoma	Pathogenic(Last reviewed: Jan 8, 1999)	no assertion criteria provided	1	85733375 - 85733377	1	85267692 - 85267694	6258	21297
NM_003921.4(BCL10):c.525_541del17 (p.Val176Asnfs)	BCL10	Follicular lymphoma|Follicular lymphoma	Pathogenic(Last reviewed: Jan 8, 1999)	no assertion criteria provided	1	85733471 - 85733487	1	85267788 - 85267804	6255	21294
NM_003921.4(BCL10):c.499_500insT (p.Ser167Phefs)	BCL10	Mesothelioma|Male germ cell tumor, somatic|Mucosa-associated lymphoma	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	1	85733513	1	85267830	6250	21289
NM_003921.5(BCL10):c.488C>T (p.Thr163Met)	BCL10	Malignant tumor of testis	Pathogenic(Last reviewed: Nov 15, 1999)	no assertion criteria provided	1	85733524	1	85267841	30361	39318
NM_003921.4(BCL10):c.428delT (p.Phe143Serfs)	BCL10	Sezary syndrome	Pathogenic(Last reviewed: Jan 8, 1999)	no assertion criteria provided	1	85733584	1	85267901	6260	21299
NM_003921.5(BCL10):c.427_428dup (p.Glu145Leufs)	BCL10	Follicular lymphoma|Follicular lymphoma	Pathogenic(Last reviewed: Jan 8, 1999)	no assertion criteria provided	1	85733584 - 85733585	1	85267901 - 85267902	6253	21292
NM_003921.4(BCL10):c.410delA (p.Asn137Ilefs)	BCL10	Follicular lymphoma|Follicular lymphoma	Pathogenic(Last reviewed: Jan 8, 1999)	no assertion criteria provided	1	85733602	1	85267919	6256	21295
NM_003921.5(BCL10):c.398dup (p.Ser134Leufs)	BCL10	Follicular lymphoma|Follicular lymphoma	Pathogenic(Last reviewed: Jan 8, 1999)	no assertion criteria provided	1	85733614	1	85267931	6257	21296
NM_003921.4(BCL10):c.345delA (p.Gly116Aspfs)	BCL10	Mucosa-associated lymphoma	Pathogenic(Last reviewed: Jan 8, 1999)	no assertion criteria provided	1	85736302	1	85270619	6252	21291
NM_003921.5(BCL10):c.231dup (p.Gly78Argfs)	BCL10	Follicular lymphoma|Follicular lymphoma	Pathogenic(Last reviewed: Jan 8, 1999)	no assertion criteria provided	1	85736416	1	85270733	6254	21293
NM_003921.5(BCL10):c.172C>T (p.Arg58Ter)	BCL10	Male germ cell tumor, somatic	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	1	85736475	1	85270792	6266	21305
NM_003921.4(BCL10):c.172C>G (p.Arg58Gly)	BCL10	Male germ cell tumor, somatic	Pathogenic(Last reviewed: Jan 8, 1999)	no assertion criteria provided	1	85736475	1	85270792	6265	21304
NM_003921.5(BCL10):c.163dup (p.Ile55Asnfs)	BCL10	Mucosa-associated lymphoma	Pathogenic(Last reviewed: Jan 8, 1999)	no assertion criteria provided	1	85736484	1	85270801	6251	21290
NM_003921.4(BCL10):c.136delA (p.Ile46Tyrfs)	BCL10	Mesothelioma	Pathogenic(Last reviewed: Jan 8, 1999)	no assertion criteria provided	1	85736511	1	85270828	6263	21302
NM_003921.4(BCL10):c.136_137insA (p.Ile46Asnfs)	BCL10	T-cell acute lymphoblastic leukemia|Carcinoma of colon|Leukemia, T-cell acute lymphoblastic, somatic	Pathogenic(Last reviewed: Jan 8, 1999)	no assertion criteria provided	1	85736511	1	85270828	6259	21298
NM_152890.6(COL24A1):c.2341C>T (p.Gln781Ter)	COL24A1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	86453307	1	85987624	219313	221002
NM_004120.4(GBP2):c.321T>G (p.Gly107=)	GBP2	not provided	Uncertain significance	no assertion criteria provided	1	89585969	1	89120286	91958	97436
NM_052942.3(GBP5):c.1745C>T (p.Pro582Leu)	GBP5	not provided	Uncertain significance	no assertion criteria provided	1	89726403	1	89260720	92020	97498
NM_003243.4(TGFBR3):c.2519C>T (p.Thr840Met)	TGFBR3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	92149333	1	91683776	161609	171329
NM_002061.3(GCLM):c.748T>G (p.Tyr250Asp)	GCLM	not provided	Uncertain significance	no assertion criteria provided	1	94354623	1	93889067	91938	97416
NM_000110.3(DPYD):c.1340-3C>G	DPYD	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	98015303	1	97549747	161459	171330
NM_001113226.2(NTNG1):c.689C>T (p.Ala230Val)	NTNG1	not provided	Uncertain significance	no assertion criteria provided	1	107867346	1	107324724	91929	97407
GRCh37/hg19 1p13.3(chr1:108115974-108313305)x3	VAV3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	108115974 - 108313305			221414	223143
NM_018061.3(PRPF38B):c.1463G>A (p.Arg488Gln)	PRPF38B	not provided	Uncertain significance	no assertion criteria provided	1	109242464	1	108699842	91998	97476
NM_022768.4(RBM15):c.1912C>A (p.Gln638Lys)	RBM15	Neuroblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	1	110883939	1	110341317	438785	432416
GRCh37/hg19 1p13.2(chr1:113134186-113265713)x3	RHOC|CAPZA1|MOV10|ST7L|TAFA3|PPM1J	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	113134186 - 113265713			221415	223144
NM_006594.4(AP4B1):c.165G>A (p.Lys55=)	AP4B1	not provided	Uncertain significance	no assertion criteria provided	1	114445433	1	113902811	100855	106715
NM_020190.4(OLFML3):c.402C>G (p.Asp134Glu)	OLFML3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	114523572	1	113980950	161730	171291
NM_001270805.1(SYT6):c.1216G>A (p.Ala406Thr)	SYT6	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	114640393	1	114097771	221298	223027
NM_002524.4(NRAS):c.182_183delAAinsGG (p.Gln61Arg)	NRAS	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	1	115256528 - 115256529	1	114713907 - 114713908	375873	362752
NM_002524.4(NRAS):c.182_183delAAinsTG (p.Gln61Leu)	NRAS	Cutaneous melanoma	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	1	115256528 - 115256529	1	114713907 - 114713908	375872	362751
NM_002524.4(NRAS):c.183A>C (p.Gln61His)	NRAS	Non-small cell lung cancer|Acute myeloid leukemia|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	1	115256528	1	114713907	375871	362750
NM_002524.4(NRAS):c.183A>T (p.Gln61His)	NRAS	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of brain|Cutaneous melanoma|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland|Nasopharyngeal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Jul 30, 2016)	criteria provided, single submitter	1	115256528	1	114713907	373003	359197
NM_002524.4(NRAS):c.181_182delCAinsAG (p.Gln61Arg)	NRAS	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	1	115256529 - 115256530	1	114713908 - 114713909	376220	363099
NM_002524.4(NRAS):c.182A>T (p.Gln61Leu)	NRAS	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Non-small cell lung cancer|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Cutaneous melanoma|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland|Nasopharyngeal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	1	115256529	1	114713908	375874	362753
NM_002524.4(NRAS):c.182A>C (p.Gln61Pro)	NRAS	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Non-small cell lung cancer|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of brain|Cutaneous melanoma|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland|Nasopharyngeal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	1	115256529	1	114713908	280409	263939
NM_002524.4(NRAS):c.182A>G (p.Gln61Arg)	NRAS	Congenital giant melanocytic nevus|Liver cancer|Chronic lymphocytic leukemia|Neurocutaneous melanosis|Malignant melanoma of skin|Multiple myeloma|Epidermal nevus syndrome|Epidermal nevus|Follicular thyroid carcinoma|Lung adenocarcinoma|Non-small cell lung cancer|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of brain|Cutaneous melanoma|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Nasopharyngeal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: May 4, 2015)	criteria provided, multiple submitters, no conflicts	1	115256529	1	114713908	13900	28939
NM_002524.4(NRAS):c.181C>T (p.Gln61Ter)	NRAS	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	1	115256530	1	114713909	376027	362906
NM_002524.4(NRAS):c.181C>G (p.Gln61Glu)	NRAS	Cutaneous melanoma	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	1	115256530	1	114713909	375875	362754
NM_002524.4(NRAS):c.181C>A (p.Gln61Lys)	NRAS	Congenital giant melanocytic nevus|Liver cancer|Chronic lymphocytic leukemia|Neurocutaneous melanosis|Malignant melanoma of skin|Multiple myeloma|Neuroblastoma|Lung adenocarcinoma|Non-small cell lung cancer|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Rasopathy|Neoplasm of brain|Cutaneous melanoma|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Nasopharyngeal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|RAS Inhibitor response|Vascular Tumors Including Pyogenic Granuloma	Uncertain significance(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	1	115256530	1	114713909	73058	83949
NM_002524.4(NRAS):c.101C>T (p.Pro34Leu)	NRAS	Noonan syndrome 1|Epidermal nevus	Pathogenic(Last reviewed: Feb 25, 2016)	no assertion criteria provided	1	115258681	1	114716060	39647	48246
NM_002524.4(NRAS):c.52G>A (p.Ala18Thr)	NRAS	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	1	115258730	1	114716109	376028	362907
NM_002524.4(NRAS):c.38G>C (p.Gly13Ala)	NRAS	Cutaneous melanoma	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	1	115258744	1	114716123	375877	362756
NM_002524.4(NRAS):c.38G>T (p.Gly13Val)	NRAS	Non-Hodgkin lymphoma|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Acute myeloid leukemia|Myelodysplastic syndrome|Cutaneous melanoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Neoplasm|Colorectal Neoplasms|Adenocarcinoma of stomach	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	1	115258744	1	114716123	375876	362755
NM_002524.4(NRAS):c.38G>A (p.Gly13Asp)	NRAS	Non-Hodgkin lymphoma|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Juvenile myelomonocytic leukemia|Noonan syndrome 6|RAS-associated autoimmune leukoproliferative disorder|Acute myeloid leukemia|Myelodysplastic syndrome|not provided|Cutaneous melanoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach	Pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	1	115258744	1	114716123	13901	28940
NM_002524.4(NRAS):c.37G>A (p.Gly13Ser)	NRAS	Neoplasm of stomach	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	1	115258745	1	114716124	376221	363100
NM_002524.4(NRAS):c.37G>T (p.Gly13Cys)	NRAS	Cutaneous melanoma	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	1	115258745	1	114716124	40471	48941
NM_002524.4(NRAS):c.37G>C (p.Gly13Arg)	NRAS	Congenital giant melanocytic nevus|Non-Hodgkin lymphoma|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Carcinoma of colon|Acute myeloid leukemia|Myelodysplastic syndrome|Cutaneous melanoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	1	115258745	1	114716124	13899	28938
NM_002524.4(NRAS):c.35G>C (p.Gly12Ala)	NRAS	Malignant melanoma of skin|Multiple myeloma|Non-small cell lung cancer|Acute myeloid leukemia|Myelodysplastic syndrome|not provided|Cutaneous melanoma|Neoplasm of the large intestine|Myelodysplastic syndrome progressed to acute myeloid leukemia|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, multiple submitters, no conflicts	1	115258747	1	114716126	219097	216786
NM_002524.4(NRAS):c.35G>T (p.Gly12Val)	NRAS	Malignant melanoma of skin|Multiple myeloma|Acute myeloid leukemia|Noonan syndrome|Myelodysplastic syndrome|not provided|Cutaneous melanoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Jan 24, 2012)	criteria provided, multiple submitters, no conflicts	1	115258747	1	114716126	40470	48940
NM_002524.4(NRAS):c.35G>A (p.Gly12Asp)	NRAS	Malignant melanoma of skin|Multiple myeloma|Juvenile myelomonocytic leukemia|Epidermal nevus|Non-small cell lung cancer|Acute myeloid leukemia|Myelodysplastic syndrome|not provided|Cutaneous melanoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	1	115258747	1	114716126	39648	48247
NM_002524.4(NRAS):c.34G>A (p.Gly12Ser)	NRAS	Malignant melanoma of skin|Multiple myeloma|Non-small cell lung cancer|Acute myeloid leukemia|Myelodysplastic syndrome|not provided|Rasopathy|Cutaneous melanoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	1	115258748	1	114716127	177778	172332
NM_002524.4(NRAS):c.34G>C (p.Gly12Arg)	NRAS	Chronic myelogenous leukemia|Malignant melanoma of skin|Multiple myeloma|Non-small cell lung cancer|Acute myeloid leukemia|Myelodysplastic syndrome|not provided|Cutaneous melanoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	1	115258748	1	114716127	40469	48939
NM_002524.4(NRAS):c.34G>T (p.Gly12Cys)	NRAS	Malignant melanoma of skin|Multiple myeloma|Non-small cell lung cancer|Acute myeloid leukemia|Myelodysplastic syndrome|not provided|Cutaneous melanoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Jun 2, 2012)	criteria provided, single submitter	1	115258748	1	114716127	40468	48938
NM_000701.7(ATP1A1):c.299_313delTCTCAATGTTACTGT (p.Phe100_Leu104del)	ATP1A1	Aldosterone Producing Adrenal Cortex Adenoma	Pathogenic(Last reviewed: Feb 17, 2013)	no assertion criteria provided	1	116930025 - 116930039	1	116387403 - 116387417	162465	172139
NM_000701.7(ATP1A1):c.311T>G (p.Leu104Arg)	ATP1A1	Aldosterone Producing Adrenal Cortex Adenoma	Pathogenic(Last reviewed: Feb 17, 2013)	no assertion criteria provided	1	116930037	1	116387415	162466	172140
NM_001160233.1(ATP1A1):c.464C>T (p.Ser155Leu)	ATP1A1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	116930829	1	116388207	161540	171292
NM_000701.7(ATP1A1):c.995T>G (p.Val332Gly)	ATP1A1	Aldosterone Producing Adrenal Cortex Adenoma	Pathogenic(Last reviewed: Feb 17, 2013)	no assertion criteria provided	1	116932301	1	116389679	162468	172141
NM_001767.4(CD2):c.974G>C (p.Gly325Ala)	CD2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	117311323	1	116768701	219311	221000
NM_001166120.1(HSD3B2):c.1004G>A (p.Arg335Gln)	HSD3B2	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	1	119965128	1	119422505	487802	480809
NM_024408.3(NOTCH2):c.6909dupC (p.Ile2304Hisfs)	NOTCH2	Hajdu-Cheney syndrome|Monoclonal B-Cell Lymphocytosis	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	1	120458436	1	119915813	223003	224678
GRCh37/hg19 1q21.1(chr1:145438928-145527669)x3	ITGA10|PEX11B|RBM8A|TXNIP|POLR3GL|LIX1L|ANKRD34A	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	145438928 - 145527669			221416	223145
NM_005266.6(GJA5):c.262C>T (p.Pro88Ser)	GJA5	Atrial fibrillation, somatic	Pathogenic(Last reviewed: Jun 22, 2006)	no assertion criteria provided	1	147231085	1	147758977	16999	32038
GRCh37/hg19 1q21.2(chr1:149783688-150049029)x3	HIST2H2AA3|HIST2H2AC|HIST2H2BE|HIST2H4A|SV2A|SF3B4|MTMR11|VPS45|BOLA1|OTUD7B|HIST2H3C|HIST2H2AB|HIST2H3A|HIST2H2BF|HIST2H4B|HIST2H3D|HIST2H2AA4	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	149783688 - 150049029			221417	223146
GRCh37/hg19 1q21.3(chr1:150531540-150679158)x3	ENSA|MCL1|ADAMTSL4|GOLPH3L|HORMAD1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	150531540 - 150679158			221418	223147
NM_005060.3(RORC):c.422C>T (p.Ala141Val)	RORC	not provided	Uncertain significance	no assertion criteria provided	1	151787778	1	151815302	91961	97439
NM_001025231.1(KPRP):c.743G>A (p.Arg248His)	KPRP	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	152732807	1	152760331	161497	171295
NM_001025231.1(KPRP):c.825T>A (p.Phe275Leu)	KPRP	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	152732889	1	152760413	161498	171296
GRCh37/hg19 1q21.3(chr1:153412418-153604246)x3	S100A1|S100A2|S100A3|S100A4|S100A5|S100A6|S100A7|S100A13|S100A14|S100A16|LOC101928034	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	153412418 - 153604246			221419	223148
NM_002960.1(S100A3):c.25G>T (p.Val9Leu)	S100A3|LOC101928034	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	153520937	1	153548461	161603	171297
GRCh37/hg19 1q21.3(chr1:153742283-153752391)x3	SLC27A3|INTS3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	153742283 - 153752391			221420	223149
NM_023015.4(INTS3):c.1700T>C (p.Ile567Thr)	INTS3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	153735772	1	153763296	161766	171298
Single allele	ADAR|BGLAP|CHRNB2|CKS1B|CLK2|CRABP2|EFNA1|EFNA3|EFNA4|FDPS|GBA|HDGF|IL6R|INSRR|KCNN3|LMNA|MEF2D|MTX1|MUC1|NTRK1|PKLR|PRCC|RIT1|SHC1|SSR2|THBS3|TPM3|CCT3|DAP3|ADAM15|SH2D2A|ARHGEF2|SLC25A44|UBAP2L|SCAMP3|HAX1|C1orf61|PMVK|FAM189B|NES|PMF1|KHDC4|SYT11|SMG5|RUSC1|C1orf43|LAMTOR2|ZBTB7B|RRNAD1|DPM3|GON4L|GPATCH4|MSTO1|YY1AP1|UBE2Q1|ASH1L|LENEP|SLC50A1|UBQLN4|RAB25|RHBG|ATP8B2|PBXIP1|HCN3|HAPLN2|BCAN|SEMA4A|MRPL24|PAQR6|TRIM46|FLAD1|ISG20L2|TMEM79|AQP10|PYGO2|MEX3A|GLMP|TDRD10|SHE|DCST2|TSACC|IQGAP3|NAXE|DCST1|TTC24|KRTCAP2|RUSC1-AS1|RXFP4|C1orf189|VHLL|MIR9-1|PMF1-BGLAP	Pediatric metastatic thyroid tumour	Likely pathogenic(Last reviewed: Jan 19, 2018)	no assertion criteria provided	1	154130985 - 156843877			495229	486726
NM_152263.3(TPM3):c.466G>A (p.Ala156Thr)	TPM3	not provided	not provided	no assertion provided	1	154145589	1	154173113	140498	150176
NM_002249.5(KCNN3):c.1448+1G>T	KCNN3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	154744450	1	154771974	161592	171299
NM_207197.2(ADAM15):c.2307C>T (p.Pro769=)	ADAM15|DCST1-AS1	not provided	Uncertain significance	no assertion criteria provided	1	155033920	1	155061444	100897	106757
NM_007112.4(THBS3):c.1440G>T (p.Gln480His)	THBS3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	155170885	1	155201094	161656	171300
NM_001282856.1(GON4L):c.2455A>G (p.Asn819Asp)	GON4L	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	1	155742897	1	155773106	487779	480786
LMNA-NTRK1 fusion	BGLAP|CRABP2|HDGF|INSRR|LMNA|MEF2D|NTRK1|PRCC|CCT3|SH2D2A|SLC25A44|C1orf61|NES|PMF1|SMG5|RRNAD1|GPATCH4|RHBG|HAPLN2|BCAN|SEMA4A|MRPL24|PAQR6|ISG20L2|TMEM79|GLMP|TSACC|IQGAP3|NAXE|TTC24|VHLL|MIR9-1|PMF1-BGLAP	Infantile Fibrosarcoma	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	1	156100565 - 156844697			617477	608839
NM_199173.5(BGLAP):c.*304G>A	BGLAP|PAQR6	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	1	156213257	1	156243466	126864	132377
NM_005973.4(PRCC):c.908C>T (p.Pro303Leu)	PRCC	YOLK SAC TUMOR AND HIGH-GRADE IMMATURE TERATOMA	other(Last reviewed: May 1, 2016)	no assertion criteria provided	1	156756791	1	156786999	438783	432414
NM_001004476.1(OR10K2):c.157A>G (p.Arg53Gly)	OR10K2	not provided	Uncertain significance	no assertion criteria provided	1	158390500	1	158420710	91921	97399
NM_001005279.2(OR6K2):c.947G>T (p.Arg316Ile)	OR6K2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	158669496	1	158699706	161485	171301
NM_198930.3(PYHIN1):c.575G>A (p.Arg192His)	PYHIN1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	158911789	1	158941999	161854	171302
NM_021189.4(CADM3):c.484G>C (p.Gly162Arg)	CADM3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	159162520	1	159192730	161748	171303
GRCh37/hg19 1q23.2(chr1:160111098-160183245)x3	ATP1A2|ATP1A4|CASQ1|PEA15	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	160111098 - 160183245			221376	223105
NM_001166664.1(CD244):c.695G>A (p.Arg232Lys)	CD244	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	160802355	1	160832565	161545	171304
NM_001014796.2(DDR2):c.187C>G (p.Leu63Val)	DDR2	Non-small cell lung cancer|Squamous cell lung carcinoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	1	162724415	1	162754625	376140	363019
NM_001014796.2(DDR2):c.716T>G (p.Leu239Arg)	DDR2	Squamous cell lung carcinoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	1	162729630	1	162759840	376141	363020
NM_001014796.2(DDR2):c.757G>T (p.Gly253Cys)	DDR2	Non-small cell lung cancer|Squamous cell lung carcinoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	1	162729671	1	162759881	376142	363021
NM_001014796.2(DDR2):c.1513G>A (p.Gly505Ser)	DDR2	Non-small cell lung cancer|Squamous cell lung carcinoma|not specified	Benign(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	1	162741822	1	162772032	282994	267231
NM_001014796.2(DDR2):c.1912A>T (p.Ile638Phe)	DDR2	Non-small cell lung cancer|Squamous cell lung carcinoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	1	162745497	1	162775707	376143	363022
NM_001014796.2(DDR2):c.2304T>A (p.Ser768Arg)	DDR2	Non-small cell lung cancer|Squamous cell carcinoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	1	162748390	1	162778600	375878	362757
NM_001014796.2(DDR2):c.2321G>T (p.Gly774Val)	DDR2	Non-small cell lung cancer|Squamous cell lung carcinoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	1	162748407	1	162778617	376144	363023
NM_000696.3(ALDH9A1):c.265T>C (p.Trp89Arg)	ALDH9A1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	165664551	1	165695314	219314	221003
NM_198053.2(CD247):c.208_210delCAGinsTAT (p.Gln70Tyr)	CD247	Immunodeficiency due to defect in cd3-zeta	Pathogenic(Last reviewed: May 4, 2006)	no assertion criteria provided	1	167408590 - 167408592	1	167439353 - 167439355	12752	27791
NM_198053.2(CD247):c.209A>T (p.Gln70Leu)	CD247	Immunodeficiency due to defect in cd3-zeta	Pathogenic(Last reviewed: May 4, 2006)	no assertion criteria provided	1	167408591	1	167439354	12751	27790
NM_198053.2(CD247):c.208_209delCAinsTG (p.Gln70Trp)	CD247	Immunodeficiency due to defect in cd3-zeta	Pathogenic(Last reviewed: May 4, 2006)	no assertion criteria provided	1	167408591 - 167408592	1	167439354 - 167439355	12750	27789
NM_000130.4(F5):c.2127G>A (p.Met709Ile)	F5	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	169512201	1	169542963	161460	171306
NM_152281.2(GORAB):c.1029G>C (p.Val343=)	GORAB	not provided	Uncertain significance	no assertion criteria provided	1	170521447	1	170552306	100891	106751
NM_152281.2(GORAB):c.1166C>G (p.Ser389Ter)	GORAB	not provided	Uncertain significance	no assertion criteria provided	1	170521584	1	170552443	92030	97508
NM_014458.3(KLHL20):c.254delT (p.Leu86Cysfs)	KLHL20	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	173703082	1	173733943	161677	171307
NM_004841.3(RASAL2):c.3397G>T (p.Glu1133Ter)	RASAL2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	178442351	1	178473216	161625	171308
NM_007314.3(ABL2):c.2085A>G (p.Leu695=)	ABL2	not provided	Uncertain significance	no assertion criteria provided	1	179078317	1	179109182	91974	97452
NM_014625.3(NPHS2):c.451+58A>T	NPHS2	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	1	179530366	1	179561231	236184	237711
NM_014625.3(NPHS2):c.451+23C>T	NPHS2	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	1	179530401	1	179561266	236185	237712
NM_014625.3(NPHS2):c.378+42T>G	NPHS2	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	1	179533783	1	179564648	236186	237713
NM_014625.3(NPHS2):c.275-56T>G	NPHS2	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	1	179533984	1	179564849	236187	237714
NM_014625.3(NPHS2):c.104G>A (p.Gly35Asp)	NPHS2	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	1	179544896	1	179575761	236188	237715
NM_014625.3(NPHS2):c.-79G>A	NPHS2	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	1	179545078	1	179575943	236189	237716
NM_173533.4(TDRD5):c.527T>C (p.Phe176Ser)	TDRD5	not provided	Uncertain significance	no assertion criteria provided	1	179562889	1	179593754	92035	97513
NM_030933.3(SHCBP1L):c.881C>A (p.Thr294Lys)	SHCBP1L	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	182908506	1	182939371	161777	171309
NM_002293.3(LAMC1):c.814T>C (p.Ser272Pro)	LAMC1	not provided	Uncertain significance	no assertion criteria provided	1	183077501	1	183108366	100838	106698
NM_052966.3(FAM129A):c.2201C>T (p.Thr734Met)	FAM129A	not provided	Uncertain significance	no assertion criteria provided	1	184764697	1	184795563	92021	97499
NM_031935.2(HMCN1):c.4673C>A (p.Ser1558Ter)	HMCN1	not provided	Uncertain significance	no assertion criteria provided	1	185984333	1	186015201	100880	106740
NM_031935.2(HMCN1):c.6295C>T (p.Arg2099Ter)	HMCN1	not provided	Uncertain significance	no assertion criteria provided	1	186010259	1	186041127	100881	106741
NM_031935.2(HMCN1):c.16792C>T (p.Arg5598Ter)	HMCN1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	186158894	1	186189762	161780	171310
NM_024529.4(CDC73):c.8_10delACGinsCT (p.Asp3Alafs)	CDC73	Ossifying fibroma of the jaw	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	1	193091338 - 193091340	1	193122208 - 193122210	252999	247400
NM_024529.4(CDC73):c.13_16delCTTA (p.Leu5Alafs)	CDC73	Ossifying fibroma of the jaw	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	1	193091343 - 193091346	1	193122213 - 193122216	252998	247401
NM_024529.4(CDC73):c.13_30del18 (p.Leu5_Gln10del)	CDC73	Parathyroid carcinoma	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	1	193091343 - 193091360	1	193122213 - 193122230	3281	18320
NM_024529.4(CDC73):c.53delT (p.Ile18Metfs)	CDC73	Cystic parathyroid adenoma	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	1	193091383	1	193122253	3273	18312
NM_024529.4(CDC73):c.85delG (p.Glu29Serfs)	CDC73	Parathyroid carcinoma	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	1	193091415	1	193122285	3280	18319
NM_024529.4(CDC73):c.128G>A (p.Trp43Ter)	CDC73	Parathyroid carcinoma	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	1	193091458	1	193122328	3271	18310
NM_024529.4(CDC73):c.131+1G>A	CDC73	Hyperparathyroidism 1|Parathyroid adenoma, somatic|not provided	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	1	193091462	1	193122332	3276	18315
NM_024529.4(CDC73):c.162C>G (p.Tyr54Ter)	CDC73	Parathyroid carcinoma	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	1	193094272	1	193125142	3274	18313
GRCh38/hg38 1q31.3(chr1:196608263-197002575)x1	CFH|CFHR1|CFHR2|CFHR4|CFHR3|CFHR5|KCNT2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	196577392 - 196971704	1	196608263 - 197002575	221377	223106
NM_000299.3(PKP1):c.1199C>T (p.Pro400Leu)	PKP1	not provided	Conflicting interpretations of pathogenicity	no assertion criteria provided	1	201287890	1	201318762	100807	106667
NM_000364.3(TNNT2):c.245C>A (p.Pro82His)	TNNT2	not provided	Uncertain significance	no assertion criteria provided	1	201334787	1	201365659	91910	97388
NM_138391.5(TMEM183A):c.708+1G>A	TMEM183A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	202985269	1	203016141	161802	171311
NM_001001396.2(ATP2B4):c.999C>A (p.Asp333Glu)	ATP2B4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	203672841	1	203703713	161476	171312
NM_001910.3(CTSE):c.319G>A (p.Val107Met)	CTSE	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	206319194	1	206022174	161586	171313
NM_000228.2(LAMB3):c.629-1G>A	LAMB3	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	1	209806122	1	209632777	14553	29592
NM_000228.2(LAMB3):c.628+42G>A	LAMB3	Junctional epidermolysis bullosa gravis of Herlitz|Adult junctional epidermolysis bullosa	Likely benign(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	1	209806373	1	209633028	14549	29588
NM_000228.2(LAMB3):c.619A>C (p.Lys207Gln)	LAMB3	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	1	209806424	1	209633079	14552	29591
NM_000228.2(LAMB3):c.596G>C (p.Gly199Ala)	LAMB3	Junctional epidermolysis bullosa gravis of Herlitz|Adult junctional epidermolysis bullosa	Uncertain significance(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	1	209806447	1	209633102	14550	29589
NM_000228.2(LAMB3):c.565-3T>C	LAMB3	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	1	209806481	1	209633136	14551	29590
NM_012424.5(RPS6KC1):c.3163T>C (p.Phe1055Leu)	RPS6KC1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	213445939	1	213272596	161662	171315
GRCh37/hg19 1q41(chr1:215747156-215751043)x5	KCTD3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	215747156 - 215751043			221421	223150
NM_206933.2(USH2A):c.5837G>T (p.Arg1946Leu)	USH2A|LOC102723833	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	216246251	1	216072909	161858	171316
NM_002107.4(H3F3A):c.83A>T (p.Lys28Met)	H3F3A	Astrocytoma|Brainstem glioma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	1	226252135	1	226064434	376435	363314
NM_002107.4(H3F3A):c.100G>C (p.Gly34Arg)	H3F3A	Neoplasm of brain|Glioblastoma|Brainstem glioma|Adrenocortical carcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	1	226252152	1	226064451	376434	363313
NM_002107.4(H3F3A):c.103G>A (p.Gly35Arg)	H3F3A	Glioblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	1	226252155	1	226064454	438766	432404
GRCh38/hg38 1q42.13(chr1:228148416-228372055)x1	GUK1|GJC2|OBSCN|IBA57|OBSCN-AS1|IBA57-DT	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	228336115 - 228559754	1	228148416 - 228372055	221378	223107
Single allele	OBSCN|IBA57	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	228353651 - 228547901			221335	223064
NM_018230.2(NUP133):c.3432G>C (p.Leu1144Phe)	NUP133	not provided	Uncertain significance	no assertion criteria provided	1	229577690	1	229441943	100870	106730
NM_014777.3(URB2):c.1372C>G (p.Gln458Glu)	URB2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	229771732	1	229635985	161685	171318
NM_014236.3(GNPAT):c.1935G>C (p.Lys645Asn)	GNPAT	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	231411242	1	231275496	161670	171319
NM_145861.2(EDARADD):c.587G>A (p.Arg196His)	EDARADD	not provided	Uncertain significance	no assertion criteria provided	1	236645888	1	236482588	100890	106750
NM_021186.4(ZP4):c.214G>A (p.Asp72Asn)	ZP4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	238053438	1	237890138	161747	171320
NM_181690.2(AKT3):c.49G>A (p.Glu17Lys)	AKT3	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	Pathogenic(Last reviewed: Jun 24, 2012)	no assertion criteria provided	1	243859016	1	243695714	39816	48415
NM_018012.4(KIF26B):c.5146_5167del22 (p.Thr1716Profs)	KIF26B	not provided	Pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	1	245851431 - 245851452	1	245688129 - 245688150	217290	213936
NM_001001966.1(OR14A16):c.341C>T (p.Thr114Met)	OR14A16	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	247978691	1	247815389	161477	171321
NM_030904.1(OR2T1):c.136G>A (p.Gly46Ser)	OR2T1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	1	248569431	1	248406130	161776	171322
chr1:248525146-248525657 complex variant	OR2T4	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	1	248525146 - 248525657			221360	223089
NM_001039362.1(ATP6V1C2):c.847A>G (p.Lys283Glu)	ATP6V1C2	not provided	Uncertain significance	no assertion criteria provided	2	10917732	2	10777606	91925	97403
NM_002236.4(KCNF1):c.248C>T (p.Pro83Leu)	KCNF1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	11052800	2	10912674	161591	171332
NM_005378.5(MYCN):c.131C>T (p.Pro44Leu)	MYCN|MYCNOS	Medulloblastoma|Neuroblastoma|Glioblastoma|Pancreatic adenocarcinoma|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	16082317	2	15942195	376460	363339
NM_000384.2(APOB):c.5562C>A (p.Asp1854Glu)	APOB	not provided	Uncertain significance	no assertion criteria provided	2	21234178	2	21011306	91911	97389
NM_006277.2(ITSN2):c.4732G>T (p.Ala1578Ser)	ITSN2	not provided	Uncertain significance	no assertion criteria provided	2	24428113	2	24205244	100854	106714
NM_175629.2(DNMT3A):c.2645G>A (p.Arg882His)	DNMT3A	Lung adenocarcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|not provided|Tatton-Brown-rahman syndrome|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2017)	criteria provided, conflicting interpretations	2	25457242	2	25234373	375881	362760
NM_175629.2(DNMT3A):c.2645G>C (p.Arg882Pro)	DNMT3A	Lung adenocarcinoma|Acute myeloid leukemia|Myelodysplastic syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	25457242	2	25234373	375880	362759
NM_175629.2(DNMT3A):c.2645G>T (p.Arg882Leu)	DNMT3A	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	25457242	2	25234373	375879	362758
NM_022552.4(DNMT3A):c.2644C>A (p.Arg882Ser)	DNMT3A	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	25457243	2	25234374	375884	362763
NM_022552.4(DNMT3A):c.2644C>G (p.Arg882Gly)	DNMT3A	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	25457243	2	25234374	375883	362762
NM_153759.3(DNMT3A):c.2077C>T (p.Arg693Cys)	DNMT3A	Lung adenocarcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Tatton-Brown-rahman syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2018)	no assertion criteria provided	2	25457243	2	25234374	375882	362761
NM_175629.2(DNMT3A):c.1204C>T (p.Gln402Ter)	DNMT3A	Early T cell progenitor acute lymphoblastic leukemia	Pathogenic	no assertion criteria provided	2	25469564	2	25246695	208338	204573
NM_007046.3(EMILIN1):c.197G>A (p.Arg66Gln)	EMILIN1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	27303045	2	27080177	219343	221032
NM_001486.3(GCKR):c.1368C>T (p.Ile456=)	GCKR	not provided	Uncertain significance	no assertion criteria provided	2	27731064	2	27508197	91935	97413
NM_199193.2(BABAM2):c.626A>G (p.Asp209Gly)	BABAM2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	28352193	2	28129326	161855	171344
NM_153021.4(PLB1):c.3195+7C>A	PLB1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	28836970	2	28614103	161820	171345
NM_004304.4(ALK):c.3833A>C (p.Tyr1278Ser)	ALK	Neuroblastoma|Neuroblastoma 3	Pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	2	29432655	2	29209789	217858	214506
NM_004304.4(ALK):c.3824G>T (p.Arg1275Leu)	ALK	Neuroblastoma|Neoplasm of the breast	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	29432664	2	29209798	376365	363244
NM_004304.4(ALK):c.3824G>A (p.Arg1275Gln)	ALK	Neuroblastoma|Neuroblastoma 3|Neoplasm of brain|Neoplasm of the breast	Pathogenic/Likely pathogenic, risk factor(Last reviewed: May 31, 2016)	no assertion criteria provided	2	29432664	2	29209798	18083	33122
NM_004304.4(ALK):c.3806G>C (p.Gly1269Ala)	ALK	Lung adenocarcinoma|Non-small cell lung cancer	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	2	29432682	2	29209816	376132	363011
NM_004304.4(ALK):c.3749T>C (p.Ile1250Thr)	ALK	Neuroblastoma|Neuroblastoma 3	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	2	29432739	2	29209873	21867	34719
NM_004304.4(ALK):c.3735C>G (p.Phe1245Leu)	ALK	Neuroblastoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	29436858	2	29213992	375885	362764
NM_004304.4(ALK):c.3735C>A (p.Phe1245Leu)	ALK	Neuroblastoma 3	Pathogenic(Last reviewed: Oct 7, 2015)	no assertion criteria provided	2	29436858	2	29213992	217857	214507
NM_004304.4(ALK):c.3734T>G (p.Phe1245Cys)	ALK	Neuroblastoma|Neuroblastoma 3	Pathogenic(Last reviewed: Oct 7, 2015)	no assertion criteria provided	2	29436859	2	29213993	217856	214508
NM_004304.4(ALK):c.3733T>C (p.Phe1245Leu)	ALK	Neuroblastoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	2	29436860	2	29213994	376712	363591
NM_004304.4(ALK):c.3733T>A (p.Phe1245Ile)	ALK	Neuroblastoma|Neuroblastoma 3	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	2	29436860	2	29213994	217855	214509
NM_004304.4(ALK):c.3733T>G (p.Phe1245Val)	ALK	Neuroblastoma|Neuroblastoma 3	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	29436860	2	29213994	65671	76579
NM_004304.4(ALK):c.3718T>G (p.Leu1240Val)	ALK	Neuroblastoma 3	Likely pathogenic(Last reviewed: Nov 3, 2015)	no assertion criteria provided	2	29436875	2	29214009	217854	214510
NM_004304.4(ALK):c.3673G>A (p.Asp1225Asn)	ALK	Rhabdomyosarcoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	29436920	2	29214054	375886	362765
NM_004304.4(ALK):c.3617C>A (p.Ser1206Tyr)	ALK	Lung adenocarcinoma|Non-small cell lung cancer	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	2	29443600	2	29220734	376133	363012
NM_004304.4(ALK):c.3604G>A (p.Gly1202Arg)	ALK	Lung adenocarcinoma|Non-small cell lung cancer	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	2	29443613	2	29220747	376134	363013
NM_004304.4(ALK):c.3586C>A (p.Leu1196Met)	ALK	Lung adenocarcinoma|Non-small cell lung cancer	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	2	29443631	2	29220765	376135	363014
NM_004304.4(ALK):c.3575G>C (p.Arg1192Pro)	ALK	Neuroblastoma|Neuroblastoma 3|Neoplasm of brain	Pathogenic/Likely pathogenic, risk factor(Last reviewed: May 13, 2016)	no assertion criteria provided	2	29443642	2	29220776	18085	33124
NM_004304.4(ALK):c.3522C>G (p.Phe1174Leu)	ALK	Neuroblastoma|Lung adenocarcinoma|Neuroblastoma 3	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	29443695	2	29220829	217852	214512
NM_004304.4(ALK):c.3522C>A (p.Phe1174Leu)	ALK	Neuroblastoma|Lung adenocarcinoma|Neuroblastoma 3|Non-small cell lung cancer|Benign Soft Tissue Neoplasm of Uncertain Differentiation	Pathogenic/Likely pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	2	29443695	2	29220829	217851	214513
NM_004304.4(ALK):c.3521T>G (p.Phe1174Cys)	ALK	Neuroblastoma	Pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	29443696	2	29220830	375887	362766
NM_004304.4(ALK):c.3520T>A (p.Phe1174Ile)	ALK	Neuroblastoma|Neuroblastoma 3	Pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	2	29443697	2	29220831	217850	214515
NM_004304.4(ALK):c.3520T>C (p.Phe1174Leu)	ALK	Neuroblastoma|Neuroblastoma 3	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	2	29443697	2	29220831	217849	214514
NM_004304.4(ALK):c.3520T>G (p.Phe1174Val)	ALK	Neuroblastoma|Neuroblastoma 3	Pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	29443697	2	29220831	65670	76578
NM_004304.4(ALK):c.3512T>C (p.Ile1171Thr)	ALK	Neuroblastoma	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	2	29445213	2	29222347	545115	535377
NM_004304.4(ALK):c.3512T>A (p.Ile1171Asn)	ALK	Neuroblastoma	Pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	2	29445213	2	29222347	375888	362767
NM_004304.4(ALK):c.3497T>G (p.Met1166Arg)	ALK	Neuroblastoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	2	29445228	2	29222362	376713	363592
NM_004304.4(ALK):c.3467G>A (p.Cys1156Tyr)	ALK	Non-small cell lung cancer	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	2	29445258	2	29222392	376340	363219
NM_004304.4(ALK):c.3455T>G (p.Leu1152Arg)	ALK	Lung adenocarcinoma|Non-small cell lung cancer	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	2	29445270	2	29222404	376136	363015
NM_004304.4(ALK):c.3452C>T (p.Thr1151Met)	ALK	Neuroblastoma|Neuroblastoma 3	Pathogenic, risk factor(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	29445273	2	29222407	18086	33125
NM_004304.4(ALK):c.3383G>C (p.Gly1128Ala)	ALK	Neuroblastoma|Neuroblastoma 3|Neoplasm of brain	Pathogenic/Likely pathogenic, risk factor(Last reviewed: May 13, 2016)	no assertion criteria provided	2	29445450	2	29222584	18084	33123
NM_004304.4(ALK):c.3271G>A (p.Asp1091Asn)	ALK	Neuroblastoma|Neuroblastoma 3|not specified	Uncertain significance(Last reviewed: Aug 28, 2017)	criteria provided, multiple submitters, no conflicts	2	29446296	2	29223430	218628	215257
chr2:29446394..42552694 inversion	ALK|CYP1B1|LTBP1|VIT|EIF2AK2|SRSF7|SLC8A1|SOS1|SPAST|SRD5A2|STRN|XDH|MAP4K3|FEZ2|CEBPZ|CDC42EP3|PRKD3|RASGRP3|QPCT|FAM98A|EML4|EHD3|MEMO1|CRIM1|YPEL5|HEATR5B|NDUFAF7|TTC27|SLC30A6|BIRC6|NLRC4|ATL2|GALNT14|GEMIN6|THUMPD2|LBH|YIPF4|DPY30|DHX57|PKDCC|CAPN13|HNRNPLL|GALM|TMEM178A|RMDN2|LCLAT1|GPATCH11|CDKL4|SULT6B1|C2orf91|CAPN14|MORN2|ARHGEF33|SOS1-IT1	Small cell lung cancer	Pathogenic	no assertion criteria provided	2	29446394 - 42552694			487484	480540
inv(2)(p21p23.2)	ALK|CYP1B1|LTBP1|VIT|EIF2AK2|SRSF7|SLC8A1|SOS1|SPAST|SRD5A2|STRN|XDH|MAP4K3|FEZ2|CEBPZ|CDC42EP3|PRKD3|RASGRP3|QPCT|FAM98A|EML4|EHD3|MEMO1|CRIM1|YPEL5|HEATR5B|NDUFAF7|TTC27|SLC30A6|BIRC6|NLRC4|ATL2|GALNT14|GEMIN6|THUMPD2|LBH|YIPF4|DPY30|DHX57|PKDCC|CAPN13|HNRNPLL|GALM|TMEM178A|RMDN2|LCLAT1|GPATCH11|CDKL4|SULT6B1|C2orf91|CAPN14|MORN2|ARHGEF33|SOS1-IT1	Endometrial carcinoma	Likely pathogenic(Last reviewed: May 7, 2018)	no assertion criteria provided	2	29447680 - 42554394			547174	537660
NM_021209.4(NLRC4):c.512C>T (p.Ser171Phe)	NLRC4	Autoinflammation with infantile enterocolitis	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	2	32476421	2	32251352	374310	361176
NM_053276.3(VIT):c.1031G>T (p.Gly344Val)	VIT	not provided	Uncertain significance	no assertion criteria provided	2	37014392	2	36787249	92022	97500
NM_005760.2(CEBPZ):c.639T>G (p.Tyr213Ter)	CEBPZ	not provided	Uncertain significance	no assertion criteria provided	2	37455697	2	37228554	91969	97447
NM_005633.3(SOS1):c.697A>T (p.Asn233Tyr)	SOS1	Lung adenocarcinoma|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	39281778	2	39054637	376542	363421
NM_003618.3(MAP4K3):c.899T>C (p.Phe300Ser)	MAP4K3	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	2	39552678	2	39325537	487798	480805
NM_000233.3(LHCGR):c.1732G>C (p.Asp578His)	LHCGR|STON1-GTF2A1L	Leydig cell adenoma, somatic, with male-limited precocious puberty	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	2	48915204	2	48688065	14403	29442
GRCh37/hg19 2p16.2(chr2:53995091-54042035)x3	ERLEC1|ASB3|CHAC2|GPR75-ASB3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	53995091 - 54042035			221422	223151
NM_003400.3(XPO1):c.1712A>C (p.Glu571Ala)	XPO1	Chronic lymphocytic leukemia|Neoplasm of the breast|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	61719471	2	61492336	376697	363576
NM_003400.3(XPO1):c.1712A>T (p.Glu571Val)	XPO1	Chronic lymphocytic leukemia|Neoplasm of the breast|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	61719471	2	61492336	376696	363575
NM_003400.3(XPO1):c.1711G>A (p.Glu571Lys)	XPO1	Chronic lymphocytic leukemia|Neoplasm of the breast|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	61719472	2	61492337	376695	363574
NM_152792.2(ASPRV1):c.95C>T (p.Pro32Leu)	ASPRV1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	70188726	2	69961594	161818	171346
GRCh37/hg19 2p13.3(chr2:70043280-70315412)x3	ANXA4|MXD1|PCBP1|SNRNP27|GMCL1|ASPRV1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	70043280 - 70315412			221423	223152
GRCh37/hg19 2p13.2(chr2:71595585-71645751)x3	ZNF638	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	71595585 - 71645751			221424	223153
NM_001615.3(ACTG2):c.806_807delGCinsAA (p.Gly269Glu)	ACTG2	Visceral myopathy	Pathogenic	no assertion criteria provided	2	74143711 - 74143712	2	73916584 - 73916585	156554	166358
NM_013247.4(HTRA2):c.695T>A (p.Leu232Gln)	HTRA2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	74757932	2	74530805	221314	223043
GRCh37/hg19 2p11.2(chr2:85598271-85843453)x3	CAPG|GGCX|MAT2A|VAMP8|USP39|VAMP5|RNF181|ELMOD3|TMEM150A|SH2D6|C2orf68	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	85598271 - 85843453			221379	223108
NM_003896.3(ST3GAL5):c.714T>C (p.Thr238=)	ST3GAL5	not provided	Uncertain significance	no assertion criteria provided	2	86073635	2	85846512	100848	106708
NM_001146688.1(KDM3A):c.2685+6_2685+9delTGTT	KDM3A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	86709231 - 86709234	2	86482108 - 86482111	161538	171347
NM_017849.3(TMEM127):c.208G>A (p.Asp70Asn)	TMEM127	Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	2	96930912	2	96265174	126964	132477
NM_001163524.1(ITPRIPL1):c.1291G>A (p.Ala431Thr)	ITPRIPL1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	96993684	2	96327946	161542	171348
NM_003048.5(SLC9A2):c.2168delC (p.Gln725Serfs)	SLC9A2	Acute megakaryoblastic leukemia|Mediastinal germ cell tumor	Uncertain significance(Last reviewed: Oct 22, 2015)	no assertion criteria provided	2	103324677	2	102708218	218345	215048
GRCh37/hg19 2q12.1-24.3(chr2:104172062-168223828)x1	ACVR1|ACVR2A|BIN1|RND3|BUB1|CACNB4|CCNT2|DARS|DBI|DPP4|EN1|ERCC3|FAP|FHL2|GALNT3|GCG|GLI2|GPD2|GPR17|GPR39|GRB14|GYPC|HNMT|IL1A|IL1B|IL1RN|INHBB|ITGB6|KCNJ3|LCT|LIMS1|LY75|MCM6|MGAT5|MYO7B|NEB|NPHP1|NR4A2|ORC4|POLR2D|POU3F3|PROC|PTPN4|RALB|RANBP2|RBMS1|SCN1A|SCN2A|SCN3A|SCN7A|SCN9A|SCTR|SLC20A1|SULT1C2|TNFAIP6|TSN|PAX8|MALL|CXCR4|NCK2|PKP4|MARCO|DDX18|KYNU|NMI|TGFBRAP1|HS6ST1|CYTIP|GCC2|ZEB2|CD302|TANK|BCL2L11|ACTR3|PSMD14|STAM2|MERTK|TBR1|MAP3K2|EDAR|RABL2A|GALNT5|NXPH2|GPR45|COBLL1|PLA2R1|RAB3GAP1|UBXN4|CLASP1|R3HDM1|PSD4|GCA|EPC2|ARL5A|PTPN18|IL36RN|IL36B|IL37|IL36A|SULT1C4|MMADHC|C2orf27A|TFCP2L1|BAZ2B|ARHGEF4|INSIG2|LRP1B|CCDC93|PLEKHB2|FIGN|RIF1|STEAP3|ACOXL|WDR33|SMPD4|PRPF40A|IWS1|LIMS2|MBD5|ARHGAP15|CFC1|IL36G|RPRM|UGGT1|SLC4A10|ERMN|DPP10|EPB41L5|SLC5A7|IFIH1|ANAPC1|MARCH7|MRPS9|SOWAHC|C2orf49|TMEM185B|SAP130|GTDC1|TTC21B|CSRNP3|MZT2B|MAP3K19|UXS1|SLC35F5|THSD7B|TMEM177|TMEM163|AMMECR1L|ZRANB3|RAB6C|POLR1B|RGPD5|CHCHD5|CCDC115|NIFK|C2orf40|ZC3H8|ST6GAL2|IL1F10|SFT2D3|TMEM87B|TANC1|KCNH7|CCDC74A|CCDC74B|DAPL1|IMP4|LIMS3|TUBA3E|TUBA3D|FMNL2|GALNT13|LYPD1|XIRP2|CNTNAP5|FBLN7|ACMSD|FAM168B|C2orf76|ACVR1C|LYPD6|LYPD6B|CCDC148|TMEM37|TTL|CKAP2L|CBWD2|SEPT10|ARL6IP6|SLC38A11|WDSUB1|UPP2|CCDC138|C1QL2|FOXD4L1|AMER3|NT5DC4|RGPD4|SPOPL|CYP27C1|NCKAP5|GPR148|RBM43|ZC3H6|MIR128-1|C2orf27B|SULT1C3|POTEE|ZNF806|POTEI|CFC1B|RGPD3|POTEJ|MZT2A|RGPD8|POTEF|RGPD6|RNU4ATAC|LIMS4|LY75-CD302	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	2	104172062 - 168223828			523163	513795
NM_021815.4(SLC5A7):c.1175C>T (p.Ala392Val)	SLC5A7	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	108626749	2	108010293	161750	171331
NM_022336.3(EDAR):c.*42G>T	RANBP2|EDAR	not provided|Hypohidrotic Ectodermal Dysplasia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	109513321	2	108896865	155862	165611
NM_022336.3(EDAR):c.1056C>T (p.Cys352=)	RANBP2|EDAR	not specified|not provided|Hypohidrotic Ectodermal Dysplasia, Dominant	Benign(Last reviewed: May 1, 2017)	criteria provided, multiple submitters, no conflicts	2	109513654	2	108897198	155865	165614
NM_022336.3(EDAR):c.1024+44C>T	RANBP2|EDAR	not provided	Uncertain significance	no assertion criteria provided	2	109522720	2	108906264	155864	165613
NM_022336.3(EDAR):c.1024+16delA	RANBP2|EDAR	not specified|not provided	Benign	criteria provided, single submitter	2	109522748	2	108906292	155863	165612
NM_022336.3(EDAR):c.750C>T (p.Ser250=)	RANBP2|EDAR	not specified|not provided|Hypohidrotic Ectodermal Dysplasia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	109526969	2	108910513	155870	165619
NM_022336.3(EDAR):c.731-62T>C	RANBP2|EDAR	not provided	Uncertain significance	no assertion criteria provided	2	109527050	2	108910594	155868	165617
NM_022336.3(EDAR):c.731-99C>T	RANBP2|EDAR	not provided	Uncertain significance	no assertion criteria provided	2	109527087	2	108910631	155869	165618
NM_022336.3(EDAR):c.655+30T>C	RANBP2|EDAR	not provided	Uncertain significance	no assertion criteria provided	2	109527373	2	108910917	155867	165616
NM_022336.3(EDAR):c.207C>T (p.Tyr69=)	RANBP2|EDAR	not provided	not provided	no assertion provided	2	109545803	2	108929347	155866	165615
NM_004336.4(BUB1):c.3069delT (p.His1024Ilefs)	BUB1	Carcinoma of colon	Pathogenic(Last reviewed: Mar 19, 1998)	no assertion criteria provided	2	111395730	2	110638153	6759	21798
NM_000576.2(IL1B):c.99+383G>C	IL1B	Coronary heart disease 2	not provided	no assertion provided	2	113592760	2	112835183	120093	125776
chr2:130949553-130952725 complex variant	TUBA3E	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	130949553 - 130952725			221361	223090
NM_018557.2(LRP1B):c.10187G>C (p.Cys3396Ser)	LRP1B	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	141202006	2	140444437	161719	171333
NM_018557.2(LRP1B):c.6648G>T (p.Glu2216Asp)	LRP1B	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	141457970	2	140700401	161720	171334
NM_018328.4(MBD5):c.904A>G (p.Thr302Ala)	MBD5	not provided	Uncertain significance	no assertion criteria provided	2	149226416	2	148468847	100871	106731
NM_001105.4(ACVR1):c.983G>T (p.Gly328Val)	ACVR1	Brainstem glioma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	158622516	2	157766004	376363	363242
NM_001105.4(ACVR1):c.983G>A (p.Gly328Glu)	ACVR1	Progressive myositis ossificans|Brainstem glioma|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	2	158622516	2	157766004	29595	38549
NM_001105.4(ACVR1):c.773G>T (p.Arg258Met)	ACVR1	Brainstem glioma|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	158626897	2	157770385	376364	363243
NM_001105.4(ACVR1):c.772A>G (p.Arg258Gly)	ACVR1	Progressive myositis ossificans|Brainstem glioma|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: Nov 27, 2012)	criteria provided, single submitter	2	158626898	2	157770386	216885	213526
NM_000888.4(ITGB6):c.1460G>A (p.Gly487Glu)	ITGB6	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	160994145	2	160137634	161475	171335
NM_022168.4(IFIH1):c.816A>C (p.Glu272Asp)	IFIH1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	163150132	2	162293622	161758	171336
NM_024753.4(TTC21B):c.2240A>G (p.Gln747Arg)	TTC21B	not provided	Uncertain significance	no assertion criteria provided	2	166769106	2	165912596	100876	106736
NM_020981.3(B3GALT1):c.539delT (p.Phe181Leufs)	B3GALT1|LOC105616981	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	168726088	2	167869578	161742	171337
GRCh37/hg19 2q31.1(chr2:170009392-170072852)x3	LRP2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	170009392 - 170072852			221425	223154
NM_003705.4(SLC25A12):c.1417C>T (p.Arg473Trp)	SLC25A12	not provided	Uncertain significance	no assertion criteria provided	2	172650166	2	171793656	100846	106706
GRCh37/hg19 2q31.1(chr2:172379152-172803266)x3	DYNC1I2|HAT1|SLC25A12|CYBRD1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	172379152 - 172803266			221426	223155
NM_001011708.2(OLA1):c.313T>G (p.Phe105Val)	OLA1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	174946734	2	174082006	161492	171338
NM_001313902.1(NFE2L2):c.237G>T (p.Glu79Asp)	NFE2L2	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	178098808	2	177234080	376468	363347
NM_001145413.3(NFE2L2):c.188A>T (p.Glu63Val)	NFE2L2	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	178098809	2	177234081	376467	363346
NM_001313904.1(NFE2L2):c.6G>A (p.Lys2=)	NFE2L2	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	2	178098810	2	177234082	376466	363345
NM_001145413.3(NFE2L2):c.187G>C (p.Glu63Gln)	NFE2L2	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	178098810	2	177234082	376465	363344
NM_006164.4(NFE2L2):c.91G>A (p.Gly31Arg)	NFE2L2	Colorectal cancer|IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	2	178098954	2	177234226	445150	438546
NM_001145412.3(NFE2L2):c.38A>G (p.Asp13Gly)	NFE2L2	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	178098959	2	177234231	376464	363343
NM_001313903.1(NFE2L2):c.85G>A (p.Asp29Asn)	NFE2L2	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	178098960	2	177234232	376463	363342
NM_001145412.3(NFE2L2):c.37G>T (p.Asp13Tyr)	NFE2L2	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	178098960	2	177234232	376462	363341
NM_001313903.1(NFE2L2):c.85G>C (p.Asp29His)	NFE2L2	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	178098960	2	177234232	376461	363340
GRCh37/hg19 2q31.3-32.1(chr2:182756899-183051256)x4	PDE1A|ITPRID2|PPP1R1C	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	182756899 - 183051256			221427	223156
NM_014585.5(SLC40A1):c.473G>T (p.Trp158Leu)	SLC40A1	not provided	Uncertain significance	no assertion criteria provided	2	190436482	2	189571756	56156	70795
NM_012433.3(SF3B1):c.2225G>A (p.Gly742Asp)	SF3B1	Chronic lymphocytic leukemia|Renal cell carcinoma, papillary, 1	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	198266611	2	197401887	376530	363409
NM_012433.3(SF3B1):c.2100A>C (p.Lys700Asn)	SF3B1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	198266832	2	197402108	376041	362920
NM_012433.3(SF3B1):c.2100A>T (p.Lys700Asn)	SF3B1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	198266832	2	197402108	376040	362919
NM_012433.3(SF3B1):c.2099A>C (p.Lys700Thr)	SF3B1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	198266833	2	197402109	376044	362923
NM_012433.3(SF3B1):c.2099A>G (p.Lys700Arg)	SF3B1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	198266833	2	197402109	376043	362922
NM_012433.3(SF3B1):c.2099A>T (p.Lys700Ile)	SF3B1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	198266833	2	197402109	376042	362921
NM_012433.3(SF3B1):c.2098A>C (p.Lys700Gln)	SF3B1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	198266834	2	197402110	376046	362925
NM_012433.3(SF3B1):c.2098A>T (p.Lys700Ter)	SF3B1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	198266834	2	197402110	376045	362924
NM_012433.3(SF3B1):c.2098A>G (p.Lys700Glu)	SF3B1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	198266834	2	197402110	376004	362883
NM_012433.3(SF3B1):c.1998G>C (p.Lys666Asn)	SF3B1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	198267359	2	197402635	376005	362884
NM_012433.3(SF3B1):c.1998G>T (p.Lys666Asn)	SF3B1	Acute myeloid leukemia|Myelodysplastic syndrome|Myelodysplastic syndrome progressed to acute myeloid leukemia	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	2	198267359	2	197402635	219098	216787
NM_012433.3(SF3B1):c.1997A>C (p.Lys666Thr)	SF3B1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	198267360	2	197402636	376007	362886
NM_012433.3(SF3B1):c.1997A>G (p.Lys666Arg)	SF3B1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	198267360	2	197402636	376006	362885
NM_012433.3(SF3B1):c.1996A>C (p.Lys666Gln)	SF3B1	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Neoplasm of the breast|Hepatocellular carcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	198267361	2	197402637	376532	363411
NM_012433.3(SF3B1):c.1996A>G (p.Lys666Glu)	SF3B1	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Acute myeloid leukemia|Neoplasm of the breast|Hepatocellular carcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	198267361	2	197402637	376008	362887
NM_012433.3(SF3B1):c.1874G>A (p.Arg625His)	SF3B1	Chronic lymphocytic leukemia|Malignant melanoma of skin|Transitional cell carcinoma of the bladder|Adenoid cystic carcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	198267483	2	197402759	376534	363413
NM_012433.3(SF3B1):c.1873C>G (p.Arg625Gly)	SF3B1	Chronic lymphocytic leukemia|Malignant melanoma of skin|Transitional cell carcinoma of the bladder|Adenoid cystic carcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	198267484	2	197402760	376536	363415
NM_012433.3(SF3B1):c.1873C>T (p.Arg625Cys)	SF3B1	Chronic lymphocytic leukemia|Malignant melanoma of skin|Transitional cell carcinoma of the bladder|Adenoid cystic carcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	198267484	2	197402760	376535	363414
NM_032977.3(CASP10):c.440T>C (p.Met147Thr)	CASP10	Neoplasm of stomach	Pathogenic(Last reviewed: Apr 25, 2002)	no assertion criteria provided	2	202052521	2	201187798	7768	22807
NM_032977.3(CASP10):c.769C>T (p.Gln257Ter)	CASP10	Non-Hodgkin lymphoma|Neoplasm of stomach	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	2	202070652	2	201205929	7766	22805
NM_032977.3(CASP10):c.1042_1043insA (p.Gly348Glufs)	CASP10	Non-Hodgkin lymphoma	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	2	202073912 - 202073913	2	201209189 - 201209190	7767	22806
NM_032977.3(CASP10):c.1241C>T (p.Ala414Val)	CASP10	Non-Hodgkin lymphoma	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	2	202074111	2	201209388	7765	22804
NM_033355.3(CASP8):c.1228_1229delGT (p.Val410Phefs)	CASP8	Liver cancer|Hepatocellular carcinoma	Pathogenic(Last reviewed: Jan 6, 2005)	no assertion criteria provided	2	202149964 - 202149965	2	201285241 - 201285242	7761	22800
NM_001168221.1(C2CD6):c.5255T>C (p.Leu1752Ser)	C2CD6	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	202352543	2	201487820	161549	171339
NM_213589.2(RAPH1):c.1123G>T (p.Glu375Ter)	RAPH1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	204322288	2	203457565	161861	171340
NM_020923.2(ZDBF2):c.5795G>A (p.Arg1932His)	ZDBF2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	207175047	2	206310323	221299	223028
NM_001282386.1(IDH1):c.395G>C (p.Arg132Pro)	IDH1	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	2	209113112	2	208248388	375890	362769
NM_005896.3(IDH1):c.395G>T (p.Arg132Leu)	IDH1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	209113112	2	208248388	375889	362768
NM_001282386.1(IDH1):c.395G>A (p.Arg132His)	IDH1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Oligodendroglioma|Acute myeloid leukemia|Myelodysplastic syndrome|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Astrocytoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Glioblastoma multiforme, somatic|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	209113112	2	208248388	156444	166215
NM_001282387.1(IDH1):c.394C>A (p.Arg132Ser)	IDH1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Astrocytoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	209113113	2	208248389	375893	362772
NM_001282387.1(IDH1):c.394C>G (p.Arg132Gly)	IDH1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	209113113	2	208248389	375892	362771
NM_001282387.1(IDH1):c.394C>T (p.Arg132Cys)	IDH1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Astrocytoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	209113113	2	208248389	375891	362770
NM_005235.2(ERBB4):c.2706C>T (p.Asp902=)	ERBB4	not provided	Uncertain significance	no assertion criteria provided	2	212293146	2	211428421	100850	106710
NM_005235.2(ERBB4):c.2614G>A (p.Glu872Lys)	ERBB4	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	2	212295699	2	211430974	376170	363049
GRCh37/hg19 2q34-35(chr2:211515125-215797412)x3	BARD1|CPS1|ERBB4|IKZF2|ABCA12|SPAG16|VWC2L	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	211515125 - 215797412			221428	223157
NM_005235.2(ERBB4):c.1630C>T (p.Arg544Trp)	ERBB4	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	2	212537975	2	211673250	74426	85317
NM_005235.2(ERBB4):c.1624G>A (p.Glu542Lys)	ERBB4	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	2	212537981	2	211673256	376171	363050
NM_005235.2(ERBB4):c.1354G>A (p.Glu452Lys)	ERBB4	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	2	212566827	2	211702102	91898	97376
NM_005235.2(ERBB4):c.1177C>T (p.Arg393Trp)	ERBB4	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	2	212570064	2	211705339	376172	363051
NM_005235.2(ERBB4):c.949G>A (p.Glu317Lys)	ERBB4	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	2	212578308	2	211713583	74427	85318
NM_001271635.1(CNOT9):c.259T>C (p.Ser87Pro)	CNOT9	Liver cancer|Malignant melanoma of skin|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	219447748	2	218583025	376526	363405
NM_001271634.1(CNOT9):c.260C>G (p.Ser87Cys)	CNOT9	Liver cancer|Malignant melanoma of skin|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	219447749	2	218583026	376527	363406
NM_001271634.1(CNOT9):c.391C>T (p.Pro131Ser)	CNOT9	Malignant melanoma of skin	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	219449405	2	218584682	376525	363404
NM_005444.2(CNOT9):c.392C>T (p.Pro131Leu)	CNOT9	Malignant melanoma of skin	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	2	219449406	2	218584683	74445	85336
NM_152389.3(CFAP65):c.405delT (p.Leu136Serfs)	CFAP65	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	219900144	2	219035422	161813	171341
GRCh37/hg19 2q35(chr2:219221864-219423299)x3	SLC11A1|VIL1|USP37|CTDSP1|CATIP|MIR26B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	219221864 - 219423299			221429	223158
NM_004238.2(TRIP12):c.724C>A (p.Pro242Thr)	TRIP12	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	230723665	2	229858949	161621	171342
NM_007237.4(SP140):c.1550A>C (p.Asn517Thr)	SP140	not provided	Uncertain significance	no assertion criteria provided	2	231149112	2	230284397	91973	97451
NM_005683.3(GPR55):c.941C>T (p.Thr314Ile)	GPR55	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	2	231774737	2	230910022	161638	171343
GRCh38/hg38 2q37.1(chr2:232379030-232526243)x1	ALPI|ALPP|ALPG|CHRND|ECEL1|PRSS56	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	233243739 - 233390952	2	232379030 - 232526243	221380	223109
NM_152879.2(DGKD):c.472G>A (p.Asp158Asn)	DGKD	not provided	Uncertain significance	no assertion criteria provided	2	234343433	2	233434787	92031	97509
GRCh37/hg19 2q37.3(chr2:238305415-238742983)x3	COL6A3|LRRFIP1|PRLH|RAB17|MLPH|RBM44	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	2	238305415 - 238742983			221430	223159
GRCh37/hg19 3p26.1(chr3:4706901-5216065)x3	ITPR1|BHLHE40|ARL8B|EGOT	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	3	4706901 - 5216065			221431	223160
GRCh37/hg19 3p26.1(chr3:4726822-5164213)x4	ITPR1|BHLHE40|ARL8B|EGOT	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	3	4726822 - 5164213			221381	223110
NM_016828.2(OGG1):c.137G>A (p.Arg46Gln)	OGG1	Clear cell carcinoma of kidney	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	3	9792107	3	9750423	7602	22641
NM_000551.3(VHL):c.241C>T (p.Pro81Ser)	VHL	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Neoplasm	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2018)	criteria provided, conflicting interpretations	3	10183772	3	10142088	2233	17272
NM_000551.3(VHL):c.254T>C (p.Leu85Pro)	VHL	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	10183785	3	10142101	376222	363101
NM_000551.3(VHL):c.266T>A (p.Leu89His)	VHL	Renal cell carcinoma, papillary, 1	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	10183797	3	10142113	376047	362926
NM_000551.3(VHL):c.311_340+20del	VHL	Von Hippel-Lindau syndrome	Likely pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	3	10183842 - 10183891	3	10142158 - 10142207	223182	224914
NM_000551.3(VHL):c.332G>T (p.Ser111Ile)	VHL	Von Hippel-Lindau syndrome	Uncertain significance(Last reviewed: Feb 26, 2016)	no assertion criteria provided	3	10183863	3	10142179	223185	224917
NM_000551.3(VHL):c.341delG (p.Gly114Valfs)	VHL|LOC107303340	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	3	10188198	3	10146514	223195	224927
NM_000551.3(VHL):c.444dupT (p.Ala149Cysfs)	VHL|LOC107303340	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	3	10188301	3	10146617	223211	224942
NM_000551.3(VHL):c.473T>A (p.Leu158Gln)	VHL|LOC107303340	Renal cell carcinoma, papillary, 1	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	10191480	3	10149796	376048	362927
NM_000551.3(VHL):c.481C>T (p.Arg161Ter)	VHL|LOC107303340	Von Hippel-Lindau syndrome|Renal cell carcinoma, papillary, 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	3	10191488	3	10149804	2217	17256
NM_000551.3(VHL):c.499C>T (p.Arg167Trp)	VHL|LOC107303340	Erythrocytosis, familial, 2|Pheochromocytoma|Von Hippel-Lindau syndrome|Renal cell carcinoma, papillary, 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	3	10191506	3	10149822	2218	17257
NM_000551.3(VHL):c.548C>A (p.Ser183Ter)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Renal cell carcinoma, papillary, 1	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	3	10191555	3	10149871	2215	17254
NM_138712.3(PPARG):c.472delA (p.Ser158Valfs)	PPARG	Carcinoma of colon	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	3	12434188	3	12392689	8132	23171
NM_138712.3(PPARG):c.857A>C (p.Gln286Pro)	PPARG	Carcinoma of colon	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	3	12458324	3	12416825	8133	23172
NM_138712.3(PPARG):c.863G>A (p.Arg288His)	PPARG	Carcinoma of colon	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	3	12458330	3	12416831	8135	23174
NM_138712.3(PPARG):c.955A>T (p.Lys319Ter)	PPARG	Carcinoma of colon	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	3	12458422	3	12416923	8134	23173
NM_002880.3(RAF1):c.1837C>G (p.Leu613Val)	RAF1	LEOPARD syndrome 2|Noonan syndrome 5|Noonan syndrome with multiple lentigines|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12626123	3	12584624	13960	28999
NM_002880.3(RAF1):c.1472C>T (p.Thr491Ile)	RAF1	Noonan syndrome with multiple lentigines|Noonan syndrome|not provided|Rasopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12627244	3	12585745	21342	34194
NM_002880.3(RAF1):c.1103G>C (p.Trp368Ser)	RAF1	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	3	12641195	3	12599696	376186	363065
NM_002880.3(RAF1):c.788T>C (p.Val263Ala)	RAF1	Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, multiple submitters, no conflicts	3	12645681	3	12604182	40608	49078
NM_002880.3(RAF1):c.782C>T (p.Pro261Leu)	RAF1	Noonan syndrome 5|Noonan syndrome|not provided	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	3	12645687	3	12604188	120246	125840
NM_002880.3(RAF1):c.781C>G (p.Pro261Ala)	RAF1	Primary familial hypertrophic cardiomyopathy|Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, multiple submitters, no conflicts	3	12645688	3	12604189	40605	49075
NM_002880.3(RAF1):c.781C>T (p.Pro261Ser)	RAF1	Noonan syndrome 5|Primary familial hypertrophic cardiomyopathy|Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12645688	3	12604189	13958	28997
NM_002880.3(RAF1):c.776C>T (p.Ser259Phe)	RAF1	Noonan syndrome|Rasopathy	Pathogenic(Last reviewed: Jul 8, 2015)	criteria provided, single submitter	3	12645693	3	12604194	40603	49073
NM_002880.3(RAF1):c.770C>G (p.Ser257Trp)	RAF1	Malignant melanoma of skin|Lung adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	12645699	3	12604200	376514	363393
NM_002880.3(RAF1):c.770C>T (p.Ser257Leu)	RAF1	LEOPARD syndrome 2|Malignant melanoma of skin|Noonan syndrome 5|Noonan syndrome with multiple lentigines|Lung adenocarcinoma|Noonan syndrome|not provided|Rasopathy|Cardiomyopathy, dilated, 1NN|Neoplasm of the large intestine|Inborn genetic diseases|Colorectal Neoplasms|Adenocarcinoma of stomach	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12645699	3	12604200	13957	28996
NM_002880.3(RAF1):c.769T>C (p.Ser257Pro)	RAF1	Primary familial hypertrophic cardiomyopathy|Noonan syndrome|not provided|Rasopathy|Cutaneous melanoma	Likely pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12645700	3	12604201	40600	49070
NM_003242.5(TGFBR2):c.1576G>C (p.Glu526Gln)	TGFBR2	Malignant tumor of esophagus|Thoracic aortic aneurysm and aortic dissection	Uncertain significance(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	3	30732963	3	30691471	12503	27542
NM_003242.5(TGFBR2):c.1583G>A (p.Arg528His)	TGFBR2	Loeys-Dietz syndrome 2|Hereditary nonpolyposis colorectal cancer type 6|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	3	30732970	3	30691478	12511	27550
NM_001024847.2(TGFBR2):c.1676_1677dupTG (p.Ala560Trpfs)	TGFBR2	Hereditary nonpolyposis colorectal cancer type 6	Pathogenic(Last reviewed: Jun 2, 1995)	no assertion criteria provided	3	30732988 - 30732989	3	30691496 - 30691497	12501	27540
NM_000404.3(GLB1):c.1903G>C (p.Ala635Pro)	GLB1	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	3	33038668	3	32997176	487803	480810
NM_000404.3(GLB1):c.1150A>T (p.Thr384Ser)	GLB1	GM1 gangliosidosis type 2	not provided	no assertion provided	3	33063141	3	33021649	66110	77008
NM_000404.3(GLB1):c.1061T>G (p.Ile354Ser)	GLB1	GM1 gangliosidosis type 2	not provided	no assertion provided	3	33087619	3	33046127	66109	77007
NM_000404.3(GLB1):c.518T>C (p.Leu173Pro)	GLB1	GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|GM1 Gangliosidosis	Likely pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	3	33106989	3	33065497	68479	79371
NM_000404.3(GLB1):c.456A>T (p.Pro152=)	GLB1	GM1 gangliosidosis type 2	not provided	no assertion provided	3	33109723	3	33068231	68480	79372
NM_000404.3(GLB1):c.176G>A (p.Arg59His)	GLB1	GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1-gangliosidosis, type I, with cardiac involvement|not provided	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, multiple submitters, no conflicts	3	33114105	3	33072613	945	15984
NM_016300.4(ARPP21):c.1355G>T (p.Gly452Val)	ARPP21	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	35770924	3	35729432	161701	171364
NM_000249.3(MLH1):c.1151T>A (p.Val384Asp)	MLH1	Lynch syndrome I|Turcot syndrome|Muir-Torré syndrome|Lynch syndrome II|Lung adenocarcinoma|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Adenocarcinoma of stomach|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37067240	3	37025749	41632	50071
NM_006309.3(LRRFIP2):c.90+1G>C	LRRFIP2	not provided	Uncertain significance	no assertion criteria provided	3	37190384	3	37148893	91970	97448
NM_001172713.1(GOLGA4):c.6240A>T (p.Arg2080Ser)	GOLGA4	not provided	not provided	no assertion provided	3	37370566	3	37329075	156204	166001
NM_002468.5(MYD88):c.755T>C (p.Leu252Pro)	MYD88	Non-Hodgkin lymphoma|Chronic lymphocytic leukemia|Myd88 deficiency|Multiple myeloma|Macroglobulinemia, waldenstrom, somatic|Lymphoma	Uncertain significance(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	3	38182641	3	38141150	37055	45735
NM_033027.3(CSRNP1):c.1432C>T (p.Leu478Phe)	CSRNP1	not provided	not provided	no assertion provided	3	39184884	3	39143393	156209	166006
NM_194293.2(XIRP1):c.1955C>A (p.Pro652Gln)	XIRP1	not provided	Uncertain significance	no assertion criteria provided	3	39228982	3	39187491	92036	97514
NM_001198621.3(XIRP1):c.352G>A (p.Val118Met)	XIRP1	not provided	not provided	no assertion provided	3	39230585	3	39189094	156205	166002
NM_001248.3(ENTPD3):c.812T>A (p.Phe271Tyr)	ENTPD3|ENTPD3-AS1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	40457545	3	40416054	161579	171365
NM_001904.3(CTNNB1):c.37G>A (p.Ala13Thr)	CTNNB1	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	41266040	3	41224549	376223	363102
NM_001904.3(CTNNB1):c.61G>A (p.Ala21Thr)	CTNNB1	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	41266064	3	41224573	376224	363103
NM_001904.3(CTNNB1):c.65T>C (p.Val22Ala)	CTNNB1	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	41266068	3	41224577	376226	363105
NC_000003.12:g.41224577_41224627del	CTNNB1	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	41266067 - 41266117	3	41224577 - 41224627	376225	363104
NM_001904.3(CTNNB1):c.73_96del24 (p.Trp25_Asp32del)	CTNNB1	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	41266076 - 41266099	3	41224585 - 41224608	376227	363106
NM_001904.3(CTNNB1):c.84_95delGTCTTACCTGGA (p.Gln28_Asp32delinsHis)	CTNNB1	Hepatoblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	3	41266087 - 41266098	3	41224596 - 41224607	438756	432378
NM_001904.3(CTNNB1):c.94G>A (p.Asp32Asn)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Endometrial neoplasm|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|Esophageal Squamous Cell Carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266097	3	41224606	376228	363107
NM_001904.3(CTNNB1):c.94G>C (p.Asp32His)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Cutaneous melanoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266097	3	41224606	376054	362933
NM_001904.3(CTNNB1):c.94G>T (p.Asp32Tyr)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Pilomatrixoma|Hepatoblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|Craniopharyngioma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic, other(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266097	3	41224606	17581	32620
NM_001904.3(CTNNB1):c.95A>T (p.Asp32Val)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Endometrial neoplasm|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266098	3	41224607	376230	363109
NM_001904.3(CTNNB1):c.95A>C (p.Asp32Ala)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Cutaneous melanoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266098	3	41224607	376229	363108
NM_001904.3(CTNNB1):c.95A>G (p.Asp32Gly)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Pilomatrixoma|not provided|Cutaneous melanoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266098	3	41224607	17578	32617
NM_001904.3(CTNNB1):c.97T>A (p.Ser33Thr)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Lung adenocarcinoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266100	3	41224609	376393	363272
NM_001904.3(CTNNB1):c.97T>G (p.Ser33Ala)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Lung adenocarcinoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266100	3	41224609	376392	363271
NM_001904.3(CTNNB1):c.97T>C (p.Ser33Pro)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Lung adenocarcinoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266100	3	41224609	376391	363270
NM_001904.3(CTNNB1):c.98C>G (p.Ser33Cys)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Lung adenocarcinoma|Neoplasm of brain|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Ovarian Neoplasms|Colorectal Neoplasms|Neoplasm of the parathyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic, other(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266101	3	41224610	376231	363110
NM_001904.3(CTNNB1):c.98C>T (p.Ser33Phe)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Pilomatrixoma|Lung adenocarcinoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|ADRENAL CORTICAL NEOPLASM	Pathogenic/Likely pathogenic, other(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266101	3	41224610	17583	32622
NM_001904.3(CTNNB1):c.98C>A (p.Ser33Tyr)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Pilomatrixoma|Lung adenocarcinoma|Carcinoma of colon|Endometrial neoplasm|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266101	3	41224610	17577	32616
NM_001904.3(CTNNB1):c.100G>C (p.Gly34Arg)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Pilomatrixoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Hepatocellular carcinoma|Craniopharyngioma|Adrenocortical carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266103	3	41224612	376233	363112
NM_001904.3(CTNNB1):c.100G>A (p.Gly34Arg)	CTNNB1	Pilomatrixoma|Craniopharyngioma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	41266103	3	41224612	376232	363111
NM_001904.3(CTNNB1):c.101G>C (p.Gly34Ala)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Hepatocellular carcinoma|Adrenocortical carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266104	3	41224613	376390	363269
NM_001904.3(CTNNB1):c.101G>A (p.Gly34Glu)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Pilomatrixoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Hepatocellular carcinoma|Ovarian Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic, other(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266104	3	41224613	17584	32623
NM_001904.3(CTNNB1):c.101G>T (p.Gly34Val)	CTNNB1	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Malignant tumor of prostate|Lung adenocarcinoma|Hepatoblastoma|Cutaneous melanoma|Hepatocellular carcinoma|Craniopharyngioma|Adrenocortical carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266104	3	41224613	17582	32621
NM_001904.3(CTNNB1):c.109T>G (p.Ser37Ala)	CTNNB1	Liver cancer|Medulloblastoma|Lung adenocarcinoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Uterine cervical neoplasms|Neoplasm of the parathyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266112	3	41224621	376235	363114
NM_001904.3(CTNNB1):c.109T>C (p.Ser37Pro)	CTNNB1	Liver cancer|Medulloblastoma|Lung adenocarcinoma|Neoplasm of stomach|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266112	3	41224621	376234	363113
NM_001904.3(CTNNB1):c.110C>A (p.Ser37Tyr)	CTNNB1	Liver cancer|Medulloblastoma|Lung adenocarcinoma|Neoplasm of stomach|Cutaneous melanoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266113	3	41224622	375894	362773
NM_001904.3(CTNNB1):c.110C>T (p.Ser37Phe)	CTNNB1	Liver cancer|Medulloblastoma|Pilomatrixoma|Lung adenocarcinoma|Cutaneous melanoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Ovarian Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266113	3	41224622	17586	32625
NM_001904.3(CTNNB1):c.110C>G (p.Ser37Cys)	CTNNB1	Liver cancer|Medulloblastoma|Pilomatrixoma|Neoplasm of ovary|Lung adenocarcinoma|not provided|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Ovarian Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266113	3	41224622	17579	32618
NM_001904.3(CTNNB1):c.118A>T (p.Thr40Ser)	CTNNB1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	41266121	3	41224630	376238	363117
NM_001904.3(CTNNB1):c.118A>G (p.Thr40Ala)	CTNNB1	Neoplasm of stomach	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	41266121	3	41224630	376237	363116
NM_001904.3(CTNNB1):c.118A>C (p.Thr40Pro)	CTNNB1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	41266121	3	41224630	376236	363115
NM_001904.3(CTNNB1):c.119C>T (p.Thr40Ile)	CTNNB1	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	41266122	3	41224631	376240	363119
NM_001904.3(CTNNB1):c.119C>G (p.Thr40Ser)	CTNNB1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	41266122	3	41224631	376239	363118
NM_001904.3(CTNNB1):c.121A>G (p.Thr41Ala)	CTNNB1	Liver cancer|Malignant melanoma of skin|Lung adenocarcinoma|Desmoid tumor, somatic|Hepatoblastoma|not provided|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adrenocortical carcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Conflicting interpretations of pathogenicity, other(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266124	3	41224633	17580	32619
NM_001904.3(CTNNB1):c.122C>A (p.Thr41Asn)	CTNNB1	Liver cancer|Malignant melanoma of skin|Lung adenocarcinoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adrenocortical carcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266125	3	41224634	376394	363273
NM_001904.3(CTNNB1):c.122C>T (p.Thr41Ile)	CTNNB1	Liver cancer|Malignant melanoma of skin|Pilomatrixoma|Lung adenocarcinoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adrenocortical carcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266125	3	41224634	17587	32626
NM_001904.3(CTNNB1):c.133T>G (p.Ser45Ala)	CTNNB1	Neoplasm of brain|Disease	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	41266136	3	41224645	376241	363120
NM_001904.3(CTNNB1):c.133T>C (p.Ser45Pro)	CTNNB1	Liver cancer|Malignant melanoma of skin|Lung adenocarcinoma|not provided|Cutaneous melanoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Disease|Adrenocortical carcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266136	3	41224645	17589	32628
NM_001904.3(CTNNB1):c.133_135delTCT (p.Ser45del)	CTNNB1	Carcinoma of colon|Wilms Tumor	Pathogenic, other(Last reviewed: May 1, 2016)	no assertion criteria provided	3	41266136 - 41266138	3	41224645 - 41224647	17576	32615
NM_001904.3(CTNNB1):c.134C>G (p.Ser45Cys)	CTNNB1	Liver cancer|Malignant melanoma of skin|Lung adenocarcinoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Disease|Adrenocortical carcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266137	3	41224646	376242	363121
NM_001904.3(CTNNB1):c.134C>A (p.Ser45Tyr)	CTNNB1	Liver cancer|Malignant melanoma of skin|Lung adenocarcinoma|Cutaneous melanoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Adrenocortical carcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266137	3	41224646	375895	362774
NM_001904.3(CTNNB1):c.134C>T (p.Ser45Phe)	CTNNB1	Liver cancer|Malignant melanoma of skin|Lung adenocarcinoma|Cutaneous melanoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Wilms Tumor|Disease|Adrenocortical carcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic, other(Last reviewed: May 31, 2016)	no assertion criteria provided	3	41266137	3	41224646	17588	32627
NM_001904.3(CTNNB1):c.723G>A (p.Val241=)	CTNNB1	not provided	Likely pathogenic	no assertion criteria provided	3	41267052	3	41225561	100837	106697
NM_001904.3(CTNNB1):c.770C>T (p.Thr257Ile)	CTNNB1	Wilms Tumor	other(Last reviewed: May 1, 2016)	no assertion criteria provided	3	41267186	3	41225695	438758	432396
NM_001904.3(CTNNB1):c.1374A>C (p.Glu458Asp)	CTNNB1	Renal cell carcinoma, papillary, 1	other(Last reviewed: May 1, 2016)	no assertion criteria provided	3	41275208	3	41233717	438755	432395
NM_173658.2(ZNF660):c.721C>T (p.Arg241Cys)	ZNF660|ZNF660-ZNF197	not provided	not provided	no assertion provided	3	44636406	3	44594914	156210	166007
NM_015340.3(LARS2):c.1584G>C (p.Trp528Cys)	LARS2|LARS2-AS1	not provided	Uncertain significance	no assertion criteria provided	3	45537827	3	45496335	100862	106722
NM_014159.6(SETD2):c.5143-1G>A	SETD2	WEE1 Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	3	47129738	3	47088248	523171	513782
GRCh37/hg19 3p21.31(chr3:48501854-48541490)x3	TREX1|SHISA5|ATRIP	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	3	48501854 - 48541490			221432	223161
GRCh38/hg38 3p21.31(chr3:48562955-48587488)x1	COL7A1|UCN2|MIR711	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	3	48600388 - 48624921	3	48562955 - 48587488	221382	223111
NM_018031.4(WDR6):c.2047T>G (p.Cys683Gly)	WDR6	not provided	Uncertain significance	no assertion criteria provided	3	49050924	3	49013491	100868	106728
NM_001664.3(RHOA):c.125A>T (p.Tyr42Phe)	RHOA	Non-Hodgkin lymphoma|Squamous cell carcinoma of the head and neck|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	49412898	3	49375465	376524	363403
NM_001664.3(RHOA):c.125A>C (p.Tyr42Ser)	RHOA	Non-Hodgkin lymphoma|Squamous cell carcinoma of the head and neck|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	49412898	3	49375465	376523	363402
NM_001664.3(RHOA):c.125A>G (p.Tyr42Cys)	RHOA	Non-Hodgkin lymphoma|Squamous cell carcinoma of the head and neck|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	49412898	3	49375465	376522	363401
NM_001664.3(RHOA):c.118G>A (p.Glu40Lys)	RHOA	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	49412905	3	49375472	376518	363397
NM_001664.3(RHOA):c.118G>C (p.Glu40Gln)	RHOA	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	49412905	3	49375472	376517	363396
NM_001664.3(RHOA):c.14G>T (p.Arg5Leu)	RHOA	Non-Hodgkin lymphoma|Neoplasm of the breast|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	49413009	3	49375576	376521	363400
NM_001664.3(RHOA):c.14G>A (p.Arg5Gln)	RHOA	Non-Hodgkin lymphoma|Neoplasm of the breast|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	49413009	3	49375576	376520	363399
NM_001664.3(RHOA):c.13C>T (p.Arg5Trp)	RHOA	Non-Hodgkin lymphoma|Neoplasm of the breast|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	49413010	3	49375577	376519	363398
NM_020998.3(MST1):c.55C>T (p.Pro19Ser)	MST1	not provided	not provided	no assertion provided	3	49726070	3	49688637	156207	166004
GRCh37/hg19 3p21.31(chr3:49758015-49829191)x3	IP6K1|GMPPB|RNF123|CDHR4	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	3	49758015 - 49829191			221433	223162
NM_002070.3(GNAI2):c.535C>G (p.Arg179Gly)	GNAI2	Pituitary dependent hypercortisolism	Pathogenic(Last reviewed: Feb 1, 1995)	no assertion criteria provided	3	50293694	3	50256262	15905	30944
NM_002070.3(GNAI2):c.535C>T (p.Arg179Cys)	GNAI2	Granulosa cell tumor of the ovary|Adrenocortical tumor, somatic|Granulosa cell tumor, somatic|Thecoma, somatic	Pathogenic(Last reviewed: Aug 10, 1990)	no assertion criteria provided	3	50293694	3	50256262	15903	30942
NM_002070.3(GNAI2):c.536G>A (p.Arg179His)	GNAI2	Granulosa cell tumor of the ovary|Adrenocortical tumor, somatic|Granulosa cell tumor, somatic|Thecoma, somatic	Pathogenic(Last reviewed: Aug 26, 2014)	no assertion criteria provided	3	50293695	3	50256263	15904	30943
NM_002070.3(GNAI2):c.600T>A (p.Phe200Leu)	GNAI2	Ventricular tachycardia, somatic	Pathogenic(Last reviewed: Jun 15, 1998)	no assertion criteria provided	3	50294161	3	50256729	15906	30945
GRCh37/hg19 3p21.31(chr3:50273827-50403519)x3	GNAI2|HYAL1|IFRD2|SEMA3B|HYAL3|HYAL2|CACNA2D2|NPRL2|CYB561D2|TMEM115|RASSF1|TUSC2|NAA80|ZMYND10|LSMEM2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	3	50273827 - 50403519			221434	223163
NM_004947.4(DOCK3):c.1153C>T (p.Arg385Cys)	DOCK3	not provided	not provided	no assertion provided	3	51251579	3	51214148	156206	166003
NM_004656.3(BAP1):c.374A>C (p.Glu125Ala)	BAP1	Adenoid cystic carcinoma	Uncertain significance(Last reviewed: Feb 1, 2018)	no assertion criteria provided	3	52441975	3	52407959	495131	486680
NM_004656.3(BAP1):c.188C>G (p.Ser63Cys)	BAP1	Hereditary cancer-predisposing syndrome|Adenoid cystic carcinoma	Uncertain significance(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	3	52442557	3	52408541	480816	473578
NM_052859.3(RFT1):c.1102G>A (p.Gly368Ser)	RFT1	not provided	Uncertain significance	no assertion criteria provided	3	53137969	3	53103953	100887	106747
NM_001128840.2(CACNA1D):c.1207G>C (p.Gly403Arg)	CACNA1D	not provided	Likely pathogenic	no assertion criteria provided	3	53707140	3	53673113	91930	97408
NM_001128840.2(CACNA1D):c.2250C>G (p.Ile750Met)	CACNA1D	not provided|Primary aldosteronism, seizures, and neurologic abnormalities	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	3	53764497	3	53730470	66073	76975
NM_000720.3(CACNA1D):c.3539delA (p.Glu1182Serfs)	CACNA1D	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	53783459	3	53749432	161471	171695
NM_001112736.1(TASOR):c.97G>A (p.Glu33Lys)	TASOR	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	3	56716938	3	56682910	487784	480791
NM_001457.3(FLNB):c.7455C>A (p.Thr2485=)	FLNB|FLNB-AS1	not provided	Uncertain significance	no assertion criteria provided	3	58155354	3	58169627	100834	106694
NM_183393.2(CADPS):c.484G>A (p.Ala162Thr)	CADPS	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	62751617	3	62765942	161849	171366
NM_001128223.3(ZNF717):c.1228C>G (p.Leu410Val)	ZNF717	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	75787546	3	75738395	161523	171367
Single allele	ZNF717	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	3	75786278 - 75790822			221336	223065
NM_000313.3(PROS1):c.1528G>A (p.Val510Met)	PROS1	Protein S deficiency|Thrombophilia due to protein S deficiency, autosomal recessive	Benign(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	3	93598123	3	93879279	161343	171089
NM_054106.1(OR5AC2):c.730G>A (p.Gly244Ser)	OR5AC2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	97806746	3	98087902	161794	171368
NM_016247.3(IMPG2):c.1265C>T (p.Pro422Leu)	IMPG2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	100964924	3	101246080	161700	171349
NM_018189.3(DPPA4):c.907T>C (p.Trp303Arg)	DPPA4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	109046843	3	109327996	161713	171350
NM_017945.4(SLC35A5):c.353T>G (p.Leu118Arg)	SLC35A5	Monoclonal B-Cell Lymphocytosis	Uncertain significance(Last reviewed: Dec 15, 2015)	no assertion criteria provided	3	112289510	3	112570663	222963	224679
NM_000388.3(CASR):c.3121C>T (p.Arg1041Trp)	CASR	Hypocalciuric hypercalcemia, familial, type 1|Malignant tumor of prostate|Hypocalcemia, autosomal dominant 1	Uncertain significance(Last reviewed: Jun 10, 2018)	criteria provided, single submitter	3	122003922	3	122285075	161466	171351
NM_053028.3(MYLK):c.1148C>T (p.Pro383Leu)	MYLK	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	123452695	3	123733848	161793	171352
NM_032638.4(GATA2):c.1192C>T (p.Arg398Trp)	GATA2	Acute myeloid leukemia|Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency|Leukemia, acute myeloid, susceptibility to	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	128200113	3	128481270	29709	38664
NM_032638.4(GATA2):c.1061C>T (p.Thr354Met)	GATA2	Acute myeloid leukemia|Lymphedema, primary, with myelodysplasia|Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency|Myelodysplastic syndrome|Leukemia, acute myeloid, susceptibility to	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	3	128200744	3	128481901	29711	38666
NM_001134194.1(ACPP):c.848_850delTCA (p.Ile284del)	ACPP	Acute megakaryoblastic leukemia|Mediastinal germ cell tumor	Uncertain significance(Last reviewed: Oct 22, 2015)	no assertion criteria provided	3	132068830 - 132068832	3	132349986 - 132349988	218346	215049
NM_003571.3(BFSP2):c.861G>A (p.Arg287=)	BFSP2|BFSP2-AS1	not provided	Uncertain significance	no assertion criteria provided	3	133169278	3	133450434	100844	106704
NM_001063.3(TF):c.1069G>T (p.Glu357Ter)	TF	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	133478039	3	133759195	161508	171353
NM_023067.4(FOXL2):c.402C>G (p.Cys134Trp)	FOXL2	Granulosa Cell Tumor	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	3	138665163	3	138946321	376348	363227
NM_001184.3(ATR):c.2320delA (p.Ile774Tyrfs)	ATR	Endometrial neoplasm	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	3	142274740	3	142555898	376356	363235
NM_003304.4(TRPC1):c.868C>T (p.Gln290Ter)	TRPC1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	142503555	3	142784713	161610	171354
NM_032383.4(HPS3):c.1509+6C>G	HPS3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	148873008	3	149155221	161782	171355
NM_002852.3(PTX3):c.108T>C (p.Asn36=)	PTX3|VEPH1	not provided	Uncertain significance	no assertion criteria provided	3	157154830	3	157437041	91946	97424
NM_001002800.2(SMC4):c.3849A>T (p.Ala1283=)	SMC4|TRIM59-IFT80	not provided	Uncertain significance	no assertion criteria provided	3	160151579	3	160433791	91919	97397
NM_015938.4(NMD3):c.503C>T (p.Thr168Ile)	NMD3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	160952926	3	161235138	161698	171356
NM_001041.3(SI):c.2094C>A (p.Phe698Leu)	SI	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	164758793	3	165041005	161506	171357
NM_001348951.1(WDR49):c.2432C>A (p.Ser811Ter)	WDR49	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	167245747	3	167527959	161841	171358
NM_005241.3(MECOM):c.2750T>C (p.Val917Ala)	MECOM	not provided	Uncertain significance	no assertion criteria provided	3	168807875	3	169090087	91962	97440
NM_005241.3(MECOM):c.1636C>T (p.Gln546Ter)	MECOM	Adenoid cystic carcinoma	Uncertain significance(Last reviewed: Feb 1, 2018)	no assertion criteria provided	3	168833460	3	169115672	495126	486679
NM_001145097.2(SKIL):c.942A>T (p.Arg314Ser)	SKIL	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	170079061	3	170361273	161532	171359
GRCh37/hg19 3q26.31(chr3:172003745-172520446)x3	ECT2|GHSR|TNFSF10|NCEH1|FNDC3B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	3	172003745 - 172520446			221435	223164
NM_022470.3(ZMAT3):c.182G>A (p.Cys61Tyr)	ZMAT3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	178785359	3	179067571	161760	171360
NM_006218.3(PIK3CA):c.112C>G (p.Arg38Gly)	PIK3CA	Squamous cell lung carcinoma|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178916725	3	179198937	376496	363375
NM_006218.3(PIK3CA):c.112C>A (p.Arg38Ser)	PIK3CA	Squamous cell lung carcinoma|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178916725	3	179198937	376494	363373
NM_006218.3(PIK3CA):c.112C>T (p.Arg38Cys)	PIK3CA	Squamous cell lung carcinoma|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Malignant Colorectal Neoplasm	Likely pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	3	178916725	3	179198937	376493	363372
NM_006218.3(PIK3CA):c.113G>T (p.Arg38Leu)	PIK3CA	Squamous cell lung carcinoma|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178916726	3	179198938	376495	363374
NM_006218.3(PIK3CA):c.113G>A (p.Arg38His)	PIK3CA	Squamous cell lung carcinoma|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178916726	3	179198938	376492	363371
NM_006218.3(PIK3CA):c.241G>A (p.Glu81Lys)	PIK3CA	Medulloblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178916854	3	179199066	376478	363357
NM_006218.3(PIK3CA):c.248T>C (p.Phe83Ser)	PIK3CA	CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH, SOMATIC	Pathogenic(Last reviewed: Oct 9, 2018)	no assertion criteria provided	3	178916861	3	179199073	585023	576075
NM_006218.3(PIK3CA):c.263G>A (p.Arg88Gln)	PIK3CA	Squamous cell carcinoma of the head and neck|Neoplasm of the breast|Glioblastoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178916876	3	179199088	376049	362928
NM_006218.3(PIK3CA):c.311C>T (p.Pro104Leu)	PIK3CA	PIK3CA related overgrowth spectrum	Likely pathogenic(Last reviewed: Dec 31, 2013)	no assertion criteria provided	3	178916924	3	179199136	217291	213941
NM_006218.3(PIK3CA):c.316G>C (p.Gly106Arg)	PIK3CA	Squamous cell lung carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178916929	3	179199141	376480	363359
NM_006218.3(PIK3CA):c.317G>T (p.Gly106Val)	PIK3CA	Squamous cell lung carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Cowden syndrome|Colorectal Neoplasms|Uterine cervical neoplasms|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	3	178916930	3	179199142	376479	363358
NM_006218.3(PIK3CA):c.331A>G (p.Lys111Glu)	PIK3CA	Multiple myeloma|Neuroblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178916944	3	179199156	376482	363361
NM_006218.3(PIK3CA):c.332A>G (p.Lys111Arg)	PIK3CA	Multiple myeloma|Neuroblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178916945	3	179199157	376484	363363
NM_006218.3(PIK3CA):c.333G>C (p.Lys111Asn)	PIK3CA	Multiple myeloma|Neuroblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178916946	3	179199158	376483	363362
NM_006218.3(PIK3CA):c.353G>A (p.Gly118Asp)	PIK3CA	Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Cowden syndrome 5|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Uterine cervical neoplasms|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178917478	3	179199690	156446	166218
NM_006218.3(PIK3CA):c.1030G>A (p.Val344Met)	PIK3CA	Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|not provided|Neoplasm of the breast|Glioblastoma|Neoplasm of the large intestine|Cowden syndrome|Colorectal Neoplasms|Uterine cervical neoplasms|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, multiple submitters, no conflicts	3	178921548	3	179203760	376498	363377
NM_006218.3(PIK3CA):c.1031T>C (p.Val344Ala)	PIK3CA	Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Neoplasm of the breast|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178921549	3	179203761	376499	363378
NM_006218.3(PIK3CA):c.1031T>G (p.Val344Gly)	PIK3CA	Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Neoplasm of the breast|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178921549	3	179203761	376497	363376
NM_006218.3(PIK3CA):c.1033A>C (p.Asn345His)	PIK3CA	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178921551	3	179203763	376490	363369
NM_006218.3(PIK3CA):c.1034A>C (p.Asn345Thr)	PIK3CA	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178921552	3	179203764	376489	363368
NM_006218.3(PIK3CA):c.1034A>T (p.Asn345Ile)	PIK3CA	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178921552	3	179203764	376488	363367
NM_006218.3(PIK3CA):c.1035T>G (p.Asn345Lys)	PIK3CA	Neoplasm of the breast|Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	178921553	3	179203765	376051	362930
NM_006218.3(PIK3CA):c.1035T>A (p.Asn345Lys)	PIK3CA	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178921553	3	179203765	376050	362929
NM_006218.3(PIK3CA):c.1133G>A (p.Cys378Tyr)	PIK3CA	Megalencephaly cutis marmorata telangiectatica congenita|PIK3CA related overgrowth spectrum	Pathogenic(Last reviewed: Dec 8, 2014)	no assertion criteria provided	3	178922364	3	179204576	39704	48303
NM_006218.3(PIK3CA):c.1252G>A (p.Glu418Lys)	PIK3CA	not specified	Uncertain significance(Last reviewed: Nov 19, 2012)	criteria provided, single submitter	3	178927974	3	179210186	45464	54631
NM_006218.3(PIK3CA):c.1258T>G (p.Cys420Gly)	PIK3CA	Squamous cell lung carcinoma|Neoplasm of the breast|Neoplasm of the large intestine|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178927980	3	179210192	376469	363348
NM_006218.3(PIK3CA):c.1258T>C (p.Cys420Arg)	PIK3CA	Neoplasm of ovary|Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi|Squamous cell lung carcinoma|Neoplasm of the breast|Neoplasm of the large intestine|PIK3CA related overgrowth spectrum|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH, SOMATIC	Pathogenic(Last reviewed: Oct 8, 2010)	criteria provided, single submitter	3	178927980	3	179210192	31945	40610
NM_006218.3(PIK3CA):c.1357G>C (p.Glu453Gln)	PIK3CA	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178928079	3	179210291	376471	363350
NM_006218.3(PIK3CA):c.1357G>A (p.Glu453Lys)	PIK3CA	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178928079	3	179210291	376470	363349
NM_006218.3(PIK3CA):c.1359A>T (p.Glu453Asp)	PIK3CA	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178928081	3	179210293	376472	363351
NM_006218.3(PIK3CA):c.1359_1373delAGATTTGCTGAACCC (p.Glu453_Pro458delinsAsp)	PIK3CA	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Oct 21, 2010)	criteria provided, single submitter	3	178928081 - 178928095	3	179210293 - 179210307	45465	54632
NM_006218.3(PIK3CA):c.1359_1361delAGA (p.Glu453del)	PIK3CA	Megalencephaly cutis marmorata telangiectatica congenita|not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	3	178928081 - 178928083	3	179210293 - 179210295	39706	48305
NM_006218.3(PIK3CA):c.1412C>T (p.Pro471Leu)	PIK3CA	Trabecular adenocarcinoma	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	3	178928226	3	179210438	376359	363238
NM_006218.3(PIK3CA):c.1540-56C>T	PIK3CA	Endometrial carcinoma	not provided	no assertion provided	3	178935942	3	179218154	132953	136702
NM_006218.3(PIK3CA):c.1571G>A (p.Arg524Lys)	PIK3CA	Familial cancer of breast	not provided	no assertion provided	3	178936029	3	179218241	132954	136703
NM_006218.3(PIK3CA):c.1616C>G (p.Pro539Arg)	PIK3CA	Neoplasm of the breast	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	178936074	3	179218286	376243	363122
NM_006218.3(PIK3CA):c.1624G>C (p.Glu542Gln)	PIK3CA	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Non-small cell lung cancer|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178936082	3	179218294	376244	363123
NM_006218.3(PIK3CA):c.1624G>A (p.Glu542Lys)	PIK3CA	Liver cancer|Squamous cell carcinoma of the head and neck|Neoplasm of ovary|Small cell lung cancer|Lung adenocarcinoma|Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi|Non-small cell lung cancer|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Ovarian Neoplasms|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH, SOMATIC	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178936082	3	179218294	31944	40609
NM_006218.3(PIK3CA):c.1625A>G (p.Glu542Gly)	PIK3CA	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Inborn genetic diseases|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	3	178936083	3	179218295	376475	363354
NM_006218.3(PIK3CA):c.1625A>T (p.Glu542Val)	PIK3CA	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178936083	3	179218295	376474	363353
NM_006218.3(PIK3CA):c.1625A>C (p.Glu542Ala)	PIK3CA	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178936083	3	179218295	376473	363352
NM_006218.3(PIK3CA):c.1633G>C (p.Glu545Gln)	PIK3CA	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Non-small cell lung cancer|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Head and Neck Neoplasms|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Carcinoma of gallbladder|Histone Methylation Therapy response	Pathogenic/Likely pathogenic, drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	3	178936091	3	179218303	375896	362775
NM_006218.3(PIK3CA):c.1633G>A (p.Glu545Lys)	PIK3CA	Liver cancer|Megalencephaly cutis marmorata telangiectatica congenita|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Keratosis, seborrheic|Small cell lung cancer|Ovarian epithelial cancer|Lung adenocarcinoma|Non-small cell lung cancer|Breast cancer, somatic|Carcinoma of colon|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of stomach|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Breast adenocarcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Sarcoma|Ovarian Neoplasms|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Carcinoma of gallbladder	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178936091	3	179218303	13655	28694
NM_006218.3(PIK3CA):c.1634A>T (p.Glu545Val)	PIK3CA	Neoplasm of the breast|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	3	178936092	3	179218304	375897	362776
NM_006218.3(PIK3CA):c.1634A>C (p.Glu545Ala)	PIK3CA	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Neoplasm of ovary|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Ovarian Neoplasms|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Carcinoma of gallbladder	Pathogenic(Last reviewed: Dec 23, 2010)	criteria provided, single submitter	3	178936092	3	179218304	13659	28698
NM_006218.3(PIK3CA):c.1634A>G (p.Glu545Gly)	PIK3CA	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Epidermal nevus|Small cell lung cancer|Lung adenocarcinoma|Carcinoma of colon|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Cutaneous melanoma|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Carcinoma of gallbladder	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178936092	3	179218304	13656	28695
NM_006218.3(PIK3CA):c.1635G>C (p.Glu545Asp)	PIK3CA	Neoplasm of the breast	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	178936093	3	179218305	376245	363124
NM_006218.3(PIK3CA):c.1635G>T (p.Glu545Asp)	PIK3CA	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|PIK3CA related overgrowth spectrum|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Carcinoma of gallbladder	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178936093	3	179218305	217293	213943
NM_006218.3(PIK3CA):c.1636C>A (p.Gln546Lys)	PIK3CA	Lung cancer|Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Malignant tumor of prostate|Ovarian epithelial cancer|Carcinoma of colon|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|PIK3CA related overgrowth spectrum|Ovarian Neoplasms|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178936094	3	179218306	13657	28696
NM_006218.3(PIK3CA):c.1636C>G (p.Gln546Glu)	PIK3CA	Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Breast cancer, somatic|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Breast adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178936094	3	179218306	13654	28693
NM_006218.3(PIK3CA):c.1637A>T (p.Gln546Leu)	PIK3CA	Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178936095	3	179218307	375899	362778
NM_006218.3(PIK3CA):c.1637A>C (p.Gln546Pro)	PIK3CA	Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178936095	3	179218307	375898	362777
NM_006218.3(PIK3CA):c.1637A>G (p.Gln546Arg)	PIK3CA	Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Neoplasm of ovary|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Aug 10, 2010)	criteria provided, single submitter	3	178936095	3	179218307	45466	54633
NM_006218.3(PIK3CA):c.1638G>T (p.Gln546His)	PIK3CA	Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178936096	3	179218308	376491	363370
NM_006218.3(PIK3CA):c.1645G>A (p.Asp549Asn)	PIK3CA	Neoplasm of the breast|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	3	178936103	3	179218315	375900	362779
NM_006218.3(PIK3CA):c.1664G>A (p.Arg555Lys)	PIK3CA	Familial cancer of breast	not provided	no assertion provided	3	178936122	3	179218334	132955	136704
NM_006218.3(PIK3CA):c.1664+18G>A	PIK3CA	Familial cancer of breast	not provided	no assertion provided	3	178936140	3	179218352	132956	136705
NM_006218.3(PIK3CA):c.1769G>A (p.Trp590Ter)	PIK3CA	Familial cancer of breast	not provided	no assertion provided	3	178937381	3	179219593	132965	136714
NM_006218.3(PIK3CA):c.2102A>C (p.His701Pro)	PIK3CA	Neoplasm of the breast	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	178938860	3	179221072	376052	362931
NM_006218.3(PIK3CA):c.2176G>A (p.Glu726Lys)	PIK3CA	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|not provided|Neoplasm of the breast|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Inborn genetic diseases|Colorectal Neoplasms|Uterine cervical neoplasms	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, multiple submitters, no conflicts	3	178938934	3	179221146	376476	363355
NM_006218.3(PIK3CA):c.2177A>C (p.Glu726Ala)	PIK3CA	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the breast|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178938935	3	179221147	376477	363356
NM_006218.3(PIK3CA):c.2740G>A (p.Gly914Arg)	PIK3CA	Megalencephaly cutis marmorata telangiectatica congenita|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	3	178947865	3	179230077	39703	48302
NM_006218.3(PIK3CA):c.3062A>G (p.Tyr1021Cys)	PIK3CA	Neoplasm of the breast	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	178952007	3	179234219	376246	363125
NM_006218.3(PIK3CA):c.3073A>G (p.Thr1025Ala)	PIK3CA	Non-small cell lung cancer	Pathogenic(Last reviewed: Aug 10, 2011)	criteria provided, single submitter	3	178952018	3	179234230	45467	54634
NM_006218.3(PIK3CA):c.3074C>G (p.Thr1025Ser)	PIK3CA	Endometrial carcinoma	Likely pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	3	178952019	3	179234231	495324	486818
NM_006218.3(PIK3CA):c.3127A>T (p.Met1043Leu)	PIK3CA	Squamous cell carcinoma of the head and neck|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178952072	3	179234284	376487	363366
NM_006218.3(PIK3CA):c.3127A>G (p.Met1043Val)	PIK3CA	Squamous cell carcinoma of the head and neck|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178952072	3	179234284	376485	363364
NM_006218.3(PIK3CA):c.3128T>C (p.Met1043Thr)	PIK3CA	Squamous cell carcinoma of the head and neck|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178952073	3	179234285	376486	363365
NM_006218.3(PIK3CA):c.3129G>T (p.Met1043Ile)	PIK3CA	Neoplasm of the large intestine|Cowden syndrome|PIK3CA related overgrowth spectrum|Colorectal Neoplasms	Pathogenic(Last reviewed: Nov 18, 2017)	criteria provided, single submitter	3	178952074	3	179234286	217292	213942
NM_006218.3(PIK3CA):c.3129G>A (p.Met1043Ile)	PIK3CA	Squamous cell carcinoma of the head and neck|Non-small cell lung cancer|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Cowden syndrome|PIK3CA related overgrowth spectrum|Colorectal Neoplasms|Neoplasm of the thyroid gland|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	3	178952074	3	179234286	179173	173901
NM_006218.3(PIK3CA):c.3139C>T (p.His1047Tyr)	PIK3CA	Liver cancer|Megalencephaly cutis marmorata telangiectatica congenita|Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Non-small cell lung cancer|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Cowden syndrome|Colorectal Neoplasms|Uterine cervical neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Malignant tumor of floor of mouth	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, multiple submitters, no conflicts	3	178952084	3	179234296	39705	48304
NM_006218.3(PIK3CA):c.3140A>T (p.His1047Leu)	PIK3CA	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi|Non-small cell lung cancer|Breast cancer, somatic|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Stroke|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Breast adenocarcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Macrodactyly of toe|Neoplasm of the large intestine|Carcinoma of esophagus|PIK3CA related overgrowth spectrum|Ovarian Neoplasms|Colorectal Neoplasms|Uterine cervical neoplasms|Stroke|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH, SOMATIC	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	3	178952085	3	179234297	13653	28692
NM_006218.3(PIK3CA):c.3140A>G (p.His1047Arg)	PIK3CA	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Keratosis, seborrheic|Neoplasm of ovary|Ovarian epithelial cancer|Lung adenocarcinoma|Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi|Non-small cell lung cancer|Breast cancer, somatic|Carcinoma of colon|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of stomach|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Breast adenocarcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Neoplasm|PIK3CA related overgrowth spectrum|Ovarian Neoplasms|Colorectal Neoplasms|Uterine cervical neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Rosette-forming glioneuronal tumor|MACRODACTYLY, SOMATIC	Pathogenic	criteria provided, multiple submitters, no conflicts	3	178952085	3	179234297	13652	28691
NM_006218.3(PIK3CA):c.3141T>G (p.His1047Gln)	PIK3CA	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	3	178952086	3	179234298	376481	363360
NM_006218.3(PIK3CA):c.3145G>A (p.Gly1049Ser)	PIK3CA	Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	178952090	3	179234302	376247	363126
NM_006218.3(PIK3CA):c.3145G>C (p.Gly1049Arg)	PIK3CA	Malignant tumor of floor of mouth	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	3	178952090	3	179234302	376053	362932
NM_006218.3(PIK3CA):c.3203dup (p.Asn1068Lysfs)	PIK3CA	Liver cancer|Neoplasm of stomach|Hepatocellular carcinoma	Pathogenic(Last reviewed: Feb 17, 2005)	no assertion criteria provided	3	178952148	3	179234360	13658	28697
NM_130446.3(KLHL6):c.268C>G (p.Leu90Val)	KLHL6	Monoclonal B-Cell Lymphocytosis	Uncertain significance(Last reviewed: Dec 15, 2015)	no assertion criteria provided	3	183273174	3	183555386	222964	224680
NM_130446.3(KLHL6):c.247T>C (p.Phe83Leu)	KLHL6	Monoclonal B-Cell Lymphocytosis	Uncertain significance(Last reviewed: Dec 15, 2015)	no assertion criteria provided	3	183273195	3	183555407	222965	224681
NM_018023.4(YEATS2):c.3131C>T (p.Pro1044Leu)	YEATS2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	3	183515744	3	183797956	221300	223029
NM_005688.3(ABCC5):c.1925A>G (p.Asn642Ser)	ABCC5	not provided	Uncertain significance	no assertion criteria provided	3	183683198	3	183965410	91967	97445
NM_018358.2(ABCF3):c.1327C>T (p.Arg443Trp)	ABCF3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	183907655	3	184189867	161716	171361
NM_001622.3(AHSG):c.574-298T>G	AHSG	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	3	186336027	3	186618238	126865	132378
NM_001622.3(AHSG):c.574-149A>G	AHSG	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	3	186336176	3	186618387	126866	132379
NM_001114980.1(TP63):c.395G>A (p.Arg132His)	TP63	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	189582118	3	189864329	161514	171362
GRCh37/hg19 3q29(chr3:193333511-194338436)x3	CPN2|GP5|HES1|OPA1|ATP13A3|TMEM44|LRRC15	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	3	193333511 - 194338436			221436	223165
NM_001136049.2(LMLN):c.1117G>T (p.Gly373Cys)	LMLN	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	3	197723115	3	197996244	161526	171363
NM_000283.3(PDE6B):c.1401+8_1401+9insA	PDE6B	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	651291 - 651292	4	657502 - 657503	161463	171381
NM_001366919.1(RNF212):c.314T>C (p.Leu105Ser)	RNF212	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	4	1079732	4	1085944	221323	223052
NM_000142.4(FGFR3):c.742C>T (p.Arg248Cys)	FGFR3	Achondroplasia|Multiple myeloma|Squamous cell carcinoma of the head and neck|Thanatophoric dysplasia type 1|Keratosis, seborrheic|Epidermal nevus|Lung adenocarcinoma|Skeletal dysplasia|Squamous cell lung carcinoma|Skeletal dysplasia with acanthosis nigricans|Short stature|Growth delay|not provided|Short ribs|Narrow chest|Growth delay|Small for gestational age|Bell-shaped thorax|Skeletal dysplasia|Femoral bowing|Bowed humerus|Transitional cell carcinoma of the bladder|Disproportionate short-limb short stature|Lethal short-limbed short stature|Lower limb undergrowth|Upper limb undergrowth|Carcinoma	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, multiple submitters, no conflicts	4	1803564	4	1801837	16332	31371
NM_000142.4(FGFR3):c.746C>G (p.Ser249Cys)	FGFR3	Carcinoma of cervix|Squamous cell carcinoma of the head and neck|Thanatophoric dysplasia type 1|Bladder cancer, somatic|Keratosis, seborrheic|Squamous cell lung carcinoma|not provided|Bladder carcinoma|Transitional cell carcinoma of the bladder|Papillary renal cell carcinoma, sporadic|Carcinoma	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, multiple submitters, no conflicts	4	1803568	4	1801841	16339	31378
NM_001163213.1(FGFR3):c.850delC (p.His284Thrfs)	FGFR3	Carcinoma of colon	Pathogenic(Last reviewed: Oct 18, 2017)	no assertion criteria provided	4	1803672	4	1801945	16352	31391
NM_000142.4(FGFR3):c.964G>A (p.Glu322Lys)	FGFR3	Carcinoma of colon	Pathogenic(Last reviewed: Oct 18, 2017)	no assertion criteria provided	4	1805452	4	1803725	16351	31390
NM_000142.4(FGFR3):c.991T>C (p.Phe331Leu)	FGFR3	Neuroblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	4	1805479	4	1803752	438762	432400
NM_000142.4(FGFR3):c.1108G>T (p.Gly370Cys)	FGFR3	Thanatophoric dysplasia type 1|Epidermal nevus|not provided|Bladder carcinoma	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	4	1806089	4	1804362	16359	31398
NM_000142.4(FGFR3):c.1111A>T (p.Ser371Cys)	FGFR3	Thanatophoric dysplasia type 1|not provided|Bladder carcinoma|Carcinoma	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	4	1806092	4	1804365	16333	31372
NM_000142.4(FGFR3):c.1118A>G (p.Tyr373Cys)	FGFR3	Thanatophoric dysplasia type 1|not provided|Myeloproliferative disorder|Bladder carcinoma|Transitional cell carcinoma of the bladder|Papillary renal cell carcinoma, sporadic|Carcinoma	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	4	1806099	4	1804372	16342	31381
NM_000142.4(FGFR3):c.1138G>A (p.Gly380Arg)	FGFR3	Achondroplasia|Epidermal nevus|not provided|Craniosynostosis	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	4	1806119	4	1804392	16327	31366
NM_000142.4(FGFR3):c.1172C>A (p.Ala391Glu)	FGFR3	Crouzon syndrome with acanthosis nigricans|not provided|Craniosynostosis|Inborn genetic diseases|Carcinoma	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	4	1806153	4	1804426	16329	31368
NM_001163213.1(FGFR3):c.1663G>A (p.Val555Met)	FGFR3	not provided|Myeloproliferative disorder	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	4	1807488	4	1805761	376216	363095
NM_000142.4(FGFR3):c.1887C>T (p.Asn629=)	FGFR3	Sarcoma	not provided	no assertion provided	4	1807828	4	1806101	132957	136706
NM_000142.4(FGFR3):c.1908C>G (p.Phe636Leu)	FGFR3	Sarcoma	not provided	no assertion provided	4	1807849	4	1806122	132958	136707
NM_000142.4(FGFR3):c.1935C>T (p.Leu645=)	FGFR3	Sarcoma	not provided	no assertion provided	4	1807876	4	1806149	132959	136708
NM_000142.4(FGFR3):c.1943A>C (p.Tyr648Ser)	FGFR3	Acanthosis nigricans	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	1807884	4	1806157	376699	363578
NM_001163213.1(FGFR3):c.1949A>T (p.Tyr650Phe)	FGFR3	Carcinoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	1807884	4	1806157	376698	363577
NM_000142.4(FGFR3):c.1948A>C (p.Lys650Gln)	FGFR3	Acanthosis nigricans|Bladder cancer, somatic|Hypochondroplasia|Bladder carcinoma|Craniosynostosis	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	4	1807889	4	1806162	16348	31387
NM_000142.4(FGFR3):c.1948A>G (p.Lys650Glu)	FGFR3	Multiple myeloma|Thanatophoric dysplasia, type 2|Spermatocytic seminoma, somatic|Spermatocytic seminoma|not provided|Carcinoma	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	4	1807889	4	1806162	16331	31370
NM_001163213.1(FGFR3):c.2095G>T (p.Gly699Cys)	FGFR3	Bladder carcinoma|Carcinoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	1808331	4	1806604	376248	363127
NM_022965.3(FGFR3):c.1793G>T (p.Gly598Val)	FGFR3	Neoplasm of ovary	not provided	no assertion provided	4	1808371	4	1806644	132967	136716
NM_022965.3(FGFR3):c.1799G>A (p.Arg600His)	FGFR3	Sarcoma	not provided	no assertion provided	4	1808377	4	1806650	132968	136717
NM_012318.2(LETM1):c.286G>A (p.Val96Met)	LETM1	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	4	1843382	4	1841655	487800	480807
NM_181808.3(POLN):c.2267G>A (p.Arg756Gln)	POLN	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	2083401	4	2081674	161845	171375
NM_002337.3(LRPAP1):c.347A>G (p.Asn116Ser)	LRPAP1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	3526636	4	3524909	161595	171376
NM_020041.2(SLC2A9):c.1240C>T (p.Leu414=)	SLC2A9	not provided	Uncertain significance	no assertion criteria provided	4	9889242	4	9887618	92005	97483
NM_012161.3(FBXL5):c.1654delT (p.Cys552Valfs)	FBXL5	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	15627071	4	15625448	219315	221004
NM_138389.3(FAM114A1):c.704G>C (p.Gly235Ala)	FAM114A1	not provided	Uncertain significance	no assertion criteria provided	4	38910259	4	38908638	92026	97504
NM_173536.3(GABRG1):c.32C>T (p.Pro11Leu)	GABRG1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	46125899	4	46123882	161829	171377
NM_006587.3(CORIN):c.1400C>G (p.Pro467Arg)	CORIN	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	47667238	4	47665221	161648	171378
NM_001142564.1(CNGA1):c.1640G>A (p.Arg547His)	CNGA1|LOC101927157	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	47939078	4	47937061	219316	221005
NM_145263.3(SPATA18):c.991G>A (p.Val331Ile)	SPATA18	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	52943177	4	52077011	161809	171379
NM_006206.5(PDGFRA):c.1679_1693delGGGTCATTGAATCAA (p.Arg560_Ser564del)	PDGFRA	Gastrointestinal stroma tumor	Pathogenic(Last reviewed: Jan 31, 2003)	no assertion criteria provided	4	55141033 - 55141047	4	54274866 - 54274880	13548	28587
NM_006206.5(PDGFRA):c.1681_1682insAGAGGG (p.Arg560_Val561insGluArg)	PDGFRA	Gastrointestinal stroma tumor	Pathogenic(Last reviewed: Jan 31, 2003)	no assertion criteria provided	4	55141035 - 55141036	4	54274868 - 54274869	13547	28586
NM_006206.5(PDGFRA):c.1682T>C (p.Val561Ala)	PDGFRA	Gastrointestinal stroma tumor	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	4	55141036	4	54274869	376354	363233
NM_006206.5(PDGFRA):c.1682T>A (p.Val561Asp)	PDGFRA	Gastrointestinal stroma tumor|Gastrointestinal stromal tumor, familial	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	4	55141036	4	54274869	13546	28585
NM_006206.5(PDGFRA):c.1696_1713del18 (p.Ser566_Glu571del)	PDGFRA	Gastrointestinal stroma tumor	Pathogenic(Last reviewed: Jan 31, 2003)	no assertion criteria provided	4	55141050 - 55141067	4	54274883 - 54274900	13549	28588
NM_006206.5(PDGFRA):c.1729C>T (p.Pro577Ser)	PDGFRA	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	4	55141083	4	54274916	376181	363060
NM_006206.5(PDGFRA):c.1973T>C (p.Val658Ala)	PDGFRA	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	4	55144144	4	54277977	376182	363061
NM_006206.5(PDGFRA):c.1977C>G (p.Asn659Lys)	PDGFRA	Gastrointestinal stroma tumor	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55144148	4	54277981	375902	362781
NM_006206.5(PDGFRA):c.1977C>A (p.Asn659Lys)	PDGFRA	Gastrointestinal stroma tumor	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55144148	4	54277981	375901	362780
NM_006206.5(PDGFRA):c.2521_2526delAGAGAC (p.Arg841_Asp842del)	PDGFRA	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	4	55152089 - 55152094	4	54285922 - 54285927	376249	363128
NM_006206.5(PDGFRA):c.2522G>A (p.Arg841Lys)	PDGFRA	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	4	55152090	4	54285923	376183	363062
NM_006206.5(PDGFRA):c.2524_2532delGACATCATG (p.Asp842_Met844del)	PDGFRA	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	4	55152092 - 55152100	4	54285925 - 54285933	376251	363130
NM_006206.5(PDGFRA):c.2524G>T (p.Asp842Tyr)	PDGFRA	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	4	55152092	4	54285925	376250	363129
NM_006206.5(PDGFRA):c.2524_2525delGAinsAT (p.Asp842Ile)	PDGFRA	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	4	55152092 - 55152093	4	54285925 - 54285926	376055	362934
NM_006206.5(PDGFRA):c.2525A>T (p.Asp842Val)	PDGFRA	Gastrointestinal stroma tumor	Pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	4	55152093	4	54285926	13543	28582
NM_006206.5(PDGFRA):c.2526_2537delCATCATGCATGA (p.Ile843_Asp846del)	PDGFRA	Gastrointestinal stroma tumor	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	4	55152094 - 55152105	4	54285927 - 54285938	13544	28583
NM_006206.5(PDGFRA):c.2527_2538delATCATGCATGAT (p.Ile843_Asp846del)	PDGFRA	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	4	55152095 - 55152106	4	54285928 - 54285939	376253	363132
NM_006206.5(PDGFRA):c.2533C>T (p.His845Tyr)	PDGFRA	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	4	55152101	4	54285934	376184	363063
NM_006206.5(PDGFRA):c.2533_2544delCATGATTCGAAC (p.His845_Asn848del)	PDGFRA	Gastrointestinal stroma tumor	Pathogenic(Last reviewed: Jan 31, 2003)	no assertion criteria provided	4	55152101 - 55152112	4	54285934 - 54285945	13545	28584
NM_006206.5(PDGFRA):c.2536G>T (p.Asp846Tyr)	PDGFRA	Gastrointestinal stroma tumor|Gastrointestinal stromal tumor, familial	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	4	55152104	4	54285937	13551	28590
NM_006206.5(PDGFRA):c.2558G>A (p.Gly853Asp)	PDGFRA	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	4	55152126	4	54285959	376185	363064
NM_000222.2(KIT):c.154G>A (p.Asp52Asn)	KIT	Gastrointestinal stroma tumor|Neoplasm	Uncertain significance(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	4	55561764	4	54695598	376254	363133
NM_000222.2(KIT):c.1468G>A (p.Glu490Lys)	KIT	Thymoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55592144	4	54725978	375903	362782
NM_000222.2(KIT):c.1510T>C (p.Phe504Leu)	KIT	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55592186	4	54726020	375904	362783
NM_000222.2(KIT):c.1621A>C (p.Met541Leu)	KIT	Gastrointestinal stroma tumor|Chronic myelogenous leukemia|Mastocytosis|Partial albinism|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	55593464	4	54727298	41599	50038
NM_000222.2(KIT):c.1648_1674del (p.Lys550_Lys558del)	KIT	Gastrointestinal stroma tumor	Pathogenic(Last reviewed: Jun 16, 2005)	no assertion criteria provided	4	55593582 - 55593608	4	54727416 - 54727442	13857	28896
NM_000222.2(KIT):c.1650A>T (p.Lys550Asn)	KIT	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55593584	4	54727418	375906	362785
NM_000222.2(KIT):c.1650A>C (p.Lys550Asn)	KIT	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55593584	4	54727418	375905	362784
NM_000222.2(KIT):c.1652_1666del (p.Pro551_Val555del)	KIT	Gastrointestinal stroma tumor	Pathogenic(Last reviewed: Jan 23, 1998)	no assertion criteria provided	4	55593586 - 55593600	4	54727420 - 54727434	13854	28893
NM_000222.2(KIT):c.1657T>A (p.Tyr553Asn)	KIT	Cutaneous melanoma|Thymoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55593591	4	54727425	375907	362786
NM_000222.2(KIT):c.1669T>G (p.Trp557Gly)	KIT	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593603	4	54727437	376732	363611
NM_000222.2(KIT):c.1669T>C (p.Trp557Arg)	KIT	Gastrointestinal stroma tumor|Cutaneous melanoma|Thymoma	Likely pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	4	55593603	4	54727437	375909	362788
NM_000222.2(KIT):c.1669T>A (p.Trp557Arg)	KIT	Gastrointestinal stroma tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593603	4	54727437	375908	362787
NM_000222.2(KIT):c.1670_1671delGGinsTT (p.Trp557Phe)	KIT	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593604 - 55593605	4	54727438 - 54727439	376736	363615
NM_000222.2(KIT):c.1670G>C (p.Trp557Ser)	KIT	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593604	4	54727438	376731	363610
NM_000222.2(KIT):c.1671G>C (p.Trp557Cys)	KIT	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593605	4	54727439	376734	363613
NM_000222.2(KIT):c.1672A>G (p.Lys558Glu)	KIT	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593606	4	54727440	376733	363612
NM_000222.2(KIT):c.1672A>C (p.Lys558Gln)	KIT	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593606	4	54727440	376730	363609
NM_000222.2(KIT):c.1674G>T (p.Lys558Asn)	KIT	Gastrointestinal stroma tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593608	4	54727442	375911	362790
NM_000222.2(KIT):c.1674G>C (p.Lys558Asn)	KIT	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55593608	4	54727442	375910	362789
NM_000222.2(KIT):c.1675G>A (p.Val559Ile)	KIT	Gastrointestinal stroma tumor|Myeloproliferative Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	4	55593609	4	54727443	376056	362935
NM_000222.2(KIT):c.1676T>G (p.Val559Gly)	KIT	Gastrointestinal stroma tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593610	4	54727444	375912	362791
NM_000222.2(KIT):c.1676T>C (p.Val559Ala)	KIT	Gastrointestinal stroma tumor|Gastrointestinal stromal tumor, familial|Cutaneous mastocytosis|Cutaneous melanoma|Cutaneous mastocytosis|Thymoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593610	4	54727444	13865	28904
NM_000222.2(KIT):c.1676T>A (p.Val559Asp)	KIT	Gastrointestinal stroma tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593610	4	54727444	13856	28895
NM_000222.2(KIT):c.1676_1681delTTGTTG (p.Val559_Val560del)	KIT	Gastrointestinal stroma tumor	Pathogenic(Last reviewed: Jan 23, 1998)	no assertion criteria provided	4	55593610 - 55593615	4	54727444 - 54727449	13846	28885
NM_000222.2(KIT):c.1678_1728del (p.Val560_Leu576del)	KIT	Gastrointestinal stroma tumor	Uncertain significance(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	4	55593612 - 55593662	4	54727446 - 54727496	523644	514292
NM_000222.2(KIT):c.1679_1680delTTinsAA (p.Val560Glu)	KIT	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593613 - 55593614	4	54727447 - 54727448	376735	363614
NM_000222.2(KIT):c.1679T>G (p.Val560Gly)	KIT	Gastrointestinal stroma tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593613	4	54727447	375916	362795
NM_000222.2(KIT):c.1679T>C (p.Val560Ala)	KIT	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55593613	4	54727447	375915	362794
NM_000222.2(KIT):c.1679T>A (p.Val560Asp)	KIT	Gastrointestinal stroma tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593613	4	54727447	375914	362793
NM_000222.2(KIT):c.1679_1681delTTG (p.Val560del)	KIT	Gastrointestinal stromal tumor, familial|Cutaneous melanoma|Thymoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	4	55593612 - 55593614	4	54727447 - 54727449	375913	362792
NM_000222.2(KIT):c.1696A>G (p.Asn566Asp)	KIT	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55593630	4	54727464	375917	362796
NM_000222.2(KIT):c.1706T>G (p.Val569Gly)	KIT	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55593640	4	54727474	375918	362797
NM_000222.2(KIT):c.1727T>C (p.Leu576Pro)	KIT	Gastrointestinal stroma tumor|Non-small cell lung cancer|Cutaneous melanoma|Thymoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55593661	4	54727495	375919	362798
NM_000222.2(KIT):c.1730_1738delCTTATGATC (p.Pro577_Asp579del)	KIT	Thymoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55593664 - 55593672	4	54727498 - 54727506	375920	362799
NM_000222.2(KIT):c.1924A>G (p.Lys642Glu)	KIT	Gastrointestinal stroma tumor|Malignant melanoma of skin|Gastrointestinal stromal tumor, familial|Hematologic neoplasm|Cutaneous melanoma|Adenocarcinoma of stomach	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	55594221	4	54728055	13866	28905
NM_000222.2(KIT):c.1926A>C (p.Lys642Asn)	KIT	Malignant melanoma of skin|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	55594223	4	54728057	376440	363319
NM_000222.2(KIT):c.1961T>A (p.Val654Glu)	KIT	Cutaneous melanoma	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55594258	4	54728092	376057	362936
NM_000222.2(KIT):c.1961T>C (p.Val654Ala)	KIT	Gastrointestinal stroma tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	4	55594258	4	54728092	375921	362800
NM_000222.2(KIT):c.1964A>G (p.Asn655Ser)	KIT	Gastrointestinal stroma tumor|Cutaneous melanoma	Uncertain significance(Last reviewed: Apr 28, 2018)	criteria provided, single submitter	4	55594261	4	54728095	375922	362801
NM_000222.2(KIT):c.1965T>G (p.Asn655Lys)	KIT	Gastrointestinal stroma tumor|Cutaneous melanoma	Uncertain significance(Last reviewed: Dec 23, 2017)	criteria provided, single submitter	4	55594262	4	54728096	375924	362803
NM_000222.2(KIT):c.1965T>A (p.Asn655Lys)	KIT	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55594262	4	54728096	375923	362802
NM_000222.2(KIT):c.2009C>T (p.Thr670Ile)	KIT	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	4	55595519	4	54729353	376058	362937
NM_000222.2(KIT):c.2089C>T (p.His697Tyr)	KIT	Gastrointestinal stroma tumor|Thymoma	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	4	55595599	4	54729433	375925	362804
NM_000222.2(KIT):c.2446_2447delGAinsAT (p.Asp816Ile)	KIT	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55599320 - 55599321	4	54733154 - 54733155	375926	362805
NM_000222.2(KIT):c.2446G>C (p.Asp816His)	KIT	Gastrointestinal stroma tumor|Malignant tumor of testis|not provided|Hematologic neoplasm|Cutaneous melanoma|Dysgerminoma|DYSGERMINOMA	Pathogenic(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	4	55599320	4	54733154	13863	28902
NM_000222.2(KIT):c.2446G>T (p.Asp816Tyr)	KIT	Gastrointestinal stroma tumor|Acute myeloid leukemia|Hematologic neoplasm|Cutaneous melanoma|MASTOCYTOSIS, CUTANEOUS AND SYSTEMIC, SOMATIC	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	55599320	4	54733154	13860	28899
NM_000222.2(KIT):c.2447A>T (p.Asp816Val)	KIT	Gastrointestinal stroma tumor|Mast cell leukemia|Cutaneous mastocytosis|Acute myeloid leukemia|Hematologic neoplasm|Dysgerminoma|Cutaneous mastocytosis|DYSGERMINOMA|MAST CELL LEUKEMIA, SOMATIC|MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC DISORDER, SOMATIC|MASTOCYTOSIS, SYSTEMIC, SOMATIC	Uncertain significance(Last reviewed: Mar 8, 2017)	criteria provided, single submitter	4	55599321	4	54733155	13852	28891
NM_000222.2(KIT):c.2458G>T (p.Asp820Tyr)	KIT	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55599332	4	54733166	375928	362807
NM_000222.2(KIT):c.2458G>C (p.Asp820His)	KIT	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55599332	4	54733166	375927	362806
NM_000222.2(KIT):c.2459A>T (p.Asp820Val)	KIT	Mast cell disease, systemic	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	4	55599333	4	54733167	376148	363027
NM_000222.2(KIT):c.2459A>G (p.Asp820Gly)	KIT	MASTOCYTOSIS, SYSTEMIC, SOMATIC	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	4	55599333	4	54733167	13853	28892
NM_000222.2(KIT):c.2460T>A (p.Asp820Glu)	KIT	Thymoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	4	55599334	4	54733168	375929	362808
NM_000222.2(KIT):c.2465A>T (p.Asn822Ile)	KIT	Gastrointestinal stroma tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	4	55599339	4	54733173	375930	362809
NM_000222.2(KIT):c.2466T>G (p.Asn822Lys)	KIT	Gastrointestinal stroma tumor|Acute myeloid leukemia|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	4	55599340	4	54733174	375932	362811
NM_000222.2(KIT):c.2466T>A (p.Asn822Lys)	KIT	Gastrointestinal stroma tumor|Acute myeloid leukemia|Cutaneous melanoma	Uncertain significance(Last reviewed: Jun 2, 2018)	criteria provided, single submitter	4	55599340	4	54733174	375931	362810
NM_000222.2(KIT):c.2467T>G (p.Tyr823Asp)	KIT	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	4	55599341	4	54733175	376101	362980
NM_000222.2(KIT):c.2474T>C (p.Val825Ala)	KIT	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	4	55599348	4	54733182	376256	363135
NM_000222.2(KIT):c.2485G>C (p.Ala829Pro)	KIT	Gastrointestinal stroma tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	4	55602664	4	54736498	375933	362812
NM_000222.2(KIT):c.2515G>A (p.Glu839Lys)	KIT	Gastrointestinal stroma tumor|Mastocytosis	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	4	55602694	4	54736528	13862	28901
NM_000222.2(KIT):c.2850_2851insGT (p.Asp952Terfs)	KIT	Dysgerminoma|DYSGERMINOMA	other(Last reviewed: May 1, 2016)	no assertion criteria provided	4	55604642 - 55604643	4	54738476 - 54738477	438769	432379
NM_000222.2(KIT):c.2881G>A (p.Gly961Ser)	KIT	Gastrointestinal stroma tumor|Regorafenib response	Uncertain significance(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	4	55604673	4	54738507	237271	239498
NM_002253.3(KDR):c.3487C>T (p.Leu1163Phe)	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55955058	4	55088891	204338	200719
NM_002253.3(KDR):c.3465G>A (p.Glu1155=)	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55955080	4	55088913	204337	200720
NM_002253.3(KDR):c.3441C>G (p.Pro1147=)	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55955104	4	55088937	204336	200721
NM_002253.3(KDR):c.3439C>T (p.Pro1147Ser)	KDR	Hemangioma, capillary infantile|not specified	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	4	55955106	4	55088939	12317	27356
NM_002253.3(KDR):c.3405-4C>T	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55955144	4	55088977	204335	200722
NM_002253.3(KDR):c.2721G>C (p.Lys907Asn)	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55962403	4	55096236	204329	200723
NM_002253.3(KDR):c.2705T>A (p.Leu902Gln)	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55962419	4	55096252	204328	200724
NM_002253.3(KDR):c.2676T>A (p.Ile892=)	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55962448	4	55096281	204327	200725
NM_002253.3(KDR):c.2656C>A (p.Leu886Ile)	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55962468	4	55096301	204326	200726
NM_002253.3(KDR):c.2615-23C>T	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55962532	4	55096365	204325	200727
NM_002253.3(KDR):c.2598A>C (p.Ala866=)	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55963845	4	55097678	204334	200728
NM_002253.3(KDR):c.2544G>T (p.Val848=)	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55963899	4	55097732	204333	200729
NM_002253.2(KDR):c.2510-27delT	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55963960	4	55097793	204332	200730
NM_002253.3(KDR):c.2509+20T>A	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55964284	4	55098117	204331	200731
NM_002253.3(KDR):c.2380G>A (p.Gly794Arg)	KDR	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	4	55964433	4	55098266	204330	200732
NM_002253.3(KDR):c.2360G>A (p.Arg787Gln)	KDR	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	55964877	4	55098710	161593	171380
NM_001281766.2(EPHA5):c.1748G>A (p.Gly583Glu)	EPHA5	Lung adenocarcinoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	4	66270137	4	65404419	376701	363580
NM_004439.7(EPHA5):c.1043A>G (p.Asp348Gly)	EPHA5	Astrocytoma	Uncertain significance	criteria provided, single submitter	4	66361129	4	65495411	503605	495045
GRCh37/hg19 4q13.2(chr4:68488897-68562395)x3	UBA6	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	4	68488897 - 68562395			221437	223166
NM_014243.2(ADAMTS3):c.64G>T (p.Gly22Ter)	ADAMTS3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	73434416	4	72568699	161671	171382
NM_001040202.1(PAQR3):c.650C>G (p.Pro217Arg)	PAQR3	not provided	Uncertain significance	no assertion criteria provided	4	79847727	4	78926573	91926	97404
NM_014991.4(WDFY3):c.10260-7C>G	WDFY3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	85598556	4	84677403	161687	171383
NM_014991.4(WDFY3):c.2630C>A (p.Ala877Asp)	WDFY3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	85722995	4	84801842	161688	171384
NM_138982.3(MAPK10):c.1271G>A (p.Ser424Asn)	MAPK10	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	86938505	4	86017352	161805	171385
NM_004827.2(ABCG2):c.421C>A (p.Gln141Lys)	ABCG2	Uric acid concentration, serum, quantitative trait locus 1|Blood group, Junior system|rosuvastatin response - Efficacy|Ovarian Neoplasms|allopurinol response - Dosage, Efficacy	drug response(Last reviewed: Feb 1, 2018)	reviewed by expert panel	4	89052323	4	88131171	30389	39346
Single allele	DSPP	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	4	88537268 - 88537420			221337	223066
chr4:88537276..88537405 complex variant	DSPP	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	4	88537276 - 88537405			221362	223091
NM_001146054.1(SNCA):c.251G>T (p.Gly84Val)	SNCA	not provided	Uncertain significance	no assertion criteria provided	4	90743452	4	89822301	91933	97411
NM_005723.3(TSPAN5):c.268C>A (p.Leu90Ile)	TSPAN5	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	99407900	4	98486749	161639	171386
GRCh37/hg19 4q24(chr4:104035661-104119449)x3	CENPE	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	4	104035661 - 104119449			221438	223167
NM_001127208.2(TET2):c.4456T>C (p.Ser1486Pro)	TET2|TET2-AS1	Wilms Tumor	other(Last reviewed: May 1, 2016)	no assertion criteria provided	4	106193994	4	105272837	438791	432420
NM_016269.4(LEF1):c.[133G>A;181T>C]	LEF1|LEF1-AS1	Sebaceous tumors, somatic	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	4|4	109088791	4|4	108167635	14382	29421|38464
NM_001204397.1(PITX2):c.559G>A (p.Ala187Thr)	PITX2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	111539676	4	110618520	161569	171369
NM_176824.2(BBS7):c.1135T>G (p.Phe379Val)	BBS7	not provided	Uncertain significance	no assertion criteria provided	4	122766754	4	121845599	100893	106753
NM_178043.2(LARP1B):c.1324G>T (p.Asp442Tyr)	LARP1B	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	129043143	4	128121988	161836	171370
NM_001040876.1(ABCE1):c.708T>G (p.Asp236Glu)	ABCE1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	146032214	4	145111062	161505	171371
NM_024605.3(ARHGAP10):c.716T>A (p.Phe239Tyr)	ARHGAP10	not provided	not provided	no assertion provided	4	148796185	4	147875034	120311	125905
NM_024605.3(ARHGAP10):c.822C>T (p.Val274=)	ARHGAP10	not provided	not provided	no assertion provided	4	148796291	4	147875140	120312	125906
NM_024605.3(ARHGAP10):c.1116+21A>G	ARHGAP10	not provided	not provided	no assertion provided	4	148827891	4	147906740	120313	125907
NM_024605.3(ARHGAP10):c.1468T>C (p.Ser490Pro)	ARHGAP10	not provided	not provided	no assertion provided	4	148886192	4	147965041	120314	125908
NM_024605.3(ARHGAP10):c.2228A>G (p.His743Arg)	ARHGAP10	not provided	not provided	no assertion provided	4	148985614	4	148064463	120315	125909
NM_001013415.2(FBXW7):c.1619G>A (p.Arg540Gln)	FBXW7	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Glioblastoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153244184	4	152323032	376427	363306
NM_033632.3(FBXW7):c.1514G>A (p.Arg505His)	FBXW7	Chronic lymphocytic leukemia|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|not provided|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	4	153247288	4	152326136	376425	363304
NM_001013415.2(FBXW7):c.1160G>T (p.Arg387Leu)	FBXW7	Chronic lymphocytic leukemia|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153247288	4	152326136	376424	363303
NM_001013415.2(FBXW7):c.1159C>A (p.Arg387Ser)	FBXW7	Chronic lymphocytic leukemia|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153247289	4	152326137	376426	363305
NM_001013415.2(FBXW7):c.1159C>G (p.Arg387Gly)	FBXW7	Chronic lymphocytic leukemia|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153247289	4	152326137	376423	363302
NM_033632.3(FBXW7):c.1513C>T (p.Arg505Cys)	FBXW7	Chronic lymphocytic leukemia|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153247289	4	152326137	69961	80852
NM_001013415.2(FBXW7):c.1082G>T (p.Arg361Leu)	FBXW7	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153247366	4	152326214	376421	363300
NM_001013415.2(FBXW7):c.1082G>C (p.Arg361Pro)	FBXW7	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153247366	4	152326214	376420	363299
NM_001013415.2(FBXW7):c.1082G>A (p.Arg361Gln)	FBXW7	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153247366	4	152326214	376419	363298
NM_001013415.2(FBXW7):c.1081C>G (p.Arg361Gly)	FBXW7	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153247367	4	152326215	376422	363301
NM_001013415.2(FBXW7):c.1040G>T (p.Arg347Leu)	FBXW7	Chronic lymphocytic leukemia|Medulloblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the breast|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153249384	4	152328232	376417	363296
NM_001013415.2(FBXW7):c.1040G>C (p.Arg347Pro)	FBXW7	Chronic lymphocytic leukemia|Medulloblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the breast|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153249384	4	152328232	376416	363295
NM_001013415.2(FBXW7):c.1040G>A (p.Arg347His)	FBXW7	Chronic lymphocytic leukemia|Medulloblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the breast|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153249384	4	152328232	376415	363294
NM_001013415.2(FBXW7):c.1039C>G (p.Arg347Gly)	FBXW7	Chronic lymphocytic leukemia|Medulloblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the breast|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153249385	4	152328233	376418	363297
NM_001013415.2(FBXW7):c.1039C>T (p.Arg347Cys)	FBXW7	Chronic lymphocytic leukemia|Medulloblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the breast|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	4	153249385	4	152328233	376414	363293
NM_001358235.1(DCHS2):c.4375G>A (p.Gly1459Arg)	DCHS2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	155242176	4	154321024	161708	171372
NM_001142552.1(DCHS2):c.2053-7021A>G	DCHS2	not provided	Uncertain significance	no assertion criteria provided	4	155305617	4	154384465	91995	97473
NM_004744.4(LRAT):c.78T>A (p.Ser26Arg)	LRAT	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	4	155665556	4	154744404	221315	223044
NM_000856.5(GUCY1A1):c.69T>A (p.Gly23=)	GUCY1A1	not provided	Uncertain significance	no assertion criteria provided	4	156618088	4	155696936	91914	97392
NM_017631.5(DDX60):c.1913A>G (p.Gln638Arg)	DDX60	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	169201551	4	168280400	219317	221006
NM_001012967.2(DDX60L):c.1633C>T (p.Arg545Trp)	DDX60L	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	169351673	4	168430522	219297	220986
GRCh37/hg19 4q32.3(chr4:169325195-169379102)x3	DDX60L	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	4	169325195 - 169379102			221439	223168
GRCh37/hg19 4q33(chr4:170482863-170581561)x4	CLCN3|NEK1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	4	170482863 - 170581561			221440	223169
GRCh37/hg19 4q34.1(chr4:173873299-174090050)x4	GALNT7|GALNTL6	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	4	173873299 - 174090050			221441	223170
GRCh37/hg19 4q34.1(chr4:174254726-174298418)x4	HMGB2|SAP30	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	4	174254726 - 174298418			221442	223171
NM_017632.3(CDKN2AIP):c.914T>G (p.Leu305Arg)	CDKN2AIP	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	184367751	4	183446598	161707	171373
NM_014476.5(PDLIM3):c.925C>T (p.Arg309Trp)	PDLIM3	not provided	Uncertain significance	no assertion criteria provided	4	186423618	4	185502464	100860	106720
NM_178556.4(TRIML1):c.1188A>T (p.Lys396Asn)	TRIML1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	4	189068307	4	188147153	161839	171374
NM_052909.4(PLEKHG4B):c.2311C>T (p.Arg771Trp)	PLEKHG4B	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	156288	5	156173	161792	171397
NM_001080478.2(LRRC14B):c.1189G>A (p.Gly397Arg)	LRRC14B	not provided	not provided	no assertion provided	5	195112	5	194997	156203	166000
NM_020731.4(AHRR):c.1472G>A (p.Arg491Gln)	AHRR	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	434261	5	434146	219350	221039
NM_001003841.2(SLC6A19):c.1540T>G (p.Phe514Val)	SLC6A19	not provided	Uncertain significance	no assertion criteria provided	5	1221267	5	1221152	100818	106678
NM_198253.2(TERT):c.2935C>T (p.Arg979Trp)	TERT	Idiopathic fibrosing alveolitis, chronic form|Aplastic anemia|Dyskeratosis congenita autosomal dominant|Dyskeratosis congenita, autosomal dominant, 2	Uncertain significance(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	5	1260624	5	1260509	39118	47724
NM_198253.2(TERT):c.2354C>A (p.Pro785Gln)	TERT	not provided	Uncertain significance	no assertion criteria provided	5	1272328	5	1272213	100894	106754
NM_198253.2(TERT):c.915G>A (p.Ala305=)	TERT	Idiopathic fibrosing alveolitis, chronic form|Aplastic anemia|Dyskeratosis congenita autosomal dominant|not specified|Dyskeratosis Congenita, Recessive	Benign(Last reviewed: Aug 8, 2016)	criteria provided, multiple submitters, no conflicts	5	1294086	5	1293971	39126	47732
NM_030782.4(CLPTM1L):c.749G>A (p.Arg250His)	CLPTM1L	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	1335219	5	1335104	161775	171390
NM_024830.4(LPCAT1):c.1235G>T (p.Cys412Phe)	LPCAT1	not provided	not provided	no assertion provided	5	1470984	5	1470869	156208	166005
NM_020546.2(ADCY2):c.489C>G (p.Val163=)	ADCY2	not provided	Uncertain significance	no assertion criteria provided	5	7520931	5	7520818	92006	97484
NM_003966.2(SEMA5A):c.2928G>C (p.Leu976=)	SEMA5A	not provided	Uncertain significance	no assertion criteria provided	5	9044662	5	9044550	91956	97434
NM_016279.3(CDH9):c.2202G>A (p.Ser734=)	CDH9	not provided	Uncertain significance	no assertion criteria provided	5	26881413	5	26881304	91992	97470
NM_002185.4(IL7R):c.553A>T (p.Ser185Cys)	IL7R	Lymphoblastic leukemia, acute, with lymphomatous features	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	5	35873597	5	35873495	376098	362977
GRCh37/hg19 5p13.2(chr5:37000955-37014827)x4	NIPBL	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	5	37000955 - 37014827			221443	223172
NM_021072.3(HCN1):c.528T>C (p.Ile176=)	HCN1	not provided	Uncertain significance	no assertion criteria provided	5	45645608	5	45645506	92010	97488
NM_019030.3(DHX29):c.875A>T (p.Glu292Val)	DHX29	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	54586078	5	55290250	161726	171401
NM_001323022.1(SETD9):c.329_337delACATTGCCT (p.Ile111_Tyr113del)	SETD9	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	5	56210766 - 56210774	5	56914939 - 56914947	487781	480788
GRCh37/hg19 5q12.1(chr5:60240797-61658323)x3	ERCC8|KIF2A|ZSWIM6|NDUFAF2|C5orf64|SMIM15	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	5	60240797 - 61658323			221383	223112
GRCh37/hg19 5q12.3(chr5:64817329-64847428)x7	CENPK	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	5	64817329 - 64847428			221384	223113
NM_018695.3(ERBIN):c.3755A>T (p.Tyr1252Phe)	ERBIN	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	65370973	5	66075145	161721	171402
NM_181523.2(PIK3R1):c.1126G>C (p.Gly376Arg)	PIK3R1	Malignant melanoma of skin|Neoplasm of brain|Glioblastoma|Neoplasm|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	5	67589138	5	68293310	376065	362944
NM_181523.2(PIK3R1):c.1126G>A (p.Gly376Arg)	PIK3R1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	67589138	5	68293310	376064	362943
NM_181523.2(PIK3R1):c.1315_1317delGAA (p.Glu439del)	PIK3R1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	67589552 - 67589554	5	68293724 - 68293726	376257	363136
NM_181523.2(PIK3R1):c.1381C>T (p.Arg461Ter)	PIK3R1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	67589618	5	68293790	376258	363137
NM_181523.2(PIK3R1):c.1678_1695del18 (p.Asp560_Ser565del)	PIK3R1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	67591085 - 67591102	5	68295257 - 68295274	376260	363139
NM_181523.2(PIK3R1):c.1678G>T (p.Asp560Tyr)	PIK3R1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	67591085	5	68295257	376259	363138
NM_181523.2(PIK3R1):c.1690A>G (p.Asn564Asp)	PIK3R1	Malignant melanoma of skin|Neoplasm of brain|Neoplasm of the large intestine|Neoplasm|Colorectal Neoplasms|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	5	67591097	5	68295269	376261	363140
NM_181523.2(PIK3R1):c.1692C>G (p.Asn564Lys)	PIK3R1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	67591099	5	68295271	376067	362946
NM_181523.2(PIK3R1):c.1692C>A (p.Asn564Lys)	PIK3R1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	67591099	5	68295271	376066	362945
NM_181523.2(PIK3R1):c.1726_1728delACG (p.Thr576del)	PIK3R1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	67591133 - 67591135	5	68295305 - 68295307	376262	363141
NM_181523.2(PIK3R1):c.1747_1749delTGG (p.Trp583del)	PIK3R1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	67591249 - 67591251	5	68295421 - 68295423	376263	363142
NM_181504.3(PIK3R1):c.1129C>A (p.Leu377Ile)	PIK3R1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	67592123	5	68296295	161844	171403
NM_016218.3(POLK):c.85G>A (p.Glu29Lys)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	5	74842932	5	75547107	218234	214847
NM_016218.3(POLK):c.410C>T (p.Ser137Phe)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Jul 8, 2013)	criteria provided, single submitter	5	74869564	5	75573739	218231	214848
NM_016218.3(POLK):c.461G>A (p.Gly154Glu)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Feb 5, 2013)	criteria provided, single submitter	5	74869615	5	75573790	218232	214849
NM_016218.3(POLK):c.464T>C (p.Phe155Ser)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	5	74869618	5	75573793	218230	214850
NM_016218.3(POLK):c.512T>C (p.Phe171Ser)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Mar 20, 2013)	criteria provided, single submitter	5	74869666	5	75573841	218233	214851
NM_016218.3(POLK):c.1256A>G (p.Glu419Gly)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	5	74882880	5	75587055	218216	214852
NM_016218.3(POLK):c.1284G>A (p.Ala428=)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	5	74886193	5	75590368	218217	214853
NM_016218.3(POLK):c.1289A>G (p.Glu430Gly)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Jun 10, 2013)	criteria provided, single submitter	5	74886198	5	75590373	218219	214854
NM_016218.3(POLK):c.1324C>T (p.Leu442Phe)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	5	74886233	5	75590408	218218	214855
NM_016218.3(POLK):c.1341G>A (p.Gln447=)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Jun 25, 2014)	criteria provided, single submitter	5	74886250	5	75590425	218220	214856
NM_016218.3(POLK):c.1345G>A (p.Glu449Lys)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Aug 14, 2013)	criteria provided, single submitter	5	74886254	5	75590429	218221	214857
NM_016218.3(POLK):c.1381A>G (p.Lys461Glu)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Apr 17, 2014)	criteria provided, single submitter	5	74889727	5	75593902	218228	214858
NM_016218.3(POLK):c.1460T>C (p.Ile487Thr)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: May 23, 2014)	criteria provided, single submitter	5	74889806	5	75593981	218229	214859
NM_016218.3(POLK):c.1582A>T (p.Ser528Cys)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Jan 23, 2013)	criteria provided, single submitter	5	74892100	5	75596275	218224	214860
NM_016218.3(POLK):c.1652A>T (p.Asp551Val)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Feb 4, 2014)	criteria provided, single submitter	5	74892170	5	75596345	218225	214861
NM_016218.3(POLK):c.1692G>A (p.Lys564=)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Mar 5, 2014)	criteria provided, single submitter	5	74892210	5	75596385	218226	214862
NM_016218.3(POLK):c.1741G>A (p.Asp581Asn)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Mar 21, 2014)	criteria provided, single submitter	5	74892259	5	75596434	218227	214863
NM_016218.3(POLK):c.2033C>T (p.Ser678Phe)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Nov 20, 2013)	criteria provided, single submitter	5	74892551	5	75596726	218222	214864
NM_016218.3(POLK):c.2192T>A (p.Leu731His)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Nov 22, 2013)	criteria provided, single submitter	5	74892710	5	75596885	218223	214865
NM_016218.3(POLK):c.2598T>G (p.Asp866Glu)	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Jun 5, 2014)	criteria provided, single submitter	5	74893828	5	75598003	218235	214866
NM_016218.3(POLK):c.*66T>C	POLK	Malignant tumor of prostate	Pathogenic(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	5	74893909	5	75598084	190430	188264
NM_003664.4(AP3B1):c.1526G>A (p.Arg509Gln)	AP3B1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	77437091	5	78141267	161617	171404
NM_002439.4(MSH3):c.1148delA (p.Lys383Argfs)	MSH3	Endometrial carcinoma|Familial adenomatous polyposis 4	Pathogenic(Last reviewed: Sep 1, 1996)	no assertion criteria provided	5	79970922	5	80675103	8738	23777
NM_012446.4(SSBP2):c.719A>T (p.Tyr240Phe)	SSBP2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	80744613	5	81448794	161664	171405
NM_001164097.1(VCAN):c.1655C>A (p.Pro552His)	VCAN|VCAN-AS1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	82833438	5	83537619	161543	171406
NM_001164097.1(VCAN):c.5092G>A (p.Val1698Ile)	VCAN|VCAN-AS1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	82836875	5	83541056	161544	171407
GRCh37/hg19 5q14.3(chr5:85913910-87524304)x3	CCNH|COX7C|RASA1|TMEM161B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	5	85913910 - 87524304			221444	223173
NM_002890.2(RASA1):c.1193G>T (p.Arg398Leu)	CCNH|RASA1	Basal cell carcinoma, somatic	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	5	86645121	5	87349304	15996	31035
NM_002890.2(RASA1):c.1198A>G (p.Lys400Glu)	CCNH|RASA1	Basal cell carcinoma, somatic	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	5	86645126	5	87349309	15997	31036
NM_002890.2(RASA1):c.1201A>G (p.Ile401Val)	CCNH|RASA1	Basal cell carcinoma, somatic	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	5	86645129	5	87349312	15998	31037
NM_020801.3(ARRDC3):c.1022A>G (p.Glu341Gly)	ARRDC3	not provided	Uncertain significance	no assertion criteria provided	5	90669942	5	91374125	92008	97486
NM_014639.3(TTC37):c.140G>C (p.Gly47Ala)	TTC37	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	94878982	5	95543278	161678	171408
NM_000439.4(PCSK1):c.700A>G (p.Lys234Glu)	PCSK1|LOC101929710	not provided	Uncertain significance	no assertion criteria provided	5	95751746	5	96416042	100812	106672
NM_001281471.2(PPIP5K2):c.2063-3_2063del	PPIP5K2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	102503773 - 102503776	5	103168069 - 103168072	219318	221007
NM_000038.5(APC):c.847C>T (p.Arg283Ter)	APC	Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis|Malignant Colorectal Neoplasm	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, multiple submitters, no conflicts	5	112151204	5	112815507	184999	182336
NM_000038.5(APC):c.1495C>T (p.Arg499Ter)	APC	Gardner syndrome|Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	5	112162891	5	112827194	824	15863
NM_000038.5(APC):c.1660C>T (p.Arg554Ter)	APC	Colorectal cancer, susceptibility to|Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	5	112164586	5	112828889	807	15846
NM_000038.5(APC):c.1682delA (p.Lys561Argfs)	APC	Malignant Colorectal Neoplasm	Likely pathogenic	no assertion criteria provided	5	112164608	5	112828911	495327	486822
NM_000038.5(APC):c.1695delA (p.Val566Leufs)	APC	Liver cancer|Hepatocellular carcinoma	Pathogenic(Last reviewed: Jul 15, 2001)	no assertion criteria provided	5	112164621	5	112828924	840	15879
NM_000038.5(APC):c.2158A>G (p.Met720Val)	APC	Monoclonal B-Cell Lymphocytosis	Uncertain significance(Last reviewed: Dec 15, 2015)	no assertion criteria provided	5	112173449	5	112837752	222966	224682
NM_000038.5(APC):c.2626C>T (p.Arg876Ter)	APC	Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Colorectal Neoplasms|Familial adenomatous polyposis	Pathogenic(Last reviewed: Mar 10, 2018)	criteria provided, multiple submitters, no conflicts	5	112173917	5	112838220	216014	212414
NM_000038.5(APC):c.2840_2841delGT (p.Cys947Phefs)	APC	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 27, 2015)	no assertion criteria provided	5	112174131 - 112174132	5	112838434 - 112838435	548662	539130
NM_000038.5(APC):c.3199C>T (p.Gln1067Ter)	APC	Neoplasm of stomach	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	5	112174490	5	112838793	803	15842
NM_000038.5(APC):c.3340C>T (p.Arg1114Ter)	APC	Lung adenocarcinoma|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Colorectal Neoplasms|Familial adenomatous polyposis	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	5	112174631	5	112838934	236589	239564
NM_000038.5(APC):c.3359G>A (p.Gly1120Glu)	APC	Neoplasm of stomach	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	5	112174650	5	112838953	802	15841
NM_001127511.2(APC):c.3862G>T (p.Glu1288Ter)	APC	Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	112175207	5	112839510	376059	362938
NM_000038.5(APC):c.3927_3931delAAAGA (p.Glu1309Aspfs)	APC	Gastric polyposis|Gardner syndrome|Adenomatous polyposis coli with congenital cholesteatoma|Adenocarcinoma of the colon|Carcinoma of colon|Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Duodenal polyposis|Adenomatous colonic polyposis|Intestinal polyp|Hyperplastic colonic polyposis|Familial adenomatous polyposis|Malignant Colorectal Neoplasm	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	5	112175218 - 112175222	5	112839521 - 112839525	816	15855
NM_001127511.2(APC):c.3874_3893del20 (p.Lys1292Terfs)	APC	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	112175219 - 112175238	5	112839522 - 112839541	376265	363144
NM_000038.5(APC):c.3928_3938delAAGATTGGAAC (p.Lys1310Terfs)	APC	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	112175219 - 112175229	5	112839522 - 112839532	376264	363143
NM_000038.5(APC):c.3956delC (p.Pro1319Leufs)	APC	Familial adenomatous polyposis 1|not provided|Malignant Colorectal Neoplasm	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, multiple submitters, no conflicts	5	112175247	5	112839550	371830	358777
NM_000038.5(APC):c.4012C>T (p.Gln1338Ter)	APC	Carcinoma of colon|Familial adenomatous polyposis 1|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, multiple submitters, no conflicts	5	112175303	5	112839606	801	15840
NM_001127511.2(APC):c.4045C>T (p.Gln1349Ter)	APC	Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	112175390	5	112839693	376060	362939
NM_000038.5(APC):c.4127_4128delAT (p.Tyr1376Cysfs)	APC	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 27, 2015)	no assertion criteria provided	5	112175418 - 112175419	5	112839721 - 112839722	548663	539131
NM_001127511.2(APC):c.4078C>T (p.Gln1360Ter)	APC	Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	112175423	5	112839726	376061	362940
NM_000038.5(APC):c.4135G>T (p.Glu1379Ter)	APC	Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	112175426	5	112839729	376062	362941
NM_000038.5(APC):c.4183A>T (p.Ser1395Cys)	APC	Hepatoblastoma	Pathogenic(Last reviewed: Jul 15, 1996)	no assertion criteria provided	5	112175474	5	112839777	817	15856
NM_001127511.2(APC):c.4231C>T (p.Gln1411Ter)	APC	Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	112175576	5	112839879	376063	362942
NM_000038.5(APC):c.4348C>T (p.Arg1450Ter)	APC	Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Colorectal Neoplasms|Familial adenomatous polyposis	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, multiple submitters, no conflicts	5	112175639	5	112839942	194585	191748
NM_000038.5(APC):c.4391_4394delAGAG (p.Glu1464Valfs)	APC	Periampullary adenoma|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	5	112175682 - 112175685	5	112839985 - 112839988	812	15851
NM_000038.5(APC):c.4393_4394delAG (p.Ser1465Trpfs)	APC	Gardner syndrome|Periampullary adenoma|Colorectal cancer, susceptibility to|Familial adenomatous polyposis 1|not provided|Familial adenomatous polyposis	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	5	112175684 - 112175685	5	112839987 - 112839988	811	15850
NM_001127511.2(APC):c.4342_4346delGGACC (p.Gly1448Terfs)	APC	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	112175687 - 112175691	5	112839990 - 112839994	376266	363145
NM_000038.5(APC):c.4669_4676delATTGATTC (p.Ile1557Terfs)	APC	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	112175960 - 112175967	5	112840263 - 112840270	376267	363146
NM_002387.2(MCC):c.2381T>C (p.Met794Thr)	MCC	not provided	Uncertain significance	no assertion criteria provided	5	112363108	5	113027411	91941	97419
NM_001085377.1(MCC):c.2663C>T (p.Ala888Val)	MCC	Carcinoma of colon	Pathogenic(Last reviewed: Mar 15, 1991)	no assertion criteria provided	5	112379320	5	113043623	14202	29241
NM_001085377.1(MCC):c.2087G>A (p.Arg696Gln)	MCC	Carcinoma of colon	Pathogenic(Last reviewed: Mar 15, 1991)	no assertion criteria provided	5	112399807	5	113064110	14203	29242
NM_001085377.1(MCC):c.800G>A (p.Arg267His)	MCC	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	112478999	5	113143302	219319	221008
NM_022828.4(YTHDC2):c.2617C>A (p.Pro873Thr)	YTHDC2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	112899730	5	113564033	161764	171387
GRCh37/hg19 5q23.1-23.2(chr5:121297746-121406237)x4	LOX|SRFBP1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	5	121297746 - 121406237			221445	223174
GRCh37/hg19 5q23.2(chr5:121409786-122337117)x3	LOX|SNX2|SNCAIP|SNX24|ZNF474	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	5	121409786 - 122337117			221446	223175
GRCh37/hg19 5q23.3(chr5:127469912-127522256)x3	SLC12A2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	5	127469912 - 127522256			221447	223176
NM_001999.3(FBN2):c.6177A>C (p.Glu2059Asp)	FBN2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	127627336	5	128291644	161589	171388
NM_002198.2(IRF1):c.31T>C (p.Trp11Arg)	IRF1	Non-small cell lung cancer	Pathogenic(Last reviewed: Jul 7, 1999)	no assertion criteria provided	5	131825140	5	132489448	14721	29760
NM_002198.2(IRF1):c.22A>T (p.Met8Leu)	IRF1	Neoplasm of stomach	Pathogenic(Last reviewed: Aug 12, 1998)	no assertion criteria provided	5	131825149	5	132489457	14720	29759
NM_005732.3(RAD50):c.1513A>G (p.Ile505Val)	RAD50	Malignant tumor of prostate|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	5	131926976	5	132591284	161640	171389
NM_002715.3(PPP2CA):c.922_924delTTC (p.Phe308del)	PPP2CA	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	133533469 - 133533471	5	134197778 - 134197780	219302	220991
NM_006790.2(MYOT):c.686G>T (p.Ser229Ile)	MYOT	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	137217664	5	137881975	161651	171391
NM_001496.3(GFRA3):c.1135C>A (p.Pro379Thr)	GFRA3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	137588725	5	138253036	161581	171392
NM_001135647.1(FAM53C):c.490C>T (p.Pro164Ser)	FAM53C	not provided	Uncertain significance	no assertion criteria provided	5	137680867	5	138345178	91932	97410
NM_018905.2(PCDHA2):c.1010C>A (p.Ser337Ter)	PCDHA@|PCDHA2|PCDHA1	not provided	Uncertain significance	no assertion criteria provided	5	140175559	5	140795974	92002	97480
NM_018906.2(PCDHA3):c.1930C>T (p.Arg644Cys)	PCDHA@|PCDHA3|PCDHA2|PCDHA1	not provided	Uncertain significance	no assertion criteria provided	5	140182712	5	140803127	92003	97481
NM_018901.3(PCDHA10):c.1166C>T (p.Thr389Met)	PCDHA9|PCDHA@|PCDHA10|PCDHA8|PCDHA7|PCDHA6|PCDHA5|PCDHA4|PCDHA3|PCDHA2|PCDHA1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	140236799	5	140857214	161724	171393
NM_018898.3(PCDHAC1):c.2396G>A (p.Arg799Gln)	PCDHA9|PCDHA@|PCDHAC1|PCDHA13|PCDHA12|PCDHA11|PCDHA10|PCDHA8|PCDHA7|PCDHA6|PCDHA5|PCDHA4|PCDHA3|PCDHA2|PCDHA1	not provided	Uncertain significance	no assertion criteria provided	5	140308873	5	140929288	92001	97479
NM_013340.3(PCDHB1):c.1655T>C (p.Val552Ala)	PCDHB1|PCDHB@|LOC101926905	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	140432710	5	141053125	161667	171394
NM_018928.2(PCDHGC4):c.462G>A (p.Leu154=)	PCDHGC3|PCDHGB4|PCDHGA8|PCDHGA12|PCDHGC4|PCDHGB7|PCDHGB6|PCDHGB5|PCDHGB3|PCDHGB2|PCDHGB1|PCDHGA11|PCDHGA10|PCDHGA9|PCDHGA7|PCDHGA6|PCDHGA5|PCDHGA4|PCDHGA3|PCDHGA2|PCDHGA1|PCDHG@	not provided	Uncertain significance	no assertion criteria provided	5	140865202	5	141485635	92004	97482
NM_003883.3(HDAC3):c.50_55+5delACTACGGTGAG	HDAC3	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	5	141016298 - 141016308	5	141636731 - 141636741	487780	480787
NM_022481.5(ARAP3):c.2806C>T (p.Arg936Trp)	ARAP3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	141041817	5	141662250	161761	171395
NM_015071.6(ARHGAP26):c.1250A>G (p.Asn417Ser)	ARHGAP26	Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	5	142421420	5	143041855	5052	20091
NM_001018074.1(NR3C1):c.1244G>T (p.Gly415Val)	NR3C1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	142693674	5	143314109	161495	171396
NM_024577.3(SH3TC2):c.3016delT (p.Ser1006Profs)	SH3TC2	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	5	148406172	5	149026609	487808	480815
NM_014945.4(ABLIM3):c.1584G>A (p.Lys528=)	ABLIM3	not provided	Uncertain significance	no assertion criteria provided	5	148627377	5	149247814	91983	97461
NM_014945.4(ABLIM3):c.1665G>A (p.Leu555=)	ABLIM3	not provided	Uncertain significance	no assertion criteria provided	5	148627458	5	149247895	91984	97462
NM_005211.3(CSF1R):c.2907T>A (p.Tyr969Ter)	CSF1R	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	149433644	5	150054081	376269	363148
NM_005211.3(CSF1R):c.2907T>G (p.Tyr969Ter)	CSF1R	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	149433644	5	150054081	376268	363147
NM_005211.3(CSF1R):c.2906A>G (p.Tyr969Cys)	CSF1R	Hematologic neoplasm|Neoplasm	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	5	149433645	5	150054082	376271	363150
NM_005211.3(CSF1R):c.2906A>T (p.Tyr969Phe)	CSF1R	Hematologic neoplasm|Neoplasm	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	5	149433645	5	150054082	376270	363149
NM_005211.3(CSF1R):c.2905T>C (p.Tyr969His)	CSF1R	Hematologic neoplasm|Neoplasm	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	5	149433646	5	150054083	376272	363151
NM_005211.3(CSF1R):c.1711T>G (p.Tyr571Asp)	CSF1R	Myeloproliferative disorder|Hematologic neoplasm	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	5	149441328	5	150061765	376166	363045
NM_005211.3(CSF1R):c.903G>T (p.Leu301Phe)	CSF1R	Hematologic neoplasm	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	5	149453043	5	150073480	376703	363582
NM_005211.3(CSF1R):c.902T>A (p.Leu301Ter)	CSF1R	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	5	149453044	5	150073481	376274	363153
NM_005211.3(CSF1R):c.902T>C (p.Leu301Ser)	CSF1R	Hematologic neoplasm|Neoplasm	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	5	149453044	5	150073481	376273	363152
NM_002609.3(PDGFRB):c.2549A>T (p.Asp850Val)	PDGFRB	Infantile myofibromatosis	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	5	149500488	5	150120925	375681	362520
NM_002609.3(PDGFRB):c.2083C>T (p.Arg695Cys)	PDGFRB	Basal ganglia calcification, idiopathic, 4	Likely pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	5	149502705	5	150123142	135650	139368
NM_002609.3(PDGFRB):c.1998C>G (p.Asn666Lys)	PDGFRB	Infantile myofibromatosis	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	5	149503838	5	150124275	375556	362366
NM_002609.3(PDGFRB):c.1998C>A (p.Asn666Lys)	PDGFRB	Infantile myofibromatosis 1|Infantile myofibromatosis	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, multiple submitters, no conflicts	5	149503838	5	150124275	218935	215769
NM_002609.3(PDGFRB):c.1697_1702delGGAAGG (p.Trp566_Val568delinsLeu)	PDGFRB	Infantile myofibromatosis	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	5	149505113 - 149505118	5	150125550 - 150125555	375555	362365
NM_002609.3(PDGFRB):c.1696T>C (p.Trp566Arg)	PDGFRB	not provided|Infantile myofibromatosis|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2017)	criteria provided, conflicting interpretations	5	149505119	5	150125556	375682	362521
NM_002609.3(PDGFRB):c.1681C>T (p.Arg561Cys)	PDGFRB	Infantile myofibromatosis 1|not provided|Infantile myofibromatosis	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	5	149505134	5	150125571	55848	70502
NM_002609.3(PDGFRB):c.1615_1616insGAT (p.Ile538_Leu539insArg)	PDGFRB	Infantile myofibromatosis	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	5	149506141 - 149506142	5	150126578 - 150126579	375557	362367
NM_001135244.1(TCOF1):c.-59G>A	TCOF1	Treacher Collins syndrome 1|Treacher Collins Syndrome, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	149737251	5	150357688	209019	205571
NM_001135244.1(TCOF1):c.108+62_108+68del	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149737479 - 149737485	5	150357916 - 150357922	209021	205572
NM_001135244.1(TCOF1):c.109-28T>C	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149740691	5	150361128	209024	205573
NM_001135244.1(TCOF1):c.305-52A>G	TCOF1	Treacher Collins syndrome 1	Benign	no assertion criteria provided	5	149747355	5	150367792	209035	205574
NM_001135244.1(TCOF1):c.579G>A (p.Ala193=)	TCOF1	Treacher Collins syndrome 1|not specified|not provided|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	5	149749105	5	150369542	209036	205575
NM_001135244.1(TCOF1):c.1028G>A (p.Ser343Asn)	TCOF1	Treacher Collins syndrome 1|not specified|not provided|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Jun 2, 2017)	criteria provided, multiple submitters, no conflicts	5	149753894	5	150374331	209020	205576
NM_001135244.1(TCOF1):c.1083+39G>A	TCOF1	Treacher Collins syndrome 1	Benign	no assertion criteria provided	5	149753988	5	150374425	209022	205577
NM_001135244.1(TCOF1):c.1086G>A (p.Ala362=)	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149754182	5	150374619	209023	205578
NM_001135244.1(TCOF1):c.1242C>T (p.Ser414=)	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149754338	5	150374775	209025	205579
NM_001135244.1(TCOF1):c.1278+60G>C	TCOF1	Treacher Collins syndrome 1	Benign	no assertion criteria provided	5	149754434	5	150374871	209026	205580
NM_001135244.1(TCOF1):c.1281G>A (p.Ala427=)	TCOF1	Treacher Collins syndrome 1|not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	5	149754519	5	150374956	209027	205581
NM_001135244.1(TCOF1):c.1854G>A (p.Ala618=)	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149755433	5	150375870	209028	205582
NM_001135244.1(TCOF1):c.1953T>C (p.Thr651=)	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149755704	5	150376141	209029	205583
NM_001135244.1(TCOF1):c.2142+22C>T	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149755915	5	150376352	209030	205584
NM_001135244.1(TCOF1):c.2762C>T (p.Pro921Leu)	TCOF1	Treacher Collins syndrome 1|not specified|not provided|Treacher Collins Syndrome, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jul 6, 2018)	criteria provided, conflicting interpretations	5	149759198	5	150379635	209031	205585
NM_001135244.1(TCOF1):c.2859+26A>G	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149759321	5	150379758	209032	205586
NM_001135244.1(TCOF1):c.2859+3303G>A	TCOF1	Treacher Collins syndrome 1	Benign	no assertion criteria provided	5	149762598	5	150383035	209033	205587
NM_001135244.1(TCOF1):c.2859+3389G>T	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149762684	5	150383121	209034	205588
NM_000356.3(TCOF1):c.3297C>T (p.Pro1099=)	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149772281	5	150392718	209011	205589
NM_000356.3(TCOF1):c.3369+64dupT	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149772417	5	150392854	209012	205590
NM_000356.3(TCOF1):c.3550+8A>G	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149773123	5	150393560	209013	205591
NM_000356.3(TCOF1):c.3711A>C (p.Ser1237=)	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149776005	5	150396442	209014	205592
NM_000356.3(TCOF1):c.4064_4065delATinsGA (p.Asp1355Gly)	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149776358 - 149776359	5	150396795 - 150396796	209015	205593
NM_000356.3(TCOF1):c.4146_4148delGAA (p.Lys1383del)	TCOF1	Treacher Collins syndrome 1	Benign(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	5	149777951 - 149777953	5	150398388 - 150398390	209016	205594
NM_000356.3(TCOF1):c.4209+106G>T	TCOF1	Treacher Collins syndrome 1	Likely benign	no assertion criteria provided	5	149778120	5	150398557	209017	205595
NM_000356.3(TCOF1):c.4209+108C>A	TCOF1	Treacher Collins syndrome 1	Benign	no assertion criteria provided	5	149778122	5	150398559	209018	205596
NM_021911.2(GABRB2):c.577C>T (p.Arg193Cys)	GABRB2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	160763741	5	161336734	161752	171398
NM_015238.2(WWC1):c.1906G>A (p.Ala636Thr)	WWC1	not provided	Uncertain significance	no assertion criteria provided	5	167855133	5	168428128	91990	97468
NM_004946.3(DOCK2):c.3352G>T (p.Glu1118Ter)	DOCK2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	169446083	5	170019079	219303	220992
NM_002520.6(NPM1):c.860_863dupTCTG (p.Trp288Cysfs)	NPM1	Acute myeloid leukemia|Myelodysplastic syndrome progressed to acute myeloid leukemia	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	5	170837544 - 170837547	5	171410540 - 171410543	13998	29037
NM_002520.6(NPM1):c.862_863insTCTG (p.Trp288Phefs)	NPM1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	5	170837546 - 170837547	5	171410542 - 171410543	376012	362891
NM_002520.6(NPM1):c.862_863insTCAG (p.Trp288Phefs)	NPM1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	5	170837546 - 170837547	5	171410542 - 171410543	376011	362890
NM_002520.6(NPM1):c.862_863insCCTG (p.Trp288Serfs)	NPM1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	5	170837546 - 170837547	5	171410542 - 171410543	376010	362889
NM_002520.6(NPM1):c.862_863insCATG (p.Trp288Serfs)	NPM1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	5	170837546 - 170837547	5	171410542 - 171410543	376009	362888
NM_002520.6(NPM1):c.863_864insCCTG (p.Trp288Cysfs)	NPM1	Acute myeloid leukemia	Pathogenic(Last reviewed: Jan 20, 2005)	no assertion criteria provided	5	170837547 - 170837548	5	171410543 - 171410544	14001	29040
NM_002520.6(NPM1):c.863_864insCGTG (p.Trp288Cysfs)	NPM1	Acute myeloid leukemia	Pathogenic(Last reviewed: Jan 20, 2005)	no assertion criteria provided	5	170837547 - 170837548	5	171410543 - 171410544	14000	29039
NM_002520.6(NPM1):c.863_864insCATG (p.Trp288Cysfs)	NPM1	Acute myeloid leukemia	Pathogenic(Last reviewed: Jan 20, 2005)	no assertion criteria provided	5	170837547 - 170837548	5	171410543 - 171410544	13999	29038
GRCh37/hg19 5q35.1(chr5:172097061-172421802)x3	DUSP1|ATP6V0E1|RPL26L1|NEURL1B|ERGIC1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	5	172097061 - 172421802			221448	223177
GRCh37/hg19 5q35.2(chr5:173043321-174953690)x3	DRD1|MSX2|CPEB4|BOD1|SFXN1|C5orf47	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	5	173043321 - 174953690			221449	223178
NM_004387.3(NKX2-5):c.896A>G (p.Asp299Gly)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects|Atrioventricular septal defect, somatic	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	5	172659651	5	173232648	9014	24053
NM_004387.3(NKX2-5):c.547A>G (p.Lys183Glu)	NKX2-5	Atrioventricular septal defect, somatic	Pathogenic(Last reviewed: Jul 15, 2005)	no assertion criteria provided	5	172660000	5	173232997	9020	24059
NM_213647.2(FGFR4):c.1100A>G (p.Tyr367Cys)	FGFR4	Neoplasm of the breast	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	5	176520181	5	177093180	376737	363616
NM_213647.2(FGFR4):c.1605C>G (p.Asn535Lys)	FGFR4	Rhabdomyosarcoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	5	176522416	5	177095415	376150	363029
NM_213647.2(FGFR4):c.1605C>A (p.Asn535Lys)	FGFR4	Rhabdomyosarcoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	5	176522416	5	177095415	376149	363028
NM_213647.2(FGFR4):c.1649T>A (p.Val550Glu)	FGFR4	Rhabdomyosarcoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	5	176522552	5	177095551	376151	363030
NM_213647.2(FGFR4):c.1684C>T (p.Leu562=)	FGFR4	not provided	Uncertain significance	no assertion criteria provided	5	176522587	5	177095586	100898	106758
NM_022455.4(NSD1):c.7147G>T (p.Gly2383Cys)	NSD1	Choroid plexus carcinoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	5	176721516	5	177294515	438779	432411
NM_003052.4(SLC34A1):c.13G>A (p.Gly5Arg)	SLC34A1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	176812755	5	177385754	161606	171399
NM_017510.5(TMED9):c.77T>A (p.Leu26Gln)	TMED9	Monoclonal B-Cell Lymphocytosis	Uncertain significance(Last reviewed: Dec 15, 2015)	no assertion criteria provided	5	177019292	5	177592291	222967	224683
NM_014244.4(ADAMTS2):c.997G>A (p.Gly333Arg)	ADAMTS2	not provided	Uncertain significance	no assertion criteria provided	5	178585859	5	179158858	100859	106719
NM_014757.4(MAML1):c.1163G>T (p.Gly388Val)	MAML1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	5	179193174	5	179766173	161684	171400
NM_182925.4(FLT4):c.3076delG (p.Glu1026Serfs)	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: May 7, 2014)	no assertion criteria provided	5	180043920	5	180616920	204353	200733
NM_182925.4(FLT4):c.3072delG (p.Met1025Trpfs)	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: May 7, 2014)	no assertion criteria provided	5	180043924	5	180616924	204354	200734
NM_182925.4(FLT4):c.3065C>T (p.Ala1022Val)	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: May 7, 2014)	no assertion criteria provided	5	180043931	5	180616931	204355	200735
NM_182925.4(FLT4):c.3064delG (p.Ala1022Profs)	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: May 7, 2014)	no assertion criteria provided	5	180043932	5	180616932	204356	200736
NM_182925.4(FLT4):c.3056delT (p.Phe1019Serfs)	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: May 7, 2014)	no assertion criteria provided	5	180043940	5	180616940	204357	200737
NM_182925.4(FLT4):c.3002-9A>C	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: May 7, 2014)	no assertion criteria provided	5	180044003	5	180617003	204358	200738
NM_182925.4(FLT4):c.2860C>T (p.Pro954Ser)	FLT4	Hemangioma, capillary infantile|not specified	Benign	criteria provided, single submitter	5	180045911	5	180618911	16264	31303
NM_182925.4(FLT4):c.2647+31del	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: May 7, 2014)	no assertion criteria provided	5	180046634	5	180619634	204352	200739
NM_182925.4(FLT4):c.2542+20delG	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	5	180047153	5	180620153	204339	200740
NM_182925.4(FLT4):c.2542+18delC	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	5	180047155	5	180620155	204340	200741
NM_182925.4(FLT4):c.2542+12A>G	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	5	180047161	5	180620161	204341	200742
NM_182925.4(FLT4):c.2519delT (p.Phe840Serfs)	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	5	180047196	5	180620196	204342	200743
NM_182925.4(FLT4):c.2507G>A (p.Ser836Asn)	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	5	180047208	5	180620208	204343	200744
NM_182925.4(FLT4):c.2502T>A (p.Asp834Glu)	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	5	180047213	5	180620213	204344	200745
NM_182925.4(FLT4):c.2498A>C (p.Tyr833Ser)	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	5	180047217	5	180620217	204345	200746
NM_182925.4(FLT4):c.2496C>G (p.Ser832=)	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	5	180047219	5	180620219	204346	200747
NM_182925.4(FLT4):c.2470C>A (p.Leu824Met)	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	5	180047245	5	180620245	204347	200748
NM_182925.4(FLT4):c.2433C>A (p.Gly811=)	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	5	180047282	5	180620282	204348	200749
NM_182925.4(FLT4):c.2414A>C (p.His805Pro)	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	5	180047301	5	180620301	204349	200750
NM_182925.4(FLT4):c.2407-6C>G	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: Jan 24, 2015)	no assertion criteria provided	5	180047314	5	180620314	204350	200751
NM_182925.4(FLT4):c.2407-7C>T	FLT4	Carcinoma of colon	Uncertain significance(Last reviewed: May 7, 2014)	no assertion criteria provided	5	180047315	5	180620315	204351	200752
NM_182925.4(FLT4):c.392T>C (p.Phe131Ser)	FLT4	Regorafenib response	drug response(Last reviewed: Mar 8, 2017)	no assertion criteria provided	5	180057563	5	180630563	440836	434459
NM_018303.5(EXOC2):c.1241G>A (p.Arg414His)	EXOC2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	576834	6	576834	161714	171424
GRCh38/hg38 6p24.2(chr6:10887131-11044230)x1	ELOVL2|SYCP2L|ELOVL2-AS1|LOC101928191	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	10887364 - 11044463	6	10887131 - 11044230	221385	223114
NM_001105568.2(KIF13A):c.2511T>C (p.Arg837=)	KIF13A	not provided	Uncertain significance	no assertion criteria provided	6	17800288	6	17800057	100825	106685
NM_001080.3(ALDH5A1):c.1608G>C (p.Ter536Tyr)	ALDH5A1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	24533940	6	24533712	161509	171414
GRCh37/hg19 6p22.2(chr6:26020923-26056336)x4	HIST1H1C|HIST1H2BB|HIST1H2AB|HIST1H3A|HIST1H3C|HIST1H3B|HIST1H4A|HIST1H4B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	26020923 - 26056336			221450	223179
GRCh37/hg19 6p22.2(chr6:26104332-26365573)x4	HIST1H1D|HIST1H1E|HIST1H1T|HIST1H2AE|HIST1H2AD|HIST1H2BD|TRX-CAT1-2|TRR-TCG4-1|HIST1H2AC|HIST1H2BG|HIST1H2BF|HIST1H2BE|HIST1H2BH|HIST1H2BI|HIST1H2BC|HIST1H3D|HIST1H3E|HIST1H3G|HIST1H4D|HIST1H4F|HIST1H4C|HIST1H4H|HIST1H4E|HIST1H4G|HIST1H3F|BTN3A2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	26104332 - 26365573			221451	223180
GRCh37/hg19 6p22.2-22.1(chr6:26545571-27115102)x3	HIST1H4I|HIST1H2AG|HIST1H2BJ|HMGN4|ABT1|ZNF322|HIST1H2AH|HIST1H2BK	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	26545571 - 27115102			221452	223181
NM_007149.2(ZNF184):c.113C>A (p.Thr38Asn)	ZNF184	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	27425151	6	27457372	161657	171415
GRCh37/hg19 6p22.1(chr6:27775494-27861432)x3	HIST1H1B|HIST1H2AI|HIST1H2AK|HIST1H2AJ|HIST1H2AL|HIST1H2AM|HIST1H2BL|HIST1H2BN|HIST1H2BM|HIST1H2BO|HIST1H3I|HIST1H3J|HIST1H3H|HIST1H4K|HIST1H4J|HIST1H4L	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	27775494 - 27861432			221453	223182
NM_003533.2(HIST1H3I):c.83A>T (p.Lys28Met)	HIST1H3I	Squamous cell carcinoma of the head and neck|Brainstem glioma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	6	27840011	6	27872233	376436	363315
NM_003533.2(HIST1H3I):c.82A>G (p.Lys28Glu)	HIST1H3I	Squamous cell carcinoma of the head and neck|Brainstem glioma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	6	27840012	6	27872234	376437	363316
NM_001509.2(GPX5):c.28C>T (p.Leu10=)	GPX5	not provided	Uncertain significance	no assertion criteria provided	6	28493818	6	28526041	91936	97414
chr6:29910378..30075843 complex variant	HLA-A|PPP1R11|TRIM31|ZNRD1|RNF39	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	29910378 - 30075843			221338	223067
chr6:29910602..29912297 complex variant	HLA-A	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	29910602 - 29912297			221363	223092
GRCh37/hg19 6p22.1(chr6:30029374-30036983)x3	PPP1R11|ZNRD1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	30029374 - 30036983			221454	223183
GRCh37/hg19 6p21.33(chr6:30698482-30853003)x3	DDR1|IER3|FLOT1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	30698482 - 30853003			221455	223184
Single allele	CDSN|HLA-B|HLA-C|POU5F1|TCF19|CCHCR1|PSORS1C1|PSORS1C2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	31085200 - 31324647			221339	223068
chr6:31237124-31378388 complex variant	HLA-B|HLA-C|MICA	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	31237124 - 31378388			221364	223093
NM_004197.1(STK19):c.265G>A (p.Asp89Asn)	STK19	Malignant melanoma of skin|Squamous cell carcinoma of the skin	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	6	31940123	6	31972346	76320	87211
Single allele	HLA-DQA1|HLA-DQB1|HLA-DRA|HLA-DRB1|HLA-DRB5|NOTCH4|TSBP1|BTNL2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	32188383 - 32629802			221340	223069
chr6:32609097-32629809 complex variant	HLA-DQA1|HLA-DQB1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	32609097 - 32629809			221365	223094
NM_000593.5(TAP1):c.2156G>A (p.Arg719Gln)	TAP1	Bare lymphocyte syndrome type 1|TAP1 deficiency, somatic	Uncertain significance(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	6	32814909	6	32847132	13731	28770
GRCh37/hg19 6p21.32(chr6:33256191-33400523)x3	DAXX|KIFC1|PHF1|RGL2|TAPBP|SYNGAP1|WDR46|ZBTB22|PFDN6|CUTA	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	33256191 - 33400523			221456	223185
NM_001141969.1(DAXX):c.1178delA (p.Lys393Argfs)	DAXX	Metastatic pancreatic neuroendocrine tumours	Likely pathogenic(Last reviewed: Nov 1, 2017)	no assertion criteria provided	6	33288230	6	33320453	446272	439678
NM_001141970.1(DAXX):c.886C>T (p.Pro296Ser)	DAXX	Metastatic pancreatic neuroendocrine tumours	Likely pathogenic(Last reviewed: Nov 1, 2017)	no assertion criteria provided	6	33288702	6	33320925	446278	439684
NM_001141969.1(DAXX):c.801_824del24 (p.Arg269_Asn276del)	DAXX	Metastatic pancreatic neuroendocrine tumours	Likely pathogenic(Last reviewed: Nov 1, 2017)	no assertion criteria provided	6	33288728 - 33288751	6	33320951 - 33320974	446280	439686
NM_001141970.1(DAXX):c.365_366delCT (p.Ser122Terfs)	DAXX	Metastatic pancreatic neuroendocrine tumours	Likely pathogenic(Last reviewed: Nov 1, 2017)	no assertion criteria provided	6	33289222 - 33289223	6	33321445 - 33321446	446274	439680
NM_152753.3(SCUBE3):c.2462C>T (p.Pro821Leu)	SCUBE3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	35213065	6	35245288	161817	171416
NM_145028.4(ARMC12):c.191C>T (p.Ala64Val)	ARMC12	not provided	Uncertain significance	no assertion criteria provided	6	35705076	6	35737299	92028	97506
NM_145028.4(ARMC12):c.682G>T (p.Asp228Tyr)	ARMC12	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	35715194	6	35747417	161808	171417
NM_001010903.4(C6orf222):c.1447C>T (p.Arg483Trp)	C6orf222	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	36291094	6	36323317	161491	171418
NM_173558.3(FGD2):c.882+3A>C	FGD2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	36982483	6	37014707	161831	171419
NM_153487.3(MDGA1):c.2674T>G (p.Phe892Val)	MDGA1	Acute megakaryoblastic leukemia|Mediastinal germ cell tumor	Uncertain significance(Last reviewed: Oct 22, 2015)	no assertion criteria provided	6	37606083	6	37638307	218340	215050
NM_001206927.1(DNAH8):c.3333+7A>G	DNAH8	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	38781912	6	38814136	161573	171420
NM_000322.4(PRPH2):c.997G>A (p.Glu333Lys)	PRPH2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	42666077	6	42698339	161464	171421
NM_015349.2(BICRAL):c.1778A>G (p.Lys593Arg)	BICRAL	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	42797849	6	42830111	161692	171422
NM_203290.3(POLR1C):c.882G>T (p.Lys294Asn)	POLR1C	not provided	Uncertain significance	no assertion criteria provided	6	43488746	6	43521008	92040	97518
NC_000006.12:g.45512244G>A	RUNX2	Cleidocranial dysostosis	Pathogenic(Last reviewed: Aug 31, 2016)	no assertion criteria provided			6	45512244	437934	431555
NM_012120.2(CD2AP):c.560C>T (p.Pro187Leu)	CD2AP	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	47541818	6	47574082	219344	221033
NM_153838.4(ADGRF4):c.1423G>T (p.Ala475Ser)	ADGRF4	not provided	Uncertain significance	no assertion criteria provided	6	47682404	6	47714668	92032	97510
NM_170724.2(PKHD1):c.544G>A (p.Ala182Thr)	PKHD1	Autosomal recessive polycystic kidney disease|Malignant tumor of prostate	Uncertain significance(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	6	51936971	6	52072173	161826	171423
GRCh38/hg38 6p12.2(chr6:52751643-52757905)x1	GSTA2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	52616441 - 52622703	6	52751643 - 52757905	221457	223186
NM_019842.3(KCNQ5):c.2110G>A (p.Ala704Thr)	KCNQ5	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	73904448	6	73194725	161727	171425
NM_003318.4(TTK):c.2089G>T (p.Asp697Tyr)	TTK	Pancreatic Neoplasms	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	6	80747723	6	80038006	376700	363579
NM_015525.3(IBTK):c.3506A>T (p.Asn1169Ile)	IBTK	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	82900859	6	82191142	161695	171426
NM_014611.2(MDN1):c.818T>C (p.Val273Ala)	MDN1	not provided	Uncertain significance	no assertion criteria provided	6	90503518	6	89793799	91980	97458
NM_032511.3(FAXC):c.892C>G (p.Gln298Glu)	FAXC	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	99739628	6	99291752	161783	171427
NM_001004317.3(LIN28B):c.5C>A (p.Ala2Asp)	LIN28B	not provided	Uncertain significance	no assertion criteria provided	6	105405130	6	104957255	91920	97398
NM_001455.3(FOXO3):c.583A>T (p.Lys195Ter)	FOXO3	Choroid plexus carcinoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	6	108882994	6	108561791	438763	432401
NM_001455.3(FOXO3):c.699G>A (p.Trp233Ter)	FOXO3	Medulloblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	6	108984735	6	108663532	438764	432402
GRCh37/hg19 6q21-23.2(chr6:112939290-132327952)x1	ARG1|COL10A1|CCN2|EPB41L2|FABP7|FRK|GJA1|HDAC2|HSF2|KPNA5|LAMA2|MARCKS|MAN1A1|ENPP1|ENPP3|PLN|PKIB|PTPRK|ROS1|TPD52L1|TSPYL1|RNF217-AS1|MED23|AKAP7|KIAA0408|TRDN|SMPDL3A|TSPYL4|HEY2|ASF1A|DSE|HDDC2|RWDD1|ECHDC1|GOPC|SERINC1|TRMT11|OR2A4|FAM184A|RNF146|L3MBTL3|RSPO3|ARHGAP18|TMEM200A|NUS1|CLVS2|NCOA7|HINT3|SAMD3|RNF217|NKAIN2|NT5DC1|CALHM4|ZUP1|FAM162B|TBC1D32|HS3ST5|GPRC6A|RFX6|SLC35F1|VGLL2|TMEM244|CALHM5|MCM9|DCBLD1|RSPH4A|C6orf58|CENPW|SOGA3|CEP85L|THEMIS|CALHM6|CTAGE9|TRAPPC3L|SMLR1	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	6	112939290 - 132327952			523159	513791
NM_002944.2(ROS1):c.6094G>A (p.Gly2032Arg)	ROS1	Lung adenocarcinoma	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	6	117638347	6	117317184	376139	363018
GRCh37/hg19 6q22.31(chr6:123319117-123837319)x3	TRDN|CLVS2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	123319117 - 123837319			221458	223187
NM_032438.3(L3MBTL3):c.1525T>C (p.Phe509Leu)	L3MBTL3	not provided	Uncertain significance	no assertion criteria provided	6	130413896	6	130092751	92018	97496
NM_078488.2(VNN2):c.291C>A (p.Asp97Glu)	VNN2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	133077069	6	132755930	219320	221009
t(6;9)(q23.3;p22.3)	MYB|NFIB	Adenoid cystic carcinoma	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	6	135515857 - 135515858			495138	486692
t(6;9)(q23.3;p22.3)	MYB|NFIB	Adenoid cystic carcinoma	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	6	135516358 - 135516359			495139	486693
t(6;9)(q23.3;p22.3)	MYB|NFIB	Adenoid cystic carcinoma	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	6	135516423 - 135516424			495140	486694
t(6;9)(q23.3;p22.3)	MYB|NFIB	Adenoid cystic carcinoma	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	6	135522688 - 135522689			495137	486691
NM_018945.3(PDE7B):c.742C>T (p.Arg248Ter)	PDE7B	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	136494965	6	136173827	161725	171409
NM_014320.2(HEBP2):c.125A>G (p.His42Arg)	HEBP2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	138726304	6	138405167	161675	171410
NM_003630.2(PEX3):c.184C>A (p.Gln62Lys)	PEX3	not provided	Uncertain significance	no assertion criteria provided	6	143780332	6	143459195	100845	106705
NM_001350339.1(LATS1):c.2050G>C (p.Asp684His)	LATS1	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	6	150001239	6	149680103	487797	480804
NM_001029884.2(PLEKHG1):c.2293C>T (p.Arg765Trp)	PLEKHG1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	151152540	6	150831404	161500	171411
NM_025059.3(CCDC170):c.1710+1144T>G	ESR1|CCDC170	Estrogen resistance	Uncertain significance(Last reviewed: Mar 1, 2014)	no assertion criteria provided	6	151918856	6	151597721	155872	165621
NM_025059.3(CCDC170):c.1810G>A (p.Val604Ile)	CCDC170	Estrogen resistance	Likely pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	6	151936677	6	151615542	155873	165622
NM_025059.3(CCDC170):c.*68A>C	CCDC170	Estrogen resistance	Uncertain significance(Last reviewed: Mar 1, 2014)	no assertion criteria provided	6	151939350	6	151618215	155874	165623
NM_025059.3(CCDC170):c.*978A>G	CCDC170	Estrogen resistance	Uncertain significance(Last reviewed: Mar 1, 2014)	no assertion criteria provided	6	151940260	6	151619125	155875	165624
NC_000006.12:g.151625494T>A	CCDC170	Estrogen resistance	Uncertain significance(Last reviewed: Mar 1, 2014)	no assertion criteria provided	6	151946629	6	151625494	155876	165625
NC_000006.12:g.151627231G>A	CCDC170	Estrogen resistance	Likely pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	6	151948366	6	151627231	155877	165626
NC_000006.12:g.151630085A>G	CCDC170	Estrogen resistance	Uncertain significance(Last reviewed: Mar 1, 2014)	no assertion criteria provided	6	151951220	6	151630085	155878	165627
NM_000125.3(ESR1):c.908A>G (p.Lys303Arg)	ESR1	Familial cancer of breast	risk factor	no assertion criteria provided	6	152265455	6	151944320	208354	204580
NM_000125.3(ESR1):c.1138G>C (p.Glu380Gln)	ESR1	Neoplasm of the breast	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	6	152332832	6	152011697	376206	363085
NM_000125.3(ESR1):c.1387T>C (p.Ser463Pro)	ESR1	Neoplasm of the breast	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	6	152415537	6	152094402	375934	362813
NM_000125.3(ESR1):c.1601T>A (p.Val534Glu)	ESR1	Neoplasm of the breast	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	6	152419914	6	152098779	375935	362814
NM_000125.3(ESR1):c.1604C>A (p.Pro535His)	ESR1	Neoplasm of the breast	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	6	152419917	6	152098782	375936	362815
NM_000125.3(ESR1):c.1607T>G (p.Leu536Arg)	ESR1	Neoplasm of the breast	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	6	152419920	6	152098785	375937	362816
NM_182961.3(SYNE1):c.11097C>G (p.Phe3699Leu)	SYNE1	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	6	152674554	6	152353419	487805	480812
NM_020732.3(ARID1B):c.751T>G (p.Cys251Gly)	ARID1B	Astrocytoma	Uncertain significance	criteria provided, single submitter	6	157099814	6	156778680	496813	488237
NM_020732.3(ARID1B):c.3345+1G>A	ARID1B	Medulloblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	6	157502313	6	157181179	438752	432393
NM_000876.3(IGF2R):c.3670+2T>C	IGF2R	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	160483653	6	160062621	161474	171412
NM_000876.3(IGF2R):c.4346G>T (p.Gly1449Val)	IGF2R	Liver cancer|Hepatocellular carcinoma	Pathogenic(Last reviewed: Oct 6, 2017)	no assertion criteria provided	6	160490993	6	160069961	14795	29834
NM_000876.3(IGF2R):c.4391G>A (p.Gly1464Glu)	IGF2R	Liver cancer|Hepatocellular carcinoma	Pathogenic(Last reviewed: Oct 6, 2017)	no assertion criteria provided	6	160491038	6	160070006	14796	29835
GRCh37/hg19 6q27(chr6:167412952-167447412)x3	FGFR1OP	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	6	167412952 - 167447412			221459	223188
NM_005618.3(DLL1):c.1711C>A (p.Leu571Met)	DLL1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	6	170592656	6	170283568	161637	171413
NM_013988.2(PARK2):c.(8_8)_(171_171)+180544del	PRKN|PACRG	Lung adenocarcinoma	Pathogenic(Last reviewed: May 13, 2003)	no assertion criteria provided			6	162262766 - 162727661	7049	22088
NM_003550.2(MAD1L1):c.1947C>G (p.Tyr649Ter)	MAD1L1	Lymphoma, somatic	Pathogenic(Last reviewed: May 31, 2001)	no assertion criteria provided	7	1937887	7	1898251	6919	21958
NM_003550.2(MAD1L1):c.175C>T (p.Arg59Cys)	MAD1L1	Prostate cancer, somatic	Pathogenic(Last reviewed: May 31, 2001)	no assertion criteria provided	7	2265161	7	2225526	6920	21959
NM_152744.3(SDK1):c.5214+8C>T	SDK1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	4245634	7	4206002	161816	171437
NM_021163.3(RBAK):c.1602A>T (p.Lys534Asn)	RBAK|RBAK-RBAKDN	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	5104689	7	5065058	161746	171438
NM_207116.2(RNF216):c.2297G>A (p.Arg766His)	RNF216	Rosette-forming glioneuronal tumor	Uncertain significance	criteria provided, single submitter	7	5662795	7	5623164	424631	411524
NM_018890.3(RAC1):c.85C>A (p.Pro29Thr)	RAC1	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell carcinoma of the skin|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	6426892	7	6387261	376513	363392
NM_018890.3(RAC1):c.85C>T (p.Pro29Ser)	RAC1	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Cutaneous melanoma|Squamous cell carcinoma of the skin|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	6426892	7	6387261	376362	363241
NM_018890.3(RAC1):c.86C>T (p.Pro29Leu)	RAC1	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell carcinoma of the skin|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	6426893	7	6387262	376512	363391
TMEM106B-BRAF fusion	ACHE|ADCY1|ADCYAP1R1|AEBP1|AHR|AKR1B1|AMPH|AOAH|AQP1|ARF5|ASL|ASNS|AZGP1|OPN1SW|BLVRA|BPGM|BRAF|CACNA2D1|CALCR|CALD1|CALU|CAMK2B|CAPZA2|CAV1|CAV2|KRIT1|CCT6A|CD36|SEPT7|CDK6|CFTR|CHN2|CHRM2|AP1S1|COL1A2|CPA1|CPA2|CLDN4|CLDN3|CRHR2|CUX1|CYP3A7|CYP3A4|CYP3A5|CYP51A1|DGKB|DDC|GSDME|DLD|DLX5|DLX6|DYNC1I1|SLC26A3|EGFR|ELN|EPHB4|EPO|ERV3-1|ETV1|EVX1|FLNC|GARS|NIPSNAP2|GCK|GHRHR|GLI3|GNAI1|GNB2|GNG11|GNGT1|GPR22|GPR37|GRB10|GRM3|GRM8|GTF2I|GUSB|HGF|HIP1|HNRNPA2B1|HOXA1|HOXA2|HOXA3|HOXA4|HOXA5|HOXA6|HOXA7|HOXA9|HOXA10|HOXA11|HOXA13|HPVC1|AGFG2|HSPB1|HUS1|IFRD1|IGFBP1|IGFBP3|IL6|IMPDH1|INHBA|IRF5|ITGB8|KCND2|LAMB1|LEP|LIMK1|LRCH4|MCM7|DNAJB9|MDH2|MEOX2|MEST|MET|MKLN1|MUC3A|NDUFA5|NDUFB2|CNOT4|NPY|NPTX2|NRCAM|NRF1|OCM2|OGDH|ORC5|SERPINE1|PAX4|PCOLCE|PDE1C|PDK4|SLC26A4|PEX1|CDK14|PGAM2|ABCB1|ABCB4|PHKG1|PIK3CG|PODXL|POLD2|POLR2J|PON1|PON2|PON3|POR|PPIA|PPP1R3A|PRKAR2B|RELN|PSMA2|PSMC2|PSPH|PTN|PTPN12|PTPRZ1|PURB|RALA|RFC2|RNU2-1|RP9|CCL24|SFRP4|SLC13A1|SMO|SP4|SPAM1|SRI|AKR1D1|SRPK2|STX1A|SYPL1|TAC1|TAF6|TBXAS1|TFR2|TRIP6|TWIST1|UBE2H|UPP1|VGF|ZAN|EIF4H|CLIP2|LAT2|WNT2|YWHAG|ZNF3|ZKSCAN1|ZSCAN21|ZNF138|ZP3|MTERF1|SEM1|TFPI2|ST7|TRRAP|FZD1|FZD9|TPST1|FKBP6|CDK13|DNAH11|TRIM24|TAX1BP1|BUD31|SGCE|SKAP2|WASL|PLOD3|BAZ1B|CLDN12|DGKI|AP4M1|TBRG4|STK17A|BCL7B|ATP6V1F|PMPCB|ATP5MF|GTF2IRD1|CREB5|NFE2L3|SEMA3E|DOCK4|HDAC9|RAPGEF5|SCRN1|ELMO1|MAGI2|TRIL|POM121|DMTF1|MUC12|ARPC1B|ARL4A|NAMPT|AKAP9|RASA4|AASS|SLC25A13|LRRC17|POP7|RAMP3|BET1|IKZF1|CCL26|SEMA3A|NOD1|FAM3C|GPNMB|COG5|ZNHIT1|SEMA3C|AGR2|ARPC1A|SH2B2|IGF2BP3|YKT6|STAG3|ZNF273|PPP1R17|FGL2|CPSF4|DBF4|COPS6|ZPBP|DUS4L|NUPL2|HIBADH|ZNF277|INMT|POU6F2|FKBP9|PDAP1|CBX3|TFEC|LAMB4|LMTK2|POMZP3|KLHDC10|HECW1|AVL9|PEG10|NACAD|SNX13|NUP205|COBL|DPY19L1|KIAA0895|AHCYL2|NUDCD3|SEC61G|TNPO3|HYAL4|TSPAN12|MKRN1|LSM5|ZKSCAN5|CLDN15|BRI3|TECPR1|SUMF2|POT1|SOSTDC1|KBTBD2|PTCD1|OSBPL3|AUTS2|TES|FBXO24|SLC13A4|TBL2|STEAP1|COPG2|HBP1|DNAJC2|SND1|VPS41|TSPAN13|DENND2A|BBS9|CRCP|RABGEF1|POLM|PCLO|BZW2|DBNL|WDR91|NPC1L1|SNX10|TRA2A|HILPDA|MDFIC|PILRA|FSCN3|ERVW-1|ATP6V0A4|PNPLA8|TAS2R16|FIS1|MLXIPL|SBDS|CHCHD2|CPA4|NT5C3A|NME8|ZNF117|MRPS17|WNT16|ACTL6B|ZNF107|ZC3HC1|SRRT|UBE2D4|LUC7L2|STYXL1|ASB4|MPP6|LSM8|ADAM22|GSAP|CYCS|GPR85|ANLN|ANKIB1|CPVL|PUS7|TOMM7|ING3|DDX56|TMEM106B|LRRN3|CROT|EPDR1|ALKBH4|SAMD9|CHCHD3|FKBP14|ZCWPW1|TMEM248|RBM28|TYW1|MAP11|TMEM140|CDCA7L|PPP1R9A|VPS50|URGCP|NSUN5|COA1|METTL2B|KMT2E|LANCL2|BAIAP2L1|SLC25A40|BCAP29|KLHL7|STK31|MEPCE|ANKRD7|ZC3HAV1|SLC12A9|SDHAF3|YAE1|AKR1B10|ANKMY2|TBX20|SMURF1|PHTF2|RHBDD2|STRIP2|CCDC146|KIAA1549|GATAD1|NFE4|MYL7|EXOC4|RINT1|NEUROD6|FIGNL1|MYO1G|LRRC4|NPVF|HERPUD2|GALNT17|TMEM168|MOSPD3|GIGYF1|CCDC136|TNS3|PARP12|CREB3L2|IFT22|CYP3A43|CASD1|MRPS24|MRPL32|CYREN|GGCT|C7orf25|ZNF655|PVRIG|TMEM243|GCC1|STEAP4|GAL3ST4|PRKRIP1|SUGCT|CFAP69|CBLL1|CPED1|TTC26|C7orf69|ORAI2|EEPD1|KDM7A|OR2AE1|VOPP1|RCC1L|TSC22D4|TRIM56|ABHD11|CCM2|ZMIZ2|CALN1|ARMC10|TMEM120A|STARD3NL|IMMP2L|CTTNBP2|RBM48|ZNF394|GTF2IRD2|MINDY4|SLC37A3|DNAJC30|FAM126A|FAM71F1|PLEKHA8|SLC35B4|TMEM209|TMEM60|SCIN|GTPBP10|TRIM4|CCDC126|ZNF479|ADCK2|PLXNA4|ZC3HAV1L|MYL10|ST7-OT3|CADPS2|CPA5|FOXP2|H2AFV|CEP41|DTX2|BUD23|TSGA13|MALSU1|TMEM270|TRIM50|COL26A1|KLF14|SSMEM1|C7orf57|SVOPL|MTPN|LRGUK|MPLKIP|SSC4D|C7orf31|ASZ1|MUC17|ASB15|RUNDC3B|ABCA13|BMT2|CLEC2L|FMC1|VKORC1L1|IQUB|KCTD7|C7orf66|TMEM213|METTL27|VPS37D|AGR3|ZNF92|ZNF679|RNF133|THAP5|CCDC71L|PKD1L1|BHLHA15|BMPER|ZNF800|ABHD11-AS1|SAMD9L|TEX47|ZNF804B|ZSCAN25|FAM200A|VWDE|PRPS1L1|TWISTNB|SP8|HOXA11-AS|JAZF1|PPP1R35|GPC2|VSTM2A|TMED4|MTURN|PRR15|SRRM3|RSBN1L|KIAA1324L|LRWD1|FAM185A|FBXL13|NAPEPLD|ATXN7L1|CDHR3|TMEM130|FERD3L|NYAP1|ITPRID1|ZNRF2|SEMA3D|CNPY4|POLR2J2|HEPACAM2|UBN2|MBLAC1|TMEM196|STEAP1B|SUN3|FAM133B|STEAP2|POM121L12|C7orf71|SPDYE1|SNHG15|ZNF789|LSMEM1|MESTIT1|ST7-OT4|ZNF680|ABCB5|FAM221A|TSPAN33|AGBL3|SEPT14|MACC1|GNAT3|MOGAT3|FAM71F2|STRA8|KLRG2|ZNF713|GJC3|CASTOR3|GPR141|VWC2|TRIM73|NAT16|SLC26A5|LHFPL3|KCP|TRIM74|RNF148|NPSR1|NUPR2|GTF2IRD2B|LAMTOR4|FEZF1|FAM180A|AGMO|C7orf65|LRRD1|C7orf76|PRRT4|RAB19|KPNA7|C7orf61|UFSP1|NPSR1-AS1|MIR106B|MIR148A|MIR182|MIR183|MIR25|MIR29A|MIR29B1|MIR93|MIR96|ZNF716|TYW1B|SPDYE3|SPDYE2|AKR1B15|ZNF727|SPDYE5|LMOD2|MIR335|MIR196B|TARP|LOC541472|POLR2J3|MIR489|CYP51A1-AS1|WIPF3|STMP1|NCF1|SNORA5C|MIR590|ZNF736|CASTOR2|SPDYE6|CRPPA|TMEM229A|ZNF735|LUZP6|POM121C|HECW1-IT1|SPATA48|UPK3BL1|RASA4B|SMKR1|SPDYE2B|HOTTIP|SAP25|LINC00972|LRRC72|HOTAIRM1|ATP5MF-PTCD1|KLHL7-DT|FMC1-LUC7L2|ZASP|LOC101928861	Pleomorphic xanthoastrocytoma	Pathogenic	no assertion criteria provided	7	12258147 - 140494267			402244	389215
NM_003112.4(SP4):c.2068C>T (p.Arg690Trp)	SP4	Monoclonal B-Cell Lymphocytosis	Uncertain significance(Last reviewed: Dec 15, 2015)	no assertion criteria provided	7	21521702	7	21482084	222968	224684
NM_001277115.1(DNAH11):c.4072G>A (p.Val1358Ile)	DNAH11	not provided	Uncertain significance	no assertion criteria provided	7	21655887	7	21616269	100831	106691
NM_001145513.1(SCRN1):c.1223C>T (p.Thr408Met)	SCRN1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	29963595	7	29923979	161537	171434
NM_001145514.1(SCRN1):c.238G>A (p.Asp80Asn)	SCRN1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	29994958	7	29955342	219321	221010
NM_001883.4(CRHR2):c.915C>T (p.Tyr305=)	CRHR2	not provided	Uncertain significance	no assertion criteria provided	7	30695545	7	30655929	91937	97415
NM_006774.4(INMT):c.625C>T (p.Arg209Cys)	INMT|INMT-MINDY4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	30795300	7	30755684	161650	171435
NM_194300.4(ITPRID1):c.419G>A (p.Trp140Ter)	ITPRID1	not provided	Uncertain significance	no assertion criteria provided	7	31614177	7	31574563	92037	97515
NM_001191059.3(PDE1C):c.335G>A (p.Arg112Gln)	PDE1C	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	31918699	7	31879086	161559	171436
NM_015198.4(COBL):c.215G>T (p.Gly72Val)	COBL	not provided	Uncertain significance	no assertion criteria provided	7	51287468	7	51219771	91989	97467
NM_005228.4(EGFR):c.322A>G (p.Arg108Gly)	EGFR	Neoplasm of brain|Glioblastoma|Brainstem glioma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	55211079	7	55143386	376400	363279
NM_005228.4(EGFR):c.323G>A (p.Arg108Lys)	EGFR	Neoplasm of brain	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	7	55211080	7	55143387	376207	363086
NM_005228.4(EGFR):c.787A>C (p.Thr263Pro)	EGFR	Neoplasm of brain	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	7	55221743	7	55154050	376208	363087
NM_005228.4(EGFR):c.865_866delGCinsAT (p.Ala289Ile)	EGFR	Squamous cell carcinoma of the head and neck|Neoplasm of brain|Glioblastoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	55221821 - 55221822	7	55154128 - 55154129	376398	363277
NM_005228.4(EGFR):c.865_866delGCinsAA (p.Ala289Asn)	EGFR	Squamous cell carcinoma of the head and neck|Neoplasm of brain|Glioblastoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	55221821 - 55221822	7	55154128 - 55154129	376397	363276
NM_005228.4(EGFR):c.865G>A (p.Ala289Thr)	EGFR	Squamous cell carcinoma of the head and neck|Neoplasm of brain|Glioblastoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	55221821	7	55154128	376395	363274
NM_005228.4(EGFR):c.866C>A (p.Ala289Asp)	EGFR	Squamous cell carcinoma of the head and neck|Neoplasm of brain|Glioblastoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	55221822	7	55154129	376396	363275
NM_005228.4(EGFR):c.866C>T (p.Ala289Val)	EGFR	Squamous cell carcinoma of the head and neck|Neoplasm of brain|Glioblastoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	55221822	7	55154129	376209	363088
NM_005228.4(EGFR):c.1474A>G (p.Ser492Gly)	EGFR	Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	7	55228007	7	55160314	376100	362979
NM_005228.4(EGFR):c.1476C>A (p.Ser492Arg)	EGFR	Neoplasm of the large intestine|Colorectal Neoplasms	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	7	55228009	7	55160316	376341	363220
NM_005228.4(EGFR):c.1636C>T (p.Pro546Ser)	EGFR	Head and Neck Neoplasms	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	7	55231430	7	55163737	376211	363090
NM_005228.4(EGFR):c.1793G>C (p.Gly598Ala)	EGFR	Neoplasm of brain|Glioblastoma|Brainstem glioma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	55233043	7	55165350	376399	363278
NM_005228.4(EGFR):c.1793G>T (p.Gly598Val)	EGFR	Neoplasm of brain|Glioblastoma|Brainstem glioma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	55233043	7	55165350	376210	363089
NM_005228.4(EGFR):c.2065G>C (p.Val689Leu)	EGFR	not specified	Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55241617	7	55173924	45217	54384
NM_005228.4(EGFR):c.2068G>A (p.Glu690Lys)	EGFR	Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	7	55241620	7	55173927	376152	363031
NM_005228.4(EGFR):c.2117T>C (p.Ile706Thr)	EGFR	not specified	Uncertain significance(Last reviewed: Jun 10, 2008)	no assertion criteria provided	7	55241669	7	55173976	45218	54385
NM_005228.4(EGFR):c.2125G>A (p.Glu709Lys)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55241677	7	55173984	177646	174095
NM_005228.4(EGFR):c.2126A>T (p.Glu709Val)	EGFR	not specified	Uncertain significance(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55241678	7	55173985	177619	174096
NM_005228.4(EGFR):c.2126A>G (p.Glu709Gly)	EGFR	Lung cancer|Tyrosine kinase inhibitor response	drug response(Last reviewed: Feb 18, 2014)	criteria provided, single submitter	7	55241678	7	55173985	163335	174230
NM_005228.4(EGFR):c.2126A>C (p.Glu709Ala)	EGFR	Lung cancer|not specified	Uncertain significance(Last reviewed: Nov 5, 2012)	criteria provided, single submitter	7	55241678	7	55173985	45219	54386
NM_005228.4(EGFR):c.2127_2130delAACTinsC (p.Glu709_Thr710delinsAsp)	EGFR	not specified	Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55241679 - 55241682	7	55173986 - 55173989	45221	54388
NM_005228.4(EGFR):c.2127_2129delAAC (p.Glu709_Thr710delinsAsp)	EGFR	Non-small cell lung cancer	Pathogenic(Last reviewed: Jun 15, 2011)	criteria provided, single submitter	7	55241679 - 55241681	7	55173986 - 55173988	45220	54387
NM_005228.4(EGFR):c.2154G>T (p.Leu718=)	EGFR	not specified	Uncertain significance(Last reviewed: Nov 18, 2008)	no assertion criteria provided	7	55241706	7	55174013	45223	54390
NM_005228.4(EGFR):c.2154G>A (p.Leu718=)	EGFR	not specified	Uncertain significance(Last reviewed: May 27, 2009)	no assertion criteria provided	7	55241706	7	55174013	45222	54389
NM_005228.4(EGFR):c.2155G>C (p.Gly719Arg)	EGFR	Squamous cell carcinoma of the head and neck|Non-small cell lung cancer	Likely pathogenic, drug response(Last reviewed: Aug 10, 2009)	no assertion criteria provided	7	55241707	7	55174014	45224	54391
NM_005228.4(EGFR):c.2155G>A (p.Gly719Ser)	EGFR	Non-small cell lung cancer|Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic|Neoplasm of the large intestine|Tyrosine kinase inhibitor response|Colorectal Neoplasms	drug response(Last reviewed: Apr 20, 2012)	criteria provided, single submitter	7	55241707	7	55174014	16612	31651
NM_005228.4(EGFR):c.2155G>T (p.Gly719Cys)	EGFR	Lung adenocarcinoma|Non-small cell lung cancer|Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic|Glioblastoma	Pathogenic/Likely pathogenic, drug response(Last reviewed: May 31, 2016)	no assertion criteria provided	7	55241707	7	55174014	16611	31650
NM_005228.4(EGFR):c.2156G>A (p.Gly719Asp)	EGFR	Lung adenocarcinoma|Non-small cell lung cancer|Squamous cell lung carcinoma|Glioblastoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	55241708	7	55174015	376075	362954
NM_005228.4(EGFR):c.2156G>C (p.Gly719Ala)	EGFR	Lung adenocarcinoma|Non-small cell lung cancer|Glioblastoma	Pathogenic(Last reviewed: Jan 4, 2013)	criteria provided, single submitter	7	55241708	7	55174015	45225	54392
NM_005228.4(EGFR):c.2166G>C (p.Ala722=)	EGFR	not specified	Likely benign(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55241718	7	55174025	45227	54394
NM_005228.4(EGFR):c.2166G>A (p.Ala722=)	EGFR	not specified	Likely benign(Last reviewed: Mar 18, 2009)	no assertion criteria provided	7	55241718	7	55174025	45226	54393
NM_005228.4(EGFR):c.2170G>A (p.Gly724Ser)	EGFR	Neoplasm of the large intestine|Colorectal Neoplasms	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	7	55241722	7	55174029	376360	363239
NM_005228.4(EGFR):c.2192G>A (p.Trp731Ter)	EGFR	not specified	Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55242422	7	55174729	45228	54395
NM_005228.4(EGFR):c.2193G>A (p.Trp731Ter)	EGFR	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55242423	7	55174730	376275	363154
NM_005228.4(EGFR):c.2198C>T (p.Pro733Leu)	EGFR	Non-small cell lung cancer|Esophageal Squamous Cell Carcinoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55242428	7	55174735	376076	362955
NM_005228.4(EGFR):c.2200G>A (p.Glu734Lys)	EGFR	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55242430	7	55174737	376077	362956
NM_005228.4(EGFR):c.2203G>A (p.Gly735Ser)	EGFR	Non-small cell lung cancer|Prostate neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55242433	7	55174740	376078	362957
NM_005228.4(EGFR):c.2217_2234dup (p.Lys745_Glu746insIleProValAlaIleLys)	EGFR	not specified	Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55242447 - 55242464	7	55174754 - 55174771	45230	54397
NM_005228.4(EGFR):c.2219T>C (p.Ile740Thr)	EGFR	not specified	Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55242449	7	55174756	45231	54398
NM_005228.4(EGFR):c.2225T>C (p.Val742Ala)	EGFR	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55242455	7	55174762	376079	362958
NM_005228.4(EGFR):c.2230_2249del20insGTCAA (p.Ile744_Ala750delinsValLys)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Mar 30, 2010)	criteria provided, single submitter	7	55242460 - 55242479	7	55174767 - 55174786	163337	174231
NM_005228.4(EGFR):c.2231_2232insAAAATTCCCGTCGCTA (p.Glu746Phefs)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Jan 2, 2008)	no assertion criteria provided	7	55242461 - 55242462	7	55174768 - 55174769	177790	174097
NM_005228.4(EGFR):c.2232_2252del21insAAAGTT (p.Glu746_Thr751delinsLeu)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Jun 21, 2011)	criteria provided, single submitter	7	55242462 - 55242482	7	55174769 - 55174789	177971	174098
NM_005228.4(EGFR):c.2232_2250del19 (p.Lys745Hisfs)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Jan 2, 2008)	no assertion criteria provided	7	55242462 - 55242480	7	55174769 - 55174787	177787	174232
NM_005228.4(EGFR):c.2232_2249del18insAAA (p.Glu746_Ala750del)	EGFR	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55242462 - 55242479	7	55174769 - 55174786	45233	54400
NM_005228.4(EGFR):c.2232C>T (p.Ile744=)	EGFR	not specified	Likely benign(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55242462	7	55174769	45232	54399
NM_005228.4(EGFR):c.2234A>G (p.Lys745Arg)	EGFR	Squamous cell carcinoma of the head and neck	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55242464	7	55174771	376080	362959
NM_005228.4(EGFR):c.2235_2251del17insAATTC (p.Glu746_Thr751delinsIlePro)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Mar 4, 2008)	no assertion criteria provided	7	55242465 - 55242481	7	55174772 - 55174788	177808	174100
NM_005228.4(EGFR):c.2235_2248delGGAATTAAGAGAAGinsAATTC (p.Glu746_Ala750delinsIlePro)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55242465 - 55242478	7	55174772 - 55174785	177690	174099
NM_005228.4(EGFR):c.2235_2243delGGAATTAAG (p.Leu747_Glu749del)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242465 - 55242473	7	55174772 - 55174780	177663	174233
NM_005228.4(EGFR):c.2235_2249delGGAATTAAGAGAAGC (p.Glu746_Ala750del)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242465 - 55242479	7	55174772 - 55174786	163343	174234
NM_005228.4(EGFR):c.2236G>A (p.Glu746Lys)	EGFR	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55242466	7	55174773	376276	363155
NM_005228.4(EGFR):c.2236_2252del17insAT (p.Glu746_Thr751delinsIle)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: May 28, 2010)	criteria provided, single submitter	7	55242466 - 55242482	7	55174773 - 55174789	177920	174236
NM_005228.4(EGFR):c.2236G>C (p.Glu746Gln)	EGFR	Non-small cell lung cancer	not provided(Last reviewed: Jul 12, 2007)	no assertion provided	7	55242466	7	55174773	177764	174235
NM_005228.4(EGFR):c.2236_2250delGAATTAAGAGAAGCA (p.Glu746_Ala750del)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Jan 16, 2007)	no assertion criteria provided	7	55242466 - 55242480	7	55174773 - 55174787	177620	174101
NM_005228.4(EGFR):c.2237_2246delAATTAAGAGAinsC (p.Glu746_Glu749delinsAla)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Apr 4, 2012)	criteria provided, single submitter	7	55242467 - 55242476	7	55174774 - 55174783	178284	174102
NM_005228.4(EGFR):c.2237_2256del20insTC (p.Glu746_Ser752delinsVal)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Mar 27, 2008)	no assertion criteria provided	7	55242467 - 55242486	7	55174774 - 55174793	177813	174240
NM_005228.4(EGFR):c.2237_2254del18 (p.Glu746_Ser752delinsAla)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55242467 - 55242484	7	55174774 - 55174791	177721	174239
NM_005228.4(EGFR):c.2237_2248delAATTAAGAGAAGinsCAC (p.Glu746_Ala750delinsAlaPro)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55242467 - 55242478	7	55174774 - 55174785	177720	174237
NM_005228.4(EGFR):c.2237_2257del21insTCT (p.Glu746_Pro753delinsValSer)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55242467 - 55242487	7	55174774 - 55174794	177691	174106
NM_005228.4(EGFR):c.2237_2255del19insT (p.Glu746_Ser752delinsVal)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242467 - 55242485	7	55174774 - 55174792	177652	174105
NM_005228.4(EGFR):c.2237_2251delAATTAAGAGAAGCAA (p.Glu746_Thr751delinsAla)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242467 - 55242481	7	55174774 - 55174788	177645	174238
NM_005228.4(EGFR):c.2237_2251delAATTAAGAGAAGCAAinsTTC (p.Glu746_Thr751delinsValPro)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Jun 26, 2008)	no assertion criteria provided	7	55242467 - 55242481	7	55174774 - 55174788	163352	174104
NM_005228.4(EGFR):c.2237_2248delAATTAAGAGAAGinsCCC (p.Glu746_Ala750delinsAlaPro)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242467 - 55242478	7	55174774 - 55174785	163350	174103
NM_005228.4(EGFR):c.2238_2248delATTAAGAGAAGinsGC (p.Leu747_Ala750delinsPro)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Aug 9, 2010)	criteria provided, single submitter	7	55242468 - 55242478	7	55174775 - 55174785	177933	174241
NM_005228.4(EGFR):c.2238_2251delATTAAGAGAAGCAAinsGC (p.Leu747_Thr751delinsPro)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Jul 23, 2012)	criteria provided, single submitter	7	55242468 - 55242481	7	55174775 - 55174788	177651	174107
NM_005228.4(EGFR):c.2239_2264del26insACGAGAGA (p.Leu747_Ala755delinsThrArgAsp)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Dec 15, 2010)	criteria provided, single submitter	7	55242469 - 55242494	7	55174776 - 55174801	177943	174110
NM_005228.4(EGFR):c.2239_2257del19insCAAT (p.Leu747_Pro753delinsGlnSer)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Dec 1, 2008)	no assertion criteria provided	7	55242469 - 55242487	7	55174776 - 55174794	177848	174244
NM_005228.4(EGFR):c.2239_2257del19insA (p.Leu747_Pro753delinsThr)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Jun 26, 2008)	no assertion criteria provided	7	55242469 - 55242487	7	55174776 - 55174794	177822	174109
NM_005228.4(EGFR):c.2239_2247delTTAAGAGAA (p.Leu747_Glu749del)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55242469 - 55242477	7	55174776 - 55174784	177765	174242
NM_005228.4(EGFR):c.2239_2248delTTAAGAGAAGinsC (p.Leu747_Ala750delinsPro)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Nov 7, 2011)	criteria provided, single submitter	7	55242469 - 55242478	7	55174776 - 55174785	177684	174108
NM_005228.4(EGFR):c.2239_2256del18 (p.Leu747_Ser752del)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242469 - 55242486	7	55174776 - 55174793	177647	174243
NM_005228.4(EGFR):c.2239_2240delTTinsCC (p.Leu747Pro)	EGFR	not specified	Uncertain significance(Last reviewed: Jan 27, 2009)	no assertion criteria provided	7	55242469 - 55242470	7	55174776 - 55174777	45235	54402
NM_005228.4(EGFR):c.2239T>C (p.Leu747=)	EGFR	not specified	Uncertain significance(Last reviewed: Aug 30, 2010)	criteria provided, single submitter	7	55242469	7	55174776	45234	54401
NM_005228.4(EGFR):c.2239_2251delTTAAGAGAAGCAAinsC (p.Leu747_Thr751delinsPro)	EGFR	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic|Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242469 - 55242481	7	55174776 - 55174788	16610	31649
NM_005228.4(EGFR):c.2240_2254delTAAGAGAAGCAACAT (p.Leu747_Thr751del)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242470 - 55242484	7	55174777 - 55174791	177649	174245
NM_005228.4(EGFR):c.2240_2248delTAAGAGAAG (p.Leu747_Ala750delinsSer)	EGFR	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55242470 - 55242478	7	55174777 - 55174785	45237	54404
NM_005228.4(EGFR):c.2240T>C (p.Leu747Ser)	EGFR	Lung cancer|Squamous cell lung carcinoma|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 13, 2016)	no assertion criteria provided	7	55242470	7	55174777	45236	54403
NM_005228.4(EGFR):c.2240_2257del18 (p.Leu747_Pro753delinsSer)	EGFR	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic|Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242470 - 55242487	7	55174777 - 55174794	16608	31647
NM_005228.4(EGFR):c.2245G>C (p.Glu749Gln)	EGFR	Lung cancer	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	7	55242475	7	55174782	376740	363619
NM_005228.4(EGFR):c.2247_2264del18 (p.Glu749_Ala755delinsAsp)	EGFR	not specified	Uncertain significance(Last reviewed: Jan 27, 2009)	no assertion criteria provided	7	55242477 - 55242494	7	55174784 - 55174801	45238	54405
NM_005228.4(EGFR):c.2248G>C (p.Ala750Pro)	EGFR	Lung adenocarcinoma|Non-small cell lung cancer|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55242478	7	55174785	45239	54406
NM_005228.4(EGFR):c.2251_2277del27insGAT (p.Thr751_Ile759delinsAsp)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Feb 26, 2010)	criteria provided, single submitter	7	55242481 - 55242507	7	55174788 - 55174814	177909	174246
NM_005228.4(EGFR):c.2251_2275del25 (p.Thr751Serfs)	EGFR	not specified	Uncertain significance(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242481 - 55242505	7	55174788 - 55174812	177693	174111
NM_005228.4(EGFR):c.2252C>T (p.Thr751Ile)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55242482	7	55174789	177773	174112
NM_005228.4(EGFR):c.2252_2277del26insAA (p.Thr751_Ile759delinsLys)	EGFR	not specified	Uncertain significance(Last reviewed: Jul 28, 2009)	no assertion criteria provided	7	55242482 - 55242507	7	55174789 - 55174814	45240	54407
NM_005228.4(EGFR):c.2253_2276del24 (p.Ser752_Ile759del)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242483 - 55242506	7	55174790 - 55174813	177618	174247
NM_005228.4(EGFR):c.2254_2277del24 (p.Ser752_Ile759del)	EGFR	Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242484 - 55242507	7	55174791 - 55174814	177617	174113
NM_005228.4(EGFR):c.2255C>A (p.Ser752Tyr)	EGFR	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55242485	7	55174792	376277	363156
NM_005228.4(EGFR):c.2257C>T (p.Pro753Ser)	EGFR	Non-small cell lung cancer|Head and Neck Neoplasms	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55242487	7	55174794	376081	362960
NM_005228.4(EGFR):c.2260A>G (p.Lys754Glu)	EGFR	not specified	Uncertain significance(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242490	7	55174797	45241	54408
NM_005228.4(EGFR):c.2265C>G (p.Ala755=)	EGFR	Non-small cell lung cancer	not provided(Last reviewed: May 1, 2008)	no assertion provided	7	55242495	7	55174802	163371	174248
NM_005228.4(EGFR):c.2270A>T (p.Lys757Met)	EGFR	not specified	Uncertain significance(Last reviewed: Apr 15, 2011)	criteria provided, single submitter	7	55242500	7	55174807	45242	54409
NM_005228.4(EGFR):c.2277_2278insT (p.Leu760Serfs)	EGFR	not specified	Uncertain significance(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242507 - 55242508	7	55174814 - 55174815	163372	174114
NM_005228.4(EGFR):c.2280C>T (p.Leu760=)	EGFR	not specified	Likely benign(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55242510	7	55174817	45243	54410
NM_005228.4(EGFR):c.2281G>A (p.Asp761Asn)	EGFR	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55242511	7	55174818	376082	362961
NM_005228.4(EGFR):c.2281G>T (p.Asp761Tyr)	EGFR	Non-small cell lung cancer|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55242511	7	55174818	45244	54411
NM_005228.4(EGFR):c.2283+1G>A	EGFR	not specified	Uncertain significance(Last reviewed: Mar 11, 2013)	criteria provided, single submitter	7	55242514	7	55174821	45246	54413
NM_005228.4(EGFR):c.2283+12_2283+147del	EGFR	not specified	Uncertain significance(Last reviewed: Mar 11, 2013)	criteria provided, single submitter	7	55242525 - 55242660	7	55174832 - 55174967	45245	54412
NM_005228.4(EGFR):c.2284-5_2290dup	EGFR|EGFR-AS1	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Jul 1, 2011)	criteria provided, single submitter	7	55248981 - 55248992	7	55181288 - 55181299	45248	54415
NM_005228.4(EGFR):c.2284-5_2290del	EGFR|EGFR-AS1	not specified	Uncertain significance(Last reviewed: Sep 4, 2009)	no assertion criteria provided	7	55248981 - 55248992	7	55181288 - 55181299	45247	54414
NM_005228.4(EGFR):c.2289C>G (p.Ala763=)	EGFR|EGFR-AS1	not specified	Likely benign(Last reviewed: Feb 22, 2010)	criteria provided, single submitter	7	55248991	7	55181298	45249	54416
NM_005228.4(EGFR):c.2290_2291insACCATC (p.Tyr764_Val765insHisHis)	EGFR|EGFR-AS1	Tyrosine kinase inhibitor response	drug response(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55248992 - 55248993	7	55181299 - 55181300	163373	174249
NM_005228.4(EGFR):c.2300_2308dupCCAGCGTGG (p.Val769_Asp770insAlaSerVal)	EGFR|EGFR-AS1	Tyrosine kinase inhibitor response	drug response(Last reviewed: Feb 24, 2010)	no assertion criteria provided	7	55249002 - 55249010	7	55181309 - 55181317	177678	178181
NM_005228.4(EGFR):c.2300C>T (p.Ala767Val)	EGFR|EGFR-AS1	not specified	Uncertain significance(Last reviewed: May 13, 2011)	criteria provided, single submitter	7	55249002	7	55181309	45250	54417
NM_005228.4(EGFR):c.2303_2311dupGCGTGGACA (p.Asp770_Asn771insSerValAsp)	EGFR|EGFR-AS1	Non-small cell lung cancer|Tyrosine kinase inhibitor response	drug response(Last reviewed: Jun 1, 2012)	criteria provided, single submitter	7	55249005 - 55249013	7	55181312 - 55181320	45253	54420
NM_005228.4(EGFR):c.2303_2304delGCinsTT (p.Ser768Ile)	EGFR|EGFR-AS1	Non-small cell lung cancer	Pathogenic(Last reviewed: Jan 4, 2013)	criteria provided, single submitter	7	55249005 - 55249006	7	55181312 - 55181313	45252	54419
NM_005228.4(EGFR):c.2303G>T (p.Ser768Ile)	EGFR|EGFR-AS1	Non-small cell lung cancer|Squamous cell lung carcinoma|Carcinoma of esophagus	Pathogenic(Last reviewed: Mar 11, 2011)	criteria provided, single submitter	7	55249005	7	55181312	45251	54418
NM_005228.4(EGFR):c.2305G>T (p.Val769Leu)	EGFR|EGFR-AS1	not specified	Uncertain significance(Last reviewed: Mar 23, 2012)	criteria provided, single submitter	7	55249007	7	55181314	45255	54422
NM_005228.4(EGFR):c.2305G>C (p.Val769Leu)	EGFR|EGFR-AS1	not specified	Uncertain significance(Last reviewed: Feb 25, 2008)	no assertion criteria provided	7	55249007	7	55181314	45254	54421
NM_005228.4(EGFR):c.2306_2320dup (p.Val774_Cys775insAspAsnProHisVal)	EGFR|EGFR-AS1	Tyrosine kinase inhibitor response	drug response(Last reviewed: Apr 21, 2011)	criteria provided, single submitter	7	55249008 - 55249022	7	55181315 - 55181329	177955	178201
NM_005228.4(EGFR):c.2307_2315dupGGACAACCC (p.Pro772_His773insAspAsnPro)	EGFR|EGFR-AS1	Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55249009 - 55249017	7	55181316 - 55181324	177654	178179
NM_005228.4(EGFR):c.2308_2309insGTT (p.Asp770delinsGlyTyr)	EGFR|EGFR-AS1	Tyrosine kinase inhibitor response	drug response(Last reviewed: May 25, 2012)	criteria provided, single submitter	7	55249010 - 55249011	7	55181317 - 55181318	177658	174115
NM_005228.4(EGFR):c.2308_2310delGACinsTGGG (p.Asp770Trpfs)	EGFR|EGFR-AS1	Tyrosine kinase inhibitor response	drug response(Last reviewed: Dec 6, 2012)	criteria provided, single submitter	7	55249010 - 55249012	7	55181317 - 55181319	163374	174250
NM_005228.4(EGFR):c.2309_2310insGTC (p.Asp770delinsGluSer)	EGFR|EGFR-AS1	Lung adenocarcinoma	Likely pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	7	55249011 - 55249012	7	55181318 - 55181319	496810	488234
NM_005228.4(EGFR):c.2310_2311insGGGTTG (p.Asp770_Asn771insGlyLeu)	EGFR|EGFR-AS1	Non-small cell lung cancer	Pathogenic(Last reviewed: Jul 17, 2009)	no assertion criteria provided	7	55249012 - 55249013	7	55181319 - 55181320	45257	54424
NM_005228.4(EGFR):c.2310C>T (p.Asp770=)	EGFR|EGFR-AS1	not specified	Likely benign(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55249012	7	55181319	45256	54423
NM_005228.4(EGFR):c.2311_2319dupAACCCCCAC (p.His773_Val774insAsnProHis)	EGFR|EGFR-AS1	Tyrosine kinase inhibitor response	drug response(Last reviewed: Apr 20, 2012)	no assertion criteria provided	7	55249013 - 55249021	7	55181320 - 55181328	177911	178198
NM_005228.4(EGFR):c.2311_2312insCAC (p.Asn771delinsThrHis)	EGFR|EGFR-AS1	Tyrosine kinase inhibitor response	drug response(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55249013 - 55249014	7	55181320 - 55181321	177662	174251
NM_005228.4(EGFR):c.2311A>G (p.Asn771Asp)	EGFR|EGFR-AS1	Tyrosine kinase inhibitor response	drug response(Last reviewed: Apr 17, 2008)	no assertion criteria provided	7	55249013	7	55181320	163376	174116
NM_005228.4(EGFR):c.2311_2312insGTT (p.Asn771delinsSerTyr)	EGFR|EGFR-AS1	Tyrosine kinase inhibitor response	drug response(Last reviewed: Apr 17, 2008)	no assertion criteria provided	7	55249013 - 55249014	7	55181320 - 55181321	163375	174117
NM_005228.4(EGFR):c.2312_2313insTGT (p.Asn771_Pro772insVal)	EGFR|EGFR-AS1	Tyrosine kinase inhibitor response	drug response(Last reviewed: Jun 2, 2011)	criteria provided, single submitter	7	55249014 - 55249015	7	55181321 - 55181322	163377	174252
NM_005228.4(EGFR):c.2312_2314dupACC (p.Asn771_Pro772insHis)	EGFR|EGFR-AS1	Non-small cell lung cancer	Pathogenic(Last reviewed: Nov 8, 2012)	criteria provided, single submitter	7	55249014 - 55249016	7	55181321 - 55181323	45258	54425
NM_005228.4(EGFR):c.2313_2321dupCCCCCACGT (p.Val774_Cys775insProHisVal)	EGFR|EGFR-AS1	not specified	Uncertain significance(Last reviewed: Dec 23, 2008)	no assertion criteria provided	7	55249015 - 55249023	7	55181322 - 55181330	45259	54426
NM_005228.4(EGFR):c.2315_2320dupCCCACG (p.His773_Val774insAlaHis)	EGFR|EGFR-AS1	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Oct 14, 2010)	criteria provided, single submitter	7	55249017 - 55249022	7	55181324 - 55181329	45260	54427
NM_005228.4(EGFR):c.2317_2318insCGAACCCCC (p.Pro772_His773insProAsnPro)	EGFR|EGFR-AS1	Tyrosine kinase inhibitor response	drug response(Last reviewed: Mar 24, 2011)	criteria provided, single submitter	7	55249019 - 55249020	7	55181326 - 55181327	177954	174118
NM_005228.4(EGFR):c.2317_2322dupCACGTG (p.Val774_Cys775insHisVal)	EGFR|EGFR-AS1	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55249019 - 55249024	7	55181326 - 55181331	45262	54429
NM_005228.4(EGFR):c.2317_2319dupCAC (p.His773_Val774insHis)	EGFR|EGFR-AS1	not specified	Uncertain significance(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55249019 - 55249021	7	55181326 - 55181328	45261	54428
NM_005228.4(EGFR):c.2318A>G (p.His773Arg)	EGFR|EGFR-AS1	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55249020	7	55181327	376083	362962
NM_005228.4(EGFR):c.2320_2321insGCCACG (p.His773_Val774insGlyHis)	EGFR|EGFR-AS1	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55249022 - 55249023	7	55181329 - 55181330	45263	54430
NM_005228.4(EGFR):c.2327G>A (p.Arg776His)	EGFR|EGFR-AS1	Squamous cell carcinoma of the head and neck|Non-small cell lung cancer	drug response	no assertion criteria provided	7	55249029	7	55181336	126515	132039
NM_005228.4(EGFR):c.2329C>T (p.Leu777=)	EGFR|EGFR-AS1	not specified	Likely benign(Last reviewed: Jun 16, 2010)	criteria provided, single submitter	7	55249031	7	55181338	45264	54431
NM_005228.4(EGFR):c.2334G>T (p.Leu778=)	EGFR|EGFR-AS1	not specified	Uncertain significance(Last reviewed: Sep 5, 2008)	no assertion criteria provided	7	55249036	7	55181343	45265	54432
NM_005228.4(EGFR):c.2335G>T (p.Gly779Cys)	EGFR|EGFR-AS1	not specified	Uncertain significance(Last reviewed: Nov 8, 2012)	criteria provided, single submitter	7	55249037	7	55181344	45266	54433
NM_005228.4(EGFR):c.2336G>T (p.Gly779Val)	EGFR|EGFR-AS1	not specified	Uncertain significance(Last reviewed: Nov 8, 2012)	criteria provided, single submitter	7	55249038	7	55181345	45267	54434
NM_005228.4(EGFR):c.2340C>T (p.Ile780=)	EGFR|EGFR-AS1	not specified	Likely benign(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55249042	7	55181349	45268	54435
NM_005228.4(EGFR):c.2349C>T (p.Thr783=)	EGFR|EGFR-AS1	not specified	Likely benign(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55249051	7	55181358	45269	54436
NM_005228.4(EGFR):c.2355C>T (p.Thr785=)	EGFR|EGFR-AS1	not specified	Likely benign(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55249057	7	55181364	45270	54437
NM_005228.4(EGFR):c.2369C>T (p.Thr790Met)	EGFR|EGFR-AS1	Lung cancer|Non-small cell lung cancer|Nonsmall cell lung cancer, resistance to tyrosine kinase inhibitor in|EGFR-related lung cancer|Tyrosine kinase inhibitor response|erlotinib response - Efficacy|gefitinib response - Efficacy	drug response(Last reviewed: Jun 23, 2016)	reviewed by expert panel	7	55249071	7	55181378	16613	31652
NM_005228.4(EGFR):c.2389T>A (p.Cys797Ser)	EGFR|EGFR-AS1	Non-small cell lung cancer	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	7	55249091	7	55181398	376342	363221
NM_005228.4(EGFR):c.2409G>A (p.Arg803=)	EGFR|EGFR-AS1	not specified	Likely benign(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55249111	7	55181418	45272	54439
NM_005228.4(EGFR):c.2428G>A (p.Gly810Ser)	EGFR|EGFR-AS1	Squamous cell carcinoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55249130	7	55181437	376278	363157
NM_005228.4(EGFR):c.2429G>A (p.Gly810Asp)	EGFR|EGFR-AS1	Squamous cell carcinoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55249131	7	55181438	376279	363158
NM_005228.4(EGFR):c.2439C>T (p.Tyr813=)	EGFR|EGFR-AS1	not specified	Likely benign(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55249141	7	55181448	45273	54440
NM_005228.4(EGFR):c.2457G>A (p.Val819=)	EGFR|EGFR-AS1	not specified	Likely benign(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55249159	7	55181466	45274	54441
NM_005228.4(EGFR):c.2464G>A (p.Ala822Thr)	EGFR|EGFR-AS1	not specified	Uncertain significance(Last reviewed: Oct 28, 2006)	no assertion criteria provided	7	55249166	7	55181473	45275	54442
NM_005228.4(EGFR):c.2484G>A (p.Leu828=)	EGFR	not specified	Likely benign(Last reviewed: Apr 16, 2007)	no assertion criteria provided	7	55259426	7	55191733	177759	174253
NM_005228.4(EGFR):c.2491C>T (p.Arg831Cys)	EGFR	not specified	Uncertain significance(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55259433	7	55191740	45276	54443
NM_005228.4(EGFR):c.2497T>G (p.Leu833Val)	EGFR	not specified	Uncertain significance(Last reviewed: Jun 20, 2008)	no assertion criteria provided	7	55259439	7	55191746	45277	54444
NM_005228.4(EGFR):c.2500G>T (p.Val834Leu)	EGFR	Non-small cell lung cancer	Pathogenic(Last reviewed: Dec 6, 2012)	criteria provided, single submitter	7	55259442	7	55191749	45279	54446
NM_005228.4(EGFR):c.2500G>C (p.Val834Leu)	EGFR	not specified	Uncertain significance(Last reviewed: Oct 15, 2008)	no assertion criteria provided	7	55259442	7	55191749	45278	54445
NM_005228.4(EGFR):c.2504_2591del88 (p.His835Argfs)	EGFR	not specified	Uncertain significance(Last reviewed: Mar 21, 2014)	criteria provided, single submitter	7	55259446 - 55259533	7	55191753 - 55191840	163379	174119
NM_005228.4(EGFR):c.2504A>T (p.His835Leu)	EGFR	Lung cancer|not specified	Uncertain significance(Last reviewed: Jun 27, 2013)	no assertion criteria provided	7	55259446	7	55191753	45280	54447
NM_005228.4(EGFR):c.2508C>T (p.Arg836=)	EGFR	Lung cancer|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	55259450	7	55191757	45281	54448
NM_005228.4(EGFR):c.2527G>A (p.Val843Ile)	EGFR	Head and Neck Neoplasms	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	7	55259469	7	55191776	376212	363091
NM_005228.4(EGFR):c.2543C>T (p.Pro848Leu)	EGFR	not specified|Hereditary cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	7	55259485	7	55191792	45282	54449
NM_005228.4(EGFR):c.2544G>A (p.Pro848=)	EGFR	Endometrial carcinoma	not provided	no assertion provided	7	55259486	7	55191793	132949	136698
NM_005228.4(EGFR):c.2572_2573delCTinsAG (p.Leu858Arg)	EGFR	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55259514 - 55259515	7	55191821 - 55191822	376280	363159
NM_005228.4(EGFR):c.2572C>T (p.Leu858=)	EGFR	not specified	Likely benign(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55259514	7	55191821	45284	54451
NM_005228.4(EGFR):c.2572C>A (p.Leu858Met)	EGFR	Non-small cell lung cancer|not specified	Uncertain significance(Last reviewed: Apr 15, 2011)	criteria provided, single submitter	7	55259514	7	55191821	45283	54450
NM_005228.4(EGFR):c.2573_2574delTGinsGT (p.Leu858Arg)	EGFR	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55259515 - 55259516	7	55191822 - 55191823	376282	363161
NM_005228.4(EGFR):c.2573T>A (p.Leu858Gln)	EGFR	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	55259515	7	55191822	376281	363160
NM_005228.4(EGFR):c.2573T>G (p.Leu858Arg)	EGFR	Lung adenocarcinoma|Non-small cell lung cancer|Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic|Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, somatic|Tyrosine kinase inhibitor response|carboplatin, docetaxel, erlotinib, gemcitabine, and paclitaxel response - Efficacy|erlotinib response - Efficacy|gefitinib response - Efficacy	drug response(Last reviewed: Mar 21, 2018)	reviewed by expert panel	7	55259515	7	55191822	16609	31648
NM_005228.4(EGFR):c.2574G>T (p.Leu858=)	EGFR	not specified	Uncertain significance(Last reviewed: Apr 21, 2011)	criteria provided, single submitter	7	55259516	7	55191823	45285	54452
NM_005228.4(EGFR):c.2580A>T (p.Lys860Asn)	EGFR	not specified	Uncertain significance(Last reviewed: Apr 16, 2009)	no assertion criteria provided	7	55259522	7	55191829	45286	54453
NM_005228.4(EGFR):c.2582T>C (p.Leu861Pro)	EGFR	Squamous cell lung carcinoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	7	55259524	7	55191831	376145	363024
NM_005228.4(EGFR):c.2582T>A (p.Leu861Gln)	EGFR	Lung adenocarcinoma|Non-small cell lung cancer|Squamous cell lung carcinoma|Tyrosine kinase inhibitor response	Pathogenic/Likely pathogenic, drug response(Last reviewed: May 31, 2016)	no assertion criteria provided	7	55259524	7	55191831	163380	174254
NM_005228.4(EGFR):c.2582T>G (p.Leu861Arg)	EGFR	Squamous cell lung carcinoma|not specified	Uncertain significance(Last reviewed: Jun 17, 2013)	criteria provided, single submitter	7	55259524	7	55191831	45287	54454
NM_005228.4(EGFR):c.2592G>A (p.Ala864=)	EGFR	not specified	Likely benign(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55259534	7	55191841	45288	54455
NM_005228.4(EGFR):c.2597A>T (p.Glu866Val)	EGFR	not specified	Uncertain significance(Last reviewed: Feb 3, 2009)	no assertion criteria provided	7	55259539	7	55191846	45289	54456
NM_005228.4(EGFR):c.2598G>A (p.Glu866=)	EGFR	not specified	Likely benign(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55259540	7	55191847	45290	54457
NM_005228.4(EGFR):c.2602G>A (p.Glu868Lys)	EGFR	Familial cancer of breast	not provided	no assertion provided	7	55259544	7	55191851	132950	136699
NM_005228.4(EGFR):c.2612C>G (p.Ala871Gly)	EGFR	not specified	Uncertain significance(Last reviewed: Feb 3, 2009)	no assertion criteria provided	7	55259554	7	55191861	45291	54458
NM_005228.4(EGFR):c.2625+6G>T	EGFR	not specified	Likely benign(Last reviewed: Jun 4, 2008)	no assertion criteria provided	7	55259573	7	55191880	45292	54459
NM_005228.4(EGFR):c.2625+8G>A	EGFR	Endometrial carcinoma	not provided	no assertion provided	7	55259575	7	55191882	132951	136700
NM_005228.4(EGFR):c.2642T>C (p.Met881Thr)	EGFR	not specified	Uncertain significance(Last reviewed: Nov 21, 2006)	no assertion criteria provided	7	55260475	7	55192782	45293	54460
NM_005228.4(EGFR):c.2654C>T (p.Ser885Leu)	EGFR	not specified	Uncertain significance(Last reviewed: Jan 18, 2007)	no assertion criteria provided	7	55260487	7	55192794	45294	54461
NM_005228.4(EGFR):c.2748C>T (p.Asp916=)	EGFR	not specified	Likely benign(Last reviewed: May 27, 2009)	no assertion criteria provided	7	55266456	7	55198763	45296	54463
NM_005228.4(EGFR):c.2775C>T (p.Ser925=)	EGFR	not specified	Likely benign(Last reviewed: Feb 27, 2007)	no assertion criteria provided	7	55266483	7	55198790	177743	174120
NM_005228.4(EGFR):c.2862C>T (p.Asp954=)	EGFR	not specified	Likely benign(Last reviewed: Mar 1, 2008)	no assertion criteria provided	7	55268022	7	55200329	45297	54464
NM_005228.4(EGFR):c.2866G>A (p.Asp956Asn)	EGFR	Endometrial carcinoma	not provided	no assertion provided	7	55268026	7	55200333	132964	136713
NM_173517.5(VKORC1L1):c.493G>T (p.Glu165Ter)	VKORC1L1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	65419249	7	65954262	161827	171439
NM_000181.3(GUSB):c.1253T>G (p.Phe418Cys)	GUSB	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	65439420	7	65974433	161461	171440
GRCh37/hg19 7q11.22(chr7:70163581-70255359)x4	AUTS2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	7	70163581 - 70255359			221460	223189
GRCh37/hg19 7q11.23(chr7:73122969-73256410)x3	CLDN4|CLDN3|STX1A|ABHD11|METTL27|ABHD11-AS1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	7	73122969 - 73256410			221461	223190
NM_002835.3(PTPN12):c.182A>G (p.Lys61Arg)	PTPN12	Carcinoma of colon	Pathogenic(Last reviewed: Feb 21, 1994)	no assertion criteria provided	7	77200477	7	77571160	9448	24487
NM_012301.3(MAGI2):c.1340A>T (p.Asp447Val)	MAGI2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	77973163	7	78343846	161661	171441
NM_000927.4(ABCB1):c.3435T>C (p.Ile1145=)	ABCB1	Non-small cell lung cancer|MDR1 POLYMORPHISM|digoxin response - Other|ondansetron response - Efficacy|methotrexate response - Toxicity/ADR|nevirapine response - Toxicity/ADR|fentanyl response - Dosage, Efficacy|methadone response - Dosage, Efficacy|morphine response - Dosage, Efficacy|opioids response - Dosage, Efficacy|oxycodone response - Dosage, Efficacy|tramadol response - Dosage, Efficacy	drug response(Last reviewed: Apr 24, 2018)	reviewed by expert panel	7	87138645	7	87509329	225939	227763
NM_000927.4(ABCB1):c.2677T>A (p.Ser893Thr)	ABCB1	not specified|Ovarian Neoplasms	Benign(Last reviewed: Jan 6, 2014)	criteria provided, single submitter	7	87160618	7	87531302	166619	177251
GRCh37/hg19 7q21.12-21.2(chr7:87840219-91707100)x3	CDK14|SRI|MTERF1|FZD1|CLDN12|AKAP9|STEAP1|STEAP4|CFAP69|GTPBP10|TEX47|ZNF804B|STEAP2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	7	87840219 - 91707100			221462	223191
NM_000466.2(PEX1):c.3645A>T (p.Glu1215Asp)	PEX1|GATAD1	not provided	Uncertain significance	no assertion criteria provided	7	92118729	7	92489415	100813	106673
GRCh37/hg19 7q21.3(chr7:92818582-92963470)x3	VPS50|HEPACAM2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	7	92818582 - 92963470			221463	223192
NM_198151.3(HEPACAM2):c.3G>A (p.Met1Ile)	HEPACAM2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	92848805	7	93219492	161850	171442
NM_021955.4(GNGT1):c.96+1G>A	GNGT1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	93536155	7	93906843	161753	171443
GRCh37/hg19 7q21.3(chr7:94156496-94285902)x3	SGCE|PEG10|CASD1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	7	94156496 - 94285902			221464	223193
NM_002612.3(PDK4):c.59T>G (p.Val20Gly)	PDK4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	95225547	7	95596235	219304	220993
NM_014916.3(LMTK2):c.649_650delTG (p.Cys217Terfs)	LMTK2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	97788729 - 97788730	7	98159417 - 98159418	219322	221011
NM_003496.3(TRRAP):c.8399A>G (p.Gln2800Arg)	TRRAP	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	98575922	7	98978299	161616	171444
NM_003439.3(ZKSCAN1):c.1454G>A (p.Gly485Glu)	ZKSCAN1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	99631582	7	100033959	161615	171428
NM_006833.4(COPS6):c.631A>C (p.Ser211Arg)	COPS6	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	99688757	7	100091134	161652	171429
NM_001040105.1(MUC17):c.8950G>A (p.Glu2984Lys)	MUC17	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	100683647	7	101040366	161504	171430
NM_175884.5(CCDC71L):c.478A>C (p.Ser160Arg)	CCDC71L	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	7	106300865	7	106660419	221313	223042
NM_001282426.1(PIK3CG):c.1414C>T (p.Arg472Cys)	PIK3CG	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	106509420	7	106868975	219323	221012
NM_001193582.1(NRCAM):c.3485T>G (p.Leu1162Arg)	NRCAM	not provided	Uncertain significance	no assertion criteria provided	7	107790506	7	108150061	100829	106689
NM_001127500.2(MET):c.985C>A (p.Leu329Ile)	MET	Neuroblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	7	116340123	7	116700069	438775	432409
NM_000245.3(MET):c.2908C>T (p.Arg970Cys)	MET	Renal cell carcinoma, papillary, 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Neoplasm	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	7	116411923	7	116771869	41623	50062
NM_000245.3(MET):c.2975C>T (p.Thr992Ile)	MET	Renal cell carcinoma, papillary, 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Congenital diaphragmatic hernia|Neoplasm|Carcinoma	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	7	116411990	7	116771936	41624	50063
NM_001127500.2(MET):c.3328G>A (p.Val1110Ile)	MET	Renal cell carcinoma, papillary, 1|Hereditary cancer-predisposing syndrome|Neoplasm|Carcinoma	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	7	116417457	7	116777403	186141	182676
NM_001127500.2(MET):c.3334C>T (p.His1112Tyr)	MET	Kidney Carcinoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	116417463	7	116777409	376068	362947
NM_001127500.2(MET):c.3335A>G (p.His1112Arg)	MET	Renal cell carcinoma, papillary, 1|not provided|Kidney Carcinoma	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, multiple submitters, no conflicts	7	116417464	7	116777410	13887	28926
NM_001127500.2(MET):c.3352A>T (p.Asn1118Tyr)	MET	Carcinoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	7	116417481	7	116777427	376729	363608
NM_001127500.2(MET):c.3572C>T (p.Thr1191Ile)	MET	Hepatocellular carcinoma, childhood type, somatic|Childhood hepatocellular carcinoma	Pathogenic(Last reviewed: Jan 15, 1999)	no assertion criteria provided	7	116419007	7	116778953	13888	28927
NM_001127500.2(MET):c.3637C>G (p.Leu1213Val)	MET	Renal cell carcinoma, papillary, 1	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	7	116422102	7	116782048	13886	28925
NM_001127500.2(MET):c.3736G>C (p.Asp1246His)	MET	Carcinoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	7	116423407	7	116783353	376728	363607
NM_001127500.2(MET):c.3736G>A (p.Asp1246Asn)	MET	Renal cell carcinoma, papillary, 1|Carcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	7	116423407	7	116783353	13884	28923
NM_001127500.2(MET):c.3742T>C (p.Tyr1248His)	MET	not provided|Carcinoma|Kidney Carcinoma	Uncertain significance(Last reviewed: Sep 22, 2014)	criteria provided, single submitter	7	116423413	7	116783359	194929	192091
NM_001127500.2(MET):c.3743A>G (p.Tyr1248Cys)	MET	Renal cell carcinoma, papillary, 1|Neoplasm|Carcinoma|Kidney Carcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	7	116423414	7	116783360	13885	28924
NM_001127500.2(MET):c.3757T>G (p.Tyr1253Asp)	MET	Neoplasm|Carcinoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	7	116423428	7	116783374	376200	363079
NM_001127500.2(MET):c.3785A>G (p.Lys1262Arg)	MET	Hepatocellular carcinoma, childhood type, somatic|Childhood hepatocellular carcinoma	Pathogenic(Last reviewed: Jan 15, 1999)	no assertion criteria provided	7	116423456	7	116783402	13890	28929
NM_001127500.2(MET):c.3803T>C (p.Met1268Thr)	MET	Carcinoma|Kidney Carcinoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	7	116423474	7	116783420	376126	363005
NM_001127500.2(MET):c.3804G>T (p.Met1268Ile)	MET	Neoplasm	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	7	116423475	7	116783421	376202	363081
NM_001127500.2(MET):c.3804G>C (p.Met1268Ile)	MET	Neoplasm	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	7	116423475	7	116783421	376201	363080
NM_001127500.2(MET):c.3804G>A (p.Met1268Ile)	MET	Hepatocellular carcinoma, childhood type, somatic|Childhood hepatocellular carcinoma|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	7	116423475	7	116783421	13889	28928
NM_033427.2(CTTNBP2):c.3823G>A (p.Glu1275Lys)	CTTNBP2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	117375020	7	117734966	219324	221013
NM_002851.2(PTPRZ1):c.663G>T (p.Leu221=)	PTPRZ1	not provided	Uncertain significance	no assertion criteria provided	7	121623762	7	121983708	100842	106702
NM_000845.2(GRM8):c.2554C>T (p.Arg852Cys)	GRM8	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	126086303	7	126446249	161472	171431
NM_005631.4(SMO):c.1234C>T (p.Leu412Phe)	SMO	Craniofacial malformations, asymmetric, with polysyndactyly and abnormal skin and gut development	Pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	7	128846398	7	129206557	245609	245206
NM_005631.4(SMO):c.1417G>C (p.Asp473His)	SMO	Medulloblastoma|Basal cell carcinoma	Pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	7	128849189	7	129209348	375938	362817
NM_005631.4(SMO):c.1604G>T (p.Trp535Leu)	SMO	Basal cell carcinoma, somatic	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	7	128850341	7	129210500	8117	23156
NM_005631.4(SMO):c.1685G>A (p.Arg562Gln)	SMO	Basal cell carcinoma, somatic	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	7	128850838	7	129210997	8118	23157
NM_004333.4(BRAF):c.1813_1814delAGinsTT (p.Ser605Phe)	BRAF	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453121 - 140453122	7	140753321 - 140753322	376284	363163
NM_004333.4(BRAF):c.1814G>A (p.Ser605Asn)	BRAF	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453121	7	140753321	376283	363162
NM_004333.4(BRAF):c.1807C>T (p.Arg603Ter)	BRAF	Endometrial carcinoma	not provided	no assertion provided	7	140453128	7	140753328	132952	136701
NM_004333.4(BRAF):c.1801_1803delAAA (p.Lys601del)	BRAF	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453132 - 140453134	7	140753332 - 140753334	376287	363166
NM_004333.4(BRAF):c.1803A>C (p.Lys601Asn)	BRAF	Chronic lymphocytic leukemia|Malignant melanoma of skin|Lung adenocarcinoma|Cutaneous melanoma|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140453132	7	140753332	376286	363165
NM_004333.4(BRAF):c.1803A>T (p.Lys601Asn)	BRAF	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453132	7	140753332	376285	363164
NM_004333.4(BRAF):c.1802A>G (p.Lys601Arg)	BRAF	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	7	140453133	7	140753333	376169	363048
NM_004333.4(BRAF):c.1802A>C (p.Lys601Thr)	BRAF	Chronic lymphocytic leukemia|Malignant melanoma of skin|Lung adenocarcinoma|Rasopathy|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140453133	7	140753333	44818	53985
NM_004333.4(BRAF):c.1799_1801delTGA (p.Val600_Lys601delinsGlu)	BRAF	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Oct 12, 2011)	criteria provided, single submitter	7	140453134 - 140453136	7	140753334 - 140753336	44817	53984
NM_004333.4(BRAF):c.1801A>G (p.Lys601Glu)	BRAF	Chronic lymphocytic leukemia|Malignant melanoma of skin|Follicular thyroid carcinoma|Lung adenocarcinoma|Non-small cell lung cancer|Carcinoma of colon|Cutaneous melanoma|Neoplasm|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic(Last reviewed: Aug 23, 2011)	criteria provided, single submitter	7	140453134	7	140753334	13966	29005
NM_004333.4(BRAF):c.1799_1800delTGinsAA (p.Val600Glu)	BRAF	Cutaneous melanoma|Neoplasm of the colon	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453135 - 140453136	7	140753335 - 140753336	376069	362948
NM_004333.4(BRAF):c.1799_1800delTGinsAT (p.Val600Asp)	BRAF	Cutaneous melanoma	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453135 - 140453136	7	140753335 - 140753336	375939	362818
NM_004333.4(BRAF):c.1799T>C (p.Val600Ala)	BRAF	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453136	7	140753336	376288	363167
NM_004333.4(BRAF):c.1798_1799delGTinsAA (p.Val600Lys)	BRAF	Cutaneous melanoma	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453136 - 140453137	7	140753336 - 140753337	375941	362820
NM_004333.4(BRAF):c.1798_1799delGTinsAG (p.Val600Arg)	BRAF	Cutaneous melanoma	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453136 - 140453137	7	140753336 - 140753337	375940	362819
NM_004333.4(BRAF):c.1799T>G (p.Val600Gly)	BRAF	Cutaneous melanoma|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Mar 3, 2016)	no assertion criteria provided	7	140453136	7	140753336	40389	48859
NM_004333.4(BRAF):c.1799T>A (p.Val600Glu)	BRAF	Gastrointestinal stroma tumor|Lung cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Papillary thyroid carcinoma|Lung adenocarcinoma|Non-small cell lung cancer|Carcinoma of colon|Astrocytoma, low-grade, somatic|Germ cell tumor, nonseminomatous|NONSEMINOMATOUS GERM CELL TUMORS, SOMATIC|not provided|Neoplasm of brain|Cutaneous melanoma|Glioblastoma|Brainstem glioma|Neoplasm of the large intestine|Neoplasm|Cardio-facio-cutaneous syndrome|Ovarian Neoplasms|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Neoplasm of the colon|Cystic epithelial invagination containing papillae lined by columnar epithelium	Pathogenic(Last reviewed: Oct 8, 2013)	criteria provided, single submitter	7	140453136	7	140753336	13961	29000
NM_004333.4(BRAF):c.1798G>C (p.Val600Leu)	BRAF	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453137	7	140753337	376289	363168
NM_004333.4(BRAF):c.1798G>T (p.Val600Leu)	BRAF	Non-small cell lung cancer|Cutaneous melanoma	Likely pathogenic(Last reviewed: Oct 4, 2011)	criteria provided, single submitter	7	140453137	7	140753337	44816	53983
NM_004333.4(BRAF):c.1798G>A (p.Val600Met)	BRAF	Non-small cell lung cancer|Cutaneous melanoma	Likely pathogenic(Last reviewed: May 9, 2012)	criteria provided, single submitter	7	140453137	7	140753337	44815	53982
NM_004333.5(BRAF):c.1794_1796dup (p.Thr599_Val600insThr)	BRAF	Non-small cell lung cancer|Carcinoma of colon|Colorectal cancer|Childhood ganglioglioma	Pathogenic(Last reviewed: Jun 20, 2013)	criteria provided, single submitter	7	140453139 - 140453141	7	140753339 - 140753341	162793	176758
NM_004333.4(BRAF):c.1796C>T (p.Thr599Ile)	BRAF	not provided|Cutaneous melanoma|Neoplasm	Pathogenic(Last reviewed: Feb 1, 2014)	criteria provided, single submitter	7	140453139	7	140753339	40388	48858
NM_004333.4(BRAF):c.1789_1790delCTinsTC (p.Leu597Ser)	BRAF	Cutaneous melanoma	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453145 - 140453146	7	140753345 - 140753346	375942	362821
NM_004333.4(BRAF):c.1790T>A (p.Leu597Gln)	BRAF	Malignant melanoma of skin|Multiple myeloma|Cutaneous melanoma|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140453145	7	140753345	76687	87578
NM_004333.4(BRAF):c.1790T>G (p.Leu597Arg)	BRAF	Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Cutaneous melanoma|Ovarian Neoplasms|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140453145	7	140753345	13968	29007
NM_004333.4(BRAF):c.1789C>G (p.Leu597Val)	BRAF	Lung cancer|Noonan syndrome 1|Non-small cell lung cancer|Noonan syndrome 7|not provided|Rasopathy|Cutaneous melanoma|Neoplasm	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, multiple submitters, no conflicts	7	140453146	7	140753346	13969	29008
NM_004333.4(BRAF):c.1787G>A (p.Gly596Asp)	BRAF	Multiple myeloma|Lung adenocarcinoma|Glioblastoma|Transitional cell carcinoma of the bladder	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140453148	7	140753348	376375	363254
NM_004333.4(BRAF):c.1787G>T (p.Gly596Val)	BRAF	Multiple myeloma|Lung adenocarcinoma|not provided|Rasopathy|Glioblastoma|Transitional cell carcinoma of the bladder|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140453148	7	140753348	40387	48857
NM_004333.4(BRAF):c.1786G>A (p.Gly596Ser)	BRAF	Multiple myeloma|Lung adenocarcinoma|Glioblastoma|Transitional cell carcinoma of the bladder	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140453149	7	140753349	376374	363253
NM_004333.4(BRAF):c.1786G>C (p.Gly596Arg)	BRAF	Multiple myeloma|Lung adenocarcinoma|Cutaneous melanoma|Glioblastoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140453149	7	140753349	375943	362822
NM_004333.4(BRAF):c.1785T>A (p.Phe595Leu)	BRAF	not provided|Cutaneous melanoma	Pathogenic(Last reviewed: Dec 5, 2013)	criteria provided, single submitter	7	140453150	7	140753350	180789	179094
NM_004333.4(BRAF):c.1785T>G (p.Phe595Leu)	BRAF	not provided|Rasopathy|Cutaneous melanoma|Neoplasm|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140453150	7	140753350	177672	174042
NM_004333.4(BRAF):c.1784T>C (p.Phe595Ser)	BRAF	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453151	7	140753351	376290	363169
NM_004333.4(BRAF):c.1783T>C (p.Phe595Leu)	BRAF	Cardiofaciocutaneous syndrome 1|not provided|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	7	140453152	7	140753352	202193	198628
NM_004333.4(BRAF):c.1782T>A (p.Asp594Glu)	BRAF	Cutaneous melanoma	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453153	7	140753353	375945	362824
NM_004333.4(BRAF):c.1782T>G (p.Asp594Glu)	BRAF	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	7	140453153	7	140753353	375944	362823
NM_004333.4(BRAF):c.1781A>C (p.Asp594Ala)	BRAF	Cutaneous melanoma	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	7	140453154	7	140753354	376070	362949
NM_004333.4(BRAF):c.1781A>T (p.Asp594Val)	BRAF	Cutaneous melanoma|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453154	7	140753354	375946	362825
NM_004333.4(BRAF):c.1781A>G (p.Asp594Gly)	BRAF	Non-Hodgkin lymphoma|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Non-small cell lung cancer|Neoplasm of brain|Cutaneous melanoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Adrenocortical carcinoma	Pathogenic(Last reviewed: Jun 11, 2012)	criteria provided, single submitter	7	140453154	7	140753354	13972	29011
NM_004333.4(BRAF):c.1779_1780delTGinsGA (p.Asp594Asn)	BRAF	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	7	140453155 - 140453156	7	140753355 - 140753356	375948	362827
NM_004333.4(BRAF):c.1780G>C (p.Asp594His)	BRAF	Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of brain|Cutaneous melanoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Adrenocortical carcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140453155	7	140753355	375947	362826
NM_004333.4(BRAF):c.1780G>A (p.Asp594Asn)	BRAF	Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Non-small cell lung cancer|Neoplasm of brain|Cutaneous melanoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Adrenocortical carcinoma	Likely pathogenic(Last reviewed: May 13, 2010)	criteria provided, single submitter	7	140453155	7	140753355	44813	53980
NM_004333.4(BRAF):c.1776A>G (p.Ile592Met)	BRAF	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453159	7	140753359	376291	363170
NM_004333.4(BRAF):c.1774A>G (p.Ile592Val)	BRAF	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453161	7	140753361	376071	362950
NM_004333.4(BRAF):c.1761C>A (p.Asp587Glu)	BRAF	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453174	7	140753374	376293	363172
NM_004333.4(BRAF):c.1761C>G (p.Asp587Glu)	BRAF	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453174	7	140753374	376292	363171
NM_004333.4(BRAF):c.1760A>C (p.Asp587Ala)	BRAF	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140453175	7	140753375	376294	363173
NM_004333.4(BRAF):c.1756G>A (p.Glu586Lys)	BRAF	not specified|Cutaneous melanoma|Neoplasm	Uncertain significance(Last reviewed: Jun 14, 2012)	criteria provided, single submitter	7	140453179	7	140753379	44812	53979
NM_004333.4(BRAF):c.1742A>C (p.Asn581Thr)	BRAF	Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140453193	7	140753393	376376	363255
NM_004333.4(BRAF):c.1742A>G (p.Asn581Ser)	BRAF	Chronic myelogenous leukemia|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Non-small cell lung cancer|Cutaneous melanoma|Neoplasm of the large intestine|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: Aug 14, 2013)	criteria provided, single submitter	7	140453193	7	140753393	177776	174177
NM_004333.4(BRAF):c.1741A>C (p.Asn581His)	BRAF	Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140453987	7	140754187	55794	70450
NM_004333.4(BRAF):c.1415A>G (p.Tyr472Cys)	BRAF	Lung cancer	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	7	140481393	7	140781593	375949	362828
NM_004333.4(BRAF):c.1411G>T (p.Val471Phe)	BRAF	not provided|Rasopathy|Cutaneous melanoma	Conflicting interpretations of pathogenicity(Last reviewed: Sep 21, 2017)	criteria provided, conflicting interpretations	7	140481397	7	140781597	40367	48837
NM_004333.4(BRAF):c.1405_1407delGGA (p.Gly469del)	BRAF	Non-small cell lung cancer	Pathogenic(Last reviewed: Sep 21, 2009)	no assertion criteria provided	7	140481401 - 140481403	7	140781601 - 140781603	44802	53969
NM_004333.4(BRAF):c.1405_1406delGGinsTC (p.Gly469Ser)	BRAF	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140481402 - 140481403	7	140781602 - 140781603	376072	362951
NM_004333.4(BRAF):c.1405_1406delGGinsTT (p.Gly469Leu)	BRAF	Lung cancer	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	7	140481402 - 140481403	7	140781602 - 140781603	375950	362829
NM_004333.4(BRAF):c.1406G>T (p.Gly469Val)	BRAF	Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Non-small cell lung cancer|Squamous cell lung carcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Neoplasm|Colorectal Neoplasms|Adenocarcinoma of prostate	Pathogenic(Last reviewed: Dec 30, 2011)	criteria provided, single submitter	7	140481402	7	140781602	44803	53970
NM_004333.5(BRAF):c.1406G>A (p.Gly469Glu)	BRAF	Cardiofaciocutaneous syndrome 1|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Squamous cell lung carcinoma|not specified|not provided|Rasopathy|Cutaneous melanoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Cardio-facio-cutaneous syndrome|Colorectal Neoplasms|Adenocarcinoma of prostate	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140481402	7	140781602	13974	29013
NM_004333.4(BRAF):c.1406G>C (p.Gly469Ala)	BRAF	Non-Hodgkin lymphoma|Lung cancer|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Non-small cell lung cancer|Squamous cell lung carcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Neoplasm|Colorectal Neoplasms|Adenocarcinoma of prostate	Pathogenic(Last reviewed: Aug 25, 2014)	criteria provided, single submitter	7	140481402	7	140781602	13971	29010
NM_004333.4(BRAF):c.1405G>A (p.Gly469Arg)	BRAF	Non-small cell lung cancer|Cutaneous melanoma	Likely pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	7	140481403	7	140781603	177775	174179
NM_004333.4(BRAF):c.1405G>T (p.Gly469Ter)	BRAF	not specified	Uncertain significance(Last reviewed: May 3, 2013)	criteria provided, single submitter	7	140481403	7	140781603	162801	174044
NM_004333.4(BRAF):c.1405G>C (p.Gly469Arg)	BRAF	Non-Hodgkin lymphoma|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Squamous cell lung carcinoma|not provided|Cutaneous melanoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of prostate	Pathogenic(Last reviewed: Dec 17, 2012)	criteria provided, single submitter	7	140481403	7	140781603	13970	29009
NM_004333.4(BRAF):c.1397G>C (p.Gly466Ala)	BRAF	Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Cutaneous melanoma|Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140481411	7	140781611	376295	363174
NM_004333.4(BRAF):c.1397G>A (p.Gly466Glu)	BRAF	Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Cutaneous melanoma|Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140481411	7	140781611	376073	362952
NM_004333.4(BRAF):c.1397G>T (p.Gly466Val)	BRAF	Lung cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Non-small cell lung cancer|Squamous cell lung carcinoma|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140481411	7	140781611	13967	29006
NM_004333.4(BRAF):c.1396G>A (p.Gly466Arg)	BRAF	Non-small cell lung cancer|Ovarian Neoplasms	Likely pathogenic(Last reviewed: Aug 20, 2010)	criteria provided, single submitter	7	140481412	7	140781612	44801	53968
NM_004333.4(BRAF):c.1391G>T (p.Gly464Val)	BRAF	Non-small cell lung cancer|Rasopathy|Neoplasm of the breast|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	criteria provided, multiple submitters, no conflicts	7	140481417	7	140781617	40364	48834
NM_004333.4(BRAF):c.1391G>A (p.Gly464Glu)	BRAF	Chronic lymphocytic leukemia|Carcinoma of colon|not provided|Rasopathy|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	criteria provided, multiple submitters, no conflicts	7	140481417	7	140781617	13964	29003
NM_004333.4(BRAF):c.1390G>A (p.Gly464Arg)	BRAF	not provided|Rasopathy|Cutaneous melanoma	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	7	140481418	7	140781618	372572	359643
NM_004333.4(BRAF):c.1388T>G (p.Ile463Ser)	BRAF	Carcinoma of colon	Pathogenic(Last reviewed: Aug 15, 2003)	no assertion criteria provided	7	140481420	7	140781620	13963	29002
NM_004333.4(BRAF):c.1385G>T (p.Arg462Ile)	BRAF	Carcinoma of colon	Pathogenic(Last reviewed: Aug 15, 2003)	no assertion criteria provided	7	140481423	7	140781623	13962	29001
NM_004333.4(BRAF):c.1330C>T (p.Arg444Trp)	BRAF	Cutaneous melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	7	140481478	7	140781678	376074	362953
NM_004456.4(EZH2):c.2045C>G (p.Ala682Gly)	EZH2	Lymphoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	7	148506467	7	148809375	376219	363098
NM_004456.4(EZH2):c.1937A>C (p.Tyr646Ser)	EZH2	Non-Hodgkin lymphoma|Malignant melanoma of skin|Lymphoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	148508727	7	148811635	376218	363097
NM_004456.4(EZH2):c.1937A>T (p.Tyr646Phe)	EZH2	Non-Hodgkin lymphoma|Malignant melanoma of skin|Lymphoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	148508727	7	148811635	76768	87659
NM_004456.4(EZH2):c.1936T>A (p.Tyr646Asn)	EZH2	Non-Hodgkin lymphoma|Malignant melanoma of skin|Lymphoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	148508728	7	148811636	376217	363096
NM_004456.4(EZH2):c.1936T>C (p.Tyr646His)	EZH2	Non-Hodgkin lymphoma|Malignant melanoma of skin|Lymphoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	148508728	7	148811636	76769	87660
NM_004456.4(EZH2):c.1922A>C (p.Glu641Ala)	EZH2	Non-Hodgkin lymphoma|Malignant melanoma of skin	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	148508742	7	148811650	376413	363292
NM_004456.4(EZH2):c.1922A>T (p.Glu641Val)	EZH2	Non-Hodgkin lymphoma|Malignant melanoma of skin	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	148508742	7	148811650	376412	363291
Single allele	SSPO|ZNF777|KRBA1|ZNF746|ZNF467	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	7	149152906 - 149518148			221341	223070
GRCh37/hg19 7q36.1(chr7:149174751-149523266)x1	SSPO|KRBA1|ZNF746|ZNF467	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	7	149174751 - 149523266			221386	223115
NM_080871.3(ASB10):c.1273A>G (p.Ser425Gly)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150873285	7	151176198	99952	105841
NM_080871.3(ASB10):c.1227G>A (p.Ser409=)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150873331	7	151176244	99951	105840
NM_080871.3(ASB10):c.1051C>T (p.Leu351Phe)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150878034	7	151180947	99948	105837
NM_080871.3(ASB10):c.1033C>T (p.Arg345Cys)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150878052	7	151180965	99947	105836
NM_080871.3(ASB10):c.1001T>C (p.Val334Ala)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150878084	7	151180997	99946	105835
NM_080871.3(ASB10):c.951C>G (p.His317Gln)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150878134	7	151181047	99969	105858
NM_080871.3(ASB10):c.941C>T (p.Thr314Met)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150878144	7	151181057	99967	105856
NM_080871.3(ASB10):c.865C>T (p.Arg289Cys)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150878220	7	151181133	99966	105855
NM_080871.3(ASB10):c.863G>A (p.Arg288His)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150878222	7	151181135	99965	105854
NM_080871.3(ASB10):c.765C>T (p.Thr255=)	ASB10	Glaucoma 1, open angle, F	Pathogenic(Last reviewed: Mar 15, 2012)	no assertion criteria provided	7	150878320	7	151181233	50951	65618
NM_080871.3(ASB10):c.692C>A (p.Ala231Asp)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150878393	7	151181306	99964	105853
NM_080871.3(ASB10):c.686G>A (p.Arg229His)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150878399	7	151181312	99963	105852
NM_080871.3(ASB10):c.574G>C (p.Val192Leu)	ASB10	Glaucoma 1, open angle, F	Pathogenic(Last reviewed: Mar 15, 2012)	no assertion criteria provided	7	150878511	7	151181424	50953	65620
NM_080871.3(ASB10):c.520C>T (p.Arg174Trp)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150883498	7	151186411	99959	105848
NM_080871.3(ASB10):c.479A>C (p.Asn160Thr)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150883539	7	151186452	99958	105847
NM_080871.3(ASB10):c.471C>T (p.Ala157=)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150883547	7	151186460	99957	105846
NM_080871.3(ASB10):c.442T>A (p.Cys148Ser)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150883576	7	151186489	99956	105845
NM_080871.3(ASB10):c.425C>T (p.Ala142Val)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150883593	7	151186506	99955	105844
NM_001142459.1(ASB10):c.271G>T (p.Asp91Tyr)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150883947	7	151186860	99945	105834
NM_001142459.1(ASB10):c.224C>A (p.Ala75Glu)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150883994	7	151186907	99944	105833
NM_001142459.1(ASB10):c.194G>A (p.Gly65Glu)	ASB10	not provided	not provided	no assertion provided	7	150884024	7	151186937	99991	105880
NM_080871.3(ASB10):c.204G>T (p.Pro68=)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150884606	7	151187519	99954	105843
NM_080871.3(ASB10):c.176T>C (p.Leu59Pro)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150884634	7	151187547	99953	105842
NM_080871.3(ASB10):c.116G>A (p.Arg39Gln)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150884694	7	151187607	99950	105839
NM_080871.3(ASB10):c.115C>T (p.Arg39Trp)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150884695	7	151187608	99949	105838
NM_080871.3(ASB10):c.94C>A (p.Arg32Ser)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150884716	7	151187629	99968	105857
NM_080871.3(ASB10):c.60C>T (p.Ser20=)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150884750	7	151187663	99962	105851
NM_080871.3(ASB10):c.56C>G (p.Pro19Arg)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150884754	7	151187667	99961	105850
NM_080871.3(ASB10):c.55C>T (p.Pro19Ser)	ASB10	Glaucoma 1, open angle, F	not provided	no assertion provided	7	150884755	7	151187668	99960	105849
NM_005614.3(RHEB):c.119A>T (p.Glu40Val)	RHEB	Hemimegalencephaly	Likely pathogenic	criteria provided, single submitter	7	151188034	7	151490948	545666	536162
NM_005614.3(RHEB):c.104A>G (p.Tyr35Cys)	RHEB	Renal cell carcinoma, papillary, 1|Transitional cell carcinoma of the bladder|Papillary renal cell carcinoma, sporadic|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	151188049	7	151490963	376516	363395
NM_005614.3(RHEB):c.103T>A (p.Tyr35Asn)	RHEB	Renal cell carcinoma, papillary, 1|Transitional cell carcinoma of the bladder|Papillary renal cell carcinoma, sporadic|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	151188050	7	151490964	376515	363394
NM_024012.3(HTR5A):c.79G>C (p.Asp27His)	HTR5A|HTR5A-AS1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	154862688	7	155070978	161768	171432
NM_022458.3(LMBR1):c.460C>A (p.Leu154Ile)	LMBR1	not provided	Uncertain significance	no assertion criteria provided	7	156556453	7	156763759	100875	106735
NM_002847.4(PTPRN2):c.2339T>C (p.Leu780Pro)	PTPRN2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	7	157414059	7	157621367	161601	171433
Single allele	AKR1B1|BPGM|BRAF|CALD1|CHRM2|CPA1|CPA2|MEST|MKLN1|NDUFB2|CNOT4|NRF1|PODXL|PTN|AKR1D1|TBXAS1|UBE2H|TRIM24|DGKI|KLHDC10|NUP205|MKRN1|SLC13A4|COPG2|DENND2A|WDR91|ATP6V0A4|CPA4|ZC3HC1|LUC7L2|CHCHD3|TMEM140|ZC3HAV1|AKR1B10|KIAA1549|EXOC4|PARP12|CREB3L2|CYREN|TTC26|KDM7A|SLC37A3|SLC35B4|TMEM209|ADCK2|PLXNA4|ZC3HAV1L|CPA5|CEP41|TSGA13|KLF14|SSMEM1|SVOPL|MTPN|LRGUK|CLEC2L|FMC1|TMEM213|UBN2|MESTIT1|AGBL3|STRA8|KLRG2|FAM180A|RAB19|MIR182|MIR183|MIR29A|MIR29B1|MIR96|AKR1B15|MIR335|STMP1|LUZP6|FMC1-LUC7L2|LOC101928861	Renal transitional cell carcinoma	Likely pathogenic(Last reviewed: Jan 14, 2019)	no assertion criteria provided	7	129367205 - 140482957			617479	608841
NM_182643.2(DLC1):c.2875A>G (p.Thr959Ala)	DLC1	Carcinoma of colon	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	8	12956971	8	13099462	5699	20738
NM_006207.2(PDGFRL):c.67C>T (p.His23Tyr)	PDGFRL	Carcinoma of colon	Pathogenic(Last reviewed: Mar 2, 1995)	no assertion criteria provided	8	17446988	8	17589479	5468	20507
GRCh37/hg19 8p22(chr8:17793168-18457910)x3	NAT1|NAT2|ASAH1|PCM1|PSD3|LOC101929066	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	8	17793168 - 18457910			221465	223194
NM_021020.3(LZTS1):c.355A>G (p.Lys119Glu)	LZTS1	Esophageal squamous cell carcinoma, somatic	Pathogenic(Last reviewed: Mar 30, 1999)	no assertion criteria provided	8	20111087	8	20253576	4246	19285
NM_021020.4(LZTS1):c.85T>C (p.Ser29Pro)	LZTS1	Esophageal squamous cell carcinoma, somatic	Pathogenic(Last reviewed: Mar 30, 1999)	no assertion criteria provided	8	20112608	8	20255097	4245	19284
NM_001495.4(GFRA2):c.725C>T (p.Ser242Phe)	GFRA2	Pazopanib response	drug response(Last reviewed: Jul 16, 2015)	no assertion criteria provided	8	21608169	8	21750657	208201	204462
NM_001160036.1(RHOBTB2):c.458C>G (p.Pro153Arg)	RHOBTB2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	8	22863568	8	23006055	161539	171449
NM_003844.3(TNFRSF10A):c.355G>A (p.Gly119Ser)	TNFRSF10A	not provided	Uncertain significance	no assertion criteria provided	8	23069677	8	23212164	100847	106707
NM_024940.7(DOCK5):c.5125G>T (p.Ala1709Ser)	DOCK5	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	8	25265530	8	25408014	219325	221014
NM_032777.9(ADGRA2):c.1314_1332del19 (p.Asn439Thrfs)	ADGRA2	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	8	37691223 - 37691241	8	37833705 - 37833723	487806	480813
NM_018310.3(BRF2):c.277G>A (p.Ala93Thr)	BRF2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	8	37704631	8	37847113	161715	171450
NM_023110.2(FGFR1):c.1968G>C (p.Lys656Asn)	FGFR1	Liver cancer|Lymphoblastic leukemia, acute, with lymphomatous features|Medulloblastoma|Glioblastoma|Astrocytoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	8	38272306	8	38414788	376428	363307
NM_023110.2(FGFR1):c.1966A>G (p.Lys656Glu)	FGFR1	Liver cancer|Lymphoblastic leukemia, acute, with lymphomatous features|Medulloblastoma|Encephalocraniocutaneous lipomatosis|Glioblastoma|Astrocytoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2017)	no assertion criteria provided	8	38272308	8	38414790	224897	226760
NM_023110.2(FGFR1):c.1638C>A (p.Asn546Lys)	FGFR1	Medulloblastoma|Neuroblastoma|Encephalocraniocutaneous lipomatosis|Astrocytoma|Brainstem glioma|Adenocarcinoma of stomach|Rosette-forming glioneuronal tumor	Pathogenic	criteria provided, single submitter	8	38274849	8	38417331	224896	226759
NM_023110.2(FGFR1):c.1636A>G (p.Asn546Asp)	FGFR1	Medulloblastoma|Neuroblastoma|Astrocytoma|Brainstem glioma|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	8	38274851	8	38417333	376429	363308
NM_023110.2(FGFR1):c.1543A>G (p.Met515Val)	FGFR1	Medulloblastoma|Neuroblastoma|Astrocytoma|Brainstem glioma|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	8	38275397	8	38417879	376430	363309
NM_023110.2(FGFR1):c.754C>A (p.Pro252Thr)	FGFR1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	8	38282209	8	38424691	376296	363175
NM_023110.2(FGFR1):c.374C>T (p.Ser125Leu)	FGFR1	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	8	38285938	8	38428420	376297	363176
GRCh37/hg19 8p11.22(chr8:39645687-39694694)x4	ADAM2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	8	39645687 - 39694694			221466	223195
NM_006749.4(SLC20A2):c.353T>C (p.Ile118Thr)	SLC20A2	not provided	Uncertain significance	no assertion criteria provided	8	42323372	8	42465854	100856	106716
NG_015833.1:g.34008_95699del61692	RB1CC1	Breast cancer, somatic|Breast adenocarcinoma	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	8	53536328 - 53598019	8	52623768 - 52685459	3976	19015
NG_015833.1:g.57807_94706del36900	RB1CC1	Breast cancer, somatic|Breast adenocarcinoma	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	8	53537321 - 53574220	8	52624761 - 52661660	3977	19016
NM_006269.1(RP1):c.5000delC (p.Arg1668Glyfs)	RP1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	8	55541442	8	54628882	221333	223062
t(8;10)(q12.1;q23.31)	ACTA2|PLAG1	Lung adenocarcinoma	Likely pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	8	57120269			431023	424557
NM_000780.3(CYP7A1):c.907A>T (p.Arg303Trp)	CYP7A1	not provided	Uncertain significance	no assertion criteria provided	8	59409164	8	58496605	91913	97391
NM_014637.3(MTFR1):c.244G>T (p.Val82Leu)	MTFR1	not provided	Uncertain significance	no assertion criteria provided	8	66605957	8	65693722	91981	97459
NM_001033578.2(SGK3):c.782A>G (p.His261Arg)	SGK3|C8orf44-SGK3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	8	67752278	8	66840043	161501	171451
NM_020361.4(CPA6):c.1217G>C (p.Gly406Ala)	CPA6|LOC102724708	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	8	68334836	8	67422601	161731	171452
t(8;9)(q13.1;p22.3)	MYBL1|NFIB	Adenoid cystic carcinoma	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	8	67501293 - 67501294			495136	486690
NM_024870.3(PREX2):c.1444-4G>A	PREX2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	8	68982066	8	68069831	161771	171453
NM_000503.5(EYA1):c.1107G>T (p.Leu369Phe)	EYA1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	8	72156871	8	71244636	161468	171454
NM_001204858.1(ELOC):c.236A>T (p.Tyr79Phe)	ELOC	Renal cell carcinoma, papillary, 1	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	8	74858968	8	73946733	376558	363437
NM_005648.3(ELOC):c.236A>C (p.Tyr79Ser)	ELOC	Renal cell carcinoma, papillary, 1	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	8	74858968	8	73946733	376556	363435
NM_001204857.1(ELOC):c.235T>A (p.Tyr79Asn)	ELOC	Renal cell carcinoma, papillary, 1	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	8	74858969	8	73946734	376557	363436
NM_002485.4(NBN):c.1925A>G (p.Lys642Arg)	NBN	Microcephaly, normal intelligence and immunodeficiency|Malignant tumor of prostate|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	8	90958513	8	89946285	141169	150883
NM_002485.4(NBN):c.244A>G (p.Lys82Glu)	NBN	Microcephaly, normal intelligence and immunodeficiency|Malignant tumor of prostate	Uncertain significance(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	8	90993679	8	89981451	161598	171455
NM_012415.3(RAD54B):c.1778A>G (p.Asn593Ser)	RAD54B	Non-Hodgkin lymphoma	Pathogenic(Last reviewed: Jun 3, 1999)	no assertion criteria provided	8	95403868	8	94391640	5638	20677
NM_012415.3(RAD54B):c.1252G>T (p.Asp418Tyr)	RAD54B	Carcinoma of colon	Pathogenic(Last reviewed: Jun 3, 1999)	no assertion criteria provided	8	95411768	8	94399540	5639	20678
NM_017864.3(INTS8):c.165delG (p.Glu56Asnfs)	INTS8	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	8	95837155	8	94824927	161711	171456
GRCh37/hg19 8q22.2(chr8:100871620-101253185)x3	COX6C|POLR2K|SPAG1|RGS22|VPS13B|FBXO43	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	8	100871620 - 101253185			221467	223196
NM_003506.3(FZD6):c.346C>T (p.Arg116Ter)	FZD6	not provided|Wilms Tumor	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	8	104330986	8	103318758	438765	432403
NM_003506.3(FZD6):c.1531C>T (p.Arg511Cys)	FZD6	Nail disorder, nonsyndromic congenital, 10|not provided|Nail disease	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	8	104340634	8	103328406	30356	39312
NM_003506.3(FZD6):c.1750G>T (p.Glu584Ter)	FZD6	Nail disorder, nonsyndromic congenital, 10|not provided|Nail disease	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	8	104342091	8	103329863	30355	39311
NM_030780.4(SLC25A32):c.548A>G (p.Tyr183Cys)	SLC25A32	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	8	104415396	8	103403168	219326	221015
NM_000127.2(EXT1):c.528_535delCAAAGTGC (p.Lys177Glufs)	EXT1	Chondrosarcoma	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	8	119122751 - 119122758	8	118110512 - 118110519	2497	17536
NM_022045.4(MTBP):c.2380A>G (p.Ile794Val)	MTBP	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	8	121530224	8	120517984	161754	171445
NM_002467.5(MYC):c.162G>C (p.Glu54Asp)	MYC	Burkitt lymphoma	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	8	128750625	8	127738379	12576	27615
NM_002467.5(MYC):c.169C>T (p.Pro57Ser)	MYC	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	8	128750632	8	127738386	376298	363177
NM_002467.5(MYC):c.173C>T (p.Pro58Leu)	MYC	Non-Hodgkin lymphoma|Malignant melanoma of skin|Neuroblastoma|Lung adenocarcinoma|Carcinoma of esophagus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	8	128750636	8	127738390	376459	363338
NM_002467.5(MYC):c.176C>T (p.Ala59Val)	MYC	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	8	128750639	8	127738393	376299	363178
NM_002467.5(MYC):c.214C>T (p.Pro72Ser)	MYC	Burkitt lymphoma	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	8	128750677	8	127738431	12574	27613
NM_002467.5(MYC):c.217A>C (p.Thr73Pro)	MYC	Non-Hodgkin lymphoma|Malignant melanoma of skin|Neuroblastoma|Lung adenocarcinoma|Carcinoma of esophagus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	8	128750680	8	127738434	376458	363337
NM_002467.5(MYC):c.218C>T (p.Thr73Ile)	MYC	Non-Hodgkin lymphoma|Malignant melanoma of skin|Neuroblastoma|Lung adenocarcinoma|Carcinoma of esophagus|Neoplasm	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	8	128750681	8	127738435	376300	363179
NM_002467.5(MYC):c.220C>G (p.Pro74Ala)	MYC	Burkitt lymphoma	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	8	128750683	8	127738437	12577	27616
NM_002467.5(MYC):c.230C>T (p.Ser77Phe)	MYC	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	8	128750693	8	127738447	376301	363180
NM_002467.5(MYC):c.302A>C (p.Asn101Thr)	MYC	Burkitt lymphoma|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	8	128750765	8	127738519	12575	27614
NM_002467.5(MYC):c.778C>G (p.Pro260Ala)	MYC	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	8	128751241	8	127738995	376302	363181
NM_001204824.1(KCNQ3):c.986A>T (p.Asn329Ile)	KCNQ3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	8	133153495	8	132141248	161570	171446
NM_003235.4(TG):c.3886T>A (p.Phe1296Ile)	TG	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	8	133920469	8	132908224	161608	171447
NM_023078.4(PYCR3):c.52C>T (p.Pro18Ser)	PYCR3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	8	144691703	8	143609533	161767	171448
NM_198488.3(FAM83H):c.2766C>T (p.Arg922=)	FAM83H	Amelogenesis imperfecta, hypoplastic/hypomaturation, X-linked 2	not provided	no assertion provided	8	144808865	8	143726695	96981	102884
NM_198488.3(FAM83H):c.2765G>T (p.Arg922Leu)	FAM83H	Amelogenesis imperfecta, hypoplastic/hypomaturation, X-linked 2	not provided	no assertion provided	8	144808866	8	143726696	96980	102883
NM_198488.3(FAM83H):c.2250C>T (p.Gly750=)	FAM83H	Amelogenesis imperfecta, hypoplastic/hypomaturation, X-linked 2	not provided	no assertion provided	8	144809381	8	143727211	96979	102882
NM_003070.4(SMARCA2):c.3638G>C (p.Arg1213Pro)	SMARCA2	Adenoid cystic carcinoma	Uncertain significance(Last reviewed: Feb 1, 2018)	no assertion criteria provided	9	2116003	9	2116003	495133	486683
NM_004972.3(JAK2):c.1615_1616delAAinsTT (p.Lys539Leu)	JAK2|INSL6	ERYTHROCYTOSIS, JAK2-RELATED, SOMATIC	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	9	5070026 - 5070027	9	5070026 - 5070027	14664	29703
NM_004972.3(JAK2):c.1691G>T (p.Arg564Leu)	JAK2|INSL6	Myeloproliferative disorder	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	9	5072541	9	5072541	376706	363585
NM_004972.3(JAK2):c.1821G>C (p.Lys607Asn)	JAK2|INSL6	Acute myeloid leukemia	Pathogenic(Last reviewed: Mar 2, 2006)	no assertion criteria provided	9	5073742	9	5073742	14663	29702
NM_004972.3(JAK2):c.1849G>T (p.Val617Phe)	JAK2|INSL6	Familial erythrocytosis, 1|Chronic myelogenous leukemia|Polycythemia vera|Budd-Chiari syndrome|Myelofibrosis|Budd-Chiari syndrome, susceptibility to, somatic|Acute myeloid leukemia|Thrombocythemia 3|Myeloproliferative disorder|Subacute lymphoid leukemia	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, multiple submitters, no conflicts	9	5073770	9	5073770	14662	29701
NM_004972.3(JAK2):c.2047A>G (p.Arg683Gly)	JAK2|INSL6	Lymphoblastic leukemia, acute, with lymphomatous features|Myeloproliferative disorder	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	9	5078360	9	5078360	375951	362830
NM_004972.3(JAK2):c.2048G>C (p.Arg683Thr)	JAK2|INSL6	Lymphoblastic leukemia, acute, with lymphomatous features	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	9	5078361	9	5078361	375952	362831
NM_004972.3(JAK2):c.2049A>T (p.Arg683Ser)	JAK2|INSL6	Lymphoblastic leukemia, acute, with lymphomatous features	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	9	5078362	9	5078362	375954	362833
NM_004972.3(JAK2):c.2049A>C (p.Arg683Ser)	JAK2|INSL6	Lymphoblastic leukemia, acute, with lymphomatous features	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	9	5078362	9	5078362	375953	362832
NM_004972.3(JAK2):c.2624C>A (p.Thr875Asn)	JAK2|INSL6	Myeloproliferative disorder	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	9	5089726	9	5089726	376705	363584
NM_004972.3(JAK2):c.2798C>A (p.Pro933Gln)	JAK2|INSL6	SMALL ROUND CELL TUMOR	other(Last reviewed: May 1, 2016)	no assertion criteria provided	9	5090482	9	5090482	438767	432405
NM_033439.3(IL33):c.712G>A (p.Val238Met)	IL33	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	6256067	9	6256067	161789	171469
NM_130391.3(PTPRD):c.4471C>T (p.Arg1491Cys)	PTPRD	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	8317921	9	8317921	161800	171473
GRCh37/hg19 9p23-21.2(chr9:10320113-26205565)x1	PLIN2|CDKN2A|CDKN2B|ELAVL2|IFNA1|IFNA2|IFNA4|IFNA5|IFNA6|IFNA7|IFNA8|IFNA10|IFNA13|IFNA14|IFNA16|IFNA17|IFNA21|IFNB1|IFNW1|MLLT3|MTAP|NFIB|PTPRD|RPS6|SH3GL2|SNAPC3|TYRP1|MPDZ|CER1|RRAGA|PSIP1|SLC24A2|BNC2|HAUS6|CNTLN|FOCAD|DENND4C|KLHL9|DMRTA1|ADAMTSL1|TTC39B|SAXO1|FREM1|CCDC171|TUSC1|LURAP1L|IFNE|ZDHHC21|ACER2|HACD4|MIR31|CDKN2B-AS1|IZUMO3	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	9	10320113 - 26205565			523160	513792
NM_173550.3(CCDC171):c.2404C>T (p.Arg802Trp)	CCDC171	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	15744625	9	15744627	161830	171466
chr9:21187003-21228040 complex variant	IFNA4|IFNA7|IFNA10|IFNA16|IFNA17	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	9	21187003 - 21228040			221366	223095
Single allele	IFNA4|IFNA7|IFNA10	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	9	21187121 - 21207037			221342	223071
GRCh38/hg38 9p21.3(chr9:21879075-22096084)x0	CDKN2A|CDKN2B|CDKN2A-DT|CDKN2B-AS1|ERVFRD-3	VEGF Inhibitors response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	9	21879074 - 22096083	9	21879075 - 22096084	523164	513796
GRCh38/hg38 9p21.3(chr9:21939409-22706614)x0	CDKN2A|CDKN2B|CDKN2A-DT|DMRTA1|LINC01239|CDKN2B-AS1	VEGF Inhibitors response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	9	21939408 - 22706613	9	21939409 - 22706614	523167	513799
NM_058195.3(CDKN2A):c.384C>A (p.Ala128=)	CDKN2A	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Squamous cell carcinoma of the skin	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	9	21971017	9	21971018	376383	363262
NM_000077.4(CDKN2A):c.341C>T (p.Pro114Leu)	CDKN2A	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Cutaneous melanoma|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the skin	Likely pathogenic(Last reviewed: Nov 4, 2016)	criteria provided, single submitter	9	21971017	9	21971018	77637	88528
NM_058195.3(CDKN2A):c.383C>A (p.Ala128Asp)	CDKN2A	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Squamous cell carcinoma of the skin	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	9	21971018	9	21971019	376382	363261
NM_058195.3(CDKN2A):c.373G>A (p.Gly125Arg)	CDKN2A	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	21971028	9	21971029	376303	363182
NM_000077.4(CDKN2A):c.329G>A (p.Trp110Ter)	CDKN2A	not provided|Neoplasm	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	9	21971029	9	21971030	376304	363183
NM_000077.4(CDKN2A):c.322G>T (p.Asp108Tyr)	CDKN2A	Hereditary cancer-predisposing syndrome|Neoplasm	Likely pathogenic(Last reviewed: Sep 25, 2015)	criteria provided, single submitter	9	21971036	9	21971037	182423	180313
NM_000077.4(CDKN2A):c.262G>T (p.Glu88Ter)	CDKN2A	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	21971096	9	21971097	376305	363184
NM_000077.4(CDKN2A):c.250G>T (p.Asp84Tyr)	CDKN2A	Hereditary cancer-predisposing syndrome|Neoplasm	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	21971108	9	21971109	376306	363185
NM_000077.4(CDKN2A):c.249C>G (p.His83Gln)	CDKN2A	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	9	21971109	9	21971110	376381	363260
NM_058195.3(CDKN2A):c.291A>G (p.Ala97=)	CDKN2A	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	9	21971110	9	21971111	376379	363258
NM_058195.3(CDKN2A):c.290C>G (p.Ala97Gly)	CDKN2A	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	9	21971111	9	21971112	376380	363259
NM_000077.4(CDKN2A):c.247C>T (p.His83Tyr)	CDKN2A	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Hereditary cutaneous melanoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm|Adenocarcinoma of stomach	Uncertain significance(Last reviewed: Jun 17, 2018)	criteria provided, single submitter	9	21971111	9	21971112	376307	363186
NM_000077.4(CDKN2A):c.239G>A (p.Arg80Gln)	CDKN2A	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	9	21971119	9	21971120	376385	363264
NM_000077.4(CDKN2A):c.238C>T (p.Arg80Ter)	CDKN2A	Cutaneous malignant melanoma 2|Cutaneous melanoma	Likely pathogenic, risk factor(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	21971120	9	21971121	9409	24448
NM_058195.3(CDKN2A):c.248G>T (p.Gly83Val)	CDKN2A	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	21971153	9	21971154	376308	363187
NM_058195.3(CDKN2A):c.224G>T (p.Gly75Val)	CDKN2A	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	21971177	9	21971178	376309	363188
NM_000077.4(CDKN2A):c.172C>T (p.Arg58Ter)	CDKN2A	Hereditary cutaneous melanoma|Neoplasm	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	9	21971186	9	21971187	376310	363189
NM_000077.4(CDKN2A):c.150G>T (p.Gln50His)	CDKN2A	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	9	21974677	9	21974678	376384	363263
NM_000077.4(CDKN2A):c.149A>G (p.Gln50Arg)	CDKN2A	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Hereditary cutaneous melanoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach	Uncertain significance(Last reviewed: Nov 7, 2017)	criteria provided, multiple submitters, no conflicts	9	21974678	9	21974679	232304	233761
Single allele	ACO1|ALDH1A1|ALDH1B1|ANXA1|NUDT2|APBA1|AQP3|AQP7|BAG1|KLF9|CA9|CCIN|CD72|CLTA|CNTFR|ELAVL2|FANCG|FXN|GALT|GCNT1|B4GALT1|GNAQ|HNRNPK|DNAJA1|IL11RA|NDUFB6|NFX1|NPR2|NTRK2|PAX5|PCSK5|PGM5|PRKACG|PRSS3|RMRP|RORB|CCL19|CCL21|SHB|TEK|TESK1|TLE1|TLE4|TLN1|TPM2|VCP|ZFAND5|PIP5K1B|RECK|PLAA|GRHPR|FAM189A2|TJP2|GDA|GNA14|RGP1|MELK|RUSC2|ZBTB5|GNE|TOPORS|SIGMAR1|CREB3|UNC13B|CCL27|DCTN3|FRMPD1|SMC5|VPS13A|PHF24|DDX58|CEMIP2|DNAJB5|DCAF12|ZNF658|SPATA31A7|SPAG8|FBXO10|OSTF1|DNAI1|SIT1|SPINK4|PSAT1|UBQLN1|STOML2|PCA3|EXOSC3|ABHD17B|UBAP1|CHMP5|TMEM8B|EQTN|APTX|UBE2R2|NMRK1|C9orf40|SMU1|RFK|KIF27|UBAP2|OR2S2|MYORG|GBA2|SLC28A3|POLR1E|LRRC19|NOL6|DCAF10|MOB3B|CAAP1|CNTNAP3|RMI1|TRPM3|IFT74|FAM214B|GKAP1|CEP78|ZCCHC7|ANKRD20A1|C9orf64|HINT2|C9orf24|PIGO|ARHGEF39|SLC25A51|FAM122A|TMC1|CARNMT1|C9orf57|C9orf85|C9orf135|TAF1L|ARID3C|RPP25L|C9orf131|TRPM6|RNF38|GLIPR2|LINGO2|RASEF|TRMT10B|PRUNE2|TMEM252|C9orf72|FAM219A|CCDC107|LINC00537|CBWD5|ANKRD18A|MAMDC2|FRMD3|FAM205A|TUSC1|FOXD4L3|KIF24|IGFBPL1|FOXD4L4|ENHO|PTAR1|SPATA31A6|SPATA31D4|SPATA31D3|SPATA31D1|FAM221B|OR13J1|TMEM215|TOMM5|MIR204|MIR7-1|IDNK|ANKRD20A3|ANKRD20A2|ANKRD18B|FOXB2|CBWD3|CBWD6|HRCT1|SPATA31A1|FOXD4L6|FOXD4L5|MSMP|FAM27D1|SPATA31A3|SPATA31A5|CBWD7|CNTNAP3B|ANKRD20A4|FAM166B|IZUMO3|BANCR|CARNMT1-AS1	Glioma	Likely pathogenic(Last reviewed: Jun 5, 2017)	no assertion criteria provided	9	23524426 - 87359888			617751	609149
NM_000459.4(TEK):c.2228G>C (p.Gly743Ala)	TEK	Acute myeloid leukemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	9	27204927	9	27204929	376738	363617
NM_001195622.1(TOPORS):c.2613A>C (p.Gln871His)	TOPORS	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	32541715	9	32541717	161562	171467
NM_001207011.1(CNTFR):c.700G>C (p.Asp234His)	CNTFR	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	34556321	9	34556323	161574	171468
NM_001304333.2(PHF24):c.242G>A (p.Arg81Gln)	PHF24	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	9	34971537	9	34971540	221301	223030
NM_006368.4(CREB3):c.823T>G (p.Tyr275Asp)	CREB3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	9	35736430	9	35736433	221316	223045
NM_003995.3(NPR2):c.3048G>T (p.Gln1016His)	NPR2|SPAG8	not provided	Uncertain significance	no assertion criteria provided	9	35809214	9	35809217	91957	97435
NM_172312.1(SPAG8):c.618C>T (p.Asp206=)	SPAG8	not provided	Uncertain significance	no assertion criteria provided	9	35811425	9	35811428	92034	97512
NM_001127608.2(FAM189A2):c.704-5delA	FAM189A2	Malignant tumor of prostate|not specified	Benign(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	9	72000706	9	69385790	161521	171470
NM_153267.4(MAMDC2):c.58G>A (p.Asp20Asn)	MAMDC2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	72659523	9	70044607	161822	171471
NM_020952.5(TRPM3):c.2320G>A (p.Gly774Arg)	TRPM3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	73213568	9	70598652	161741	171472
NM_017662.4(TRPM6):c.5600A>G (p.His1867Arg)	TRPM6	not provided	Uncertain significance	no assertion criteria provided	9	77353499	9	74738583	100866	106726
NM_017662.4(TRPM6):c.2392-2A>G	TRPM6	not provided	Uncertain significance	no assertion criteria provided	9	77407688	9	74792772	91996	97474
NM_004297.3(GNA14):c.614A>T (p.Gln205Leu)	GNA14	Kaposiform hemangioendothelioma|Congenital tufted angioma|Lobular capillary hemangioma|Kaposiform Hemangioendotheliomas	Likely pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	9	80043932	9	77429016	548667	539144
NM_002072.4(GNAQ):c.625_626delCAinsTT (p.Gln209Leu)	GNAQ	Intraocular melanoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	80409488 - 80409489	9	77794572 - 77794573	376311	363190
NM_002072.4(GNAQ):c.626A>C (p.Gln209Pro)	GNAQ	Intraocular melanoma|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	80409488	9	77794572	375957	362836
NM_002072.4(GNAQ):c.626A>G (p.Gln209Arg)	GNAQ	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	9	80409488	9	77794572	375956	362835
NM_002072.4(GNAQ):c.626A>T (p.Gln209Leu)	GNAQ	Intraocular melanoma|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	80409488	9	77794572	375955	362834
NM_002072.4(GNAQ):c.548G>A (p.Arg183Gln)	GNAQ	Capillary malformation|Sturge-Weber syndrome	Pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, single submitter	9	80412493	9	77797577	50853	59839
GRCh37/hg19 9q21.2(chr9:79816302-79908341)x3	VPS13A	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	9	79816302 - 79908341			221468	223197
NM_006180.4(NTRK2):c.970T>A (p.Leu324Met)	NTRK2	Neuroblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	9	87342685	9	84727770	438780	432412
NM_005392.3(PHF2):c.2563G>A (p.Asp855Asn)	PHF2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	96436081	9	93673799	161633	171474
GRCh37/hg19 9q22.31(chr9:95051642-95264865)x3	ECM2|IARS|OMD|OGN|ASPN|NOL8|CENPP	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	9	95051642 - 95264865			221469	223198
NM_001083602.2(PTCH1):c.3142A>T (p.Arg1048Trp)	PTCH1	Basal cell carcinoma, somatic	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	9	98215869	9	95453587	8220	23259
NM_020893.3(CCDC180):c.1975C>G (p.Pro659Ala)	SUGT1P4-STRA6LP-CCDC180|CCDC180	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	9	100092618	9	97330336	221302	223031
NM_001145368.1(PTPN3):c.632C>T (p.Ala211Val)	PTPN3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	112199206	9	109436926	161535	171457
NM_147150.2(PALM2-AKAP2):c.625G>T (p.Glu209Ter)	AKAP2|PALM2-AKAP2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	112898449	9	110136169	161812	171458
NM_003408.2(ZFP37):c.19G>C (p.Val7Leu)	ZFP37	not provided	Uncertain significance	no assertion criteria provided	9	115818950	9	113056670	91951	97429
NM_138424.1(KIF12):c.1284-4C>A	KIF12	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	116854735	9	114092455	161803	171459
NM_015404.3(WHRN):c.1469G>A (p.Arg490His)	WHRN	Deafness, autosomal recessive 31	not provided	no assertion provided	9	117185751	9	114423471	156029	165839
NM_001735.2(C5):c.3286A>G (p.Asn1096Asp)	C5	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	123745037	9	120982759	161582	171460
NM_012363.1(OR1N1):c.853C>A (p.Pro285Thr)	OR1J2|OR1N1	not provided	Uncertain significance	no assertion criteria provided	9	125288720	9	122526441	91977	97455
GRCh37/hg19 9q33.2(chr9:123939453-123954476)x4	CNTRL|RAB14	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	9	123939453 - 123954476			221470	223199
NM_001123369.1(PPP6C):c.724C>T (p.Arg242Cys)	PPP6C	Malignant melanoma of skin|Squamous cell lung carcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	9	127912080	9	125149801	376508	363387
NM_003165.3(STXBP1):c.587A>G (p.Lys196Arg)	STXBP1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	130427534	9	127665255	161607	171461
NM_001114753.2(ENG):c.1479C>A (p.Cys493Ter)	ENG|LOC102723566	Osler hemorrhagic telangiectasia syndrome	Likely pathogenic	no assertion criteria provided	9	130580606	9	127818327	444099	437737
NM_001114753.2(ENG):c.1306C>T (p.Gln436Ter)	ENG|LOC102723566	Osler hemorrhagic telangiectasia syndrome|not provided	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	9	130581906	9	127819627	439662	433055
NM_001114753.2(ENG):c.816+1G>A	ENG	Osler hemorrhagic telangiectasia syndrome	Likely pathogenic	no assertion criteria provided	9	130587509	9	127825230	444098	437738
NM_001122821.1(SET):c.319G>C (p.Ala107Pro)	SET	not provided	Uncertain significance	no assertion criteria provided	9	131454946	9	128692667	100826	106686
NM_001122821.1(SET):c.740A>G (p.Glu247Gly)	SET	Liver cancer|Hepatocellular carcinoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	9	131456212	9	128693933	438787	432418
NM_001122821.1(SET):c.814_815insA (p.Asp273Argfs)	SET	Dysgerminoma|DYSGERMINOMA	other(Last reviewed: May 1, 2016)	no assertion criteria provided	9	131456287	9	128694007 - 128694008	438789	432380
NM_007313.2(ABL1):c.763G>A (p.Glu255Lys)	ABL1	Chronic myelogenous leukemia|Leukemia, Philadelphia chromosome-positive, resistant to imatinib	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	9	133738306	9	130862919	12626	27665
NM_005157.5(ABL1):c.730A>G (p.Met244Val)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133738330	9	130862943	376084	362963
NM_005157.5(ABL1):c.742C>G (p.Leu248Val)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133738342	9	130862955	376085	362964
NM_005157.5(ABL1):c.749G>A (p.Gly250Glu)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133738349	9	130862962	376086	362965
NM_007313.2(ABL1):c.813G>T (p.Gln271His)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133738356	9	130862969	376088	362967
NM_005157.5(ABL1):c.756G>C (p.Gln252His)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133738356	9	130862969	376087	362966
NM_007313.2(ABL1):c.814T>C (p.Tyr272His)	ABL1	Lymphoblastic leukemia, acute, with lymphomatous features|Chronic myelogenous leukemia|Leukemia, Philadelphia chromosome-positive, resistant to imatinib	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133738357	9	130862970	12627	27666
NM_005157.5(ABL1):c.758A>T (p.Tyr253Phe)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133738358	9	130862971	376089	362968
NM_007313.2(ABL1):c.820G>A (p.Glu274Lys)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133738363	9	130862976	376090	362969
NM_005157.5(ABL1):c.764A>T (p.Glu255Val)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133738364	9	130862977	376091	362970
NM_005157.5(ABL1):c.847T>G (p.Phe283Val)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133747540	9	130872153	376092	362971
NM_007313.2(ABL1):c.952G>C (p.Val318Leu)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	9	133747588	9	130872201	376117	362996
NM_005157.5(ABL1):c.943A>G (p.Thr315Ala)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	9	133748282	9	130872895	376118	362997
NM_007313.2(ABL1):c.1001C>T (p.Thr334Ile)	ABL1	Lymphoblastic leukemia, acute, with lymphomatous features|Chronic myelogenous leukemia|Leukemia, Philadelphia chromosome-positive, resistant to imatinib	Pathogenic/Likely pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	9	133748283	9	130872896	12624	27663
NM_005157.5(ABL1):c.949T>C (p.Phe317Leu)	ABL1	Chronic myelogenous leukemia	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	9	133748288	9	130872901	376352	363231
NM_007313.2(ABL1):c.1006T>G (p.Phe336Val)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	9	133748288	9	130872901	376120	362999
NM_005157.5(ABL1):c.949T>A (p.Phe317Ile)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	9	133748288	9	130872901	376119	362998
NM_007313.2(ABL1):c.1007T>G (p.Phe336Cys)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	9	133748289	9	130872902	376121	363000
NM_007313.2(ABL1):c.1008C>G (p.Phe336Leu)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133748290	9	130872903	376094	362973
NM_005157.5(ABL1):c.951C>A (p.Phe317Leu)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133748290	9	130872903	376093	362972
NM_007313.2(ABL1):c.1109T>C (p.Met370Thr)	ABL1	Chronic myelogenous leukemia|Chronic myeloid leukemia, resistant to imatinib	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133748391	9	130873004	12629	27668
NM_005157.5(ABL1):c.1064A>G (p.Glu355Gly)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133748403	9	130873016	376095	362974
NM_005157.5(ABL1):c.1075T>C (p.Phe359Leu)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	9	133748414	9	130873027	376123	363002
NM_007313.2(ABL1):c.1132T>A (p.Phe378Ile)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	9	133748414	9	130873027	376122	363001
NM_005157.5(ABL1):c.1075T>G (p.Phe359Val)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133748414	9	130873027	376096	362975
NM_005157.5(ABL1):c.1076T>G (p.Phe359Cys)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	9	133748415	9	130873028	376124	363003
NM_005157.5(ABL1):c.1187A>G (p.His396Arg)	ABL1	Chronic myelogenous leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	9	133750356	9	130874969	376097	362976
NM_198679.1(RAPGEF1):c.1715A>G (p.Tyr572Cys)	RAPGEF1	Monoclonal B-Cell Lymphocytosis	Uncertain significance(Last reviewed: Dec 15, 2015)	no assertion criteria provided	9	134497376	9	131621989	222969	224685
NM_000368.4(TSC1):c.610C>T (p.Arg204Cys)	TSC1	Tuberous sclerosis 1|Focal cortical dysplasia type II	Uncertain significance(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	9	135797259	9	132921872	417732	404633
NM_000368.4(TSC1):c.64C>T (p.Arg22Trp)	TSC1	Tuberous sclerosis 1|Focal cortical dysplasia type II|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	9	135804196	9	132928809	417731	404632
Single allele	ABL1	T-cell acute lymphoblastic leukemia|Leukemia, T-cell acute lymphoblastic, somatic	Pathogenic(Last reviewed: Aug 24, 2017)	no assertion criteria provided	9	133709770 - 133709771			617566	608935
NM_001291921.1(RXRA):c.989C>A (p.Ser330Tyr)	RXRA	Liver cancer|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	9	137328351	9	134436505	376529	363408
NM_001291921.1(RXRA):c.989C>T (p.Ser330Phe)	RXRA	Liver cancer|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	9	137328351	9	134436505	376528	363407
NM_000093.4(COL5A1):c.3055C>G (p.Pro1019Ala)	COL5A1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	137694782	9	134802936	161458	171462
NM_002003.4(FCN1):c.454G>A (p.Gly152Arg)	FCN1	Monoclonal B-Cell Lymphocytosis	Uncertain significance(Last reviewed: Dec 15, 2015)	no assertion criteria provided	9	137804876	9	134913030	222970	224686
GRCh37/hg19 9q34.13-34.3(chr9:135377559-141213431)x1	ABCA2|ABO|C8G|CACNA1B|ENTPD2|CEL|COL5A1|DBH|SARDH|FCN1|FCN2|FUT7|GRIN1|LCN1|NOTCH1|PAEP|PTGDS|RALGDS|RPL7A|RXRA|SNAPC4|SURF1|SURF2|SURF4|MED22|SURF6|TRAF2|TSC1|VAV2|BRD3|LHX3|GFI1B|SSNA1|EDF1|CLIC3|GTF3C5|GTF3C4|ADAMTSL2|PPP1R26|SEC16A|TUBB4B|UBAC1|OLFM1|AGPAT2|ENTR1|NOXA1|WDR5|SPACA9|ADAMTS13|CACFD1|SLC2A6|MAN1B1|PMPCA|NELFB|NSMF|GPSM1|GBGT1|NDOR1|PHPT1|ANAPC2|DPP7|OBP2B|OBP2A|MRPS2|EGFL7|FBXW5|TOR4A|EXD3|RABL6|INPP5E|NPDC1|BARHL1|REXO4|KCNT1|CARD9|DDX31|MRPL41|EHMT1|CCDC183|SNHG7|TMEM141|SAPCD2|TMEM250|UAP1L1|ARRDC1|DPH7|TMEM203|ZMYND19|NACC2|C9orf116|LCN8|DIPK1B|SLC34A3|CAMSAP1|C9orf62|C9orf163|MAMDC4|LCN6|AK8|STKLD1|QSOX2|LCN12|PAXX|TPRN|GLT6D1|PNPLA7|CYSRT1|ENTPD8|CFAP77|LCN15|AJM1|LRRC26|MYMK|LCN9|LCNL1|C9orf139|FAM166A|SOHLH1|MIR126|LCN10|STPG3|NRARP|FAM163B|RNF224|LOC651337|RNF208|DNLZ|FAM157B|RNU6ATAC|TMEM210	mTOR Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	9	135377559 - 141213431			523169	513801
GRCh38/hg38 9q34.3(chr9:135665886-135775364)x1	KCNT1|LCN9|SOHLH1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	9	138557731 - 138667209	9	135665886 - 135775364	221387	223116
NM_017617.5(NOTCH1):c.6979C>T (p.Arg2327Trp)	NOTCH1	Non-small cell lung cancer|Adams-Oliver syndrome 5	Uncertain significance(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	9	139391212	9	136496760	376346	363225
NM_017617.5(NOTCH1):c.4924G>C (p.Asp1642His)	NOTCH1	Non-small cell lung cancer	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	9	139399219	9	136504767	376345	363224
NM_017617.5(NOTCH1):c.4775T>G (p.Phe1592Cys)	NOTCH1	Early T cell progenitor acute lymphoblastic leukemia	Pathogenic	no assertion criteria provided	9	139399368	9	136504916	208337	204574
NM_017617.4(NOTCH1):c.4045_4052delGCTCGTAC (p.Ala1349Leufs)	NOTCH1	Adenoid cystic carcinoma	Likely pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	9	139400296 - 139400303	9	136505844 - 136505851	495129	486681
NM_017617.5(NOTCH1):c.2825G>A (p.Cys942Tyr)	NOTCH1	Adenoid cystic carcinoma	Likely pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	9	139404329	9	136509877	495128	486682
NM_006412.3(AGPAT2):c.248delC (p.Pro83Argfs)	AGPAT2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	139571943	9	136677491	161646	171463
NM_001185090.1(GRIN1):c.350C>T (p.Pro117Leu)	GRIN1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	140036556	9	137142104	161558	171464
NM_138778.4(DPH7):c.932A>G (p.Asn311Ser)	DPH7	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	9	140458903	9	137564451	161804	171465
GRCh37/hg19 10p15.3(chr10:1-1)x1		mTOR Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	10	1			523168	513800
NM_001300.5(KLF6):c.506T>C (p.Leu169Pro)	KLF6	Prostate cancer, somatic	Pathogenic(Last reviewed: Dec 21, 2001)	no assertion criteria provided	10	3824003	10	3781811	7573	22612
NM_001300.5(KLF6):c.465C>A (p.Ser155Arg)	KLF6	Neoplasm of stomach	Pathogenic(Last reviewed: Jun 30, 2005)	no assertion criteria provided	10	3824044	10	3781852	7574	22613
NM_001300.5(KLF6):c.410C>A (p.Ser137Ter)	KLF6	Prostate cancer, somatic	Pathogenic(Last reviewed: Dec 21, 2001)	no assertion criteria provided	10	3824099	10	3781907	7570	22609
NM_001300.5(KLF6):c.368C>A (p.Ala123Asp)	KLF6	Prostate cancer, somatic	Pathogenic(Last reviewed: Dec 21, 2001)	no assertion criteria provided	10	3824141	10	3781949	7571	22610
NM_001300.5(KLF6):c.346T>C (p.Ser116Pro)	KLF6	Prostate cancer, somatic	Pathogenic(Last reviewed: Dec 21, 2001)	no assertion criteria provided	10	3824163	10	3781971	7569	22608
NM_001300.5(KLF6):c.190T>C (p.Trp64Arg)	KLF6	Prostate cancer, somatic	Pathogenic(Last reviewed: Dec 21, 2001)	no assertion criteria provided	10	3824319	10	3782127	7572	22611
NM_003739.5(AKR1C3):c.27G>T (p.Lys9Asn)	AKR1C3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	5136663	10	5094471	161618	171487
NM_001047160.2(NET1):c.498G>T (p.Glu166Asp)	NET1	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	10	5494455	10	5452492	487790	480797
NM_032807.4(FBH1):c.2260C>T (p.Arg754Trp)	FBH1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	5963227	10	5921264	161784	171488
NM_030569.6(ITIH5):c.2545G>T (p.Asp849Tyr)	ITIH5	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	7605330	10	7563367	161774	171490
NM_001002295.1(GATA3):c.925-16C>T	GATA3	Neoplasm of ovary	not provided	no assertion provided	10	8111420	10	8069457	132960	136709
NM_001002295.1(GATA3):c.1032C>T (p.Leu344=)	GATA3	Familial cancer of breast	not provided	no assertion provided	10	8111543	10	8069580	132961	136710
NM_001033855.2(DCLRE1C):c.1342A>G (p.Asn448Asp)	DCLRE1C	not provided	Uncertain significance	no assertion criteria provided	10	14951144	10	14909145	100821	106681
NM_001081.3(CUBN):c.4268C>T (p.Thr1423Met)	CUBN	not specified|not provided	Uncertain significance(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	10	17032415	10	16990416	100823	106683
NM_001004470.2(ST8SIA6):c.344G>T (p.Trp115Leu)	ST8SIA6	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	17401546	10	17359547	161480	171482
GRCh37/hg19 10p12.33-12.31(chr10:18439858-20357134)x3	CACNB2|PLXDC2|NSUN6|ARL5B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	10	18439858 - 20357134			221471	223200
GRCh37/hg19 10p12.31-12.2(chr10:22193496-22634700)x3	BMI1|SPAG6|COMMD3|DNAJC1|EBLN1|COMMD3-BMI1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	10	22193496 - 22634700			221472	223201
NM_017433.5(MYO3A):c.2090T>G (p.Leu697Trp)	MYO3A	Nonsyndromic hearing loss and deafness	Pathogenic	criteria provided, single submitter			10	26125584	617675	609078
NM_017433.4(MYO3A):c.2845G>T (p.Val949Phe)	MYO3A	not provided	Uncertain significance	no assertion criteria provided	10	26446290	10	26157361	100865	106725
GRCh37/hg19 10p12.1(chr10:27326892-27356151)x3	ANKRD26	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	10	27326892 - 27356151			221473	223202
GRCh37/hg19 10p11.23(chr10:30728036-30900919)x3	MAP3K8|LYZL2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	10	30728036 - 30900919			221474	223203
GRCh37/hg19 10p11.22-11.21(chr10:32323692-37520394)x3	CREM|ITGB1|KIF5B|FZD8|CUL2|NRP1|PARD3|CCDC7|EPC1|ANKRD30A|GJD4|CCNY	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	10	32323692 - 37520394			221475	223204
NM_001184789.1(PARD3):c.684G>A (p.Met228Ile)	PARD3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	34739275	10	34450347	161557	171483
NM_001184789.1(PARD3):c.573C>G (p.Cys191Trp)	PARD3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	34759022	10	34470094	161556	171484
NM_001184789.1(PARD3):c.572G>T (p.Cys191Phe)	PARD3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	34759023	10	34470095	161555	171485
GRCh37/hg19 10q11.21-26.3(chr10:42347406-135534747)x1	ACADSB|ACTA2|ADAM8|ADD3|ADK|ADRA2A|ADRB1|ALOX5|ANK3|ANXA7|ANXA11|FAS|ARL3|BMPR1A|BNIP3|CAMK2G|CASP7|ENTPD1|CDK1|CHAT|CHUK|ABCC2|COL13A1|COL17A1|COX15|CPN1|CTBP2|CYP2C19|CYP2C8|CYP2C9|CYP2C18|CYP2E1|CYP17A1|CYP26A1|DMBT1|DNA2|DNTT|DOCK1|DUSP5|ECHS1|EGR2|EIF4EBP2|EMX2|ERCC6|FGF8|FGFR2|GDF2|GDF10|GFRA1|GLUD1|GOT1|PRLHR|GPR26|GRK5|GRID1|HABP2|HELLS|HHEX|HK1|HMX2|HNRNPF|HNRNPH3|TLX1|HPS1|HTR7|IDE|IFIT2|IFIT1|IFIT3|INPP5A|KCNMA1|KIF11|ABLIM1|LIPA|MAT1A|MBL2|MGMT|MKI67|MSMB|MXI1|NDUFB8|NFKB2|NODAL|NRAP|OAT|P4HA1|PAX2|PCBD1|PDE6C|PGAM1|PITX3|PLAU|PNLIP|PNLIPRP1|PNLIPRP2|PPA1|PPP1R3C|PPP3CB|NPY4R|PRF1|SRGN|PRKG1|MAPK8|HTRA1|PSAP|PSD|PTEN|PTPRE|ALDH18A1|RBP3|RBP4|RET|RGR|RGS10|RPS24|SCD|CXCL12|SFRP5|SFTPD|FBXW4|SLC18A2|SLC18A3|SLIT1|SNCG|SUPV3L1|TACR2|TAF5|TCF7L2|TECTB|TFAM|TIAL1|TLL2|UBE2D1|UROS|VCL|VDAC2|WNT8B|XPNPEP1|ZNF22|ZNF32|ZNF33B|CCDC6|NCOA4|SLC25A16|SHOC2|ADAM12|ZNF239|UTF1|PARG|NDST2|LIPF|EIF3A|GBF1|LDB1|SGPL1|BTRC|CH25H|PKD2L1|BTAF1|PAPSS2|INA|PDLIM1|SMC3|NEURL1|BUB3|DDX21|LGI1|NOLC1|DLG5|GSTO1|CHST3|BAG3|VPS26A|MINPP1|KIF20B|SEC24C|SH3PXD2A|FAM53B|GPRIN2|SLK|BMS1|SPOCK2|ZNF518A|RHOBTB1|DCLRE1A|FRAT1|PPIF|ACTR1A|SMNDC1|NPM3|MICU1|GLRX3|RPP30|DPYSL4|TACC2|SORBS1|ERLIN1|LBX1|NRG3|OGA|TUBGCP2|PRDX3|ADIRF|VAX1|DEPP1|ATE1|POLR3A|ZWINT|LDB3|SEC23IP|ECD|RAB11FIP2|CPEB3|INPP5F|ZNF365|DKK1|NT5C2|PDCD11|SORCS3|ZSWIM8|WAPL|PPRC1|ABRAXAS2|RRP12|TBC1D12|DNAJC9|DNMBP|CSTF2T|FRAT2|SIRT1|KAT6B|TSPAN15|IFIT5|DPCD|SEC31B|NUDT13|ATRNL1|HERC4|PTPN20|EDRF1|LRIT1|TCTN3|KIF1BP|C10orf12|ANKRD2|CNNM1|MYOF|AP3M1|ANKRD1|GHITM|PALD1|PDCD4|VENTX|R3HCC1L|POLL|CTNNA3|BLNK|A1CF|NRBF2|KCNIP2|CUZD1|CALY|NEUROG3|ASCC1|EXOSC1|MRPS16|CALHM2|CUTC|PLCE1|DUSP13|CHST15|SUFU|ACSL5|PANK1|FXYD4|CCSER2|EXOC6|SHLD2|DDIT4|CCNJ|MARCH5|ZRANB1|CFAP46|NSMCE4A|DNAJB12|CNNM2|WBP1L|CCDC186|CRTAC1|CEP55|LRRC20|CWF19L1|SLC29A3|RNLS|PI4K2A|CSGALNACT2|H2AFY2|HIF1AN|RUFY2|WDR11|SLF2|CCAR1|OGDHL|DHX32|PPP2R2D|CISD1|TDRD1|DNAJC12|ASAH2|BCCIP|TWNK|SAR1A|TM9SF3|ENTPD7|ZMIZ1|AS3MT|STAMBPL1|GPAM|SHTN1|FAM160B1|WDFY4|SEMA4G|ARHGAP22|MYOZ1|PLEKHA1|AVPI1|HPSE2|FAM204A|CDH23|LHPP|PBLD|NPFFR1|VSIR|MMS19|NOC3L|IKZF5|ZDHHC6|PCDH15|CUEDC2|DDX50|FBXL15|OR13A1|ARMH3|HPS6|MMRN2|MFSD13A|MCMBP|SYNPO2L|C10orf95|PLEKHS1|PDZD7|STN1|C10orf88|UBTD1|BICC1|TMEM254|HKDC1|CFAP43|TET1|LRRC27|TNKS2|TRIM8|TSPAN14|KAZALD1|SFXN3|SLC25A28|ELOVL3|MARVELD1|SYT15|RASSF4|LRMDA|PCGF6|ARID5B|LOXL4|ZDHHC16|PRXL2A|DYDC2|PCGF5|ADGRA1|LZTS2|PHYHIPL|LCOR|NKX6-2|MRPL43|AFAP1L2|PLA2G12B|MYPN|PYROXD2|ATP5MD|ZNF503|AIFM2|ADO|ATAD1|ARHGAP19|KNDC1|ITPRIP|MCU|MTG1|CDHR1|BBIP1|FANK1|OPALIN|SYCE1|ZFAND4|OPN4|HOGA1|SORCS1|C10orf71|PRAP1|ZNF511|CHCHD1|MSS51|CFAP70|C10orf90|BTBD16|FAM24A|PSTK|ZNF488|PIK3AP1|MORN4|ZFYVE27|MMP21|COMTD1|FRA10AC1|ANKRD22|SFXN2|PDZD8|AGAP4|BORCS7|AGAP11|GSTO2|SFR1|CALHM3|CLRN3|ANAPC16|PNLIPRP3|SFXN4|CPXM2|ADAMTS14|ACSM6|SAMD8|LIPJ|TRUB1|FRMPD2|VTI1A|DYDC1|EIF5AL1|HECTD2|FGFBP3|C10orf82|CACUL1|USP54|NKX2-3|SLC35G1|CFAP58|FAM170B|TMEM273|FUT11|OIT3|C10orf91|PWWP2B|EMX2OS|PLPP4|VSTM4|PAOX|FAM24B|PLAC9|CABCOCO1|TMEM26|ZCCHC24|UNC5B|STOX1|FAM241B|TYSND1|RTKN2|TBATA|ATOH7|SLC16A9|FAM13C|MARCH8|C10orf25|ZNF485|RASGEF1A|REEP3|JMJD1C|IPMK|WASHC2C|EBF3|CALHM1|CASC2|TCERG1L|HSPA12A|SGMS1|PGBD3|C10orf53|FUOM|JAKMIP3|STK32C|BLOC1S2|RBM20|FAM149B1|FFAR4|KCNK18|DUPD1|LIPM|CYP26C1|VWA2|NANOS1|LRIT2|HMX3|LRRTM3|NHLRC2|CCDC172|WASHC2A|SH2D4B|C10orf99|SLC16A12|CC2D2B|ENO4|ARMS2|TEX36|NKX1-2|C10orf120|EEF1AKMT2|FOXI2|GOLGA7B|FAM45A|MIR107|C10orf105|C10orf62|AGAP6|C10orf55|IFIT1B|FRG2B|MIR346|LRRC18|SPRN|MIR146B|NPS|AGAP9|INSYN2A|FAM25A|TMEM72|LIPK|LIPN|FAM25E|FAM25C|DRGX|ANXA8|ASAH2B|SFTPA1|SNORA12|ANXA8L1|NUTM2A|AGAP10|AGAP5|SFTPA2|NUTM2B|TLX1NB|C10orf131|LOC100131132|FAM25G|ADIRF-AS1|KLLN|TIMM23|FAS-AS1|MTRNR2L5|TCERG1L-AS1|LINC01166|LOC101929662|LINC01520	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	10	42347406 - 135534747			523165	513797
NM_020975.4(RET):c.1826G>A (p.Cys609Tyr)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Familial medullary thyroid carcinoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITH HIRSCHSPRUNG DISEASE|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	10	43609070	10	43113622	13933	28972
NM_020630.4(RET):c.1834_1860del27 (p.Phe612_Cys620del)	RET	Medullary thyroid carcinoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	10	43609078 - 43609104	10	43113630 - 43113656	376312	363191
NM_020975.4(RET):c.1852T>C (p.Cys618Arg)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Familial medullary thyroid carcinoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not provided	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	10	43609096	10	43113648	13929	28968
NM_020975.4(RET):c.1853G>A (p.Cys618Tyr)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	10	43609097	10	43113649	24901	36242
NM_020975.5(RET):c.1859G>A (p.Cys620Tyr)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|Hirschsprung disease|not provided	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, multiple submitters, no conflicts	10	43609103	10	43113655	13916	28955
NM_020975.4(RET):c.1888T>C (p.Cys630Arg)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	10	43609936	10	43114488	24908	36249
NM_020630.4(RET):c.1892A>G (p.Asp631Gly)	RET	Medullary thyroid carcinoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	10	43609940	10	43114492	24916	36257
NM_020975.4(RET):c.1894_1899delGAGCTG (p.Glu632_Leu633del)	RET	Medullary thyroid carcinoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	10	43609942 - 43609947	10	43114494 - 43114499	376313	363192
NM_020975.5(RET):c.1900T>C (p.Cys634Arg)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not provided|Thyroid carcinoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	10	43609948	10	43114500	13917	28956
NM_020975.4(RET):c.1901G>A (p.Cys634Tyr)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not specified|not provided|Hereditary cancer-predisposing syndrome|Neoplasm	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	10	43609949	10	43114501	13909	28948
NM_020975.4(RET):c.1902C>G (p.Cys634Trp)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not provided|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, multiple submitters, no conflicts	10	43609950	10	43114502	13918	28957
NM_020975.4(RET):c.2304G>C (p.Glu768Asp)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Familial medullary thyroid carcinoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: May 4, 2018)	no assertion criteria provided	10	43613840	10	43118392	13931	28970
NM_020630.5(RET):c.2372A>T (p.Tyr791Phe)	RET	Familial cancer of breast|Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Renal adysplasia|Familial medullary thyroid carcinoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|Hirschsprung disease|not specified|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia|Hirschsprung Disease, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	10	43613908	10	43118460	13936	28975
NM_020975.4(RET):c.2410G>C (p.Val804Leu)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not provided	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	10	43614996	10	43119548	38613	47217
NM_020975.4(RET):c.2647_2648delGCinsTT (p.Ala883Phe)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 4, 2018)	no assertion criteria provided	10	43615568 - 43615569	10	43120120 - 43120121	38629	47233
NM_020975.4(RET):c.2671T>G (p.Ser891Ala)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Familial medullary thyroid carcinoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia IIA	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	10	43615592	10	43120144	13951	28990
NM_020630.4(RET):c.2692_2703delGATGTTTATGAA (p.Asp898_Glu901del)	RET	Medullary thyroid carcinoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	10	43615613 - 43615624	10	43120165 - 43120176	376314	363193
NM_020975.4(RET):c.2753T>C (p.Met918Thr)	RET	Hypertelorism|Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Tetralogy of Fallot|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Thyroid carcinoma, sporadic medullary|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|Short stature|Hypothyroidism|Constipation|not provided|Gingival overgrowth|Hypertelorism|Joint hypermobility|Tetralogy of Fallot|Thick vermilion border|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	10	43617416	10	43121968	13919	28958
NC_000010.10:g.43611191_61663279inv	ALOX5|CHAT|ERCC6|GDF2|GDF10|HNRNPF|MBL2|MSMB|NPY4R|PRKG1|MAPK8|RBP3|RET|CXCL12|SLC18A3|TFAM|UBE2D1|ZNF22|ZNF32|CCDC6|NCOA4|ZNF239|PARG|GPRIN2|DEPP1|ZWINT|DKK1|CSTF2T|PTPN20|A1CF|FXYD4|CSGALNACT2|OGDHL|CISD1|ASAH2|WDFY4|ARHGAP22|PCDH15|OR13A1|BICC1|SYT15|RASSF4|PHYHIPL|ZFAND4|C10orf71|ZNF488|AGAP4|FRMPD2|FAM170B|TMEM273|VSTM4|SLC16A9|FAM13C|MARCH8|C10orf25|ZNF485|RASGEF1A|IPMK|WASHC2C|SGMS1|PGBD3|C10orf53|WASHC2A|AGAP6|LRRC18|AGAP9|TMEM72|FAM25E|FAM25C|DRGX|ANXA8|ASAH2B|ANXA8L1|AGAP10|FAM25G|TIMM23|MTRNR2L5	Pediatric metastatic thyroid tumour	Likely pathogenic(Last reviewed: Jan 19, 2018)	no assertion criteria provided	10	43611191 - 61663279			495230	486727
NM_000698.4(ALOX5):c.490T>G (p.Leu164Val)	ALOX5	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	10	45907697	10	45412249	221317	223046
NM_004962.4(GDF10):c.1217C>T (p.Ala406Val)	GDF10	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	48428669	10	47310693	161627	171486
NM_001143773.1(FAM13C):c.1178T>A (p.Leu393His)	FAM13C	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	61012664	10	59252904	161530	171489
NM_024045.1(DDX50):c.122C>T (p.Ser41Leu)	DDX50	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	70666501	10	68906745	219327	221016
NM_152635.2(OIT3):c.1598C>T (p.Thr533Met)	OIT3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	74692242	10	72932484	219345	221034
NM_012330.3(KAT6B):c.2486T>A (p.Leu829His)	KAT6B	not provided	Uncertain significance	no assertion criteria provided	10	76744950	10	74985192	91976	97454
NM_012330.3(KAT6B):c.3827C>T (p.Pro1276Leu)	KAT6B|DUPD1	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	10	76788409	10	75028651	487787	480794
NM_004747.3(DLG5):c.5486A>C (p.His1829Pro)	DLG5	not provided	Uncertain significance	no assertion criteria provided	10	79554667	10	77794909	91960	97438
GRCh37/hg19 10q23.1-25.1(chr10:85557432-105804295)x1	ACTA2|FAS|ARL3|BMPR1A|ENTPD1|CHUK|ABCC2|COL17A1|COX15|CPN1|CYP2C19|CYP2C8|CYP2C9|CYP2C18|CYP17A1|CYP26A1|DNTT|FGF8|GLUD1|GOT1|GRID1|HELLS|HHEX|TLX1|HPS1|HTR7|IDE|IFIT2|IFIT1|IFIT3|KIF11|LIPA|NDUFB8|NFKB2|PAX2|PDE6C|PGAM1|PITX3|PPP1R3C|PSD|PTEN|ALDH18A1|RBP4|RGR|SCD|SFRP5|FBXW4|SLIT1|SNCG|TAF5|TLL2|WNT8B|LIPF|GBF1|LDB1|BTRC|CH25H|PKD2L1|BTAF1|PAPSS2|INA|PDLIM1|NEURL1|LGI1|NOLC1|MINPP1|KIF20B|SH3PXD2A|SLK|ZNF518A|FRAT1|ACTR1A|NPM3|RPP30|SORBS1|ERLIN1|LBX1|OGA|ADIRF|LDB3|CPEB3|NT5C2|PDCD11|WAPL|PPRC1|RRP12|TBC1D12|DNMBP|FRAT2|IFIT5|DPCD|SEC31B|LRIT1|TCTN3|C10orf12|ANKRD2|CNNM1|MYOF|ANKRD1|GHITM|R3HCC1L|POLL|BLNK|KCNIP2|EXOSC1|CALHM2|CUTC|PLCE1|SUFU|PANK1|CCSER2|EXOC6|SHLD2|CCNJ|MARCH5|CNNM2|WBP1L|CRTAC1|CEP55|CWF19L1|RNLS|PI4K2A|HIF1AN|SLF2|TWNK|TM9SF3|ENTPD7|AS3MT|STAMBPL1|SEMA4G|AVPI1|HPSE2|MMS19|NOC3L|CUEDC2|FBXL15|ARMH3|HPS6|MMRN2|MFSD13A|C10orf95|PDZD7|STN1|UBTD1|TNKS2|TRIM8|KAZALD1|SFXN3|SLC25A28|ELOVL3|MARVELD1|PCGF6|LOXL4|ZDHHC16|PCGF5|LZTS2|LCOR|MRPL43|PYROXD2|ATP5MD|ATAD1|ARHGAP19|CDHR1|OPALIN|OPN4|HOGA1|PIK3AP1|MORN4|ZFYVE27|FRA10AC1|ANKRD22|SFXN2|BORCS7|AGAP11|CALHM3|ACSM6|LIPJ|HECTD2|FGFBP3|NKX2-3|SLC35G1|CALHM1|BLOC1S2|FFAR4|LIPM|CYP26C1|LRIT2|C10orf99|SLC16A12|CC2D2B|GOLGA7B|MIR107|C10orf62|IFIT1B|MIR346|MIR146B|FAM25A|LIPK|LIPN|SNORA12|NUTM2A|TLX1NB|C10orf131|ADIRF-AS1|KLLN|FAS-AS1|LOC101929662|LINC01520	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	10	85557432 - 105804295			377387	364269
NM_017551.2(GRID1):c.884C>T (p.Thr295Met)	GRID1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	87628834	10	85869077	219328	221017
NM_004897.4(MINPP1):c.122C>T (p.Ser41Leu)	MINPP1	Follicular thyroid carcinoma	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	10	89264794	10	87505037	5021	20060
GRCh38/hg38 10q23.31(chr10:87830830-88617225)x1	PTEN|RNLS|ATAD1|LIPJ|KLLN	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	10	89590587 - 90376982	10	87830830 - 88617225	523155	513787
NM_000314.6(PTEN):c.55G>A (p.Asp19Asn)	PTEN	Cutaneous melanoma	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	10	89624281	10	87864524	7837	22876
NM_000314.6(PTEN):c.362C>G (p.Ala121Gly)	PTEN	Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	10	89692878	10	87933121	7842	22881
NM_000314.6(PTEN):c.388C>G (p.Arg130Gly)	PTEN	Endometrial carcinoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Glioblastoma|Neoplasm of the large intestine|Ovarian Neoplasms|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Malignant tumor of floor of mouth	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	10	89692904	10	87933147	375958	362837
NM_000314.6(PTEN):c.388C>T (p.Arg130Ter)	PTEN	Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome|Cowden syndrome 1|not specified|not provided|Neoplasm of brain|Hereditary cancer-predisposing syndrome|Ovarian Neoplasms	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	10	89692904	10	87933147	7819	22858
NM_000314.6(PTEN):c.389G>T (p.Arg130Leu)	PTEN	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of the breast|Glioblastoma|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	10	89692905	10	87933148	376509	363388
NM_000314.6(PTEN):c.389G>C (p.Arg130Pro)	PTEN	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|PTEN hamartoma tumor syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Glioblastoma|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2018)	criteria provided, conflicting interpretations	10	89692905	10	87933148	142018	151732
NM_000314.6(PTEN):c.389G>A (p.Arg130Gln)	PTEN	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|PTEN hamartoma tumor syndrome|Squamous cell lung carcinoma|Cowden syndrome 1|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of the breast|Glioblastoma|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Neoplasm|Ovarian Neoplasms|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89692905	10	87933148	7829	22868
NM_000314.6(PTEN):c.406T>C (p.Cys136Arg)	PTEN	PTEN hamartoma tumor syndrome|Acute megakaryoblastic leukemia|not provided|Hereditary cancer-predisposing syndrome|Cowden syndrome|Mediastinal germ cell tumor	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	10	89692922	10	87933165	183726	183028
NM_000314.6(PTEN):c.477G>T (p.Arg159Ser)	PTEN	Neoplasm of the breast|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	10	89692993	10	87933236	375959	362838
NM_000314.6(PTEN):c.517C>T (p.Arg173Cys)	PTEN	PTEN hamartoma tumor syndrome|not specified|not provided|Neoplasm of brain|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89711899	10	87952142	189500	187363
NM_000314.6(PTEN):c.518G>A (p.Arg173His)	PTEN	PTEN hamartoma tumor syndrome|not provided|Neoplasm of brain	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	10	89711900	10	87952143	376032	362911
NM_000314.6(PTEN):c.564T>A (p.Tyr188Ter)	PTEN	Prostate cancer, somatic|PTEN hamartoma tumor syndrome	Likely pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89711946	10	87952189	7831	22870
NM_000314.6(PTEN):c.633C>A (p.Cys211Ter)	PTEN	Cowden syndrome 1|Cutaneous melanoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, multiple submitters, no conflicts	10	89712015	10	87952258	7836	22875
NM_000314.6(PTEN):c.649G>A (p.Val217Ile)	PTEN	Cutaneous melanoma	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	10	89717624	10	87957867	7838	22877
NM_000314.6(PTEN):c.697C>T (p.Arg233Ter)	PTEN	Macrocephaly/autism syndrome|Non-small cell lung cancer|PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided|Neoplasm of the breast|Glioblastoma|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Cowden syndrome|Colorectal Neoplasms	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	10	89717672	10	87957915	7813	22852
NM_000314.6(PTEN):c.698G>A (p.Arg233Gln)	PTEN	PTEN hamartoma tumor syndrome|Glioblastoma|Hereditary cancer-predisposing syndrome|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Sep 29, 2016)	criteria provided, multiple submitters, no conflicts	10	89717673	10	87957916	376510	363389
NM_000314.6(PTEN):c.700C>T (p.Arg234Trp)	PTEN	not provided|Hereditary cancer-predisposing syndrome|Neoplasm	Uncertain significance(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	10	89717675	10	87957918	184844	183040
NM_000314.6(PTEN):c.761_765delAAGTA (p.Lys254Argfs)	PTEN	Prostate cancer, somatic	Pathogenic(Last reviewed: Nov 15, 1997)	no assertion criteria provided	10	89717736 - 89717740	10	87957979 - 87957983	7830	22869
NM_000314.6(PTEN):c.800delA (p.Lys267Argfs)	PTEN	PTEN hamartoma tumor syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, multiple submitters, no conflicts	10	89717775	10	87958018	92828	98735
NM_000314.6(PTEN):c.1003C>T (p.Arg335Ter)	PTEN	Macrocephaly/autism syndrome|Proteus-like syndrome|PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided|Neoplasm of brain|Hereditary cancer-predisposing syndrome|Inborn genetic diseases|PTEN-related disorder	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	10	89720852	10	87961095	7833	22872
NM_000314.6(PTEN):c.1009del (p.Ser338Leufs)	PTEN	Endometrial carcinoma	Pathogenic	no assertion criteria provided	10	89720858	10	87961101	562182	553356
NM_000043.5(FAS):c.183G>A (p.Lys61=)	FAS	Autoimmune lymphoproliferative syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2017)	criteria provided, conflicting interpretations	10	90762938	10	89003181	155871	165620
NM_000043.5(FAS):c.353A>G (p.Asn118Ser)	FAS	SQUAMOUS CELL CARCINOMA, BURN SCAR-RELATED, SOMATIC	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	10	90768664	10	89008907	16511	31550
NM_000043.5(FAS):c.532T>C (p.Cys178Arg)	FAS	SQUAMOUS CELL CARCINOMA, BURN SCAR-RELATED, SOMATIC	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	10	90770536	10	89010779	16512	31551
NM_000043.5(FAS):c.763A>G (p.Asn255Asp)	FAS	SQUAMOUS CELL CARCINOMA, BURN SCAR-RELATED, SOMATIC	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	10	90773962	10	89014205	16510	31549
NM_000043.5(FAS):c.785T>C (p.Ile262Thr)	FAS	not provided	Uncertain significance	no assertion criteria provided	10	90773984	10	89014227	100802	106662
NM_005398.6(PPP1R3C):c.458A>G (p.Gln153Arg)	PPP1R3C	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	93390180	10	91630423	161634	171491
NM_153226.3(SLC35G1):c.424G>A (p.Ala142Thr)	SLC35G1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	95660576	10	93900819	161821	171492
GRCh37/hg19 10q23.33(chr10:94368870-94715405)x3	HHEX|KIF11|EXOC6	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	10	94368870 - 94715405			221476	223205
NM_001034954.1(SORBS1):c.3140G>C (p.Arg1047Pro)	SORBS1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	97096777	10	95337020	161502	171493
NM_001346516.1(LCOR):c.2564G>A (p.Arg855His)	C10orf12|LCOR	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	98742781	10	96983024	219346	221035
NM_020348.2(CNNM1):c.957G>C (p.Glu319Asp)	CNNM1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	10	101090101	10	99330344	221303	223032
NM_000392.5(ABCC2):c.2352A>G (p.Leu784=)	ABCC2	not provided	Uncertain significance	no assertion criteria provided	10	101578627	10	99818870	100810	106670
NM_001278.4(CHUK):c.1270C>G (p.Arg424Gly)	CHUK	not provided	Uncertain significance	no assertion criteria provided	10	101964918	10	100205161	100832	106692
NM_016112.2(PKD2L1):c.70G>A (p.Ala24Thr)	PKD2L1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	102089791	10	100330034	161699	171475
NM_003990.4(PAX2):c.57_58insGTGAACC (p.Gln22Argfs)	PAX2	not provided	Pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	10	102509516 - 102509517	10	100749759 - 100749760	217288	213937
NM_003990.4(PAX2):c.119_120delGC (p.Arg40Hisfs)	PAX2	not provided	Pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	10	102509578 - 102509579	10	100749821 - 100749822	217286	213938
NM_003990.4(PAX2):c.187G>A (p.Gly63Ser)	PAX2	not provided	Pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	10	102509646	10	100749889	217287	213939
NM_003990.4(PAX2):c.223_224dupAC (p.Gly76Profs)	PAX2	not provided	Pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	10	102510461 - 102510462	10	100750704 - 100750705	217289	213940
NM_015448.2(DPCD):c.11C>T (p.Thr4Met)	DPCD	not provided	Uncertain significance	no assertion criteria provided	10	103348104	10	101588347	91991	97469
NM_015062.4(PPRC1):c.904A>G (p.Ile302Val)	PPRC1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	103899169	10	102139412	161691	171476
NM_016169.3(SUFU):c.44C>T (p.Pro15Leu)	SUFU	Medulloblastoma	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	10	104263953	10	102504196	3569	18608
NM_001178133.1(SUFU):c.875G>A (p.Cys292Tyr)	SUFU	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	104357015	10	102597258	161552	171477
NM_016169.3(SUFU):c.1022+1G>A	SUFU	Gorlin syndrome|Medulloblastoma, desmoplastic|not provided	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	10	104359302	10	102599545	3571	18610
NM_030912.2(TRIM8):c.1561G>T (p.Val521Phe)	TRIM8	not provided	Uncertain significance	no assertion criteria provided	10	104417016	10	102657259	92016	97494
NM_012229.4(NT5C2):c.1220A>C (p.Asp407Ala)	NT5C2	Leukemia-Lymphoma, Adult T-Cell	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	10	104850745	10	103090988	376351	363230
NM_012229.4(NT5C2):c.1100G>A (p.Arg367Gln)	NT5C2	Leukemia-Lymphoma, Adult T-Cell	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	10	104852955	10	103093198	376349	363228
NM_012229.4(NT5C2):c.1075A>C (p.Lys359Gln)	NT5C2	Lymphoblastic leukemia, acute, with lymphomatous features|Leukemia-Lymphoma, Adult T-Cell	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	10	104852980	10	103093223	376350	363229
NM_025145.6(CFAP43):c.2051A>G (p.His684Arg)	CFAP43	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	105944864	10	104185106	161773	171478
NM_001206572.1(SORCS1):c.3380C>T (p.Pro1127Leu)	SORCS1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	108339001	10	106579243	161572	171479
NM_022970.3(FGFR2):c.1978A>G (p.Lys660Glu)	FGFR2	Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	10	123247516	10	121488002	376153	363032
NM_000141.4(FGFR2):c.1974A>T (p.Lys658Asn)	FGFR2	Endometrial neoplasm	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	10	123247517	10	121488003	376727	363606
NM_000141.4(FGFR2):c.1972A>G (p.Lys658Glu)	FGFR2	Endometrial neoplasm	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	10	123247519	10	121488005	376725	363604
NM_022970.3(FGFR2):c.1917T>A (p.Asn639Lys)	FGFR2	Lung adenocarcinoma|Neoplasm of the breast|Endometrial neoplasm|Nasopharyngeal Neoplasms|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	10	123247577	10	121488063	376315	363194
NM_000141.4(FGFR2):c.1913A>C (p.Asn638Thr)	FGFR2	Craniosynostosis syndrome	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	10	123247578	10	121488064	376750	363629
NM_000141.4(FGFR2):c.1849T>A (p.Leu617Met)	FGFR2	Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	10	123256060	10	121496546	376154	363033
NM_000141.4(FGFR2):c.1694A>G (p.Glu565Gly)	FGFR2	Pfeiffer syndrome|Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	10	123256215	10	121496701	374823	361707
NM_000141.4(FGFR2):c.1694A>C (p.Glu565Ala)	FGFR2	Pfeiffer syndrome|Craniosynostosis syndrome	Likely pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	10	123256215	10	121496701	13294	28333
NM_000141.4(FGFR2):c.1690G>A (p.Val564Ile)	FGFR2	Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	10	123256219	10	121496705	376155	363034
NM_000141.4(FGFR2):c.1647T>A (p.Asn549Lys)	FGFR2	Lung adenocarcinoma|Neoplasm of the breast|Nasopharyngeal Neoplasms|Malignant neoplasm of body of uterus|Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	10	123258034	10	121498520	376157	363036
NM_022970.3(FGFR2):c.1650T>G (p.Asn550Lys)	FGFR2	Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	10	123258034	10	121498520	376156	363035
NM_000141.4(FGFR2):c.1645A>C (p.Asn549His)	FGFR2	Crouzon syndrome|Lung adenocarcinoma|Neoplasm of the breast|Nasopharyngeal Neoplasms|Malignant neoplasm of body of uterus|Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	10	123258036	10	121498522	374821	361709
NM_000141.4(FGFR2):c.1642A>C (p.Ile548Leu)	FGFR2	Lung adenocarcinoma|Neoplasm of the breast|Endometrial neoplasm|Nasopharyngeal Neoplasms|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	10	123258039	10	121498525	376433	363312
NM_000141.4(FGFR2):c.1639A>G (p.Ile547Val)	FGFR2	Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	10	123258042	10	121498528	376158	363037
NM_000141.4(FGFR2):c.1611G>A (p.Met537Ile)	FGFR2	Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	10	123258070	10	121498556	376161	363040
NM_022970.3(FGFR2):c.1614G>C (p.Met538Ile)	FGFR2	Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	10	123258070	10	121498556	376160	363039
NM_022970.3(FGFR2):c.1614G>T (p.Met538Ile)	FGFR2	Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	10	123258070	10	121498556	376159	363038
NM_022970.3(FGFR2):c.1608G>A (p.Met536Ile)	FGFR2	Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	10	123258076	10	121498562	376164	363043
NM_022970.3(FGFR2):c.1608G>C (p.Met536Ile)	FGFR2	Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	10	123258076	10	121498562	376163	363042
NM_000141.4(FGFR2):c.1605G>T (p.Met535Ile)	FGFR2	Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	10	123258076	10	121498562	376162	363041
NM_000141.4(FGFR2):c.1570A>G (p.Thr524Ala)	FGFR2	Craniosynostosis syndrome	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	10	123258111	10	121498597	376749	363628
NM_022970.3(FGFR2):c.1148G>A (p.Cys383Tyr)	FGFR2	Carcinoma of esophagus|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	10	123274773	10	121515259	376432	363311
NM_000141.4(FGFR2):c.1144T>C (p.Cys382Arg)	FGFR2	Carcinoma of esophagus|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2018)	no assertion criteria provided	10	123274774	10	121515260	376431	363310
NM_022970.3(FGFR2):c.1144T>C (p.Tyr382His)	FGFR2	Endometrial neoplasm|Carcinoma of esophagus|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	10	123274777	10	121515263	376316	363195
NM_000141.4(FGFR2):c.1124A>G (p.Tyr375Cys)	FGFR2	Endometrial carcinoma|Cutis Gyrata syndrome of Beare and Stevenson|not provided|Endometrial neoplasm|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, multiple submitters, no conflicts	10	123274794	10	121515280	13277	28316
NM_000141.4(FGFR2):c.1121A>G (p.Asp374Gly)	FGFR2	Endometrial neoplasm	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	10	123274797	10	121515283	376726	363605
NM_000141.4(FGFR2):c.1115C>G (p.Ser372Cys)	FGFR2	Cutis Gyrata syndrome of Beare and Stevenson|Endometrial neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	10	123274803	10	121515289	13278	28317
NM_000141.4(FGFR2):c.1025G>A (p.Cys342Tyr)	FGFR2	Pfeiffer syndrome|Crouzon syndrome|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	10	123276892	10	121517378	13263	28302
NM_022970.3(FGFR2):c.959C>G (p.Ser320Cys)	FGFR2	Squamous cell lung carcinoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	10	123278324	10	121518810	376147	363026
NM_000141.4(FGFR2):c.929A>G (p.Lys310Arg)	FGFR2	Endometrial neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	10	123279503	10	121519989	376317	363196
NM_000141.4(FGFR2):c.870G>C (p.Trp290Cys)	FGFR2	Pfeiffer syndrome|Squamous cell lung carcinoma	Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	10	123279562	10	121520048	13281	28320
NM_000141.4(FGFR2):c.799T>C (p.Ser267Pro)	FGFR2	Pfeiffer syndrome|Crouzon syndrome|Neoplasm of stomach|not provided|FGFR2 related craniosynostosis	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	10	123279633	10	121520119	13290	28329
NM_000141.4(FGFR2):c.758C>G (p.Pro253Arg)	FGFR2	Acrocephalosyndactyly type I|not provided|FGFR2 related craniosynostosis|Head and Neck Neoplasms	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	10	123279674	10	121520160	13273	28312
NM_022970.3(FGFR2):c.755C>G (p.Ser252Trp)	FGFR2	Acrocephalosyndactyly type I|Endometrial carcinoma|not provided|Endometrial neoplasm|FGFR2 related craniosynostosis|Acrocephalosyndactyly|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	10	123279677	10	121520163	13272	28311
NM_144587.3(BTBD16):c.82C>T (p.Pro28Ser)	BTBD16	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	124036369	10	122276854	161806	171480
NM_007329.2(DMBT1):c.1012T>C (p.Ser338Pro)	DMBT1	not provided	Uncertain significance	no assertion criteria provided	10	124340390	10	122580874	100857	106717
GRCh37/hg19 10q26.12-26.13(chr10:122608791-123684530)x64	FGFR2|ATE1|WDR11	Neoplasm of the large intestine|Colorectal Neoplasms	Uncertain significance(Last reviewed: Jan 1, 2016)	no assertion criteria provided	10	122608791 - 123684530			252991	247393
NM_153442.3(GPR26):c.71C>T (p.Ala24Val)	GPR26	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	10	125425994	10	123666478	161823	171481
NM_198148.2(CPXM2):c.497G>A (p.Gly166Glu)	CPXM2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	10	125622146	10	123862630	221324	223053
NM_000274.3(OAT):c.293T>C (p.Val98Ala)	OAT	not provided	Uncertain significance	no assertion criteria provided	10	126097441	10	124408872	100806	106666
NM_002412.5(MGMT):c.-28C>T (p.Arg22=)	MGMT	Glioblastoma	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	10	131265545	10	129467281	376361	363240
NM_001005463.2(EBF3):c.534A>T (p.Ser178=)	EBF3	not provided	Uncertain significance	no assertion criteria provided	10	131755542	10	129957278	100819	106679
NM_152643.7(KNDC1):c.2914G>T (p.Glu972Ter)	KNDC1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	10	135013889	10	133200385	221318	223047
NM_001012302.2(ANO9):c.2046C>G (p.Asp682Glu)	ANO9	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	418804	11	418804	161493	171503
NM_005343.3(HRAS):c.437C>T (p.Ala146Val)	HRAS|LRRC56	Multiple myeloma|Costello syndrome|Lung adenocarcinoma|Acute myeloid leukemia|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	11	533466	11	533466	12611	27650
NM_005343.3(HRAS):c.436G>C (p.Ala146Pro)	HRAS|LRRC56	Multiple myeloma|Lung adenocarcinoma|Acute myeloid leukemia|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	11	533467	11	533467	376442	363321
NM_005343.3(HRAS):c.436G>A (p.Ala146Thr)	HRAS|LRRC56	Multiple myeloma|Costello syndrome|Lung adenocarcinoma|Acute myeloid leukemia|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	11	533467	11	533467	12607	27646
NM_005343.3(HRAS):c.182_183delAGinsGA (p.Gln61Arg)	HRAS|LRRC56	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	11	533873 - 533874	11	533873 - 533874	376321	363200
NM_005343.3(HRAS):c.182_183delAGinsGT (p.Gln61Arg)	HRAS|LRRC56	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	11	533873 - 533874	11	533873 - 533874	376320	363199
NM_005343.3(HRAS):c.183G>C (p.Gln61His)	HRAS|LRRC56	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	11	533873	11	533873	376319	363198
NM_005343.3(HRAS):c.183G>T (p.Gln61His)	HRAS|LRRC56	Malignant melanoma of skin|Noonan syndrome 3|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the breast|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm|Neoplasm of the thyroid gland|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	11	533873	11	533873	376318	363197
NM_005343.3(HRAS):c.182A>C (p.Gln61Pro)	HRAS|LRRC56	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Neoplasm|Colorectal Neoplasms|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	11	533874	11	533874	376322	363201
NM_005343.3(HRAS):c.182A>T (p.Gln61Leu)	HRAS|LRRC56	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	11	533874	11	533874	376033	362912
NM_176795.4(HRAS):c.182A>G (p.Gln61Arg)	HRAS|LRRC56	Epidermal nevus syndrome|not provided|Neoplasm|Neoplasm of the thyroid gland|Vascular Tumors Including Pyogenic Granuloma	Likely pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	11	533874	11	533874	160364	170209
NM_005343.3(HRAS):c.181C>G (p.Gln61Glu)	HRAS|LRRC56	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	11	533875	11	533875	376444	363323
NM_005343.3(HRAS):c.181C>A (p.Gln61Lys)	HRAS|LRRC56	Noonan syndrome 3|Follicular thyroid carcinoma|Spermatocytic seminoma, somatic|Spermatocytic seminoma|not provided|Neoplasm of the breast	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	11	533875	11	533875	12601	27640
NM_005343.3(HRAS):c.175G>A (p.Ala59Thr)	HRAS|LRRC56	Costello syndrome|Non-small cell lung cancer	Likely pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	11	533881	11	533881	40435	48905
NM_176795.4(HRAS):c.145G>A (p.Glu49Lys)	HRAS|LRRC56	Vascular Tumors Including Pyogenic Granuloma	Likely pathogenic(Last reviewed: Feb 19, 2015)	no assertion criteria provided	11	533911	11	533911	548638	539145
NM_176795.4(HRAS):c.100C>T (p.Pro34Ser)	HRAS|LRRC56	Vascular Tumors Including Pyogenic Granuloma	Uncertain significance(Last reviewed: Feb 19, 2015)	no assertion criteria provided	11	534223	11	534223	548640	539146
NM_176795.4(HRAS):c.44G>A (p.Gly15Asp)	HRAS|LRRC56	Vascular Tumors Including Pyogenic Granuloma	Uncertain significance(Last reviewed: Feb 19, 2015)	no assertion criteria provided	11	534279	11	534279	548639	539147
NM_005343.3(HRAS):c.38G>C (p.Gly13Ala)	HRAS|LRRC56	Liver cancer|Chronic lymphocytic leukemia|Multiple myeloma|Lung adenocarcinoma|Acute myeloid leukemia|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	11	534285	11	534285	376443	363322
NM_005343.3(HRAS):c.38G>T (p.Gly13Val)	HRAS|LRRC56	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Costello syndrome|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|not provided|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Thymoma|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, multiple submitters, no conflicts	11	534285	11	534285	180848	179419
NM_005343.3(HRAS):c.38G>A (p.Gly13Asp)	HRAS|LRRC56	Costello syndrome|not provided|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Jan 4, 2017)	criteria provided, multiple submitters, no conflicts	11	534285	11	534285	12604	27643
NM_176795.4(HRAS):c.37G>A (p.Gly13Ser)	HRAS|LRRC56	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the breast|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm|Vascular Tumors Including Pyogenic Granuloma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	11	534286	11	534286	376323	363202
NM_005343.3(HRAS):c.37G>C (p.Gly13Arg)	HRAS|LRRC56	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Epidermal nevus syndrome|Epidermal nevus|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Nevus sebaceous|NEVUS SEBACEOUS, SOMATIC|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Nevus sebaceous|Neoplasm of the large intestine|NEVUS SPILUS, SOMATIC|SPITZ NEVUS, SOMATIC|Colorectal Neoplasms|Uterine cervical neoplasms|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	11	534286	11	534286	35554	44227
NM_005343.3(HRAS):c.37G>T (p.Gly13Cys)	HRAS|LRRC56	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Costello syndrome|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Noonan syndrome|not provided|Rasopathy|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Neoplasm|Colorectal Neoplasms|Uterine cervical neoplasms|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	11	534286	11	534286	12606	27645
NM_005343.3(HRAS):c.35G>A (p.Gly12Asp)	HRAS|LRRC56	Costello syndrome|Costello syndrome, severe|Nevus sebaceous|NEVUS SEBACEOUS, SOMATIC|not provided|Rasopathy|Neoplasm of the breast|Nevus sebaceous	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, multiple submitters, no conflicts	11	534288	11	534288	12612	27651
NM_005343.3(HRAS):c.35G>C (p.Gly12Ala)	HRAS|LRRC56	Liver cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Costello syndrome|Lung adenocarcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|not provided|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Inborn genetic diseases|Colorectal Neoplasms|Uterine cervical neoplasms|Neoplasm of the thyroid gland|Papillary renal cell carcinoma, sporadic|Adenoid cystic carcinoma|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	11	534288	11	534288	12603	27642
NM_005343.3(HRAS):c.35G>T (p.Gly12Val)	HRAS|LRRC56	Bladder cancer, somatic|Costello syndrome|Epidermal nevus|Myopathy, congenital, with excess of muscle spindles|not provided|Cutaneous melanoma|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, multiple submitters, no conflicts	11	534288	11	534288	12600	27639
NM_005343.3(HRAS):c.34G>C (p.Gly12Arg)	HRAS|LRRC56	Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	11	534289	11	534289	375961	362840
NM_005343.3(HRAS):c.34G>T (p.Gly12Cys)	HRAS|LRRC56	Liver cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Costello syndrome|Epidermal nevus|Lung adenocarcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Nevus sebaceous|NEVUS SEBACEOUS, SOMATIC|not provided|Rasopathy|Neoplasm of the breast|Glioblastoma|Bladder carcinoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Nevus sebaceous|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Neoplasm of the thyroid gland|Papillary renal cell carcinoma, sporadic|Adenoid cystic carcinoma|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, multiple submitters, no conflicts	11	534289	11	534289	12613	27652
NM_176795.4(HRAS):c.34G>A (p.Gly12Ser)	HRAS|LRRC56	Liver cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Costello syndrome|Lung adenocarcinoma|Myopathy, congenital, with excess of muscle spindles|Acute myeloid leukemia|Myelodysplastic syndrome|Epidermal nevus with urothelial cancer, somatic|Nevus sebaceous|NEVUS SEBACEOUS, SOMATIC|not provided|Rasopathy|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Nevus sebaceous|Neoplasm of the large intestine|Carcinoma of esophagus|Nevus, woolly hair|Colorectal Neoplasms|Uterine cervical neoplasms|Neoplasm of the thyroid gland|Papillary renal cell carcinoma, sporadic|Adenoid cystic carcinoma|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	11	534289	11	534289	12602	27641
NM_021008.3(DEAF1):c.1526G>A (p.Arg509Gln)	DEAF1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	654029	11	654029	161743	171515
NM_001191061.1(SLC25A22):c.178G>T (p.Glu60Ter)	SLC25A22	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	794482	11	794482	161560	171516
GRCh37/hg19 11p15.5(chr11:850336-1491561)x1	AP2A2|MUC2|MUC5AC|MUC6|TSPAN4|BRSK2|TOLLIP|CHID1|MOB2|MUC5B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	11	850336 - 1491561			221388	223117
Single allele	AP2A2|CTSD|DUSP8|MUC2|MUC5AC|MUC6|BRSK2|TOLLIP|CHID1|MOB2|SYT8|KRTAP5-1|KRTAP5-3|KRTAP5-4|IFITM10|KRTAP5-5|KRTAP5-2|KRTAP5-6|MUC5B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	11	870446 - 1857751			221343	223072
NM_005961.2(MUC6):c.4382C>T (p.Thr1461Ile)	MUC6	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	1018419	11	1018419	161643	171494
chr11:1092954..1857751 complex variant	CTSD|DUSP8|MUC2|MUC5AC|BRSK2|TOLLIP|MOB2|SYT8|KRTAP5-1|KRTAP5-3|KRTAP5-4|IFITM10|KRTAP5-5|KRTAP5-2|KRTAP5-6|MUC5B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	11	1092954 - 1857751			221367	223096
NM_003282.3(TNNI2):c.466C>T (p.Arg156Ter)	TNNI2	Distal arthrogryposis type 2B|Distal arthrogryposis|not provided|Calcaneovalgus deformity|Ulnar deviation of the wrist|Distal arthrogryposis|Congenital finger flexion contractures	Pathogenic(Last reviewed: Nov 25, 2015)	criteria provided, multiple submitters, no conflicts	11	1862698	11	1841468	12436	27475
NM_003282.3(TNNI2):c.521G>A (p.Arg174Gln)	TNNI2	Distal arthrogryposis type 2B|not provided	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, multiple submitters, no conflicts	11	1862753	11	1841523	12435	27474
NM_002555.5(SLC22A18):c.257G>A (p.Arg86His)	SLC22A18	Rhabdomyosarcoma, somatic	Pathogenic(Last reviewed: Mar 31, 1998)	no assertion criteria provided	11	2930440	11	2909210	6977	22016
NM_183233.2(SLC22A18):c.698C>T (p.Ser233Phe)	SLC22A18	Lung cancer	Pathogenic(Last reviewed: Sep 15, 1998)	no assertion criteria provided	11	2939260	11	2918030	6978	22017
NM_000518.4(HBB):c.-80del	LOC106099062|LOC107133510	beta Thalassemia	not provided	no assertion provided	11	5248331	11	5227101	60706	75268
NM_001003827.1:c.-5G>A	TRIM34|TRIM5	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	5653557	11	5632327	161478	171511
NM_032127.3(FAM160A2):c.2584C>T (p.Arg862Cys)	FAM160A2|C11orf42	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	6235656	11	6214426	219307	220996
NM_001014794.2(ILK):c.1020C>T (p.Val340=)	ILK	not provided	Uncertain significance	no assertion criteria provided	11	6631208	11	6609977	91924	97402
NM_000391.4(TPP1):c.380+5G>A	TPP1	Ceroid lipofuscinosis neuronal 2	Pathogenic	criteria provided, single submitter	11	6638852	11	6617621	599035	590164
NM_001289059.1(STK33):c.408T>G (p.Phe136Leu)	STK33	Pancreatic Neoplasms	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	11	8457665	11	8436118	376702	363581
GRCh37/hg19 11p15.4(chr11:9042668-9165735)x3	DENND5A|SCUBE2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	11	9042668 - 9165735			221477	223206
NM_014632.3(MICAL2):c.3131A>G (p.Asp1044Gly)	MICAL2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	11	12278507	11	12256960	221304	223033
NM_001177314.1(RRAS2):c.110A>T (p.Gln37Leu)	RRAS2	Neoplasm of ovary	Pathogenic(Last reviewed: Aug 2, 1994)	no assertion criteria provided	11	14316390	11	14294844	9447	24486
NM_005013.2(NUCB2):c.-427A>C	NUCB2	not provided	not provided	no assertion provided	11	17298104	11	17276557	127107	132616
NM_005013.2(NUCB2):c.-406C>G	NUCB2	not provided	Likely pathogenic	no assertion criteria provided	11	17298125	11	17276578	127108	132617
NM_001352663.1(NUCB2):c.-431G>A	NUCB2	not provided	not provided	no assertion provided	11	17298223	11	17276676	127109	132618
NM_001352662.1(NUCB2):c.-461A>G	NUCB2	not provided	not provided	no assertion provided	11	17298277	11	17276730	127110	132619
NM_005013.2(NUCB2):c.-166G>C	NUCB2	not provided	not provided	no assertion provided	11	17298365	11	17276818	127111	132620
NM_005709.3(USH1C):c.569C>T (p.Ser190Leu)	USH1C	Usher syndrome, type 1C|Deafness, autosomal recessive 18|Usher syndrome, type 1C|not provided	Uncertain significance(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	11	17548310	11	17526763	91968	97446
NM_006157.4(NELL1):c.1666G>T (p.Gly556Ter)	NELL1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	21555940	11	21534394	161645	171502
GRCh37/hg19 11p14.3(chr11:22646794-22851268)x3	FANCF|GAS2|SVIP	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	11	22646794 - 22851268			221478	223207
NM_000510.2(FSHB):c.-280G>T	FSHB	isolated follicle-stimulating hormone deficiency	association	no assertion criteria provided	11	30252352	11	30230805	139460	143150
NM_001198551.1(WT1):c.506_507insTGTACGGT (p.Ala170Valfs)	WT1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	11	32417909 - 32417910	11	32396363 - 32396364	376013	362892
NM_024426.4(WT1):c.1021A>G (p.Ser341Gly)	WT1	Mesothelioma	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	11	32421571	11	32400025	3499	18538
NM_001198551.1(WT1):c.229_231delTAC (p.Tyr77del)	WT1	Wilms tumor 1	Pathogenic(Last reviewed: Mar 23, 2013)	no assertion criteria provided	11	32449508 - 32449510	11	32427961 - 32427963	438757	432382
NM_024662.2(NAT10):c.2424G>C (p.Leu808=)	NAT10	not provided	Uncertain significance	no assertion criteria provided	11	34161951	11	34140404	92013	97491
NM_000610.3(CD44):c.67+11205G>A	CD44	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	11	35172122	11	35150575	126867	132380
NM_000610.3(CD44):c.67+14128T>C	CD44	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	11	35175045	11	35153498	126868	132381
NM_000610.3(CD44):c.68-18471G>A	CD44	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	11	35179651	11	35158104	126869	132382
NM_000610.3(CD44):c.68-13570A>T	CD44|SNORD164	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	11	35184552	11	35163005	126870	132383
NM_000610.3(CD44):c.68-9931G>A	CD44	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	11	35188191	11	35166644	126871	132384
NM_000610.3(CD44):c.68-6677C>G	CD44	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	11	35191445	11	35169898	126872	132385
NM_000610.3(CD44):c.68-5908G>A	CD44	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	11	35192214	11	35170667	126873	132386
NM_000610.3(CD44):c.68-5843A>G	CD44	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	11	35192279	11	35170732	126874	132387
NM_000610.3(CD44):c.68-5493C>T	CD44	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	11	35192629	11	35171082	126875	132388
NM_000610.3(CD44):c.234-905G>A	CD44	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	11	35200916	11	35179369	126876	132389
NM_000610.3(CD44):c.923-767T>A	CD44	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	11	35221862	11	35200315	126877	132390
NM_000610.3(CD44):c.2024+779A>G	CD44	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	11	35244058	11	35222511	126878	132391
NM_001145265.1(SLC35C1):c.517G>A (p.Asp173Asn)	SLC35C1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	45832347	11	45810796	161533	171504
NM_001205119.1(ATG13):c.1576-1G>C	ATG13	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	46693804	11	46672254	161571	171505
NM_000506.4(F2):c.734delT (p.Leu245Argfs)	F2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	46747583	11	46726033	161469	171506
NM_014756.3(CKAP5):c.721A>G (p.Lys241Glu)	CKAP5	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	46831334	11	46809784	161683	171507
NM_003682.3(MADD):c.3400G>A (p.Ala1134Thr)	MADD	not provided	Uncertain significance	no assertion criteria provided	11	47314132	11	47292581	91953	97431
NM_002843.3(PTPRJ):c.640C>T (p.Arg214Cys)	PTPRJ	Carcinoma of colon	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	11	48145188	11	48123636	8689	23728
NM_002843.3(PTPRJ):c.827A>C (p.Gln276Pro)	PTPRJ	Carcinoma of colon	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	11	48145375	11	48123823	8690	23729
NM_001005270.4(OR4C12):c.74C>T (p.Thr25Met)	OR4C12	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	50003964	11	49982428	161484	171508
NM_001004738.2(OR5L1):c.494G>T (p.Arg165Met)	OR5L1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	55579436	11	55811960	161482	171509
NM_001005202.1(OR8K3):c.700C>A (p.Gln234Lys)	OR8K3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	56086482	11	56319006	161483	171510
NM_000062.2(SERPING1):c.51G>A (p.Gly17=)	SERPING1	not provided	not provided	no assertion provided	11	57365794	11	57598321	92195	97585
NM_000062.2(SERPING1):c.685+88G>A	SERPING1	not provided	not provided	no assertion provided	11	57369730	11	57602257	92196	97586
NM_000062.2(SERPING1):c.686-9T>C	SERPING1	not provided|Hereditary Angioedema	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	57373474	11	57606001	92194	97584
NM_001005211.1(OR9I1):c.218A>G (p.Tyr73Cys)	OR9I1|OR9Q1	not provided	Uncertain significance	no assertion criteria provided	11	57886699	11	58119227	91923	97401
NM_001004459.1(OR1S2):c.502A>G (p.Ile168Val)	OR1S2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	57971152	11	58203680	161479	171512
NM_001004706.1(OR4D11):c.575C>A (p.Thr192Asn)	OR4D11	not provided	Uncertain significance	no assertion criteria provided	11	59271623	11	59504150	91922	97400
NM_001142565.1(CPSF7):c.523+1_523+2insT	CPSF7	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	61187419	11	61419947	161527	171513
NM_013279.3(MYRF):c.1229C>T (p.Thr410Met)	MYRF	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	61541579	11	61774107	161665	171514
NM_001290048.1(ATL3):c.1146G>T (p.Lys382Asn)	ATL3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	63398851	11	63631379	219308	220997
GRCh37/hg19 11q13.1(chr11:63995089-64012419)x3	FKBP2|DNAJC4|VEGFB|PPP1R14B|NUDT22	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	11	63995089 - 64012419			221479	223208
NM_000244.3(MEN1):c.1762T>G (p.Ser588Ala)	MEN1	not provided	Uncertain significance	no assertion criteria provided	11	64571892	11	64804420	100804	106664
NM_000244.3(MEN1):c.1669A>T (p.Thr557Ser)	MEN1	Adenoma of the adrenal gland|Adrenal adenoma, somatic	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	11	64571985	11	64804513	16698	31737
NM_130799.2(MEN1):c.1579C>T (p.Arg527Ter)	MEN1	Multiple endocrine neoplasia, type 1|not provided|Hereditary cancer-predisposing syndrome|Metastatic pancreatic neuroendocrine tumours	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	11	64572060	11	64804588	16688	31727
NM_000244.3(MEN1):c.1089_1090delGGinsAA (p.Glu364Lys)	MEN1	Angiofibroma, somatic	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	11	64573217 - 64573218	11	64805745 - 64805746	16695	31734
NM_130799.2(MEN1):c.981_1006del26 (p.Tyr327Terfs)	MEN1	Metastatic pancreatic neuroendocrine tumours	Likely pathogenic(Last reviewed: Nov 1, 2017)	no assertion criteria provided	11	64573747 - 64573772	11	64806275 - 64806300	446279	439685
NM_130799.2(MEN1):c.783+1G>A	MEN1	Multiple endocrine neoplasia, type 1|not specified|Hereditary cancer-predisposing syndrome|Metastatic pancreatic neuroendocrine tumours	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	11	64575023	11	64807551	428081	419830
NM_000244.3(MEN1):c.711dup (p.Lys238Glnfs)	MEN1	Ependymoma	Pathogenic(Last reviewed: Dec 29, 2017)	no assertion criteria provided	11	64575111	11	64807639	487778	480785
NM_000244.3(MEN1):c.403A>T (p.Lys135Ter)	MEN1	Angiofibroma, somatic	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	11	64577179	11	64809707	16694	31733
NM_130799.2(MEN1):c.245_259delACCTGTCTATCATCG (p.Asp82_Ile86del)	MEN1	Metastatic pancreatic neuroendocrine tumours	Likely pathogenic(Last reviewed: Nov 1, 2017)	no assertion criteria provided	11	64577323 - 64577337	11	64809851 - 64809865	446273	439679
NM_130799.2(MEN1):c.249_252delGTCT (p.Ile85Serfs)	MEN1	Multiple endocrine neoplasia, type 1|Lipoma, somatic|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	11	64577330 - 64577333	11	64809858 - 64809861	16693	31732
NM_130799.2(MEN1):c.152delA (p.Asn51Thrfs)	MEN1	Primary hyperparathyroidism	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	11	64577430	11	64809958	217128	213769
NM_130799.2(MEN1):c.76G>A (p.Glu26Lys)	MEN1	Parathyroid adenoma, somatic|not provided	Likely pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	11	64577506	11	64810034	16689	31728
NM_182710.2(KAT5):c.638T>G (p.Val213Gly)	KAT5	Familial colorectal cancer	not provided	no assertion provided	11	65481267	11	65713796	55934	70573
NM_006842.2(SF3B2):c.1997A>C (p.His666Pro)	SF3B2	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Neoplasm of the breast|Hepatocellular carcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	11	65830499	11	66063028	376531	363410
NM_006842.2(SF3B2):c.2099A>G (p.Glu700Gly)	SF3B2	Chronic lymphocytic leukemia|Medulloblastoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Myelodysplastic syndrome|Neoplasm of the breast|Pancreatic adenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	11	65830884	11	66063413	376533	363412
NM_207354.2(ANKRD13D):c.251G>T (p.Gly84Val)	ANKRD13D	not provided	Uncertain significance	no assertion criteria provided	11	67057817	11	67290346	92041	97519
NM_000852.3(GSTP1):c.313A>G (p.Ile105Val)	GSTP1	Neoplasm of the large intestine|cyclophosphamide and epirubicin response - Efficacy, Toxicity/ADR|fluorouracil and oxaliplatin response - Efficacy|cisplatin response - Toxicity/ADR|Platinum compounds response - Toxicity/ADR|Colorectal Neoplasms	drug response(Last reviewed: May 3, 2017)	reviewed by expert panel	11	67352689	11	67585218	37340	37785
NM_003369.3(UVRAG):c.500A>G (p.Glu167Gly)	UVRAG	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	75599940	11	75888896	219329	221018
NM_015885.3(PCF11):c.3223delT (p.Phe1075Leufs)	PCF11	Acute megakaryoblastic leukemia|Mediastinal germ cell tumor	Uncertain significance(Last reviewed: Oct 22, 2015)	no assertion criteria provided	11	82880600	11	83169558	218347	215051
NM_012193.3(FZD4):c.362G>T (p.Cys121Phe)	FZD4|PRSS23	not provided	Uncertain significance	no assertion criteria provided	11	86663436	11	86952394	91975	97453
NM_000372.4(TYR):c.-9_-7delAGAinsGG	TYR	not provided	not provided	no assertion provided	11	88911113 - 88911115	11	89177945 - 89177947	127112	132621
GRCh37/hg19 11q21(chr11:94696615-95528715)x3	CEP57|SRSF8|ENDOD1|CWC15|KDM4D|FAM76B|SESN3|KDM4E	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	11	94696615 - 95528715			221480	223209
NM_001161630.1(KDM4E):c.1493A>G (p.Asn498Ser)	KDM4E	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	11	94760214	11	95027050	221305	223034
NM_004621.5(TRPC6):c.*86C>T	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101323600	11	101452869	236151	237717
NM_004621.5(TRPC6):c.2645-8T>C	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101323845	11	101453114	236152	237718
NM_004621.5(TRPC6):c.2644+78G>T	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101324303	11	101453572	236153	237719
NM_004621.5(TRPC6):c.2644+29C>T	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101324352	11	101453621	236154	237720
NM_004621.5(TRPC6):c.2644+27C>G	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101324354	11	101453623	236155	237721
NM_004621.5(TRPC6):c.2485-14T>C	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101325846	11	101455115	236156	237722
NM_004621.5(TRPC6):c.2485-44A>G	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101325876	11	101455145	236157	237723
NM_004621.5(TRPC6):c.2460A>G (p.Ser820=)	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101340182	11	101469451	236158	237724
NM_004621.5(TRPC6):c.2455C>T (p.Leu819Phe)	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101340187	11	101469456	236159	237725
NM_004621.5(TRPC6):c.2435T>C (p.Ile812Thr)	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101340207	11	101469476	236160	237726
NM_004621.5(TRPC6):c.2410-22T>C	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101340254	11	101469523	236161	237727
NM_004621.5(TRPC6):c.2142G>T (p.Thr714=)	TRPC6	not specified|Focal segmental glomerulosclerosis|Prednisolone response	Benign/Likely benign, drug response(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	101342931	11	101472200	236162	237728
NM_004621.5(TRPC6):c.2022T>C (p.Ser674=)	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101343051	11	101472320	236163	237729
NM_004621.5(TRPC6):c.2010-31T>C	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101343094	11	101472363	236164	237730
NM_004621.5(TRPC6):c.2010-67A>T	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101343130	11	101472399	236165	237731
NM_004621.5(TRPC6):c.1766C>G (p.Ser589Cys)	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101344483	11	101473752	236166	237732
NM_004621.5(TRPC6):c.1745-50T>A	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101344554	11	101473823	236167	237733
NM_004621.5(TRPC6):c.1533A>G (p.Lys511=)	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101347243	11	101476512	236168	237734
NM_004621.5(TRPC6):c.1510+24T>C	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101353656	11	101482925	236169	237735
NM_004621.5(TRPC6):c.1440A>G (p.Ala480=)	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101353750	11	101483019	236170	237736
NM_004621.5(TRPC6):c.1294-23T>A	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101353919	11	101483188	236171	237737
NM_004621.5(TRPC6):c.1294-53T>C	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101353949	11	101483218	236172	237738
NM_004621.5(TRPC6):c.1293+54G>T	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101359614	11	101488883	236173	237739
NM_004621.5(TRPC6):c.1293+48T>C	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101359620	11	101488889	236174	237740
NM_004621.5(TRPC6):c.1293+45T>C	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101359623	11	101488892	236175	237741
NM_004621.5(TRPC6):c.946-8T>C	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101362477	11	101491746	236176	237742
NM_004621.5(TRPC6):c.945+175A>T	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101374580	11	101503849	236177	237743
NM_004621.5(TRPC6):c.945+174C>T	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101374581	11	101503850	236178	237744
NM_004621.5(TRPC6):c.539T>C (p.Ile180Thr)	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101375161	11	101504430	236179	237745
NM_004621.5(TRPC6):c.455T>C (p.Leu152Pro)	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101375245	11	101504514	236180	237746
NM_004621.5(TRPC6):c.419C>A (p.Ala140Glu)	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101375281	11	101504550	236181	237747
NM_004621.5(TRPC6):c.171-68G>A	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101375597	11	101504866	236182	237748
NM_004621.5(TRPC6):c.171-69T>C	TRPC6	Prednisolone response	drug response(Last reviewed: Jan 18, 2016)	no assertion criteria provided	11	101375598	11	101504867	236183	237749
NM_000051.3(ATM):c.3118A>G (p.Met1040Val)	ATM	Ataxia-telangiectasia syndrome|B-cell non-Hodgkin lymphoma|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 6, 2018)	criteria provided, conflicting interpretations	11	108143299	11	108272572	3027	18066
NM_000051.3(ATM):c.4081C>T (p.Gln1361Ter)	ATM	Ataxia-telangiectasia syndrome|Mantle cell lymphoma	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	11	108158414	11	108287687	3041	18080
NM_000051.3(ATM):c.5044G>C (p.Asp1682His)	ATM	T-cell prolymphocytic leukemia	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	11	108170479	11	108299752	3026	18065
NM_000051.3(ATM):c.5309C>G (p.Ser1770Ter)	ATM	T-cell prolymphocytic leukemia	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	11	108172506	11	108301779	3042	18081
NM_000051.3(ATM):c.7088delA (p.Lys2363Argfs)	ATM|C11orf65	Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	11	108198484	11	108327757	230341	234306
NM_000051.3(ATM):c.7271T>G (p.Val2424Gly)	ATM|C11orf65	Familial cancer of breast|Ataxia-telangiectasia syndrome|Ataxia-telangiectasia variant|Breast cancer, susceptibility to|T-cell prolymphocytic leukemia|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	11	108199929	11	108329202	3023	18062
NM_000051.3(ATM):c.7638_7646delTAGAATTTC (p.Arg2547_Ser2549del)	ATM|C11orf65	Familial cancer of breast|Ataxia-telangiectasia syndrome|Ataxia-telangiectasia, complementation group E|T-cell prolymphocytic leukemia|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	11	108202614 - 108202622	11	108331887 - 108331895	3019	18058
NM_000051.3(ATM):c.8623A>C (p.Asn2875His)	ATM|C11orf65	Prostate neoplasm	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	11	108218044	11	108347317	376353	363232
NM_020809.3(ARHGAP20):c.464T>C (p.Val155Ala)	ARHGAP20	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	110494925	11	110624201	161737	171495
GRCh37/hg19 11q23.1(chr11:111735939-111784393)x3	CRYAB|HSPB2|C11orf1|ALG9|FDXACB1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	11	111735939 - 111784393			221481	223210
NM_181699.2(PPP2R1B):c.269G>A (p.Gly90Asp)	PPP2R1B	Lung cancer	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	11	111635566	11	111764842	6621	21660
GRCh37/hg19 11q23.1(chr11:111789713-111857622)x4	DIXDC1|C11orf52	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	11	111789713 - 111857622			221482	223211
NM_001931.4(DLAT):c.1339T>C (p.Tyr447His)	DLAT	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	111916635	11	112045911	161587	171496
NM_003002.3(SDHD):c.1A>G (p.Met1Val)	SDHD	Pheochromocytoma|Paragangliomas 1|Chemodectoma	Pathogenic(Last reviewed: May 20, 2016)	criteria provided, single submitter	11	111957632	11	112086908	6911	21950
NM_003002.3(SDHD):c.242C>T (p.Pro81Leu)	SDHD	Paraganglioma and gastric stromal sarcoma|Pheochromocytoma|Paragangliomas 1|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Paragangliomas 1 with sensorineural hearing loss|not provided|Cowden syndrome 3|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	11	111959663	11	112088939	6896	21935
NM_003002.3(SDHD):c.298delA (p.Thr100Leufs)	SDHD	Paragangliomas 1	Likely pathogenic	no assertion criteria provided	11	111959719	11	112088995	425555	413896
NM_020886.3(USP28):c.571C>T (p.Leu191Phe)	USP28	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	113705021	11	113834299	161740	171497
NM_020693.3(DSCAML1):c.2321A>G (p.Asp774Gly)	DSCAML1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	117375680	11	117504965	161735	171498
t(11;17)(q23;q25)	KMT2A|SEPT9	Acute megakaryoblastic leukemia	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided			11	118482092 - 118482093	590282	581224
NM_198489.2(CCDC84):c.815A>G (p.Gln272Arg)	CCDC84	not provided	Uncertain significance	no assertion criteria provided	11	118886026	11	119015316	92038	97516
NM_022169.4(ABCG4):c.237G>T (p.Arg79Ser)	ABCG4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	119020912	11	119150202	161759	171499
NM_005188.3(CBL):c.1111T>C (p.Tyr371His)	CBL	Noonan syndrome-like disorder with juvenile myelomonocytic leukemia|not provided|Hematologic neoplasm|Rasopathy	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	11	119148891	11	119278181	13811	28850
NM_005188.3(CBL):c.1150T>C (p.Cys384Arg)	CBL	Noonan syndrome-like disorder with juvenile myelomonocytic leukemia|Hematologic neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	11	119148930	11	119278220	29822	38777
NM_005188.3(CBL):c.1228-2A>G	CBL	Malignant germ cell tumor of ovary|Juvenile myelomonocytic leukemia|Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia|not provided|Rasopathy	Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2018)	criteria provided, conflicting interpretations	11	119149218	11	119278508	177959	175345
GRCh37/hg19 11q23.3(chr11:120169037-120308055)x3	ARHGEF12|POU2F3|TMEM136	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	11	120169037 - 120308055			221483	223212
NM_005422.2(TECTA):c.2925G>T (p.Arg975=)	TECTA	not provided	Uncertain significance	no assertion criteria provided	11	121000904	11	121130195	91965	97443
GRCh37/hg19 11q24.2(chr11:124824717-124951727)x3	CCDC15|SLC37A2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	11	124824717 - 124951727			221484	223213
NM_025004.2(CCDC15):c.901-1G>C	CCDC15	not provided	Uncertain significance	no assertion criteria provided	11	124857022	11	124987126	92014	97492
NM_020108.4(ACRV1):c.413C>T (p.Thr138Ile)	ACRV1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	125546304	11	125676409	161729	171500
NM_153765.2(KCNJ1):c.1145A>T (p.Asn382Ile)	KCNJ1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	11	128709045	11	128839150	161825	171501
NM_000890.3(KCNJ5):c.451G>C (p.Gly151Arg)	KCNJ5	not provided	Likely pathogenic	no assertion criteria provided	11	128781619	11	128911724	91916	97394
NM_000890.3(KCNJ5):c.451G>A (p.Gly151Arg)	KCNJ5	Familial hyperaldosteronism type 3|not provided|Aldosterone-producing adrenal adenoma, somatic	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2012)	no assertion criteria provided	11	128781619	11	128911724	91915	97393
NM_000890.4(KCNJ5):c.472A>G (p.Thr158Ala)	KCNJ5	Andersen Tawil syndrome|Familial hyperaldosteronism type 3|Aldosterone-producing adrenal adenoma, somatic	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	11	128781640	11	128911745	30125	39081
NM_000890.3(KCNJ5):c.503T>G (p.Leu168Arg)	KCNJ5	not provided	Likely pathogenic	no assertion criteria provided	11	128781671	11	128911776	91917	97395
NM_001142685.1(ARHGAP32):c.4703C>G (p.Thr1568Ser)	ARHGAP32	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	11	128840363	11	128970468	487793	480800
NM_001012393.2(OPCML):c.263C>G (p.Pro88Arg)	OPCML	Neoplasm of ovary	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	11	132527098	11	132657203	8983	24022
NM_000719.6(CACNA1C):c.5143C>T (p.Arg1715Trp)	CACNA1C|CACNA1C-AS1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	2788661	12	2679495	221325	223054
GRCh37/hg19 12p13.32(chr12:4627993-4665594)x3	RAD51AP1|C12orf4	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	4627993 - 4665594			221485	223214
GRCh38/hg38 12p13.32-13.31(chr12:4772521-5854093)x1	KCNA1|KCNA5|KCNA6|NTF3|GALNT8|ANO2|LINC02443|LOC107436002|LOC107832854|LOC108178986|LOC108178987	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	4881687 - 5963259	12	4772521 - 5854093	221486	223215
chr12:4920767-5603935 complex variant	KCNA1|KCNA5|KCNA6|NTF3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	4920767 - 5603935			221368	223097
NM_001038.5(SCNN1A):c.1129A>G (p.Ile377Val)	SCNN1A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	6464452	12	6355286	161503	171529
NM_001127585.1(ING4):c.254C>A (p.Ala85Asp)	ING4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	6762167	12	6653001	161520	171530
NM_004054.3(C3AR1):c.1148T>C (p.Val383Ala)	C3AR1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	8211634	12	8059038	161619	171532
chr12:10074776-18800953 complex variant	ARHGDIB|ART4|CDKN1B|CREBL2|EMP1|EPS8|ETV6|GPR19|GRIN2B|GUCY2C|KLRC1|KLRC2|KLRC3|KLRD1|LRP6|MGP|MGST1|OLR1|PDE6H|PIK3C2G|PRB1|PRB3|PRB4|PRH1|PRH2|PTPRO|KLRC4|YBX3|GPRC5A|STRAP|PRR4|KLRK1|GABARAPL1|TAS2R9|TAS2R8|TAS2R7|TAS2R13|TAS2R10|TAS2R14|HEBP1|DERA|DDX47|CLEC1B|CLEC1A|WBP11|MANSC1|MAGOHB|STYK1|GPRC5D|ATF7IP|H2AFJ|LMO3|FAM234B|CLEC7A|BCL2L14|RERGL|PLBD1|DUSP16|APOLD1|GSG1|RERG|BORCS5|TMEM52B|HIST4H4|ERP27|C12orf60|CLEC12A|TAS2R43|TAS2R31|TAS2R46|TAS2R30|TAS2R19|TAS2R20|TAS2R50|CLEC9A|TAS2R42|CLEC2A|CLEC12B|SMCO3|PRB2|SLC15A5	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	10074776 - 18800953			221369	223098
NM_176889.3(TAS2R20):c.254C>G (p.Ser85Cys)	PRH1|TAS2R20|PRH1-PRR4|PRH1-TAS2R14	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	11150221	12	10997622	161835	171517
NM_001987.4(ETV6):c.226G>T (p.Glu76Ter)	ETV6	Acute myeloid leukemia	Pathogenic(Last reviewed: Jun 9, 2005)	no assertion criteria provided	12	11992136	12	11839202	8984	24023
NM_001987.4(ETV6):c.1307_1308insGGG (p.His436delinsGlnGly)	ETV6	Acute myeloid leukemia	Pathogenic(Last reviewed: Jun 9, 2005)	no assertion criteria provided	12	12043928 - 12043929	12	11890994 - 11890995	8985	24024
NM_002336.2(LRP6):c.3241C>G (p.Pro1081Ala)	LRP6	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	12300456	12	12147522	161594	171518
GRCh38/hg38 12p13.2(chr12:12198797-12200966)x1	LRP6	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	9906131 - 19671632	12	12198797 - 12200966	221487	223216
GRCh37/hg19 12p13.2-13.1(chr12:12419642-13256423)x3	CDKN1B|CREBL2|GPR19|LRP6|GPRC5A|HEBP1|DDX47|MANSC1|GPRC5D|FAM234B|DUSP16|APOLD1|GSG1|BORCS5	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	12419642 - 13256423			221389	223118
NM_004064.4(CDKN1B):c.127delCinsTAA (p.Arg43Terfs)	CDKN1B	Neuroendocrine neoplasm	Likely pathogenic(Last reviewed: Sep 5, 2014)	no assertion criteria provided	12	12870900	12	12717966	157518	167379
NM_004064.4(CDKN1B):c.279_280insT (p.Pro94Serfs)	CDKN1B	Neuroendocrine neoplasm	Likely pathogenic(Last reviewed: Sep 5, 2014)	no assertion criteria provided	12	12871052 - 12871053	12	12718118 - 12718119	157519	167380
NM_004064.4(CDKN1B):c.334delA (p.Ser112Alafs)	CDKN1B	Neuroendocrine neoplasm	Likely pathogenic(Last reviewed: Sep 5, 2014)	no assertion criteria provided	12	12871107	12	12718173	157520	167381
NM_024730.3(RERGL):c.415C>A (p.Gln139Lys)	RERGL	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	18234328	12	18081394	161770	171521
NM_000921.4(PDE3A):c.2832G>C (p.Met944Ile)	PDE3A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	20803441	12	20650507	219347	221036
NM_005691.3(ABCC9):c.2663G>T (p.Gly888Val)	ABCC9	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	22005137	12	21852203	221326	223055
NM_004985.4(KRAS):c.437C>T (p.Ala146Val)	KRAS	Non-small cell lung cancer|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	12	25378561	12	25225627	375962	362841
NM_033360.3(KRAS):c.436G>C (p.Ala146Pro)	KRAS	Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	12	25378562	12	25225628	375963	362842
NM_004985.4(KRAS):c.436G>A (p.Ala146Thr)	KRAS	not provided|Neoplasm of the large intestine|Colorectal Neoplasms	Uncertain significance(Last reviewed: Jun 6, 2014)	criteria provided, single submitter	12	25378562	12	25225628	197243	194404
NM_004985.4(KRAS):c.351A>C (p.Lys117Asn)	KRAS	Liver cancer|Malignant melanoma of skin|Multiple myeloma|Hepatocellular carcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	12	25378647	12	25225713	375965	362844
NM_033360.3(KRAS):c.351A>T (p.Lys117Asn)	KRAS	Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	12	25378647	12	25225713	375964	362843
NM_004985.4(KRAS):c.290G>A (p.Arg97Lys)	KRAS	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Aug 28, 2014)	no assertion criteria provided	12	25380168	12	25227234	163761	175713
NM_033360.3(KRAS):c.261delT (p.Lys88Asnfs)	KRAS	not specified	Uncertain significance(Last reviewed: Jul 22, 2011)	criteria provided, single submitter	12	25380197	12	25227263	45120	54287
NM_004985.4(KRAS):c.228G>A (p.Glu76=)	KRAS	not specified	Uncertain significance(Last reviewed: Oct 28, 2006)	criteria provided, single submitter	12	25380230	12	25227296	163762	175853
NM_033360.3(KRAS):c.219G>A (p.Arg73=)	KRAS	Sarcoma	not provided	no assertion provided	12	25380239	12	25227305	132971	136720
NM_033360.3(KRAS):c.216G>A (p.Met72Ile)	KRAS	Sarcoma	not provided	no assertion provided	12	25380242	12	25227308	132970	136719
NM_004985.4(KRAS):c.183A>C (p.Gln61His)	KRAS	Non-small cell lung cancer|Acute myeloid leukemia|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	12	25380275	12	25227341	177881	175854
NM_033360.3(KRAS):c.183A>T (p.Gln61His)	KRAS	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Non-small cell lung cancer|Squamous cell lung carcinoma|Acute myeloid leukemia|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	12	25380275	12	25227341	45117	54284
NM_004985.4(KRAS):c.182A>C (p.Gln61Pro)	KRAS	Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	12	25380276	12	25227342	375966	362845
NM_033360.3(KRAS):c.182A>T (p.Gln61Leu)	KRAS	Non-small cell lung cancer|Medullary thyroid carcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Nov 2, 2011)	criteria provided, single submitter	12	25380276	12	25227342	45116	54283
NM_033360.3(KRAS):c.182A>G (p.Gln61Arg)	KRAS	Non-small cell lung cancer|Noonan syndrome|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Nov 4, 2009)	criteria provided, single submitter	12	25380276	12	25227342	45115	54282
NM_033360.3(KRAS):c.181C>G (p.Gln61Glu)	KRAS	Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	12	25380277	12	25227343	376324	363203
NM_004985.4(KRAS):c.181C>A (p.Gln61Lys)	KRAS	Non-small cell lung cancer|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Aug 28, 2014)	criteria provided, single submitter	12	25380277	12	25227343	177777	175715
NM_033360.3(KRAS):c.180T>A (p.Gly60=)	KRAS	not specified	Uncertain significance(Last reviewed: Dec 3, 2008)	no assertion criteria provided	12	25380278	12	25227344	45114	54281
NM_004985.4(KRAS):c.179G>T (p.Gly60Val)	KRAS	Non-small cell lung cancer|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, multiple submitters, no conflicts	12	25380279	12	25227345	163766	175855
NM_033360.3(KRAS):c.176C>T (p.Ala59Val)	KRAS	Familial cancer of breast	not provided	no assertion provided	12	25380282	12	25227348	132969	136718
NM_033360.3(KRAS):c.175G>A (p.Ala59Thr)	KRAS	Bladder cancer, transitional cell, somatic|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	12	25380283	12	25227349	12581	27620
NM_004985.4(KRAS):c.112-9C>T	KRAS	not specified	Uncertain significance(Last reviewed: Jan 12, 2007)	no assertion criteria provided	12	25380355	12	25227421	177714	175856
NM_004985.4(KRAS):c.64C>A (p.Gln22Lys)	KRAS	Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	12	25398255	12	25245321	376325	363204
NM_004985.4(KRAS):c.57G>T (p.Leu19Phe)	KRAS	Angiosarcoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	12	25398262	12	25245328	376034	362913
NM_004985.4(KRAS):c.57G>C (p.Leu19Phe)	KRAS	Oculoectodermal syndrome|Angiosarcoma	Conflicting interpretations of pathogenicity(Last reviewed: Jul 14, 2015)	no assertion criteria provided	12	25398262	12	25245328	217822	214479
NM_004985.4(KRAS):c.40G>A (p.Val14Ile)	KRAS	Endometrial carcinoma|Noonan syndrome 3|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	25398279	12	25245345	12589	27628
NM_004985.4(KRAS):c.39C>A (p.Gly13=)	KRAS	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	12	25398280	12	25245346	163769	175857
NM_033360.3(KRAS):c.39C>T (p.Gly13=)	KRAS	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Oct 12, 2011)	criteria provided, single submitter	12	25398280	12	25245346	45125	54292
NM_033360.3(KRAS):c.38G>C (p.Gly13Ala)	KRAS	Non-small cell lung cancer|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	12	25398281	12	25245347	375967	362846
NM_033360.3(KRAS):c.38G>T (p.Gly13Val)	KRAS	Non-small cell lung cancer|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland|cetuximab response - Dosage|panitumumab response - Dosage	drug response(Last reviewed: Nov 23, 2016)	reviewed by expert panel	12	25398281	12	25245347	45124	54291
NM_033360.3(KRAS):c.38G>A (p.Gly13Asp)	KRAS	Juvenile myelomonocytic leukemia|Non-small cell lung cancer|Breast cancer, somatic|RAS-associated autoimmune leukoproliferative disorder|Acute myeloid leukemia|Breast adenocarcinoma|Neoplasm of the large intestine|Ovarian Neoplasms|Colorectal Neoplasms|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Nov 2, 2011)	criteria provided, single submitter	12	25398281	12	25245347	12580	27619
NM_033360.3(KRAS):c.37G>A (p.Gly13Ser)	KRAS	Non-small cell lung cancer|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	12	25398282	12	25245348	375968	362847
NM_004985.4(KRAS):c.37G>T (p.Gly13Cys)	KRAS	Non-small cell lung cancer|RAS-associated autoimmune leukoproliferative disorder|not provided|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	12	25398282	12	25245348	45123	54290
NM_033360.3(KRAS):c.37G>C (p.Gly13Arg)	KRAS	Non-small cell lung cancer|Pilocytic astrocytoma, somatic|Pilocytic astrocytoma|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Apr 15, 2011)	criteria provided, single submitter	12	25398282	12	25245348	12593	27632
NM_033360.3(KRAS):c.35G>C (p.Gly12Ala)	KRAS	Gastrointestinal stroma tumor|Lung adenocarcinoma|Non-small cell lung cancer|Neoplasm of the large intestine|Ovarian Neoplasms|Colorectal Neoplasms	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	12	25398284	12	25245350	45122	54289
NM_004985.4(KRAS):c.35G>T (p.Gly12Val)	KRAS	Cerebral arteriovenous malformation|Juvenile myelomonocytic leukemia|Carcinoma of pancreas|Non-small cell lung cancer|Acute myeloid leukemia|Nevus sebaceous|NEVUS SEBACEOUS, SOMATIC|not provided|Nevus sebaceous|Neoplasm of the large intestine|Ovarian Neoplasms|Colorectal Neoplasms|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	12	25398284	12	25245350	12583	27622
NM_004985.4(KRAS):c.35G>A (p.Gly12Asp)	KRAS	Lung cancer|Epidermal nevus syndrome|Cerebral arteriovenous malformation|Juvenile myelomonocytic leukemia|Epidermal nevus|Neoplasm of ovary|Carcinoma of pancreas|Non-small cell lung cancer|RAS-associated autoimmune leukoproliferative disorder|Acute myeloid leukemia|Neoplasm of stomach|Nevus sebaceous|NEVUS SEBACEOUS, SOMATIC|not provided|Rasopathy|Nevus sebaceous|Neoplasm of the large intestine|Ovarian Neoplasms|Colorectal Neoplasms|Neoplasm of the thyroid gland|Vascular Tumors Including Pyogenic Granuloma	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	12	25398284	12	25245350	12582	27621
NM_033360.3(KRAS):c.34G>A (p.Gly12Ser)	KRAS	Juvenile myelomonocytic leukemia|Neoplasm of ovary|Non-small cell lung cancer|Neoplasm of stomach|Neoplasm of the large intestine|Colorectal Neoplasms|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Sep 2, 2011)	criteria provided, single submitter	12	25398285	12	25245351	12584	27623
NM_033360.3(KRAS):c.34G>C (p.Gly12Arg)	KRAS	Bladder cancer, somatic|Non-small cell lung cancer|Squamous cell lung carcinoma|Neoplasm of the large intestine|Ovarian Neoplasms|Colorectal Neoplasms|Neoplasm of the thyroid gland|Adenoid cystic carcinoma	Pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	12	25398285	12	25245351	12579	27618
NM_033360.3(KRAS):c.34G>T (p.Gly12Cys)	KRAS	Endometrial carcinoma|Lung cancer|Lung adenocarcinoma|Non-small cell lung cancer|Neoplasm of the large intestine|Ovarian Neoplasms|Colorectal Neoplasms|Neoplasm of the thyroid gland	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	12	25398285	12	25245351	12578	27617
NM_033360.3(KRAS):c.33T>C (p.Ala11=)	KRAS	not specified	Likely benign(Last reviewed: Nov 1, 2011)	criteria provided, single submitter	12	25398286	12	25245352	45121	54288
NM_004985.4(KRAS):c.27_29dupTGG (p.Gly10_Ala11insGly)	KRAS	Acute myeloid leukemia	Pathogenic(Last reviewed: Dec 20, 1996)	no assertion criteria provided	12	25398290 - 25398292	12	25245356 - 25245358	12585	27624
NM_004985.4(KRAS):c.24A>G (p.Val8=)	KRAS	not specified|Rasopathy	Likely benign(Last reviewed: Apr 18, 2017)	reviewed by expert panel	12	25398295	12	25245361	45119	54286
NM_152641.3(ARID2):c.2989C>T (p.Gln997Ter)	ARID2	Adenoid cystic carcinoma	Likely pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	12	46244895	12	45851112	495130	486684
GRCh37/hg19 12q12-13.11(chr12:46325342-46765019)x3	SCAF11|SLC38A2|SLC38A1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	46325342 - 46765019			221488	223217
NM_000289.5(PFKM):c.2137A>G (p.Met713Val)	PFKM	not provided	Uncertain significance	no assertion criteria provided	12	48539037	12	48145254	91909	97387
NM_003482.3(KMT2D):c.15876G>C (p.Glu5292Asp)	KMT2D	Astrocytoma	Uncertain significance	criteria provided, single submitter	12	49418638	12	49024855	503606	495046
NM_003482.3(KMT2D):c.8506C>T (p.Arg2836Cys)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	49432633	12	49038850	561047	552163
NM_000020.2(ACVRL1):c.100dup (p.Cys34Leufs)	ACVRL1	Osler hemorrhagic telangiectasia syndrome	Likely pathogenic	no assertion criteria provided	12	52306921	12	51913137	444102	437739
NM_000020.2(ACVRL1):c.200G>C (p.Arg67Pro)	ACVRL1	Osler hemorrhagic telangiectasia syndrome	Likely pathogenic	no assertion criteria provided	12	52307021	12	51913237	444100	437740
NM_000020.2(ACVRL1):c.772G>A (p.Gly258Ser)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Osler hemorrhagic telangiectasia syndrome	Uncertain significance(Last reviewed: May 23, 2018)	criteria provided, single submitter	12	52308369	12	51914585	444101	437741
NM_000020.2(ACVRL1):c.1204G>A (p.Gly402Ser)	ACVRL1	Osler hemorrhagic telangiectasia syndrome	Likely pathogenic	no assertion criteria provided	12	52309975	12	51916191	444103	437742
NM_000020.2(ACVRL1):c.1435C>T (p.Arg479Ter)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Osler hemorrhagic telangiectasia syndrome|not specified|not provided	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	12	52314600	12	51920816	372722	360048
NM_020328.3(ACVR1B):c.1282_1286delGATGA (p.Asp428Asnfs)	ACVR1B	Carcinoma of pancreas	Pathogenic(Last reviewed: Mar 13, 2001)	no assertion criteria provided	12	52380624 - 52380628	12	51986840 - 51986844	8227	23266
NM_020328.3(ACVR1B):c.1385-502_1515+24del	ACVR1B	Carcinoma of pancreas	Pathogenic(Last reviewed: Mar 13, 2001)	no assertion criteria provided	12	52385145 - 52385801	12	51991361 - 51992017	8228	23267
NM_033033.3(KRT82):c.630G>C (p.Glu210Asp)	KRT82	not provided	Uncertain significance	no assertion criteria provided	12	52795124	12	52401340	100885	106745
NM_006121.3(KRT1):c.757G>T (p.Asp253Tyr)	KRT1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	53072375	12	52678591	161644	171522
GRCh37/hg19 12q13.13(chr12:53421635-53645669)x3	EIF4B|IGFBP6|ITGB7|RARG|SOAT2|TNS2|CSAD|SPRYD3|MFSD5|ZNF740	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	53421635 - 53645669			221489	223218
NM_014311.2(SMUG1):c.285+5A>T	SMUG1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	54577435	12	54183651	161674	171523
NM_002136.3(HNRNPA1):c.755G>A (p.Ser252Asn)	HNRNPA1	Relapsing remitting multiple sclerosis	Uncertain significance	no assertion criteria provided	12	54677599	12	54283815	135590	139316
NM_002136.3(HNRNPA1):c.775A>G (p.Ser259Gly)	HNRNPA1	Relapsing remitting multiple sclerosis	Uncertain significance	no assertion criteria provided	12	54677619	12	54283835	135591	139317
NM_002136.3(HNRNPA1):c.787T>C (p.Phe263Leu)	HNRNPA1	Chronic progressive multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677631	12	54283847	135592	139318
NM_002136.3(HNRNPA1):c.793A>G (p.Asn265Asp)	HNRNPA1	Chronic progressive multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677637	12	54283853	135593	139319
NM_002136.3(HNRNPA1):c.817T>G (p.Phe273Val)	HNRNPA1	Chronic progressive multiple sclerosis	Pathogenic	no assertion criteria provided	12	54677661	12	54283877	135595	139321
NM_002136.3(HNRNPA1):c.817T>C (p.Phe273Leu)	HNRNPA1	Chronic progressive multiple sclerosis	Pathogenic	no assertion criteria provided	12	54677661	12	54283877	135594	139320
NM_002136.3(HNRNPA1):c.823C>T (p.Pro275Ser)	HNRNPA1	Chronic progressive multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677667	12	54283883	135596	139322
NM_002136.3(HNRNPA1):c.826A>C (p.Met276Leu)	HNRNPA1	Relapsing remitting multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677670	12	54283886	135597	139323
NM_002136.3(HNRNPA1):c.831G>T (p.Lys277Asn)	HNRNPA1	Chronic progressive multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677675	12	54283891	135598	139324
NM_002136.3(HNRNPA1):c.839A>G (p.Asn280Ser)	HNRNPA1	Relapsing remitting multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677683	12	54283899	135599	139325
NM_002136.3(HNRNPA1):c.841T>C (p.Phe281Leu)	HNRNPA1	Chronic progressive multiple sclerosis	Pathogenic	no assertion criteria provided	12	54677685	12	54283901	135600	139326
NM_002136.3(HNRNPA1):c.850A>G (p.Arg284Gly)	HNRNPA1	Chronic progressive multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677694	12	54283910	135601	139327
NM_002136.3(HNRNPA1):c.853A>G (p.Ser285Gly)	HNRNPA1	Chronic progressive multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677697	12	54283913	135602	139328
NM_002136.3(HNRNPA1):c.884A>G (p.Tyr295Cys)	HNRNPA1	Chronic progressive multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677728	12	54283944	135603	139329
NM_002136.3(HNRNPA1):c.886T>C (p.Phe296Leu)	HNRNPA1	Chronic progressive multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677730	12	54283946	135604	139330
NM_002136.3(HNRNPA1):c.896C>T (p.Pro299Leu)	HNRNPA1	Chronic progressive multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677740	12	54283956	135605	139331
NM_002136.3(HNRNPA1):c.898C>T (p.Arg300Ter)	HNRNPA1	Chronic progressive multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677742	12	54283958	135606	139332
NM_002136.3(HNRNPA1):c.901A>G (p.Asn301Asp)	HNRNPA1	Chronic progressive multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677745	12	54283961	135607	139333
NM_002136.3(HNRNPA1):c.902A>G (p.Asn301Ser)	HNRNPA1	Chronic progressive multiple sclerosis	Likely pathogenic	no assertion criteria provided	12	54677746	12	54283962	135608	139334
NM_002136.3(HNRNPA1):c.922T>G (p.Ser308Ala)	HNRNPA1	Chronic progressive multiple sclerosis	Likely benign	no assertion criteria provided	12	54678056	12	54284272	135609	139335
NM_002136.3(HNRNPA1):c.937A>G (p.Ser313Gly)	HNRNPA1	Relapsing remitting multiple sclerosis	Likely benign	no assertion criteria provided	12	54678071	12	54284287	135610	139336
NM_002136.3(HNRNPA1):c.940T>C (p.Tyr314His)	HNRNPA1	Relapsing remitting multiple sclerosis	Likely benign	no assertion criteria provided	12	54678074	12	54284290	135611	139337
NM_002136.3(HNRNPA1):c.941A>G (p.Tyr314Cys)	HNRNPA1	Chronic progressive multiple sclerosis	Likely benign	no assertion criteria provided	12	54678075	12	54284291	135612	139338
NM_002136.3(HNRNPA1):c.950G>A (p.Gly317Asp)	HNRNPA1	Chronic progressive multiple sclerosis	Likely benign	no assertion criteria provided	12	54678084	12	54284300	135613	139339
NM_002136.3(HNRNPA1):c.955A>G (p.Arg319Gly)	HNRNPA1	Relapsing remitting multiple sclerosis	Likely benign	no assertion criteria provided	12	54678089	12	54284305	135614	139340
NM_002136.3(HNRNPA1):c.958T>C (p.Phe320Leu)	HNRNPA1	Chronic progressive multiple sclerosis	Likely benign	no assertion criteria provided	12	54678092	12	54284308	135615	139341
NM_006741.3(PPP1R1A):c.372_373delGTinsCA (p.Glu124_Ser125delinsAspThr)	PPP1R1A	Rosette-forming glioneuronal tumor	Uncertain significance	criteria provided, single submitter	12	54975790 - 54975791	12	54582006 - 54582007	424630	411525
NM_001780.5(CD63):c.486G>A (p.Lys162=)	CD63	not provided	Uncertain significance	no assertion criteria provided	12	56119986	12	55726202	100835	106695
NM_001982.3(ERBB3):c.310G>T (p.Val104Leu)	ERBB3	Neoplasm of the breast|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	12	56478854	12	56085070	376411	363290
NM_001982.3(ERBB3):c.310G>A (p.Val104Met)	ERBB3	Neoplasm of the breast|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	12	56478854	12	56085070	376410	363289
NM_001982.3(ERBB3):c.785C>A (p.Pro262His)	ERBB3	Neoplasm	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	12	56481857	12	56088073	376190	363069
NM_001982.3(ERBB3):c.850G>A (p.Gly284Arg)	ERBB3	Neoplasm of stomach|Neoplasm of the colon	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	12	56481922	12	56088138	376167	363046
NM_001982.3(ERBB3):c.889G>A (p.Asp297Asn)	ERBB3	Neoplasm of the breast|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	12	56482341	12	56088557	376409	363288
NM_001982.3(ERBB3):c.889G>T (p.Asp297Tyr)	ERBB3	Neoplasm of the breast|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	12	56482341	12	56088557	376407	363286
NM_001982.3(ERBB3):c.890A>T (p.Asp297Val)	ERBB3	Neoplasm of the breast|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	12	56482342	12	56088558	376408	363287
NM_001982.3(ERBB3):c.2426A>G (p.Gln809Arg)	ERBB3	Neoplasm	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	12	56490980	12	56097196	376191	363070
NM_001982.3(ERBB3):c.2802G>C (p.Gln934His)	ERBB3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	56492652	12	56098868	161588	171524
NM_003075.4(SMARCC2):c.3577A>C (p.Thr1193Pro)	SMARCC2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	56557541	12	56163757	219351	221040
NM_005419.3(STAT2):c.598C>T (p.Gln200Ter)	STAT2	not provided	Uncertain significance	no assertion criteria provided	12	56748597	12	56354813	91964	97442
NM_005379.3(MYO1A):c.2887G>A (p.Val963Met)	MYO1A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	57423034	12	57029250	161632	171525
NM_003153.4(STAT6):c.278T>G (p.Leu93Arg)	STAT6	not provided	Uncertain significance	no assertion criteria provided	12	57501075	12	57107292	100843	106703
NM_002332.2(LRP1):c.2309G>A (p.Arg770Gln)	LRP1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	57556206	12	57162423	219352	221041
NM_001167609.1(GLI1):c.407G>A (p.Cys136Tyr)	GLI1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	57859034	12	57465251	161547	171526
NM_032496.3(ARHGAP9):c.409C>T (p.Arg137Cys)	ARHGAP9	not provided	Uncertain significance	no assertion criteria provided	12	57872448	12	57478665	92019	97497
NM_004984.3(KIF5A):c.2492C>T (p.Ser831Phe)	KIF5A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	57972079	12	57578296	161628	171527
NM_182947.3(ARHGEF25):c.657-7C>A	ARHGEF25	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	58008107	12	57614324	161847	171528
NM_000075.3(CDK4):c.71G>T (p.Arg24Leu)	CDK4	Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	12	58145430	12	57751647	376377	363256
NM_000075.3(CDK4):c.71G>A (p.Arg24His)	CDK4	Malignant melanoma of skin|Multiple myeloma|Cutaneous malignant melanoma 3|Lung adenocarcinoma|Cutaneous melanoma	Likely pathogenic, risk factor(Last reviewed: May 31, 2016)	no assertion criteria provided	12	58145430	12	57751647	16929	31968
NM_000075.3(CDK4):c.70C>A (p.Arg24Ser)	CDK4	Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	12	58145431	12	57751648	376378	363257
NM_000075.3(CDK4):c.70C>T (p.Arg24Cys)	CDK4	Malignant melanoma of skin|Multiple myeloma|Cutaneous malignant melanoma 3|Lung adenocarcinoma|not provided|Hereditary cutaneous melanoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, multiple submitters, no conflicts	12	58145431	12	57751648	16928	31967
NM_018448.4(CAND1):c.737G>A (p.Gly246Asp)	CAND1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	67691432	12	67297652	161718	171531
NM_004616.2(TSPAN8):c.528T>A (p.Asp176Glu)	TSPAN8	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	71526521	12	71132741	221306	223035
GRCh37/hg19 12q21.2(chr12:76763038-76780400)x4	OSBPL8	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	76763038 - 76780400			221490	223219
GRCh37/hg19 12q21.31(chr12:80927874-81503412)x3	MYF5|MYF6|LIN7A|ACSS3|PTPRQ	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	80927874 - 81503412			221491	223220
NM_032230.2(METTL25):c.208G>A (p.Glu70Lys)	CCDC59|METTL25	not provided	Uncertain significance	no assertion criteria provided	12	82752552	12	82358773	92017	97495
NM_006183.4(NTS):c.185G>A (p.Cys62Tyr)	NTS	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	86272172	12	85878394	221327	223056
NM_025114.3(CEP290):c.1104C>T (p.Thr368=)	CEP290	not provided	Uncertain significance	no assertion criteria provided	12	88519108	12	88125331	100878	106738
NM_021229.3(NTN4):c.823C>T (p.His275Tyr)	NTN4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	96131685	12	95737907	161749	171533
NM_000895.2(LTA4H):c.*640C>A		not provided	not provided	no assertion provided	12	96394127	12	96000349	111275	116957
NM_000895.2(LTA4H):c.-574C>T	LTA4H	not provided	not provided	no assertion provided	12	96429871	12	96036093	120094	125777
GRCh37/hg19 12q23.1(chr12:96422898-98921728)x3	ELK3|LTA4H|CDK17|TMPO|NEDD1|CFAP54|RMST	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	96422898 - 98921728			221492	223221
NM_213594.2(RFX4):c.175C>T (p.Pro59Ser)	RFX4|LOC100287944	not provided	Uncertain significance	no assertion criteria provided	12	107033154	12	106639376	92042	97520
NM_001018072.1(BTBD11):c.148A>G (p.Ser50Gly)	BTBD11	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	107712865	12	107319088	219309	220998
NM_170665.3(ATP2A2):c.131A>G (p.Glu44Gly)	ATP2A2	not provided	Uncertain significance	no assertion criteria provided	12	110720421	12	110282616	92033	97511
NM_005475.2(SH2B3):c.603_607delGCGCT (p.Arg202Glnfs)	SH2B3	Myelofibrosis	Pathogenic(Last reviewed: Aug 12, 2010)	no assertion criteria provided	12	111856552 - 111856556	12	111418748 - 111418752	30444	39401
NM_005475.2(SH2B3):c.622G>T (p.Glu208Ter)	SH2B3	Familial erythrocytosis, 1	Affects(Last reviewed: Sep 16, 2010)	no assertion criteria provided	12	111856571	12	111418767	30446	39403
NM_005475.2(SH2B3):c.622G>C (p.Glu208Gln)	SH2B3	Essential thrombocythemia	Pathogenic(Last reviewed: Aug 12, 2010)	no assertion criteria provided	12	111856571	12	111418767	30445	39402
NM_002834.4(PTPN11):c.181G>T (p.Asp61Tyr)	PTPN11	Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Feb 6, 2015)	criteria provided, single submitter	12	112888165	12	112450361	228392	230257
NM_002834.4(PTPN11):c.214G>A (p.Ala72Thr)	PTPN11	Chronic lymphocytic leukemia|Neuroblastoma|Acute myeloid leukemia|not provided|Rasopathy|Neoplasm of brain	Pathogenic/Likely pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, multiple submitters, no conflicts	12	112888198	12	112450394	177754	175540
NM_002834.4(PTPN11):c.215C>A (p.Ala72Asp)	PTPN11	Chronic lymphocytic leukemia|Neuroblastoma|Acute myeloid leukemia|Neoplasm of brain	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	12	112888199	12	112450395	376511	363390
NM_002834.4(PTPN11):c.215C>T (p.Ala72Val)	PTPN11	Chronic lymphocytic leukemia|Neuroblastoma|Acute myeloid leukemia|not provided|Neoplasm of brain	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2016)	criteria provided, conflicting interpretations	12	112888199	12	112450395	41443	49881
NM_002834.4(PTPN11):c.226G>A (p.Glu76Lys)	PTPN11	Multiple myeloma|Neuroblastoma|Juvenile myelomonocytic leukemia|Squamous cell lung carcinoma|Noonan syndrome|not provided|Rasopathy|Astrocytoma|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Feb 5, 2013)	criteria provided, single submitter	12	112888210	12	112450406	13336	28375
NM_002834.4(PTPN11):c.227A>C (p.Glu76Ala)	PTPN11	Multiple myeloma|Neuroblastoma|Juvenile myelomonocytic leukemia|Squamous cell lung carcinoma|not provided|Astrocytoma|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	12	112888211	12	112450407	13339	28378
NM_002834.4(PTPN11):c.227A>G (p.Glu76Gly)	PTPN11	Multiple myeloma|Neuroblastoma|Juvenile myelomonocytic leukemia|Squamous cell lung carcinoma|not provided|Astrocytoma|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	12	112888211	12	112450407	13338	28377
NM_002834.4(PTPN11):c.227A>T (p.Glu76Val)	PTPN11	Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	12	112888211	12	112450407	13337	28376
NM_002834.4(PTPN11):c.854T>C (p.Phe285Ser)	PTPN11	Noonan syndrome 1|Noonan syndrome|not provided|Rasopathy|Early T cell progenitor acute lymphoblastic leukemia	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	12	112915455	12	112477651	13335	28374
NM_002834.4(PTPN11):c.1508G>T (p.Gly503Val)	PTPN11	Multiple myeloma|Lung adenocarcinoma|Rhabdomyosarcoma embryonal|Squamous cell lung carcinoma|Embryonal rhabdomyosarcoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach	Likely pathogenic, other(Last reviewed: May 31, 2016)	no assertion criteria provided	12	112926888	12	112489084	40560	49030
GRCh37/hg19 12q24.21(chr12:115109877-115120812)x4	TBX3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	115109877 - 115120812			221493	223222
GRCh37/hg19 12q24.21(chr12:116399137-116714901)x3	MED13L	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	12	116399137 - 116714901			221494	223223
NM_016281.3(TAOK3):c.512T>C (p.Met171Thr)	TAOK3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	118673402	12	118235597	219330	221019
NM_000545.6(HNF1A):c.872dupC (p.Gly292Argfs)	HNF1A	Diabetes mellitus type 1|Diabetes mellitus, insulin-dependent, 20|Maturity-onset diabetes of the young, type 3|Hepatic adenomas, familial|not provided|Clear cell carcinoma of kidney	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	12	121432125	12	120994322	14927	29966
NM_014708.4(KNTC1):c.6626C>T (p.Ser2209Leu)	KNTC1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	123110771	12	122626224	219331	221020
NM_001167856.2(SBNO1):c.132+4A>C	SBNO1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	123834853	12	123350306	161548	171519
NM_020382.4(KMT5A):c.290-3C>A	KMT5A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	12	123879591	12	123395044	161732	171520
NM_133448.2(TMEM132D):c.315G>T (p.Val105=)	TMEM132D	not provided	Uncertain significance	no assertion criteria provided	12	130185008	12	129700463	92025	97503
NM_006231.3(POLE):c.1231G>T (p.Val411Leu)	POLE	Glioblastoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	12	133250289	12	132673703	376503	363382
NM_006231.3(POLE):c.1165T>G (p.Phe389Val)	POLE	Anti-PDL1 response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	12	133252045	12	132675459	523176	513783
NM_006231.3(POLE):c.857C>A (p.Pro286His)	POLE	Neoplasm of the breast|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	12	133253184	12	132676598	376502	363381
NM_006231.3(POLE):c.857C>G (p.Pro286Arg)	POLE	Colorectal cancer, susceptibility to, 12|Neoplasm of the breast|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Anti-PDL1 response	Uncertain significance(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	12	133253184	12	132676598	376500	363379
NM_006231.3(POLE):c.856C>T (p.Pro286Ser)	POLE	Neoplasm of the breast|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	12	133253185	12	132676599	376501	363380
GRCh37/hg19 13q12.12-13.2(chr13:24080918-34361992)x1	PARP4|ALOX5AP|ATP12A|BRCA2|CDK8|CDX2|FLT1|FLT3|GPR12|GTF3A|HMGB1|PDX1|MIPEP|PABPC3|UBL3|RNF6|RPL21|SLC7A1|MTMR6|KL|NUP58|FRY|USPL1|N4BP2L2|HSPH1|WASF3|PDS5B|MTUS2|POLR1D|POMP|ATP8A2|TNFRSF19|CENPJ|RNF17|KATNAL1|MEDAG|STARD13|N4BP2L1|RXFP2|TEX26|B3GLCT|AMER2|USP12|MTIF3|GSX1|SPATA13|LNX2|PAN3|SLC46A3|C1QTNF9|RASL11A|C1QTNF9B|SHISA2|PCOTH|URAD|ZAR1L|LINC00543	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	13	24080918 - 34361992			523170	513802
NM_018451.4(CENPJ):c.3725G>A (p.Arg1242Lys)	CENPJ|RNF17	not provided	Uncertain significance	no assertion criteria provided	13	25458200	13	24884062	100872	106732
NM_018451.4(CENPJ):c.669C>A (p.Tyr223Ter)	CENPJ	not provided	Uncertain significance	no assertion criteria provided	13	25484124	13	24909986	92000	97478
NM_005977.3(RNF6):c.731G>A (p.Gly244Asp)	RNF6	Esophageal squamous cell carcinoma, somatic	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	13	26789288	13	26215151	5702	20741
NM_005977.3(RNF6):c.724G>A (p.Ala242Thr)	RNF6	Esophageal squamous cell carcinoma, somatic	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	13	26789295	13	26215158	5701	20740
NM_005977.3(RNF6):c.305G>A (p.Arg102Lys)	RNF6	Esophageal squamous cell carcinoma, somatic	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	13	26789714	13	26215577	5700	20739
NM_004119.2(FLT3):c.2525A>G (p.Tyr842Cys)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	13	28592620	13	28018483	376102	362981
NM_004119.2(FLT3):c.2524T>C (p.Tyr842His)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	13	28592621	13	28018484	376103	362982
NM_004119.2(FLT3):c.2523C>A (p.Asn841Lys)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	13	28592622	13	28018485	376718	363597
NM_004119.2(FLT3):c.2521A>C (p.Asn841His)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	13	28592624	13	28018487	376723	363602
NM_004119.2(FLT3):c.2520_2521insGGATCC (p.Ser840_Asn841insGlySer)	FLT3	Acute myeloid leukemia	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	13	28592624 - 28592625	13	28018487 - 28018488	16271	31310
NM_004119.2(FLT3):c.2516A>G (p.Asp839Gly)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	13	28592629	13	28018492	376014	362893
NM_004119.2(FLT3):c.2506_2508delATC (p.Ile836del)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	13	28592637 - 28592639	13	28018500 - 28018502	376326	363205
NM_004119.2(FLT3):c.2508C>G (p.Ile836Met)	FLT3	Acute myeloid leukemia	Pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	13	28592637	13	28018500	375969	362848
NM_004119.2(FLT3):c.2507T>G (p.Ile836Ser)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	13	28592638	13	28018501	376717	363596
NM_004119.2(FLT3):c.2506A>T (p.Ile836Phe)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	13	28592639	13	28018502	376722	363601
NM_004119.2(FLT3):c.2506A>G (p.Ile836Val)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	13	28592639	13	28018502	376720	363599
NM_004119.2(FLT3):c.2506A>C (p.Ile836Leu)	FLT3	Acute myeloid leukemia	Pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	13	28592639	13	28018502	375970	362849
NM_004119.2(FLT3):c.2505T>A (p.Asp835Glu)	FLT3	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	13	28592640	13	28018503	375972	362851
NM_004119.2(FLT3):c.2505T>G (p.Asp835Glu)	FLT3	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	13	28592640	13	28018503	375971	362850
NM_004119.2(FLT3):c.2503_2505delGAT (p.Asp835del)	FLT3	Acute myeloid leukemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	13	28592640 - 28592642	13	28018503 - 28018505	16277	31316
NM_004119.2(FLT3):c.2503_2504delGAinsTT (p.Asp835Phe)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	13	28592641 - 28592642	13	28018504 - 28018505	376104	362983
NM_004119.2(FLT3):c.2504A>C (p.Asp835Ala)	FLT3	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	13	28592641	13	28018504	375973	362852
NM_004119.2(FLT3):c.2504A>T (p.Asp835Val)	FLT3	Acute lymphoid leukemia|Acute myeloid leukemia	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	13	28592641	13	28018504	16272	31311
NM_004119.2(FLT3):c.2503G>T (p.Asp835Tyr)	FLT3	Acute lymphoid leukemia|Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	13	28592642	13	28018505	16276	31315
NM_004119.2(FLT3):c.2503G>A (p.Asp835Asn)	FLT3	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	13	28592642	13	28018505	16274	31313
NM_004119.2(FLT3):c.2503G>C (p.Asp835His)	FLT3	Acute myeloid leukemia	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	13	28592642	13	28018505	16273	31312
NM_004119.2(FLT3):c.2073T>A (p.Phe691Leu)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	13	28601359	13	28027222	376106	362985
NM_004119.2(FLT3):c.2073T>G (p.Phe691Leu)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	13	28601359	13	28027222	376105	362984
NM_004119.2(FLT3):c.2059A>T (p.Ile687Phe)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	13	28601373	13	28027236	376107	362986
NM_004119.2(FLT3):c.2028C>A (p.Asn676Lys)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	13	28602340	13	28028203	376109	362988
NM_004119.2(FLT3):c.2028C>G (p.Asn676Lys)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	13	28602340	13	28028203	376108	362987
NM_004119.2(FLT3):c.2026A>G (p.Asn676Asp)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	13	28602342	13	28028205	376110	362989
NM_004119.2(FLT3):c.1987A>C (p.Lys663Gln)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	13	28602381	13	28028244	376724	363603
NM_004119.2(FLT3):c.1952A>G (p.Asp651Gly)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	13	28602416	13	28028279	376111	362990
NM_004119.2(FLT3):c.1855G>T (p.Gly619Cys)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	13	28608111	13	28033974	376112	362991
NM_004119.2(FLT3):c.1773_1793dup (p.Tyr597_Glu598insAspValAspPheArgGluTyr)	FLT3	Myelodysplastic syndrome progressed to acute myeloid leukemia	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	13	28608263 - 28608283	13	28034126 - 28034146	219096	216788
NM_004119.2(FLT3):c.1780T>C (p.Phe594Leu)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	13	28608276	13	28034139	376715	363594
NM_004119.2(FLT3):c.1777_1779del (p.Asp593del)	FLT3	Acute lymphoid leukemia	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	13	28608277 - 28608279	13	28034140 - 28034142	16278	31317
NM_004119.2(FLT3):c.1775T>C (p.Val592Ala)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	13	28608281	13	28034144	376721	363600
NM_004119.2(FLT3):c.1772A>G (p.Tyr591Cys)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	13	28608284	13	28034147	376719	363598
NM_004119.2(FLT3):c.1771T>G (p.Tyr591Asp)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	13	28608285	13	28034148	376748	363627
NM_004119.2(FLT3):c.1736T>C (p.Val579Ala)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	13	28608320	13	28034183	376716	363595
NM_004119.2(FLT3):c.1715A>G (p.Tyr572Cys)	FLT3	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	13	28608341	13	28034204	376328	363207
NM_002019.4(FLT1):c.3329G>C (p.Cys1110Ser)	FLT1	Carcinoma of colon	not provided	no assertion provided	13	28891692	13	28317555	183436	181542
NM_002019.4(FLT1):c.3287-16A>C	FLT1	Carcinoma of colon	not provided	no assertion provided	13	28891750	13	28317613	162071	171787
NM_002019.4(FLT1):c.3204T>C (p.Pro1068=)	FLT1	Carcinoma of colon	not provided	no assertion provided	13	28893642	13	28319505	162072	171788
NM_002019.4(FLT1):c.3175-69A>T	FLT1	Carcinoma of colon	not provided	no assertion provided	13	28893740	13	28319603	162073	171789
NM_002019.4(FLT1):c.3042_3043insA (p.Ser1015Ilefs)	FLT1	Carcinoma of colon	not provided	no assertion provided	13	28896407 - 28896408	13	28322270 - 28322271	162074	171790
NM_002019.4(FLT1):c.2901G>A (p.Ala967=)	FLT1	Carcinoma of colon	not provided	no assertion provided	13	28896979	13	28322842	162078	171791
NM_002019.4(FLT1):c.2871A>T (p.Leu957=)	FLT1	Carcinoma of colon	not provided	no assertion provided	13	28897009	13	28322872	162079	171792
NM_002019.4(FLT1):c.2708-29A>C	FLT1	Carcinoma of colon	not provided	no assertion provided	13	28901716	13	28327579	162075	171793
NM_002019.4(FLT1):c.2708-39G>C	FLT1	Carcinoma of colon	not provided	no assertion provided	13	28901726	13	28327589	162076	171794
NM_002019.4(FLT1):c.2654_2655insA (p.Gly886Trpfs)	FLT1	Carcinoma of colon	not provided	no assertion provided	13	28903804 - 28903805	13	28329667 - 28329668	162077	171795
NM_002019.4(FLT1):c.2439_2466del28 (p.Tyr815Glyfs)	FLT1	Carcinoma of colon	Uncertain significance(Last reviewed: Apr 19, 2013)	no assertion criteria provided	13	28913327 - 28913354	13	28339190 - 28339217	204359	200753
NM_001135919.1(SLC46A3):c.1189G>A (p.Val397Ile)	SLC46A3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	13	29278192	13	28704055	161525	171535
GRCh37/hg19 13q12.3-13.1(chr13:32178877-33860144)x0	BRCA2|KL|FRY|N4BP2L2|PDS5B|STARD13|N4BP2L1|RXFP2|ZAR1L	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	13	32178877 - 33860144			377385	364267
NM_000059.3(BRCA2):c.-26G>A	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32890572	13	32316435	125965	131503
NM_000059.3(BRCA2):c.68-7delT	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2017)	criteria provided, conflicting interpretations	13	32893207	13	32319070	52188	66856
NM_000059.3(BRCA2):c.250C>T (p.Gln84Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32893396	13	32319259	51298	65966
NM_000059.3(BRCA2):c.274C>T (p.Gln92Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32893420	13	32319283	37799	46355
NM_000059.3(BRCA2):c.1075G>A (p.Glu359Lys)	BRCA2	Neuroblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	13	32906690	13	32332553	438754	432394
NM_000059.3(BRCA2):c.1190_1197del (p.Gln397Profs)	BRCA2	Neoplasm of the breast	Pathogenic(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	13	32906805 - 32906812	13	32332668 - 32332675	224439	226158
NM_000059.3(BRCA2):c.1261C>T (p.Gln421Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32906876	13	32332739	51092	65760
NM_000059.3(BRCA2):c.1786G>A (p.Asp596Asn)	BRCA2	Neoplasm of the breast	Uncertain significance(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	13	32907401	13	32333264	224458	226163
NM_000059.3(BRCA2):c.1813dupA (p.Ile605Asnfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32907428	13	32333291	37762	46318
NM_000059.3(BRCA2):c.2175dupA (p.Val726Serfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Neoplasm of the breast	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32910667	13	32336530	37776	46332
NM_000059.3(BRCA2):c.2595delA (p.Glu866Lysfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Neoplasm of the breast	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32911087	13	32336950	125988	131526
NM_000059.3(BRCA2):c.2808_2811del (p.Ala938Profs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32911300 - 32911303	13	32337163 - 32337166	9322	24361
NM_000059.3(BRCA2):c.3001del (p.Ser1001Glnfs)	BRCA2	Neoplasm of the breast	Pathogenic(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	13	32911493	13	32337356	224443	226165
NM_000059.3(BRCA2):c.3052A>C (p.Lys1018Gln)	BRCA2	Neoplasm of the breast	Uncertain significance(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	13	32911544	13	32337407	224463	226166
NM_000059.3(BRCA2):c.3109C>T (p.Gln1037Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32911601	13	32337464	37819	46375
NM_000059.3(BRCA2):c.3202delG (p.Val1068Tyrfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32911694	13	32337557	51422	66090
NM_000059.3(BRCA2):c.3396A>G (p.Lys1132=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32911888	13	32337751	126010	131548
NM_000059.3(BRCA2):c.3504G>T (p.Met1168Ile)	BRCA2	Metastatic pancreatic neuroendocrine tumours	Likely pathogenic(Last reviewed: Nov 1, 2017)	no assertion criteria provided	13	32911996	13	32337859	446277	439683
NM_000059.3(BRCA2):c.3639delA (p.Val1214Trpfs)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912131	13	32337994	254520	248955
NM_000059.3(BRCA2):c.4041_4042del (p.Cys1348Tyrfs)	BRCA2	Neoplasm of the breast	Pathogenic(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	13	32912533 - 32912534	13	32338396 - 32338397	224442	226170
NM_000059.3(BRCA2):c.4092_4093delAT (p.Ile1364Metfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912584 - 32912585	13	32338447 - 32338448	37877	46433
NM_000059.3(BRCA2):c.4563_4564delAT (p.Leu1522Glyfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913055 - 32913056	13	32338918 - 32338919	126049	131587
NM_000059.3(BRCA2):c.5218_5223delTTAAGT (p.Leu1740_Ser1741del)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	13	32913710 - 32913715	13	32339573 - 32339578	51824	66492
NM_000059.3(BRCA2):c.5238dupT (p.Asn1747Terfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913730	13	32339593	37954	46510
NM_000059.3(BRCA2):c.5351dupA (p.Asn1784Lysfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913843	13	32339706	37960	46516
NM_000059.3(BRCA2):c.5555T>A (p.Val1852Asp)	BRCA2	Familial cancer of breast	not provided	no assertion provided	13	32914047	13	32339910	127128	132631
NM_000059.3(BRCA2):c.5722_5723delCT (p.Leu1908Argfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32914214 - 32914215	13	32340077 - 32340078	9320	24359
NM_000059.3(BRCA2):c.5771_5774delTTCA (p.Ile1924Argfs)	BRCA2	Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914263 - 32914266	13	32340126 - 32340129	51932	66600
NM_000059.3(BRCA2):c.6098dupT (p.Arg2034Thrfs)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32914590	13	32340453	126089	131627
NM_000059.3(BRCA2):c.6100C>T (p.Arg2034Cys)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32914592	13	32340455	41558	49997
NM_000059.3(BRCA2):c.6256A>G (p.Ile2086Val)	BRCA2	Neoplasm of the breast	Uncertain significance(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	13	32914748	13	32340611	224464	226177
NM_000059.3(BRCA2):c.6841+80_6841+83delTTAA	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32915413 - 32915416	13	32341276 - 32341279	126122	131660
NM_000059.3(BRCA2):c.6952C>T (p.Arg2318Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32920978	13	32346841	38076	46632
NM_000059.3(BRCA2):c.7007G>T (p.Arg2336Leu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	13	32921033	13	32346896	52242	66910
NM_000059.3(BRCA2):c.7469dupT (p.Gln2491Thrfs)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32930598	13	32356461	126137	131675
NM_000059.3(BRCA2):c.7471C>T (p.Gln2491Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32930600	13	32356463	52339	67007
NM_000059.3(BRCA2):c.7672G>C (p.Glu2558Gln)	BRCA2	Neoplasm of the breast	Uncertain significance(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	13	32931933	13	32357796	224472	226182
NM_000059.3(BRCA2):c.7772A>G (p.Asn2591Ser)	BRCA2	Breast-ovarian cancer, familial 2|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	13	32932033	13	32357896	52407	67075
NM_000059.3(BRCA2):c.7806-9T>G	BRCA2	Breast-ovarian cancer, familial 2|not specified	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	13	32936651	13	32362514	52420	67088
NM_000059.3(BRCA2):c.7878G>A (p.Trp2626Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32936732	13	32362595	38124	46680
NM_000059.3(BRCA2):c.7976+1G>A	BRCA2	Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	13	32936831	13	32362694	52452	67120
NM_000059.3(BRCA2):c.8068_8069delGT (p.Val2690Phefs)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32937407 - 32937408	13	32363270 - 32363271	52495	67163
NM_000059.3(BRCA2):c.8208_8209insAG (p.Leu2737Serfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32937547 - 32937548	13	32363410 - 32363411	126169	131707
NM_000059.3(BRCA2):c.8322dupT (p.Met2775Tyrfs)	BRCA2	Breast-ovarian cancer, familial 2|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32937661	13	32363524	38153	46709
NM_000059.3(BRCA2):c.8360G>A (p.Arg2787His)	BRCA2	Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 14, 2018)	criteria provided, conflicting interpretations	13	32944567	13	32370430	38156	46712
NM_000059.3(BRCA2):c.8490G>A (p.Trp2830Ter)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32945095	13	32370958	155722	165476
NM_000059.3(BRCA2):c.8633_8754del122 (p.Glu2878Glyfs)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Feb 20, 2013)	no assertion criteria provided	13	32950807 - 32950928	13	32376670 - 32376791	52645	67313
NM_000059.3(BRCA2):c.9014G>C (p.Arg3005Thr)	BRCA2	Neoplasm of the breast	Uncertain significance(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	13	32953947	13	32379810	224477	226187
NM_000059.3(BRCA2):c.9098_9099insA (p.Gln3034Serfs)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32954031 - 32954032	13	32379894 - 32379895	52747	67415
NM_000059.3(BRCA2):c.10150C>T (p.Arg3384Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Cancer of the pancreas	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2017)	criteria provided, conflicting interpretations	13	32972800	13	32398663	51049	65717
NM_003306.2(TRPC4):c.523C>T (p.Arg175Cys)	TRPC4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	13	38320448	13	37746311	161611	171536
NM_207361.5(FREM2):c.3497G>A (p.Arg1166His)	FREM2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	13	39264978	13	38690841	161860	171537
NM_001002264.3(EPSTI1):c.350C>T (p.Thr117Ile)	EPSTI1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	13	43538257	13	42964121	219332	221021
NM_001127615.2(ENOX1):c.759_765delATCCCCG (p.Ser254Leufs)	ENOX1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	13	43930113 - 43930119	13	43355977 - 43355983	161522	171538
NM_025113.4(RUBCNL):c.1141C>T (p.Arg381Ter)	RUBCNL	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	13	46933745	13	46359610	161772	171539
NM_000321.2(RB1):c.31G>T (p.Ala11Ser)	RB1	Retinoblastoma	Uncertain significance(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48878079	13	48303943	126816	132326
NM_000321.2(RB1):c.78_80delGCC (p.Pro29del)	RB1	Retinoblastoma|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 23, 2017)	criteria provided, conflicting interpretations	13	48878126 - 48878128	13	48303990 - 48303992	410949	399429
NM_000321.2(RB1):c.103C>T (p.Gln35Ter)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48878151	13	48304015	126818	132328
NM_000321.2(RB1):c.113_115delGCCinsCT (p.Gly38Alafs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48878161 - 48878163	13	48304025 - 48304027	126819	132329
NM_000321.2(RB1):c.217delA (p.Arg73Glufs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48881495	13	48307359	126843	132353
NM_000321.2(RB1):c.219_220delAG (p.Arg73Serfs)	RB1	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	13	48881497 - 48881498	13	48307361 - 48307362	126844	132354
NM_000321.2(RB1):c.227_228dup (p.Thr77Terfs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48881505 - 48881506	13	48307369 - 48307370	126845	132355
NM_000321.2(RB1):c.305_306delGT (p.Cys102Tyrfs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48916775 - 48916776	13	48342639 - 48342640	126809	132319
NM_000321.2(RB1):c.409G>T (p.Glu137Ter)	RB1	Retinoblastoma|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	13	48919244	13	48345108	126810	132320
NM_000321.2(RB1):c.438_441delTGCT (p.Asn146Lysfs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48919273 - 48919276	13	48345137 - 48345140	126811	132321
NM_000321.2(RB1):c.446C>G (p.Ser149Ter)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48919281	13	48345145	126812	132322
NM_000321.2(RB1):c.463dup (p.Tyr155Leufs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48919298	13	48345162	126813	132323
NM_000321.2(RB1):c.508G>T (p.Glu170Ter)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48921968	13	48347832	126814	132324
NM_000321.2(RB1):c.596T>A (p.Leu199Ter)	RB1	Retinoblastoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	13	48923148	13	48349012	376329	363208
NM_000321.2(RB1):c.763C>T (p.Arg255Ter)	RB1	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	13	48936995	13	48362859	126820	132330
NM_000321.2(RB1):c.795delA (p.Lys265Asnfs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48937027	13	48362891	126821	132331
NM_000321.2(RB1):c.884dup (p.Asn295Lysfs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48939052	13	48364916	126822	132332
NM_000321.2(RB1):c.937G>T (p.Glu313Ter)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48939105	13	48364969	126823	132333
NM_000321.2(RB1):c.958C>T (p.Arg320Ter)	RB1	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	13	48941648	13	48367512	126824	132334
NM_000321.2(RB1):c.1024delA (p.Thr342Leufs)	RB1	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	13	48941714	13	48367578	126826	132336
NM_000321.2(RB1):c.1049+1G>A	RB1	Retinoblastoma|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Nov 11, 2013)	criteria provided, single submitter	13	48941740	13	48367604	126827	132337
NM_000321.2(RB1):c.1049+1G>T	RB1	Retinoblastoma	Pathogenic(Last reviewed: Dec 21, 1989)	no assertion criteria provided	13	48941740	13	48367604	13075	28114
NM_000321.2(RB1):c.1060_1061delCA (p.Gln354Glufs)	RB1	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	13	48942673 - 48942674	13	48368537 - 48368538	126828	132338
NM_000321.2(RB1):c.1072C>T (p.Arg358Ter)	RB1	Retinoblastoma|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, multiple submitters, no conflicts	13	48942685	13	48368549	13076	28115
NM_000321.2(RB1):c.1107T>C (p.Ile369=)	RB1	Retinoblastoma	Uncertain significance(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48942720	13	48368584	126829	132339
NM_000321.2(RB1):c.1147dup (p.Gln383Profs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48947560	13	48373424	126830	132340
NM_000321.2(RB1):c.1166T>A (p.Leu389Ter)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48947579	13	48373443	126831	132341
NM_000321.2(RB1):c.1215+1G>A	RB1	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, multiple submitters, no conflicts	13	48947629	13	48373493	126832	132342
NM_000321.2(RB1):c.1216-1G>A	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48951053	13	48376917	126833	132343
NM_000321.2(RB1):c.1332+1G>T	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48951171	13	48377035	126835	132345
NM_000321.2(RB1):c.1332+1G>A	RB1	Retinoblastoma	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	13	48951171	13	48377035	126834	132344
NM_000321.2(RB1):c.1346G>T (p.Gly449Val)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48953743	13	48379607	126836	132346
NM_000321.2(RB1):c.1363C>T (p.Arg455Ter)	RB1	Retinoblastoma|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	13	48953760	13	48379624	126837	132347
NM_000321.2(RB1):c.1399C>T (p.Arg467Ter)	RB1	Retinoblastoma|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	13	48954198	13	48380062	92839	98746
NM_000321.2(RB1):c.1456_1457delTT (p.Leu486Ilefs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48954335 - 48954336	13	48380199 - 48380200	126838	132348
NM_000321.2(RB1):c.1654C>T (p.Arg552Ter)	RB1	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 27, 2018)	criteria provided, multiple submitters, no conflicts	13	48955538	13	48381402	126840	132350
NM_000321.2(RB1):c.1666C>T (p.Arg556Ter)	RB1	Retinoblastoma|Retinoblastoma, trilateral|Hereditary cancer-predisposing syndrome|Neoplasm	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	13	48955550	13	48381414	13090	28129
NM_000321.2(RB1):c.1688G>A (p.Trp563Ter)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48955572	13	48381436	126841	132351
NM_000321.2(RB1):c.1695+1G>A	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	48955580	13	48381444	126842	132352
NM_000321.2(RB1):c.1723C>T (p.Gln575Ter)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49027156	13	48453020	126784	132294
NM_000321.2(RB1):c.1735C>T (p.Arg579Ter)	RB1	Retinoblastoma|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, multiple submitters, no conflicts	13	49027168	13	48453032	126785	132295
NM_000321.2(RB1):c.1738G>T (p.Glu580Ter)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49027171	13	48453035	126786	132296
NM_000321.2(RB1):c.1909C>T (p.Gln637Ter)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49030434	13	48456298	126788	132298
NM_000321.2(RB1):c.1925T>A (p.Leu642Ter)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49030450	13	48456314	126789	132299
NM_000321.2(RB1):c.1927A>G (p.Lys643Glu)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49030452	13	48456316	126790	132300
NM_000321.2(RB1):c.1960G>A (p.Val654Met)	RB1	not provided	Conflicting interpretations of pathogenicity	no assertion criteria provided	13	49030485	13	48456349	100808	106668
NM_000321.2(RB1):c.1960+2T>C	RB1	Retinoblastoma	Pathogenic(Last reviewed: Dec 21, 1989)	no assertion criteria provided	13	49030487	13	48456351	13070	28109
NM_000321.2(RB1):c.1960+5G>A	RB1	Retinoblastoma|not provided	Likely pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	13	49030490	13	48456354	126791	132301
NM_000321.2(RB1):c.1961-2A>T	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49033822	13	48459686	126792	132302
NM_000321.2(RB1):c.1973C>A (p.Ala658Asp)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49033836	13	48459700	126793	132303
NM_000321.2(RB1):c.1981C>T (p.Arg661Trp)	RB1	Retinoblastoma|Hereditary cancer-predisposing syndrome|Vulvar adenocarcinoma of mammary gland type	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, multiple submitters, no conflicts	13	49033844	13	48459708	13087	28126
NM_000321.2(RB1):c.1994T>G (p.Leu665Arg)	RB1	not provided	Likely pathogenic	no assertion criteria provided	13	49033857	13	48459721	100809	106669
NM_000321.2(RB1):c.2101G>A (p.Asp701Asn)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49033964	13	48459828	126794	132304
NM_000321.2(RB1):c.2107-1G>C	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49037866	13	48463730	126795	132305
NM_000321.2(RB1):c.2117G>T (p.Cys706Phe)	RB1	Small cell lung cancer	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	13	49037877	13	48463741	376330	363209
NM_000321.2(RB1):c.2164A>T (p.Lys722Ter)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49037924	13	48463788	126796	132306
NM_000321.2(RB1):c.2197C>T (p.His733Tyr)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49037957	13	48463821	126797	132307
NM_000321.2(RB1):c.2209G>T (p.Glu737Ter)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49037969	13	48463833	126798	132308
NM_000321.2(RB1):c.2212-1G>A	RB1	Retinoblastoma	Pathogenic(Last reviewed: Nov 1, 1989)	no assertion criteria provided	13	49039133	13	48464997	13084	28123
NM_000321.2(RB1):c.2227_2230dup (p.Lys745Aspfs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49039149 - 49039152	13	48465013 - 48465016	126800	132310
NM_000321.2(RB1):c.2242G>T (p.Glu748Ter)	RB1	Small cell lung cancer|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	13	49039164	13	48465028	13078	28117
NM_000321.2(RB1):c.2244delG (p.Glu748Aspfs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Dec 21, 1989)	no assertion criteria provided	13	49039166	13	48465030	13074	28113
NM_000321.2(RB1):c.2247T>A (p.Tyr749Ter)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49039169	13	48465033	126801	132311
NM_000321.2(RB1):c.2359C>T (p.Arg787Ter)	RB1	Retinoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	13	49039374	13	48465238	13073	28112
NM_000321.2(RB1):c.2453delG (p.Gly818Valfs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49039468	13	48465332	126803	132313
NM_000321.2(RB1):c.2490-1G>A	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49047495	13	48473359	126804	132314
NM_000321.2(RB1):c.2520+1G>A	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49047527	13	48473391	126805	132315
NM_000321.2(RB1):c.2520+1delG	RB1	Retinoblastoma	Pathogenic(Last reviewed: Dec 21, 1989)	no assertion criteria provided	13	49047527	13	48473391	13069	28108
NM_000321.2(RB1):c.2525dup (p.Glu843Terfs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49050841	13	48476705	126806	132316
NM_000321.2(RB1):c.2663+2T>C	RB1	Retinoblastoma	Pathogenic(Last reviewed: Sep 16, 2013)	no assertion criteria provided	13	49050981	13	48476845	126807	132317
NM_000053.3(ATP7B):c.[1924G>C];[3809A>G]	ATP7B	Wilson disease	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	13|13	52511706	13|13	51937570	437912	18898|186903
NM_000053.3(ATP7B):c.2672G>C (p.Gly891Ala)	ATP7B	not provided	Uncertain significance	no assertion criteria provided	13	52524201	13	51950065	100803	106663
NM_015057.4(MYCBP2):c.13840A>G (p.Thr4614Ala)	MYCBP2	not provided	Uncertain significance	no assertion criteria provided	13	77625213	13	77051078	91986	97464
NM_015057.4(MYCBP2):c.7770G>A (p.Met2590Ile)	MYCBP2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	13	77700567	13	77126432	161690	171540
NM_032229.2(SLITRK6):c.1915_1916insT (p.Tyr639Leufs)	SLITRK6	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	13	86368729	13	85794594	221332	223061
NM_005845.4(ABCC4):c.2672G>T (p.Arg891Leu)	ABCC4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	13	95735408	13	95083154	219333	221022
NM_001105515.2(ABCC4):c.1645G>T (p.Val549Leu)	ABCC4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	13	95830043	13	95177789	161513	171541
NM_006260.4(DNAJC3):c.580C>T (p.Arg194Ter)	DNAJC3	Malignant tumor of prostate|Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2014)	no assertion criteria provided	13	96412327	13	95760073	162620	172297
NM_015011.2(MYO16):c.3428T>G (p.Leu1143Trp)	MYO16	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	13	109772773	13	109120425	161689	171534
NM_198217.2(ING1):c.443C>A (p.Ala148Asp)	ING1	Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: Jun 15, 2000)	no assertion criteria provided	13	111372014	13	110719667	8069	23108
NM_198217.2(ING1):c.512G>C (p.Cys171Ser)	ING1	Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: Jun 15, 2000)	no assertion criteria provided	13	111372083	13	110719736	8067	23106
NM_198217.2(ING1):c.515A>G (p.Asn172Ser)	ING1	Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: Jun 15, 2000)	no assertion criteria provided	13	111372086	13	110719739	8068	23107
GRCh37/hg19 14q11.2(chr14:20922785-20937690)x3	APEX1|PNP|OSGEP|PIP4P1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	14	20922785 - 20937690			221495	223224
NM_018071.4(ARHGEF40):c.1177C>G (p.Arg393Gly)	ARHGEF40	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	21543066	14	21074907	219348	221037
NM_016423.2(ZNF219):c.60C>T (p.Phe20=)	ZNF219	not provided	Uncertain significance	no assertion criteria provided	14	21561396	14	21093237	91993	97471
NM_020366.3(RPGRIP1):c.1978G>T (p.Asp660Tyr)	RPGRIP1	not provided	Uncertain significance	no assertion criteria provided	14	21792992	14	21324833	100874	106734
NM_005015.4(OXA1L):c.1018A>G (p.Thr340Ala)	OXA1L	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	23240305	14	22771096	161629	171544
NM_002471.3(MYH6):c.5036G>T (p.Arg1679Leu)	MYH6	not provided	Uncertain significance	no assertion criteria provided	14	23855264	14	23386055	100839	106699
NM_001199823.2(NEDD8-MDP1):c.451C>G (p.Leu151Val)	MDP1|NEDD8-MDP1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	24683519	14	24214313	161565	171545
NM_001002001.2(GMPR2):c.812C>T (p.Ser271Phe)	GMPR2	not provided	Uncertain significance	no assertion criteria provided	14	24707566	14	24238360	91918	97396
NM_002742.2(PRKD1):c.1993G>A (p.Asp665Asn)	PRKD1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	30068936	14	29599730	161599	171546
GRCh37/hg19 14q13.3-21.1(chr14:37145530-38064142)x4	FOXA1|PAX9|SLC25A21|MIPOL1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	14	37145530 - 38064142			221496	223225
NC_000014.9:g.38411139_38421941dup		Astrocytoma	Likely pathogenic	criteria provided, single submitter			14	38411139 - 38421941	504473	495913
NM_080746.2(RPL10L):c.94C>T (p.Arg32Cys)	RPL10L	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	47120846	14	46651643	161797	171547
NM_004713.5(NEMF):c.2431_2432delCA (p.Gln811Glufs)	NEMF	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	50266226 - 50266227	14	49799508 - 49799509	219305	220994
NM_181054.2(HIF1A):c.700G>A (p.Glu234Lys)	HIF1A|LOC105370526	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	62194300	14	61727582	161843	171548
NM_004569.4(PIGH):c.471C>G (p.Phe157Leu)	PIGH|GPHN	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	68059355	14	67592638	161623	171549
GRCh38/hg38 14q24.1(chr14:67823656-68813174)x1	ZFP36L1|RAD51B|LOC100996664|LOC108281166|LOC110121358|LOC110121412|LOC110121431|LOC111365187	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	14	68290373 - 69279891	14	67823656 - 68813174	523157	513789
NM_058240.3(SLC8A3):c.1690G>A (p.Val564Ile)	SLC8A3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	70633450	14	70166733	161796	171550
NM_014982.2(PCNX1):c.3049G>T (p.Ala1017Ser)	PCNX1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	71485778	14	71019061	161686	171551
NM_014381.2(MLH3):c.2482G>T (p.Glu828Ter)	MLH3	Carcinoma of colon	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	14	75513877	14	75047174	5557	20596
NM_033116.5(NEK9):c.1756dupA (p.Thr586Asnfs)	NEK9	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	75568445	14	75101742	161787	171552
NM_033116.4(NEK9):c.1817T>C (p.Ile573Thr)	NEK9	Nevus comedonicus	Pathogenic(Last reviewed: Jul 12, 2016)	no assertion criteria provided	14	75570558	14	75103855	242988	244070
NM_033116.4(NEK9):c.[1715G>T;1731+1G>T]	NEK9	Nevus comedonicus	Pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	14|14	75570561	14|14	75103858	242987	244069|248590
NM_033116.5(NEK9):c.500T>C (p.Ile167Thr)	NEK9	Nevus comedonicus	Pathogenic(Last reviewed: Jul 12, 2016)	no assertion criteria provided	14	75587237	14	75120534	243002	244082
NM_052873.2(IFT43):c.21G>T (p.Leu7Phe)	IFT43	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	76452150	14	75985807	161790	171553
NM_000369.2(TSHR):c.842G>T (p.Ser281Ile)	TSHR	Thyroid adenoma, hyperfunctioning, somatic|Thyroid adenoma, hyperfunctioning	Pathogenic(Last reviewed: Sep 15, 1997)	no assertion criteria provided	14	81606172	14	81139828	6446	21485
NM_000369.2(TSHR):c.1856A>G (p.Asp619Gly)	TSHR	Thyroid adenoma, hyperfunctioning, somatic|Thyroid adenoma, hyperfunctioning	Pathogenic(Last reviewed: Oct 14, 1993)	no assertion criteria provided	14	81610258	14	81143914	6431	21470
NM_000369.2(TSHR):c.1867_1868delGCinsAT (p.Ala623Ile)	TSHR	Thyroid adenoma, hyperfunctioning, somatic|Thyroid adenoma, hyperfunctioning	Pathogenic(Last reviewed: Oct 14, 1993)	no assertion criteria provided	14	81610269 - 81610270	14	81143925 - 81143926	6432	21471
NM_000369.2(TSHR):c.1887G>T (p.Leu629Phe)	TSHR	Hyperthyroidism, nonautoimmune|Thyroid adenoma, hyperfunctioning, somatic|Thyroid adenoma, hyperfunctioning	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	14	81610289	14	81143945	6451	21490
NM_000369.2(TSHR):c.1891T>C (p.Phe631Leu)	TSHR	Hyperthyroidism, nonautoimmune|Thyroid adenoma, hyperfunctioning, somatic|Thyroid adenoma, hyperfunctioning	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	14	81610293	14	81143949	6433	21472
NM_000369.2(TSHR):c.1897G>C (p.Asp633His)	TSHR	THYROID CARCINOMA WITH THYROTOXICOSIS, SOMATIC	Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	14	81610299	14	81143955	6437	21476
NM_007039.3(PTPN21):c.94A>C (p.Asn32His)	PTPN21	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	89016668	14	88550324	161654	171554
NM_002802.2(PSMC1):c.279+8G>A	PSMC1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	90729794	14	90263450	161600	171555
NM_020818.4(UNC79):c.3797C>T (p.Thr1266Met)	UNC79	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	94084641	14	93618295	161738	171556
NM_177438.2(DICER1):c.4426_4427insT (p.D1476Vfs5*)	DICER1	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	14	95562830 - 95562831	14	95096493 - 95096494	254334	248832
NM_177438.2(DICER1):c.2236A>G (p.Arg746Gly)	DICER1	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	14	95577674	14	95111337	254305	248859
NM_177438.2(DICER1):c.2026C>T (p.Arg676Ter)	DICER1	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	14	95579443	14	95113106	242054	241976
NM_177438.2(DICER1):c.1716delT (p.F572Lfs*15)	DICER1	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	14	95582826	14	95116489	254292	248872
NM_177438.2(DICER1):c.996C>A (p.Y332*)	DICER1	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	14	95590913	14	95124576	254356	248882
NM_177438.2(DICER1):c.832C>T (p.Leu278Phe)	DICER1	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	14	95592988	14	95126651	254354	248884
NM_177438.2(DICER1):c.745C>T (p.G249*)	DICER1	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 11, 2014)	criteria provided, single submitter	14	95593075	14	95126738	254353	248885
NM_032632.4(PAPOLA):c.1464A>G (p.Val488=)	PAPOLA	not provided	Conflicting interpretations of pathogenicity	no assertion criteria provided	14	97014198	14	96547861	100882	106742
NM_001127258.2(HHIPL1):c.1471G>C (p.Gly491Arg)	HHIPL1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	100126712	14	99660375	161519	171557
NM_003403.4(YY1):c.1115C>G (p.Thr372Arg)	YY1	not provided	Uncertain significance	no assertion criteria provided	14	100743807	14	100277470	91950	97428
NM_207117.3(SLC25A47):c.56C>T (p.Pro19Leu)	SLC25A47	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	100792152	14	100325815	161859	171542
NM_178586.2(PPP2R5C):c.715C>G (p.Leu239Val)	PPP2R5C	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	14	102359362	14	101893025	161840	171543
NM_145725.2(TRAF3):c.53C>G (p.Pro18Arg)	TRAF3	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	14	103336591	14	102870254	487799	480806
chr14:104643721..105932775 complex variant	AKT1|BRF1|JAG2|MTA1|SIVA1|PACS2|KIF26A|GPR132|CDCA4|INF2|BTBD6|AHNAK2|CLBA1|PLD4|ADSSL1|NUDT14|CEP170B|TMEM179|C14orf180|TEX22|ZBTB42	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	14	104643721 - 105932775			221344	223073
NM_005163.2(AKT1):c.235C>A (p.Gln79Lys)	AKT1	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	14	105243048	14	104776711	376168	363047
NM_005163.2(AKT1):c.49G>A (p.Glu17Lys)	AKT1	Liver cancer|Malignant melanoma of skin|Osteosarcoma|Proteus syndrome|Squamous cell carcinoma of the head and neck|Neoplasm of ovary|Small cell lung cancer|Lung adenocarcinoma|Non-small cell lung cancer|Breast cancer, somatic|Carcinoma of colon|Squamous cell lung carcinoma|Neoplasm of the breast|Hepatocellular carcinoma|Breast adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Prostate neoplasm|Colorectal Neoplasms|Uterine cervical neoplasms|Neoplasm of the thyroid gland|Meningeal Neoplasms|Adenocarcinoma of stomach|Adenocarcinoma of prostate|Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	14	105246551	14	104780214	13983	29022
GRCh37/hg19 14q32.33(chr14:105936477-105995652)x3	CRIP1|CRIP2|MTA1|TMEM121|TEDC1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	14	105936477 - 105995652			221497	223226
NM_033223.4(GABRG3):c.336A>G (p.Thr112=)	GABRG3	not provided	Uncertain significance	no assertion criteria provided	15	27572021	15	27326874	100886	106746
NM_004667.5(HERC2):c.2263_2277delTTGCCAGGACTGGAC (p.Leu755_Asp759del)	HERC2	Neoplasm of the breast	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	15	28505962 - 28505976	15	28260816 - 28260830	375974	362853
NM_004667.5(HERC2):c.2264T>C (p.Leu755Ser)	HERC2	Neoplasm of the breast	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	15	28505975	15	28260829	375975	362854
NM_004667.5(HERC2):c.926C>G (p.Ala309Gly)	HERC2	Neoplasm of the breast	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	15	28517518	15	28272372	375976	362855
NM_002420.5(TRPM1):c.217A>C (p.Ile73Leu)	TRPM1	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	15	31360292	15	31068089	487810	480817
NM_152453.3(TMCO5A):c.645G>C (p.Lys215Asn)	TMCO5A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	15	38239874	15	37947673	161814	171559
GRCh37/hg19 15q14-15.1(chr15:39874092-40492503)x3	BUB1B|SRP14|THBS1|GPR176|BMF|FSIP1|EIF2AK4	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	15	39874092 - 40492503			221498	223227
NM_001211.5(BUB1B):c.119C>T (p.Thr40Met)	BUB1B	Carcinoma of colon|not specified|Mosaic variegated aneuploidy syndrome	Benign(Last reviewed: Mar 13, 2018)	criteria provided, multiple submitters, no conflicts	15	40457337	15	40165136	6758	21797
NM_001142761.1(KNSTRN):c.71C>T (p.Ser24Phe)	KNSTRN	Malignant melanoma of skin|Squamous cell carcinoma of the skin	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	40675107	15	40382906	376441	363320
NM_001142776.3(CHAC1):c.279G>A (p.Trp93Ter)	CHAC1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	15	41247582	15	40955384	161528	171560
NM_153700.2(STRC):c.179T>C (p.Phe60Ser)	STRC	Deafness, autosomal recessive 16|not specified	Benign(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	15	43910440	15	43618242	156030	165840
NM_004048.3(B2M):c.1A>T (p.Met1Leu)	B2M	Non-Hodgkin lymphoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	45003745	15	44711547	376370	363249
NM_004048.3(B2M):c.1A>G (p.Met1Val)	B2M	Non-Hodgkin lymphoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	45003745	15	44711547	376369	363248
NM_004048.3(B2M):c.2T>G (p.Met1Arg)	B2M	Non-Hodgkin lymphoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	45003746	15	44711548	376372	363251
NM_004048.3(B2M):c.2T>C (p.Met1Thr)	B2M	Non-Hodgkin lymphoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	45003746	15	44711548	376371	363250
NM_004048.3(B2M):c.3G>A (p.Met1Ile)	B2M	Non-Hodgkin lymphoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	45003747	15	44711549	376368	363247
GRCh37/hg19 15q15.3-21.1(chr15:44791968-44852484)x3	EIF3J|CTDSPL2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	15	44791968 - 44852484			221499	223228
NM_000138.4(FBN1):c.5243G>T (p.Cys1748Phe)	FBN1	Geleophysic dysplasia 2	Pathogenic(Last reviewed: Oct 27, 2018)	no assertion criteria provided	15	48752496	15	48460299	590974	581917
NM_005154.3(USP8):c.[2138T>G;2150A>G]	USP8	Pituitary dependent hypercortisolism	Pathogenic(Last reviewed: Nov 18, 2014)	no assertion criteria provided	15|15	50782626	15|15	50490429	161994	171716|171717
NM_005154.4(USP8):c.2152T>C (p.Ser718Pro)	USP8	Pituitary dependent hypercortisolism	Pathogenic(Last reviewed: Sep 26, 2017)	no assertion criteria provided	15	50782640	15	50490443	161992	171718
NM_005154.4(USP8):c.2153C>G (p.Ser718Cys)	USP8	Pituitary dependent hypercortisolism	Pathogenic(Last reviewed: Nov 18, 2014)	no assertion criteria provided	15	50782641	15	50490444	161993	171719
NM_005154.4(USP8):c.2155_2157delTCC (p.Ser719del)	USP8	Pituitary dependent hypercortisolism	Pathogenic(Last reviewed: Sep 26, 2017)	no assertion criteria provided	15	50782643 - 50782645	15	50490446 - 50490448	161991	171720
NM_005154.4(USP8):c.2159C>G (p.Pro720Arg)	USP8	Pituitary dependent hypercortisolism	Pathogenic(Last reviewed: Sep 26, 2017)	no assertion criteria provided	15	50782647	15	50490450	161995	171721
NM_000259.3(MYO5A):c.2573G>T (p.Arg858Leu)	MYO5A	not provided	Uncertain significance	no assertion criteria provided	15	52667505	15	52375308	100805	106665
NM_182758.3(WDR72):c.2686C>T (p.Arg896Ter)	WDR72	Renal tubular acidosis, distal, with hemolytic anemia|Amelogenesis imperfecta, hypomaturation type, IIA3	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	15	53907717	15	53615520	522610	513221
NM_182758.3(WDR72):c.2522T>A (p.Leu841Gln)	WDR72	Renal tubular acidosis, distal, with hemolytic anemia	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	15	53907881	15	53615684	522609	513222
NM_182758.3(WDR72):c.1777A>G (p.Arg593Gly)	WDR72	Renal tubular acidosis, distal, with hemolytic anemia	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	15	53957954	15	53665757	522608	513223
NM_032866.4(CGNL1):c.2322T>C (p.His774=)	CGNL1	not provided	Conflicting interpretations of pathogenicity	no assertion criteria provided	15	57754009	15	57461811	100883	106743
NM_001143688.2(DIS3L):c.3089G>A (p.Gly1030Glu)	DIS3L	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	15	66625574	15	66333236	161529	171561
NM_002755.3(MAP2K1):c.157T>A (p.Phe53Ile)	MAP2K1	Malignant melanoma of skin|Lung adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	66727441	15	66435103	376447	363326
NM_002755.3(MAP2K1):c.157T>G (p.Phe53Val)	MAP2K1	Malignant melanoma of skin|Lung adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	66727441	15	66435103	376446	363325
NM_002755.3(MAP2K1):c.157T>C (p.Phe53Leu)	MAP2K1	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	15	66727441	15	66435103	375977	362856
NM_002755.3(MAP2K1):c.159T>G (p.Phe53Leu)	MAP2K1	Malignant melanoma of skin|Lung adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	66727443	15	66435105	376445	363324
NM_002755.3(MAP2K1):c.167A>C (p.Gln56Pro)	MAP2K1	Non-small cell lung cancer|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	15	66727451	15	66435113	375978	362857
NM_002755.3(MAP2K1):c.169A>G (p.Lys57Glu)	MAP2K1	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	15	66727453	15	66435115	376173	363052
NM_002755.3(MAP2K1):c.170A>C (p.Lys57Thr)	MAP2K1	Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Adenocarcinoma of stomach|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	66727454	15	66435116	376448	363327
NM_002755.3(MAP2K1):c.171G>C (p.Lys57Asn)	MAP2K1	Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Cutaneous melanoma|Adenocarcinoma of stomach|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	66727455	15	66435117	376174	363053
NM_002755.3(MAP2K1):c.171G>T (p.Lys57Asn)	MAP2K1	Lung adenocarcinoma|Non-small cell lung cancer|Cutaneous melanoma|Cardio-facio-cutaneous syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 3, 2016)	no assertion criteria provided	15	66727455	15	66435117	223140	224866
NM_002755.3(MAP2K1):c.199G>A (p.Asp67Asn)	MAP2K1	Non-small cell lung cancer|Autism spectrum disorder|not provided|Rasopathy|Cardiofaciocutaneous syndrome 3|Cutaneous melanoma|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	15	66727483	15	66435145	40781	49251
NM_002755.3(MAP2K1):c.296T>C (p.Ile99Thr)	MAP2K1	Neoplasm	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	15	66729088	15	66436750	376192	363071
NM_002755.3(MAP2K1):c.308T>A (p.Ile103Asn)	MAP2K1	Neoplasm	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	15	66729100	15	66436762	376193	363072
NM_002755.3(MAP2K1):c.332T>A (p.Ile111Asn)	MAP2K1	Neoplasm	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	15	66729124	15	66436786	376194	363073
NM_002755.3(MAP2K1):c.332T>G (p.Ile111Ser)	MAP2K1	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	15	66729124	15	66436786	375979	362858
NM_002755.3(MAP2K1):c.356A>C (p.His119Pro)	MAP2K1	Neoplasm	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	15	66729148	15	66436810	376195	363074
NM_002755.3(MAP2K1):c.360G>T (p.Glu120Asp)	MAP2K1	Neoplasm	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	15	66729152	15	66436814	376197	363076
NM_002755.3(MAP2K1):c.360G>C (p.Glu120Asp)	MAP2K1	Neoplasm	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	15	66729152	15	66436814	376196	363075
NM_002755.3(MAP2K1):c.361T>A (p.Cys121Ser)	MAP2K1	Lung adenocarcinoma	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	15	66729153	15	66436815	376331	363210
NM_002755.3(MAP2K1):c.362G>C (p.Cys121Ser)	MAP2K1	Lung adenocarcinoma|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	15	66729154	15	66436816	375980	362859
NM_002755.3(MAP2K1):c.370C>T (p.Pro124Ser)	MAP2K1	Malignant melanoma of skin|not provided|Cutaneous melanoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	15	66729162	15	66436824	375981	362860
NM_002755.3(MAP2K1):c.371C>T (p.Pro124Leu)	MAP2K1	Malignant melanoma of skin|not provided|Cutaneous melanoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Cardio-facio-cutaneous syndrome|Colorectal Neoplasms|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, multiple submitters, no conflicts	15	66729163	15	66436825	40744	49214
NM_002755.3(MAP2K1):c.371C>A (p.Pro124Gln)	MAP2K1	Malignant melanoma of skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	66729163	15	66436825	40743	49213
NM_002755.3(MAP2K1):c.383G>A (p.Gly128Asp)	MAP2K1	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	15	66729175	15	66436837	40746	49216
NM_002755.3(MAP2K1):c.385T>C (p.Phe129Leu)	MAP2K1	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	15	66729177	15	66436839	376175	363054
NM_002755.3(MAP2K1):c.607G>A (p.Glu203Lys)	MAP2K1	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	15	66774131	15	66481793	375982	362861
NM_002755.3(MAP2K1):c.632T>A (p.Val211Asp)	MAP2K1	Neoplasm	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	15	66774156	15	66481818	376198	363077
NM_002755.3(MAP2K1):c.644T>C (p.Leu215Pro)	MAP2K1	Neoplasm	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	15	66774168	15	66481830	376199	363078
NM_002755.3(MAP2K1):c.790C>T (p.Pro264Ser)	MAP2K1	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	15	66777424	15	66485086	375983	362862
NM_002755.3(MAP2K1):c.1144A>C (p.Asn382His)	MAP2K1|SNAPC5	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	15	66782915	15	66490577	375984	362863
GRCh37/hg19 15q23(chr15:69079813-72040847)x3	RPLP1|TLE3|ANP32A|KIF23|GLCE|LRRC49|PAQR5|UACA|LARP6|THAP10|NOX5|THSD4|CT62|SPESP1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	15	69079813 - 72040847			221500	223229
NM_033028.4(BBS4):c.1316C>T (p.Pro439Leu)	BBS4	not provided	Uncertain significance	no assertion criteria provided	15	73029170	15	72736829	100884	106744
NM_002499.3(NEO1):c.2935C>G (p.Pro979Ala)	NEO1	not provided	Conflicting interpretations of pathogenicity	no assertion criteria provided	15	73564873	15	73272532	100841	106701
NM_033238.2(PML):c.2264G>C (p.Arg755Pro)	PML	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	15	74336964	15	74044623	221319	223048
NM_021819.2(LMAN1L):c.1338G>T (p.Lys446Asn)	LMAN1L	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	15	75116706	15	74824365	161751	171562
GRCh38/hg38 15q25.2(chr15:82663590-82826799)x1	AP3B2|WHAMM|FSD2|CPEB1-AS1|SCARNA15|SNHG21	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	15	83332342 - 83495551	15	82663590 - 82826799	221501	223230
NM_181877.3(ZSCAN2):c.1255C>A (p.Gln419Lys)	ZSCAN2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	15	85164681	15	84621450	161846	171563
NM_022163.3(MRPL46):c.289C>T (p.Arg97Ter)	MRPL46	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	15	89008944	15	88465713	161757	171564
NM_002168.3(IDH2):c.516G>C (p.Arg172Ser)	IDH2	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	15	90631837	15	90088605	375985	362864
NM_001289910.1(IDH2):c.359G>A (p.Arg120Lys)	IDH2	Liver cancer|Acute myeloid leukemia|Myelodysplastic syndrome|Neoplasm of brain|Hepatocellular carcinoma|Brainstem glioma|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	90631838	15	90088606	375987	362866
NM_001289910.1(IDH2):c.359G>T (p.Arg120Met)	IDH2	Liver cancer|Acute myeloid leukemia|Neoplasm of brain|Hepatocellular carcinoma|Brainstem glioma|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	90631838	15	90088606	375986	362865
NM_001289910.1(IDH2):c.358A>G (p.Arg120Gly)	IDH2	Liver cancer|Acute myeloid leukemia|Neoplasm of brain|Hepatocellular carcinoma|Brainstem glioma|Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	90631839	15	90088607	376439	363318
NM_001289910.1(IDH2):c.358A>T (p.Arg120Trp)	IDH2	Liver cancer|Acute myeloid leukemia|Neoplasm of brain|Hepatocellular carcinoma|Brainstem glioma|Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	90631839	15	90088607	376438	363317
NM_002168.3(IDH2):c.419G>T (p.Arg140Leu)	IDH2	Multiple myeloma|Squamous cell carcinoma of the head and neck|Acute myeloid leukemia|Myelodysplastic syndrome|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	90631934	15	90088702	375988	362867
NM_002168.3(IDH2):c.419G>A (p.Arg140Gln)	IDH2	Multiple myeloma|Squamous cell carcinoma of the head and neck|Acute myeloid leukemia|D-2-hydroxyglutaric aciduria 2|Myelodysplastic syndrome|not provided|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	15	90631934	15	90088702	14716	29755
NM_002168.3(IDH2):c.418C>T (p.Arg140Trp)	IDH2	Multiple myeloma|Squamous cell carcinoma of the head and neck|Acute myeloid leukemia|Myelodysplastic syndrome|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	15	90631935	15	90088703	375989	362868
NM_022769.4(CRTC3):c.1387C>A (p.Arg463Ser)	CRTC3|CRTC3-AS1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	15	91181798	15	90638566	161762	171565
GRCh37/hg19 15q26.1(chr15:90770832-90777093)x3	SEMA4B|CIB1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	15	90770832 - 90777093			221502	223231
GRCh37/hg19 15q26.1(chr15:90931601-90976990)x3	IQGAP1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	15	90931601 - 90976990			221503	223232
NM_001167580.2(SV2B):c.1084C>T (p.Arg362Trp)	SV2B	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	15	91827280	15	91284050	161546	171566
GRCh37/hg19 15q26.1(chr15:91475054-91478581)x3	UNC45A|HDDC3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	15	91475054 - 91478581			221504	223233
NM_001042572.2(CHD2):c.2T>C (p.Met1Thr)	CHD2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	15	93444469	15	92901239	161507	171567
GRCh37/hg19 15q26.1(chr15:93198718-93536159)x3	CHD2|FAM174B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	15	93198718 - 93536159			221505	223234
GRCh37/hg19 15q26.2-26.3(chr15:96869560-99486217)x3	IGF1R|NR2F2|ARRDC4|SPATA8|FAM169B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	15	96869560 - 99486217			221506	223235
NM_178842.4(CERS3):c.609+7G>T	CERS3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	15	101016284	15	100476079	161842	171558
NM_014918.4(CHSY1):c.731G>A (p.Arg244Gln)	CHSY1	not provided	Uncertain significance	no assertion criteria provided	15	101775372	15	101235167	91982	97460
GRCh37/hg19 15q14-15.1 chr15:34638237..42057083 complex variant	ACTC1|BUB1B|GCHFR|ITPKA|IVD|LTK|MEIS2|PLCB2|RAD51|SPINT1|SRP14|THBS1|TYRO3|AQR|RASGRP1|GPR176|CHP1|OIP5|BAHD1|GOLGA8A|RTF1|MGA|RPAP1|RPUSD2|NDUFAF1|NUSAP1|DLL4|INO80|PPP1R14D|ZNF770|RMDN3|DNAJC17|PAK6|KNL1|GJD2|VPS18|CHAC1|C15orf41|ZFYVE19|DISP2|DPH6|CCDC32|KNSTRN|BMF|CHST14|TMCO5A|SPRED1|EXD1|FSIP1|RHOV|LPCAT4|NUTM1|FAM98B|CCDC9B|C15orf53|C15orf54|GOLGA8B|EIF2AK4|C15orf62|C15orf56|PHGR1|ANKRD63	Spindle cell sarcoma	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	15	34638237 - 42057083			585332	576381
NM_022450.3(RHBDF1):c.47A>C (p.Lys16Thr)	RHBDF1	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	16	114967	16	64969	487618	480720
GRCh37/hg19 16p13.3(chr16:97494-323799)x3	HBA1|HBA2|HBM|HBQ1|HBZ|MPG|NPRL3|RGS11|POLR3K|LUC7L|RHBDF1|SNRNP25|FAM234A	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	97494 - 323799			221507	223236
GRCh37/hg19 16p13.3(chr16:97494-1257060)x3	ARHGDIG|HBA1|HBA2|HBM|HBQ1|HBZ|MPG|NME4|CAPN15|SSTR5|NPRL3|AXIN1|RGS11|CACNA1H|RHBDL1|PIGQ|RAB11FIP3|MSLN|STUB1|MRPL28|DECR2|SOX8|POLR3K|GNG13|LUC7L|RAB40C|TMEM8A|CHTF18|RHBDF1|CIAO3|PDIA2|LMF1|FAM173A|METRN|SNRNP25|FAM234A|WDR24|HAGHL|METTL26|MCRIP2|RHOT2|RPUSD1|WFIKKN1|CCDC78|PRR35|FBXL16|WDR90|NHLRC4|JMJD8|PRR25|C1QTNF8	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	97494 - 1257060			221390	223119
NM_003502.3(AXIN1):c.1085_1116del32 (p.Val362Alafs)	AXIN1	Liver cancer|Hepatocellular carcinoma	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	16	359973 - 360004	16	309973 - 310004	6037	21076
GRCh37/hg19 16p13.3(chr16:324072-705832)x3	ARHGDIG|NME4|CAPN15|AXIN1|RGS11|PIGQ|RAB11FIP3|MRPL28|DECR2|RAB40C|TMEM8A|PDIA2|METTL26|MCRIP2|WFIKKN1|PRR35|WDR90|NHLRC4	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	324072 - 705832			221508	223237
GRCh37/hg19 16p13.3(chr16:706802-772110)x4	RHBDL1|STUB1|FAM173A|METRN|WDR24|RHOT2|FBXL16|WDR90|JMJD8	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	706802 - 772110			221509	223238
GRCh37/hg19 16p13.3(chr16:772433-857560)x3	MSLN|GNG13|CHTF18|CIAO3|FAM173A|HAGHL|RPUSD1|CCDC78|PRR25	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	772433 - 857560			221510	223239
NM_058192.2(RPUSD1):c.521A>G (p.His174Arg)	RPUSD1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	836368	16	786368	161795	171582
NM_021098.2(CACNA1H):c.1624G>A (p.Glu542Lys)	CACNA1H	not provided|Ductal breast carcinoma	Uncertain significance(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	16	1252074	16	1202074	221328	223057
GRCh37/hg19 16p13.3-12.3(chr16:1274615-19073133)x3	ABAT|ABCA3|ADCY9|ABCC6|ATP6V0C|TNFRSF17|CCNF|CLCN7|CREBBP|ECI1|DNASE1|DNASE1L2|E4F1|EMP2|ERCC4|GFER|GRIN2A|GSPT1|HAGH|HMOX2|IGFALS|MEFV|CIITA|ABCC1|MYH11|NUBP1|NDUFB10|NME3|NTHL1|NTN3|OR1F1|OR2C1|PARN|PDPK1|PKD1|PMM2|PPL|PRM1|PRM2|RPL3L|RPS2|RPS15A|SRL|ELOB|TFAP4|TNP2|TPSAB1|TSC2|UBE2I|ZNF75A|ZNF174|ZNF200|ZNF205|ZNF213|USP7|SNN|PLA2G10|SOCS1|BAIAP3|CLDN6|CLDN9|PKMYT1|DNAJA3|SYNGR3|IL32|NPIPA1|SLC9A3R2|LITAF|MARF1|SEC14L5|IFT140|TELO2|NUBP2|ZNF263|TRAP1|TBL3|RNPS1|PRSS21|PDXDC1|SMG1|CLUAP1|MAPK8IP3|ARL6IP1|CLEC16A|MGRN1|NOMO1|TPSD1|SRRM2|CARHSP1|TPSG1|RAB26|TMEM186|ZNF500|RSL1D1|DEXI|C16orf72|ZC3H7A|UBN1|CDIP1|AMDHD2|PAM16|TXNDC11|NAGPA|BFAR|TNFRSF12A|MSRB1|KCTD5|RRN3|RBFOX1|NDE1|ZSCAN32|HCFC1R1|CPPED1|ALG1|NMRAL1|TBC1D24|MRTFB|CASKIN1|CRAMP1|PRM3|PRSS22|XYLT1|MLST8|MMP25|TPSB2|HS3ST6|UNKL|MRPS34|METTL22|THOC6|KREMEN2|CORO7|ROGDI|TMEM204|NAA60|TMC7|ATF7IP2|TEDC2|FAHD1|PRSS27|TRAF7|FLYWCH1|NUDT16L1|SLX4|GNPTG|GLYR1|GLIS2|ZSCAN10|BMERB1|ZNF598|JPT2|SPSB3|TIGD7|SNX29|FLYWCH2|VASN|TSR3|RMI2|NTAN1|FOPNL|NOXO1|ZG16B|PAQR4|ANKS3|UBALD1|SEPT12|TEKT5|RNF151|ZNF597|BICDL2|C16orf89|C16orf71|EEF2KMT|EME2|NLRC3|MEIOB|MPV17L|PRSS33|NOMO2|NPW|BRICD5|PGP|C16orf91|TMEM114|C16orf96|PRSS41|PTX4|BCAR4|NOMO3|SMIM22|MIR193B|NPIPA3|NPIPA2|CCDC154|C16orf90|SHISA9|SNHG9|CEMP1|TVP23A|MIR365A|MIR1225|NPIPA5|MTRNR2L4|CORO7-PAM16	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	1274615 - 19073133			221511	223240
GRCh37/hg19 16p13.3-11.2(chr16:1279324-31926800)x3	ABAT|ABCA3|ADCY9|ALDOA|AQP8|ABCC6|ATP2A1|ATP6V0C|TNFRSF17|CCNF|CD19|CDR2|CLCN7|CLN3|COX6A2|CREBBP|CRYM|CTF1|ECI1|SEPT1|DNASE1|DNASE1L2|E4F1|EMP2|ERCC4|FUS|GFER|GP2|GRIN2A|GSPT1|GTF3C1|HAGH|HMOX2|IGFALS|IL4R|ITGAD|ITGAL|ITGAM|ITGAX|KIF22|MAZ|MEFV|CIITA|ABCC1|MYH11|NUBP1|NDUFAB1|NDUFB10|NME3|NTHL1|NTN3|OR1F1|OR2C1|PARN|PDPK1|PHKG2|PKD1|PLK1|PMM2|PPL|PPP4C|PRKCB|MAPK3|PRM1|PRM2|PRSS8|RBBP6|RPL3L|RPS2|RPS15A|ACSM3|SCNN1B|SCNN1G|SRL|SLC5A2|SPN|SULT1A2|STX4|SULT1A1|SULT1A3|TBX6|ELOB|TFAP4|TGFB1I1|TNP2|TPSAB1|TSC2|TUFM|UBE2I|UMOD|UQCRC2|ZNF75A|ZNF174|ZNF200|ZNF205|ZNF213|ZP2|USP7|SNN|PLA2G10|DOC2A|HIRIP3|SOCS1|EIF3C|BAIAP3|CLDN6|CLDN9|PKMYT1|DNAJA3|SYNGR3|IL32|BCL7C|NPIPA1|TAOK2|SLC9A3R2|LITAF|MARF1|SEC14L5|ZNF646|CCP110|SETD1A|IFT140|RNF40|TELO2|HS3ST4|HS3ST2|MVP|NUBP2|ZNF263|TRAP1|COQ7|IGSF6|BCKDK|ZNF267|CACNG3|CD2BP2|CDIPT|ERN2|TBL3|SRCAP|RNPS1|PRSS21|CORO1A|ATXN2L|SEPHS2|PDXDC1|SMG1|CLUAP1|GGA2|NPIPB3|MAPK8IP3|ARL6IP1|XPO6|KIAA0556|CLEC16A|MGRN1|ZNF629|NOMO1|TPSD1|QPRT|SRRM2|CARHSP1|RAB26|TMEM186|SH2B1|TBC1D10B|ZNF500|RSL1D1|SEZ6L2|NUPR1|LAT|TNRC6A|DEXI|C16orf72|ZC3H7A|PYCARD|UBN1|MYLPF|EEF2K|CDIP1|IL21R|AMDHD2|PAM16|TXNDC11|METTL9|NAGPA|BFAR|AHSP|TNFRSF12A|ZNF771|LCMT1|GDE1|GPRC5B|MSRB1|SYT17|KCTD5|FBXL19|RRN3|RBFOX1|NDE1|ZSCAN32|HCFC1R1|ACSM5|ARHGAP17|CPPED1|DNAH3|THUMPD1|POLR3E|APOBR|ALG1|UBFD1|VPS35L|TMEM159|LYRM1|NMRAL1|TBC1D24|USP31|MRTFB|CASKIN1|CRAMP1|PRM3|CHP2|PRSS22|XYLT1|MLST8|FBRS|MMP25|TPSB2|HS3ST6|UNKL|C16orf58|ZNF747|MRPS34|PRR14|VKORC1|SLX1B|DCTPP1|METTL22|GDPD3|THOC6|KREMEN2|PAGR1|CORO7|ROGDI|TMEM204|ZNF768|PALB2|ZNF668|ARMC5|KDM8|TMC5|RABEP2|NAA60|TMC7|ATF7IP2|TEDC2|HSD3B7|FAHD1|YPEL3|FAM57B|PRSS27|SPNS1|KAT8|TRAF7|FLYWCH1|NUDT16L1|SLX4|DCTN5|GNPTG|GLYR1|GLIS2|ZSCAN10|NFATC2IP|BMERB1|CCDC189|ZNF598|JPT2|SPSB3|TIGD7|COG7|SNX29|ZNF764|ORAI3|PRRT2|ERI2|STX1B|SGF29|FLYWCH2|VASN|ZNF689|SLC5A11|TSR3|RMI2|ACSM1|NTAN1|FOPNL|ACSM2A|DCUN1D3|NOXO1|IQCK|ZG16B|PAQR4|GPR139|ANKS3|UBALD1|SEPT12|ZNF720|TMEM219|EARS2|VWA3A|OTOA|TEKT5|RNF151|C16orf92|GSG1L|ZNF597|BICDL2|ZNF785|ZNF688|PRSS36|C16orf89|C16orf71|ITPRIPL2|C16orf82|EEF2KMT|EME2|NLRC3|NSMCE1|ZNF48|PDILT|IL27|KCTD13|ASPHD1|MEIOB|MPV17L|PDZD9|ANKS4B|PRSS33|PYDC1|NOMO2|NPW|BRICD5|PGP|C16orf54|INO80E|ZNF843|C16orf91|TMEM114|PRSS53|C16orf96|ZKSCAN2|ACSM2B|PRSS41|SBK1|PTX4|BCAR4|KNOP1|NOMO3|SMIM22|NPIPB4|SULT1A4|TRIM72|SLX1A|BOLA2|MIR193B|NPIPA3|NPIPA2|CCDC154|C16orf90|ZG16|BOLA2B|CLEC19A|EIF3CL|NPIPB6|SHISA9|MOSMO|SNHG9|CEMP1|TVP23A|MIR365A|NPIPB5|MIR1225|SDR42E2|NPIPA5|MTRNR2L4|CORO7-PAM16	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	1279324 - 31926800			221391	223120
maternal UPD(16p)	ABAT|ABCA3|ADCY9|ALDOA|AQP8|ABCC6|ATP2A1|ATP6V0C|TNFRSF17|CCNF|CD19|CDR2|CLCN7|CLN3|COX6A2|CREBBP|CRYM|CTF1|ECI1|SEPT1|DNASE1|DNASE1L2|E4F1|EMP2|ERCC4|FUS|GFER|GP2|GRIN2A|GSPT1|GTF3C1|HAGH|HMOX2|IGFALS|IL4R|ITGAD|ITGAL|ITGAM|ITGAX|KIF22|MAZ|MEFV|CIITA|ABCC1|MYH11|NUBP1|NDUFAB1|NDUFB10|NME3|NTHL1|NTN3|OR1F1|OR2C1|PARN|PDPK1|PHKG2|PKD1|PLK1|PMM2|PPL|PPP4C|PRKCB|MAPK3|PRM1|PRM2|PRSS8|RBBP6|RPL3L|RPS2|RPS15A|ACSM3|SCNN1B|SCNN1G|SRL|SLC5A2|SPN|SULT1A2|STX4|SULT1A1|SULT1A3|TBX6|ELOB|TFAP4|TGFB1I1|TNP2|TPSAB1|TSC2|TUFM|UBE2I|UMOD|UQCRC2|ZNF75A|ZNF174|ZNF200|ZNF205|ZNF213|ZP2|USP7|SNN|PLA2G10|DOC2A|HIRIP3|SOCS1|EIF3C|BAIAP3|CLDN6|CLDN9|PKMYT1|DNAJA3|SYNGR3|IL32|BCL7C|NPIPA1|TAOK2|SLC9A3R2|LITAF|MARF1|SEC14L5|ZNF646|CCP110|SETD1A|IFT140|RNF40|TELO2|HS3ST4|HS3ST2|MVP|NUBP2|ZNF263|TRAP1|COQ7|IGSF6|BCKDK|ZNF267|CACNG3|CD2BP2|CDIPT|ERN2|TBL3|SRCAP|RNPS1|PRSS21|CORO1A|ATXN2L|SEPHS2|PDXDC1|SMG1|CLUAP1|GGA2|NPIPB3|MAPK8IP3|ARL6IP1|XPO6|KIAA0556|CLEC16A|MGRN1|ZNF629|NOMO1|TPSD1|QPRT|SRRM2|CARHSP1|TP53TG3|RAB26|TMEM186|SH2B1|TBC1D10B|ZNF500|RSL1D1|SEZ6L2|NUPR1|LAT|TNRC6A|DEXI|C16orf72|ZC3H7A|PYCARD|UBN1|MYLPF|EEF2K|CDIP1|IL21R|AMDHD2|PAM16|TXNDC11|METTL9|NAGPA|BFAR|AHSP|TNFRSF12A|ZNF771|LCMT1|GDE1|GPRC5B|MSRB1|SYT17|KCTD5|FBXL19|RRN3|RBFOX1|NDE1|ZSCAN32|HCFC1R1|ACSM5|ARHGAP17|CPPED1|DNAH3|THUMPD1|POLR3E|APOBR|ALG1|UBFD1|VPS35L|TMEM159|LYRM1|NMRAL1|TBC1D24|USP31|MRTFB|CASKIN1|CRAMP1|PRM3|CHP2|PRSS22|XYLT1|MLST8|FBRS|MMP25|TPSB2|HS3ST6|UNKL|C16orf58|ZNF747|MRPS34|PRR14|VKORC1|SLX1B|DCTPP1|METTL22|GDPD3|THOC6|KREMEN2|PAGR1|CORO7|ROGDI|TMEM204|ZNF768|PALB2|ZNF668|ARMC5|KDM8|TMC5|RABEP2|NAA60|TMC7|ATF7IP2|TEDC2|HSD3B7|FAHD1|YPEL3|FAM57B|PRSS27|SPNS1|KAT8|TRAF7|FLYWCH1|NUDT16L1|SLX4|DCTN5|GNPTG|GLYR1|GLIS2|ZSCAN10|NFATC2IP|BMERB1|CCDC189|ZNF598|JPT2|SPSB3|TIGD7|COG7|SNX29|ZNF764|ORAI3|PRRT2|ERI2|STX1B|SGF29|FLYWCH2|VASN|ZNF689|SLC5A11|TSR3|RMI2|ACSM1|NTAN1|FOPNL|ACSM2A|DCUN1D3|NOXO1|IQCK|ZG16B|PAQR4|GPR139|ANKS3|UBALD1|SEPT12|ZNF720|TMEM219|EARS2|VWA3A|OTOA|TEKT5|RNF151|C16orf92|GSG1L|ZNF597|BICDL2|ZNF785|ZNF688|PRSS36|C16orf89|C16orf71|ITPRIPL2|C16orf82|EEF2KMT|EME2|NLRC3|NSMCE1|ZNF48|PDILT|IL27|KCTD13|ASPHD1|MEIOB|MPV17L|PDZD9|ANKS4B|PRSS33|PYDC1|NOMO2|NPW|BRICD5|PGP|C16orf54|INO80E|ZNF843|C16orf91|TMEM114|PRSS53|C16orf96|ZKSCAN2|ACSM2B|PRSS41|SBK1|PTX4|BCAR4|KNOP1|NOMO3|SMIM22|NPIPB4|SULT1A4|TRIM72|SLX1A|BOLA2|MIR193B|NPIPA3|NPIPA2|CCDC154|C16orf90|TP53TG3C|ZG16|BOLA2B|CLEC19A|EIF3CL|NPIPB6|TP53TG3D|TP53TG3B|SHISA9|MOSMO|SNHG9|CEMP1|TVP23A|MIR365A|NPIPB5|MIR1225|SDR42E2|NPIPA5|MTRNR2L4|CORO7-PAM16	Hemimegalencephaly	Pathogenic	no assertion criteria provided	16	1280042 - 33710558			375693	362583
NM_000548.4(TSC2):c.1096G>T (p.Glu366Ter)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	16	2110791	16	2060790	12400	27439
NM_000548.4(TSC2):c.1832G>A (p.Arg611Gln)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	16	2120572	16	2070571	12397	27436
NM_000548.4(TSC2):c.2764_2765delTT (p.Leu922Valfs)	TSC2	Osteosarcoma|Tuberous sclerosis 2	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	16	2126513 - 2126514	16	2076512 - 2076513	438794	432384
NM_000548.4(TSC2):c.3284+1G>T	TSC2	Neuroblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	16	2129430	16	2079429	438793	432422
NM_000548.4(TSC2):c.4639G>A (p.Val1547Ile)	TSC2	Focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 30, 2018)	criteria provided, conflicting interpretations	16	2135300	16	2085299	238056	242315
NM_000548.4(TSC2):c.4859A>G (p.His1620Arg)	TSC2	Tuberous sclerosis syndrome|Everolimus response	drug response(Last reviewed: Jan 1, 2017)	no assertion criteria provided	16	2136742	16	2086741	65243	76175
NM_000548.4(TSC2):c.4949A>G (p.Tyr1650Cys)	TSC2	Tuberous sclerosis syndrome|Everolimus response	drug response(Last reviewed: Jan 1, 2017)	no assertion criteria provided	16	2136832	16	2086831	49334	58496
NM_001089.2(ABCA3):c.2086G>A (p.Asp696Asn)	ABCA3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	2347507	16	2297506	161510	171569
NM_001199107.1(TBC1D24):c.919A>C (p.Asn307His)	TBC1D24	Deafness, autosomal dominant 65	Likely pathogenic	no assertion criteria provided	16	2547068	16	2497067	425556	413897
NM_022119.3(PRSS22):c.806G>A (p.Arg269His)	PRSS22	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	2903242	16	2853241	161756	171570
NM_172229.2(KREMEN2):c.494G>T (p.Gly165Val)	KREMEN2	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	16	3016650	16	2966649	487788	480795
NM_000243.2(MEFV):c.*267G>A	MEFV	Familial Mediterranean fever	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	3292874	16	3242874	224065	225792
NM_000243.2(MEFV):c.*245G>A	MEFV	Familial Mediterranean fever	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	3292896	16	3242896	224064	225793
NM_000243.2(MEFV):c.*133G>A	MEFV	Familial Mediterranean fever	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	3293008	16	3243008	224066	225794
NM_000243.2(MEFV):c.2305C>G (p.Pro769Ala)	MEFV	Familial Mediterranean fever	not provided	no assertion provided	16	3293182	16	3243182	56149	70788
NM_000243.2(MEFV):c.2060G>A (p.Gly687Asp)	MEFV	Familial Mediterranean fever|not provided	Pathogenic(Last reviewed: May 26, 2015)	criteria provided, single submitter	16	3293427	16	3243427	56148	70787
NM_000243.2(MEFV):c.2053G>A (p.Glu685Lys)	MEFV	Familial Mediterranean fever	not provided	no assertion provided	16	3293434	16	3243434	160368	170212
NM_000243.2(MEFV):c.1996A>G (p.Ile666Val)	MEFV	Familial Mediterranean fever	not provided	no assertion provided	16	3293491	16	3243491	56147	70786
NM_000243.2(MEFV):c.1949C>A (p.Ser650Tyr)	MEFV	Familial Mediterranean fever	not provided	no assertion provided	16	3293538	16	3243538	56146	70785
NM_000243.2(MEFV):c.1910A>G (p.Asp637Gly)	MEFV	Familial Mediterranean fever	not provided	no assertion provided	16	3293577	16	3243577	56145	70784
NM_000243.2(MEFV):c.1166A>T (p.Asp389Val)	MEFV	Familial Mediterranean fever	not provided	no assertion provided	16	3299525	16	3249525	192297	190090
NM_000243.2(MEFV):c.1082G>C (p.Arg361Thr)	MEFV	Familial Mediterranean fever	not provided	no assertion provided	16	3299609	16	3249609	160359	170203
NM_000243.2(MEFV):c.1012G>C (p.Val338Leu)	MEFV	Familial Mediterranean fever	not provided	no assertion provided	16	3299679	16	3249679	132873	136622
NM_000243.2(MEFV):c.866C>A (p.Ala289Glu)	MEFV	Familial Mediterranean fever	not provided	no assertion provided	16	3304202	16	3254202	56153	70792
NM_000243.2(MEFV):c.863C>A (p.Ser288Tyr)	MEFV	Familial Mediterranean fever	not provided	no assertion provided	16	3304205	16	3254205	56152	70791
NM_000243.2(MEFV):c.818C>T (p.Ser273Leu)	MEFV	Familial Mediterranean fever|not specified	Uncertain significance(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	16	3304250	16	3254250	132874	136623
NM_000243.2(MEFV):c.688G>C (p.Glu230Gln)	MEFV	Familial Mediterranean fever	not provided	no assertion provided	16	3304380	16	3254380	56151	70790
NM_000243.2(MEFV):c.464G>C (p.Arg155Thr)	MEFV	Familial Mediterranean fever	not provided	no assertion provided	16	3304604	16	3254604	132872	136621
NM_000243.2(MEFV):c.369C>A (p.His123Gln)	MEFV	Familial Mediterranean fever|not provided	Uncertain significance(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	16	3304699	16	3254699	161092	170936
NM_000243.2(MEFV):c.343C>A (p.Pro115Thr)	MEFV	Familial Mediterranean fever|not specified	Uncertain significance(Last reviewed: Apr 7, 2017)	criteria provided, multiple submitters, no conflicts	16	3304725	16	3254725	96982	102885
NM_000243.2(MEFV):c.314C>A (p.Ala105Glu)	MEFV	Familial Mediterranean fever	not provided	no assertion provided	16	3304754	16	3254754	56150	70789
NM_004380.2(CREBBP):c.4337G>A (p.Arg1446His)	CREBBP	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	16	3788617	16	3738616	376387	363266
NM_004380.2(CREBBP):c.4337G>T (p.Arg1446Leu)	CREBBP	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	16	3788617	16	3738616	376386	363265
NM_004380.2(CREBBP):c.4336C>G (p.Arg1446Gly)	CREBBP	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	16	3788618	16	3738617	376388	363267
NM_004380.2(CREBBP):c.4336C>T (p.Arg1446Cys)	CREBBP	Liver cancer|Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Rubinstein-Taybi syndrome 1|Squamous cell lung carcinoma|not provided|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach	Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2018)	criteria provided, conflicting interpretations	16	3788618	16	3738617	95047	100947
NM_024535.4(CORO7):c.2772+50C>T	CORO7|CORO7-PAM16	Acute megakaryoblastic leukemia|Mediastinal germ cell tumor	Uncertain significance(Last reviewed: Oct 22, 2015)	no assertion criteria provided	16	4405237	16	4355236	218341	215052
NM_001192.2(TNFRSF17):c.524C>T (p.Thr175Met)	TNFRSF17|NPIPB2	Desmoplastic small round cell tumor	other(Last reviewed: May 1, 2016)	no assertion criteria provided	16	12061673	16	11967816	438792	432421
GRCh37/hg19 16p12.3(chr16:19083339-19586433)x4	CCP110|COQ7|GDE1|SYT17|VPS35L|TMC5|ITPRIPL2|CLEC19A	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	19083339 - 19586433			221512	223241
GRCh37/hg19 16p12.3-11.2(chr16:19590412-29814175)x3	AQP8|ATP2A1|CD19|CDR2|CLN3|CRYM|GP2|GTF3C1|IL4R|KIF22|NDUFAB1|PLK1|PRKCB|RBBP6|ACSM3|SCNN1B|SCNN1G|SPN|SULT1A2|SULT1A1|TUFM|UMOD|UQCRC2|ZP2|EIF3C|HS3ST4|HS3ST2|IGSF6|CACNG3|ERN2|ATXN2L|GGA2|NPIPB3|XPO6|KIAA0556|QPRT|SH2B1|NUPR1|LAT|TNRC6A|EEF2K|IL21R|METTL9|LCMT1|GPRC5B|ACSM5|ARHGAP17|DNAH3|THUMPD1|POLR3E|APOBR|UBFD1|VPS35L|TMEM159|LYRM1|USP31|CHP2|SLX1B|PALB2|KDM8|RABEP2|SPNS1|DCTN5|NFATC2IP|COG7|ERI2|SGF29|SLC5A11|ACSM1|ACSM2A|DCUN1D3|IQCK|GPR139|EARS2|VWA3A|OTOA|GSG1L|C16orf82|NSMCE1|PDILT|IL27|PDZD9|ANKS4B|C16orf54|ZKSCAN2|ACSM2B|SBK1|KNOP1|NPIPB4|SULT1A4|BOLA2|ZG16|EIF3CL|NPIPB6|MOSMO|NPIPB5|SDR42E2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	19590412 - 29814175			221513	223242
NM_017539.2(DNAH3):c.6268C>A (p.His2090Asn)	DNAH3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	21011699	16	21000377	161706	171568
GRCh37/hg19 16p11.2(chr16:29814850-29830976)x4	KIF22|MAZ|PAGR1|PRRT2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	29814850 - 29830976			221514	223243
GRCh37/hg19 16p11.2(chr16:29841933-30381027)x3	ALDOA|PPP4C|MAPK3|SULT1A3|TBX6|DOC2A|HIRIP3|TAOK2|MVP|CD2BP2|CDIPT|CORO1A|TBC1D10B|SEZ6L2|GDPD3|YPEL3|FAM57B|TMEM219|C16orf92|KCTD13|ASPHD1|INO80E|SLX1A|BOLA2B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	29841933 - 30381027			221515	223244
NM_013292.4(MYLPF):c.431C>A (p.Pro144His)	MYLPF	not provided	Uncertain significance	no assertion criteria provided	16	30389142	16	30377821	91978	97456
GRCh37/hg19 16p11.2(chr16:30386180-30390806)x5	SEPT1|MYLPF|ZNF48	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	30386180 - 30390806			221516	223245
GRCh37/hg19 16p11.2(chr16:30391304-31122666)x3	CTF1|SEPT1|ITGAL|PHKG2|STX4|BCL7C|ZNF646|SETD1A|RNF40|BCKDK|SRCAP|SEPHS2|ZNF629|ZNF771|FBXL19|FBRS|ZNF747|PRR14|VKORC1|DCTPP1|ZNF768|ZNF668|HSD3B7|CCDC189|ZNF764|ORAI3|STX1B|ZNF689|ZNF785|ZNF688|ZNF48|PRSS53	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	30391304 - 31122666			221517	223246
NM_001214909.1(ZNF48):c.1624C>T (p.Pro542Ser)	ZNF48	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	30410195	16	30398874	161575	171571
GRCh37/hg19 16p11.2(chr16:31123271-31153163)x4	PRSS8|BCKDK|KAT8|PRSS36	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	31123271 - 31153163			221518	223247
GRCh37/hg19 16p11.2(chr16:31154186-31926800)x3	COX6A2|FUS|ITGAD|ITGAM|ITGAX|SLC5A2|TGFB1I1|ZNF267|PYCARD|AHSP|C16orf58|ARMC5|ZNF720|PRSS36|PYDC1|ZNF843|TRIM72	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	31154186 - 31926800			221519	223248
NM_005353.2(ITGAD):c.2836A>C (p.Lys946Gln)	ITGAD	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	31434490	16	31423169	161631	171572
NM_003041.3(SLC5A2):c.395G>A (p.Arg132His)	SLC5A2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	31497141	16	31485820	161605	171573
NM_022744.3(C16orf58):c.831C>G (p.Arg277=)	C16orf58	not provided	Uncertain significance	no assertion criteria provided	16	31505051	16	31493730	92012	97490
GRCh37/hg19 16q11.2-24.3(chr16:46455960-90354753)x1	AARS|ADCY7|AP1G1|AGRP|AMFR|APRT|ZFHX3|BBS2|GAS8-AS1|CA5A|CA7|CALB2|CBFA2T3|CBFB|CBLN1|CDH1|CDH3|CDH5|CDH8|CDH11|CDH13|CDH15|CDH16|CES1|CETP|CNGB1|COX4I1|CSNK2A2|CTRB1|CTRL|CYBA|CYLD|DHODH|NQO1|DYNC1LI2|DPEP1|E2F4|FANCA|FOXF1|FOXL1|FOXC2|GALNS|GAS8|GCSH|GLG1|GNAO1|GOT2|HAS3|HP|HPR|HSBP1|HSD11B2|HSD17B2|HSF4|IRF8|KARS|KIFC3|LCAT|MAF|MC1R|CHST6|MMP2|MMP15|MT1A|MT1B|MT1E|MT1F|MT1G|MT1H|MT1M|MT1X|MT2A|MT3|MVD|NFATC3|CHMP1A|PHKB|PLCG2|POLR2C|PSKH1|PSMB10|PSMD7|RBL2|RPL13|RRAD|SALL1|CCL17|CCL22|CX3CL1|SIAH1|ST3GAL2|SLC6A2|SLC9A5|SLC12A3|SLC12A4|SNTB2|SPG7|TAT|TERF2|TK2|ZNF19|ZNF23|GAN|SLC7A5|CDK10|TRADD|MBTPS1|CES2|NAE1|NOL3|TAF1C|SLC7A6|USP10|ATP6V0D1|ADGRG1|BCAR1|VPS9D1|N4BP1|NUP93|HERPUD1|KIAA0513|PIEZO1|DHX38|IST1|ATP2C2|CLEC3A|CHST4|MPHOSPH6|NUTF2|IRX5|DNAJA2|KATNB1|EMC8|TUBB3|CFDP1|CTCF|NFAT5|NUDT21|WWP2|PRDM7|DDX19B|GABARAPL2|MON1B|TCF25|CNOT1|PHLPP2|ZNF423|ZCCHC14|GSE1|ATMIN|RPGRIP1L|COTL1|MLYCD|SF3B3|CES3|ADAT1|CHST5|ARL2BP|ORC6|EDC4|PLA2G15|COG4|PLEKHG4|LRRC29|CPNE7|VPS4A|IL17C|TOX3|NOB1|CCDC113|TMEM208|CFAP20|FHOD1|BRD7|ANKRD11|ZDHHC1|OSGIN1|PARD6A|PLLP|CKLF|NIP7|CIAO2B|GINS2|TPPP3|TRAPPC2L|WWOX|BCO1|TERF2IP|PRMT7|NECAB2|KLHDC4|HYDIN|DEF8|DUS2|CHTF8|LPCAT2|TXNL4B|BANP|HEATR3|PDPR|RFWD3|SLC38A7|OGFOD1|LRRC36|DDX19A|FBXL8|SMPD3|ZNF821|ZDHHC7|VAC14|DOK4|VPS35|CMTR2|DDX28|TSNAXIP1|CENPN|CMC2|COQ9|CIAPIN1|THAP11|JPH3|PDP2|ZNF319|RANBP10|VAT1L|MEAK7|WFDC1|NOD2|PDF|DPEP2|DPEP3|TENT4B|AKTIP|MTHFSD|GINS3|NDRG4|ACD|DBNDD1|FTO|FA2H|IRX6|IRX3|RIPOR1|TMEM231|TANGO6|USB1|WDR59|ELMO3|KLHL36|FBXO31|SHCBP1|SETD6|ESRP2|FAM192A|CENPT|CHD9|C16orf70|CYB5B|CMIP|ITFG1|GFOD2|CDT1|MAP1LC3B|NETO2|PMFBP1|DYNLRB2|HSDL1|CRISPLD2|LONP2|ENKD1|SLC7A6OS|NLRC5|DRC7|CAPNS2|COG8|SPIRE2|MT4|ZNF469|GPT2|B3GNT9|UTP4|ZNRF1|ABCC11|NKD1|CNTNAP4|RSPRY1|MYLK3|MARVELD3|MTSS2|CENPBD1|ZNF276|CCDC102A|KCNG4|SDR42E1|ABCC12|CMTM1|PKD1L2|RNF166|EXOSC6|C16orf46|DNAAF1|NRN1L|CMTM3|C16orf78|SPATA2L|SPATA33|ZC3H18|CDYL2|SNX20|TMEM170A|SLC38A8|ZFP90|CARMIL2|KCTD19|CMTM4|CMTM2|BEAN1|SLC22A31|IL34|TMED6|ZFPM1|ADAD2|ZFP1|ADAMTS18|LDHD|FCSK|MLKL|ZNF778|ACSF3|CPNE2|ADGRG5|PRSS54|CES5A|ADGRG3|CNEP1R1|TERB1|CES4A|EXOC3L1|NUDT7|CLEC18C|SNAI3|FAM92B|ATXN1L|PKD1L3|CLEC18A|CTU2|TEPP|C16orf87|C16orf97|C16orf86|C16orf47|PABPN1L|LOC400541|FENDRR|C16orf74|MIR138-2|MIR140|NPIPB15|CTRB2|MIR328|CLEC18B|KIAA0895L|LOC654780|SYCE1L|LINC01082|C16orf95|CKLF-CMTM1|LOC101927817|LOC101928417|LOC101928737	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	16	46455960 - 90354753			523162	513794
GRCh37/hg19 16q11.2-24.3(chr16:46497599-90354753)x1	AARS|ADCY7|AP1G1|AGRP|AMFR|APRT|ZFHX3|BBS2|GAS8-AS1|CA5A|CA7|CALB2|CBFA2T3|CBFB|CBLN1|CDH1|CDH3|CDH5|CDH8|CDH11|CDH13|CDH15|CDH16|CES1|CETP|CNGB1|COX4I1|CSNK2A2|CTRB1|CTRL|CYBA|CYLD|DHODH|NQO1|DYNC1LI2|DPEP1|E2F4|FANCA|FOXF1|FOXL1|FOXC2|GALNS|GAS8|GCSH|GLG1|GNAO1|GOT2|HAS3|HP|HPR|HSBP1|HSD11B2|HSD17B2|HSF4|IRF8|KARS|KIFC3|LCAT|MAF|MC1R|CHST6|MMP2|MMP15|MT1A|MT1B|MT1E|MT1F|MT1G|MT1H|MT1M|MT1X|MT2A|MT3|MVD|NFATC3|CHMP1A|PHKB|PLCG2|POLR2C|PSKH1|PSMB10|PSMD7|RBL2|RPL13|RRAD|SALL1|CCL17|CCL22|CX3CL1|SIAH1|ST3GAL2|SLC6A2|SLC9A5|SLC12A3|SLC12A4|SNTB2|SPG7|TAT|TERF2|TK2|ZNF19|ZNF23|GAN|SLC7A5|CDK10|TRADD|MBTPS1|CES2|NAE1|NOL3|TAF1C|SLC7A6|USP10|ATP6V0D1|ADGRG1|BCAR1|VPS9D1|N4BP1|NUP93|HERPUD1|KIAA0513|PIEZO1|DHX38|IST1|ATP2C2|CLEC3A|CHST4|MPHOSPH6|NUTF2|IRX5|DNAJA2|KATNB1|EMC8|TUBB3|CFDP1|CTCF|NFAT5|NUDT21|WWP2|PRDM7|DDX19B|GABARAPL2|MON1B|TCF25|CNOT1|PHLPP2|ZNF423|ZCCHC14|GSE1|ATMIN|RPGRIP1L|COTL1|MLYCD|SF3B3|CES3|ADAT1|CHST5|ARL2BP|ORC6|EDC4|PLA2G15|COG4|PLEKHG4|LRRC29|CPNE7|VPS4A|IL17C|TOX3|NOB1|CCDC113|TMEM208|CFAP20|FHOD1|BRD7|ANKRD11|ZDHHC1|OSGIN1|PARD6A|PLLP|CKLF|NIP7|CIAO2B|GINS2|TPPP3|TRAPPC2L|WWOX|BCO1|TERF2IP|PRMT7|NECAB2|KLHDC4|HYDIN|DEF8|DUS2|CHTF8|LPCAT2|TXNL4B|BANP|HEATR3|PDPR|RFWD3|SLC38A7|OGFOD1|LRRC36|DDX19A|FBXL8|SMPD3|ZNF821|ZDHHC7|VAC14|DOK4|VPS35|CMTR2|DDX28|TSNAXIP1|CENPN|CMC2|COQ9|CIAPIN1|THAP11|JPH3|PDP2|ZNF319|RANBP10|VAT1L|MEAK7|WFDC1|NOD2|PDF|DPEP2|DPEP3|TENT4B|AKTIP|MTHFSD|GINS3|NDRG4|ACD|DBNDD1|FTO|FA2H|IRX6|IRX3|RIPOR1|TMEM231|TANGO6|USB1|WDR59|ELMO3|KLHL36|FBXO31|SHCBP1|SETD6|ESRP2|FAM192A|CENPT|CHD9|C16orf70|CYB5B|CMIP|ITFG1|GFOD2|CDT1|MAP1LC3B|NETO2|PMFBP1|DYNLRB2|HSDL1|CRISPLD2|LONP2|ENKD1|SLC7A6OS|NLRC5|DRC7|CAPNS2|COG8|SPIRE2|MT4|ZNF469|GPT2|B3GNT9|UTP4|ZNRF1|ABCC11|NKD1|CNTNAP4|RSPRY1|MYLK3|MARVELD3|MTSS2|CENPBD1|ZNF276|CCDC102A|KCNG4|SDR42E1|ABCC12|CMTM1|PKD1L2|RNF166|EXOSC6|C16orf46|DNAAF1|NRN1L|CMTM3|C16orf78|SPATA2L|SPATA33|ZC3H18|CDYL2|SNX20|TMEM170A|SLC38A8|ZFP90|CARMIL2|KCTD19|CMTM4|CMTM2|BEAN1|SLC22A31|IL34|TMED6|ZFPM1|ADAD2|ZFP1|ADAMTS18|LDHD|FCSK|MLKL|ZNF778|ACSF3|CPNE2|ADGRG5|PRSS54|CES5A|ADGRG3|CNEP1R1|TERB1|CES4A|EXOC3L1|NUDT7|CLEC18C|SNAI3|FAM92B|ATXN1L|PKD1L3|CLEC18A|CTU2|TEPP|C16orf87|C16orf97|C16orf86|C16orf47|PABPN1L|LOC400541|FENDRR|C16orf74|MIR138-2|MIR140|NPIPB15|CTRB2|MIR328|CLEC18B|KIAA0895L|LOC654780|SYCE1L|LINC01082|C16orf95|CKLF-CMTM1|LOC101927817|LOC101928417|LOC101928737	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	16	46497599 - 90354753			523156	513788
GRCh37/hg19 16q11.2-12.1(chr16:46615804-47345238)x1	DNAJA2|ORC6|VPS35|SHCBP1|ITFG1|NETO2|GPT2|MYLK3|C16orf87	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	46615804 - 47345238			221520	223249
GRCh37/hg19 16q11.2-24.3(chr16:46615804-90142285)x1	AARS|ADCY7|AP1G1|AGRP|AMFR|APRT|ZFHX3|BBS2|GAS8-AS1|CA5A|CA7|CALB2|CBFA2T3|CBFB|CBLN1|CDH1|CDH3|CDH5|CDH8|CDH11|CDH13|CDH15|CDH16|CES1|CETP|CNGB1|COX4I1|CSNK2A2|CTRB1|CTRL|CYBA|CYLD|DHODH|NQO1|DYNC1LI2|DPEP1|E2F4|FANCA|FOXF1|FOXL1|FOXC2|GALNS|GAS8|GCSH|GLG1|GNAO1|GOT2|HAS3|HP|HPR|HSBP1|HSD11B2|HSD17B2|HSF4|IRF8|KARS|KIFC3|LCAT|MAF|MC1R|CHST6|MMP2|MMP15|MT1A|MT1B|MT1E|MT1F|MT1G|MT1H|MT1M|MT1X|MT2A|MT3|MVD|NFATC3|CHMP1A|PHKB|PLCG2|POLR2C|PSKH1|PSMB10|PSMD7|RBL2|RPL13|RRAD|SALL1|CCL17|CCL22|CX3CL1|SIAH1|ST3GAL2|SLC6A2|SLC9A5|SLC12A3|SLC12A4|SNTB2|SPG7|TAT|TERF2|TK2|ZNF19|ZNF23|GAN|SLC7A5|CDK10|TRADD|MBTPS1|CES2|NAE1|NOL3|TAF1C|SLC7A6|USP10|ATP6V0D1|ADGRG1|BCAR1|VPS9D1|N4BP1|NUP93|HERPUD1|KIAA0513|PIEZO1|DHX38|IST1|ATP2C2|CLEC3A|CHST4|MPHOSPH6|NUTF2|IRX5|DNAJA2|KATNB1|EMC8|TUBB3|CFDP1|CTCF|NFAT5|NUDT21|WWP2|PRDM7|DDX19B|GABARAPL2|MON1B|TCF25|CNOT1|PHLPP2|ZNF423|ZCCHC14|GSE1|ATMIN|RPGRIP1L|COTL1|MLYCD|SF3B3|CES3|ADAT1|CHST5|ARL2BP|ORC6|EDC4|PLA2G15|COG4|PLEKHG4|LRRC29|CPNE7|VPS4A|IL17C|TOX3|NOB1|CCDC113|TMEM208|CFAP20|FHOD1|BRD7|ANKRD11|ZDHHC1|OSGIN1|PARD6A|PLLP|CKLF|NIP7|CIAO2B|GINS2|TPPP3|TRAPPC2L|WWOX|BCO1|TERF2IP|PRMT7|NECAB2|KLHDC4|HYDIN|DEF8|DUS2|CHTF8|LPCAT2|TXNL4B|BANP|HEATR3|PDPR|RFWD3|SLC38A7|OGFOD1|LRRC36|DDX19A|FBXL8|SMPD3|ZNF821|ZDHHC7|VAC14|DOK4|VPS35|CMTR2|DDX28|TSNAXIP1|CENPN|CMC2|COQ9|CIAPIN1|THAP11|JPH3|PDP2|ZNF319|RANBP10|VAT1L|MEAK7|WFDC1|NOD2|PDF|DPEP2|DPEP3|TENT4B|AKTIP|MTHFSD|GINS3|NDRG4|ACD|DBNDD1|FTO|FA2H|IRX6|IRX3|RIPOR1|TMEM231|TANGO6|USB1|WDR59|ELMO3|KLHL36|FBXO31|SHCBP1|SETD6|ESRP2|FAM192A|CENPT|CHD9|C16orf70|CYB5B|CMIP|ITFG1|GFOD2|CDT1|MAP1LC3B|NETO2|PMFBP1|DYNLRB2|HSDL1|CRISPLD2|LONP2|ENKD1|SLC7A6OS|NLRC5|DRC7|CAPNS2|COG8|SPIRE2|MT4|ZNF469|GPT2|B3GNT9|UTP4|ZNRF1|ABCC11|NKD1|CNTNAP4|RSPRY1|MYLK3|MARVELD3|MTSS2|CENPBD1|ZNF276|CCDC102A|KCNG4|SDR42E1|ABCC12|CMTM1|PKD1L2|RNF166|EXOSC6|C16orf46|DNAAF1|NRN1L|CMTM3|C16orf78|SPATA2L|SPATA33|ZC3H18|CDYL2|SNX20|TMEM170A|SLC38A8|ZFP90|CARMIL2|KCTD19|CMTM4|CMTM2|BEAN1|SLC22A31|IL34|TMED6|ZFPM1|ADAD2|ZFP1|ADAMTS18|LDHD|FCSK|MLKL|ZNF778|ACSF3|CPNE2|ADGRG5|PRSS54|CES5A|ADGRG3|CNEP1R1|TERB1|CES4A|EXOC3L1|NUDT7|CLEC18C|SNAI3|FAM92B|ATXN1L|PKD1L3|CLEC18A|CTU2|TEPP|C16orf87|C16orf97|C16orf86|C16orf47|PABPN1L|LOC400541|FENDRR|C16orf74|MIR138-2|MIR140|NPIPB15|CTRB2|MIR328|CLEC18B|KIAA0895L|LOC654780|SYCE1L|LINC01082|C16orf95|CKLF-CMTM1|LOC101927817|LOC101928417|LOC101928737	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	46615804 - 90142285			221392	223121
NM_018092.4(NETO2):c.1532G>C (p.Arg511Thr)	NETO2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	47117178	16	47083267	161712	171574
GRCh38/hg38 16q12.1(chr16:47497444-48230506)x1	PHKB|ABCC11|ABCC12|LINC02192|LINC02133|LINC02134	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	47531355 - 48264417	16	47497444 - 48230506	221521	223250
NM_031490.4(LONP2):c.471G>T (p.Leu157Phe)	LONP2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	48290523	16	48256612	161779	171575
GRCh38/hg38 16q12.1-12.2(chr16:48543083-53879916)x1	ADCY7|CBLN1|CYLD|RBL2|SALL1|N4BP1|ZNF423|RPGRIP1L|TOX3|BRD7|HEATR3|NOD2|TENT4B|AKTIP|FTO|CHD9|NKD1|C16orf78|SNX20|CNEP1R1|CASC22|C16orf97|CASC16|LOC643802|MIR3181|LINC00919|LINC02179|LOC101927272|LINC02127|LINC01571|MIR6771|LINC02180|LOC102723373|LINC02187|LINC02178|LINC02168|LOC105371267|LOC110120581|LOC110120582|LOC110120583|LOC110120584|LOC110120585|LOC110120586|LOC110120587|LOC110120588|LOC110120823|LOC110120826|LOC110120836|LOC110120840|LOC110120841|LOC110120912|LOC110120939|LOC110121339	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	48576994 - 53913828	16	48543083 - 53879916	221522	223251
NM_001173984.2(BRD7):c.1837C>T (p.Arg613Ter)	BRD7	malignant granular cell tumor	Likely pathogenic(Last reviewed: Jul 16, 2015)	no assertion criteria provided	16	50353864	16	50319953	208203	204463
GRCh37/hg19 16q12.2-22.2(chr16:55359026-70884455)x1	AARS|AGRP|AMFR|BBS2|CA7|CBFB|CDH1|CDH3|CDH5|CDH8|CDH11|CDH16|CES1|CETP|CNGB1|CSNK2A2|CTRL|NQO1|DYNC1LI2|E2F4|GNAO1|GOT2|HAS3|HSD11B2|HSF4|KIFC3|LCAT|MMP2|MMP15|MT1A|MT1B|MT1E|MT1F|MT1G|MT1H|MT1M|MT1X|MT2A|MT3|NFATC3|POLR2C|PSKH1|PSMB10|RRAD|CCL17|CCL22|CX3CL1|ST3GAL2|SLC6A2|SLC9A5|SLC12A3|SLC12A4|SNTB2|TERF2|TK2|TRADD|CES2|NAE1|NOL3|SLC7A6|ATP6V0D1|ADGRG1|NUP93|HERPUD1|NUTF2|KATNB1|CTCF|NFAT5|NUDT21|WWP2|DDX19B|CNOT1|SF3B3|CES3|ARL2BP|EDC4|PLA2G15|COG4|PLEKHG4|LRRC29|VPS4A|NOB1|CCDC113|TMEM208|CFAP20|FHOD1|ZDHHC1|PARD6A|PLLP|CKLF|NIP7|CIAO2B|TPPP3|PRMT7|HYDIN|DUS2|CHTF8|LPCAT2|PDPR|SLC38A7|OGFOD1|LRRC36|DDX19A|FBXL8|SMPD3|VAC14|DOK4|DDX28|TSNAXIP1|COQ9|CIAPIN1|THAP11|PDP2|ZNF319|RANBP10|PDF|DPEP2|DPEP3|GINS3|NDRG4|ACD|IRX6|RIPOR1|TANGO6|USB1|ELMO3|SETD6|ESRP2|FAM192A|CENPT|C16orf70|CYB5B|GFOD2|ENKD1|SLC7A6OS|NLRC5|DRC7|CAPNS2|COG8|MT4|B3GNT9|UTP4|RSPRY1|MTSS2|CCDC102A|CMTM1|EXOSC6|NRN1L|CMTM3|ZFP90|CARMIL2|KCTD19|CMTM4|CMTM2|BEAN1|IL34|TMED6|FCSK|CPNE2|ADGRG5|PRSS54|CES5A|ADGRG3|TERB1|CES4A|EXOC3L1|CLEC18C|CLEC18A|TEPP|C16orf86|LOC400541|MIR138-2|MIR140|MIR328|KIAA0895L|CKLF-CMTM1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	55359026 - 70884455			221523	223252
NM_001144.5(AMFR):c.1786C>T (p.Arg596Cys)	AMFR	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	56396967	16	56363055	221329	223058
Single allele	AARS|AP1G1|AGRP|AMFR|APRT|ZFHX3|BBS2|GAS8-AS1|CA5A|CA7|CALB2|CBFA2T3|CBFB|CDH1|CDH3|CDH5|CDH8|CDH11|CDH13|CDH15|CDH16|CETP|CNGB1|COX4I1|CSNK2A2|CTRB1|CTRL|CYBA|DHODH|NQO1|DYNC1LI2|DPEP1|E2F4|FANCA|FOXF1|FOXL1|FOXC2|GALNS|GAS8|GCSH|GLG1|GNAO1|GOT2|HAS3|HP|HPR|HSBP1|HSD11B2|HSD17B2|HSF4|IRF8|KARS|KIFC3|LCAT|MAF|MC1R|CHST6|MMP15|MT1A|MT1B|MT1E|MT1F|MT1G|MT1H|MT1M|MT1X|MT2A|MT3|MVD|NFATC3|CHMP1A|PLCG2|POLR2C|PSKH1|PSMB10|PSMD7|RPL13|RRAD|CCL17|CCL22|CX3CL1|ST3GAL2|SLC9A5|SLC12A3|SLC12A4|SNTB2|SPG7|TAT|TERF2|TK2|ZNF19|ZNF23|GAN|SLC7A5|CDK10|TRADD|MBTPS1|CES2|NAE1|NOL3|TAF1C|SLC7A6|USP10|ATP6V0D1|ADGRG1|BCAR1|VPS9D1|NUP93|HERPUD1|KIAA0513|PIEZO1|DHX38|IST1|ATP2C2|CLEC3A|CHST4|MPHOSPH6|NUTF2|KATNB1|EMC8|TUBB3|CFDP1|CTCF|NFAT5|NUDT21|WWP2|PRDM7|DDX19B|GABARAPL2|MON1B|TCF25|CNOT1|PHLPP2|ZCCHC14|GSE1|ATMIN|COTL1|MLYCD|SF3B3|CES3|ADAT1|CHST5|ARL2BP|EDC4|PLA2G15|COG4|PLEKHG4|LRRC29|CPNE7|VPS4A|IL17C|NOB1|CCDC113|TMEM208|CFAP20|FHOD1|ANKRD11|ZDHHC1|OSGIN1|PARD6A|PLLP|CKLF|NIP7|CIAO2B|GINS2|TPPP3|TRAPPC2L|WWOX|BCO1|TERF2IP|PRMT7|NECAB2|KLHDC4|HYDIN|DEF8|DUS2|CHTF8|TXNL4B|BANP|PDPR|RFWD3|SLC38A7|OGFOD1|LRRC36|DDX19A|FBXL8|SMPD3|ZNF821|ZDHHC7|VAC14|DOK4|CMTR2|DDX28|TSNAXIP1|CENPN|CMC2|COQ9|CIAPIN1|THAP11|JPH3|PDP2|ZNF319|RANBP10|VAT1L|MEAK7|WFDC1|PDF|DPEP2|DPEP3|MTHFSD|GINS3|NDRG4|ACD|DBNDD1|FA2H|RIPOR1|TMEM231|TANGO6|USB1|WDR59|ELMO3|KLHL36|FBXO31|SETD6|ESRP2|FAM192A|CENPT|C16orf70|CYB5B|CMIP|GFOD2|CDT1|MAP1LC3B|PMFBP1|DYNLRB2|HSDL1|CRISPLD2|ENKD1|SLC7A6OS|NLRC5|DRC7|COG8|SPIRE2|MT4|ZNF469|B3GNT9|UTP4|ZNRF1|CNTNAP4|RSPRY1|MARVELD3|MTSS2|CENPBD1|ZNF276|CCDC102A|KCNG4|SDR42E1|CMTM1|PKD1L2|RNF166|EXOSC6|C16orf46|DNAAF1|NRN1L|CMTM3|SPATA2L|SPATA33|ZC3H18|CDYL2|TMEM170A|SLC38A8|ZFP90|CARMIL2|KCTD19|CMTM4|CMTM2|BEAN1|SLC22A31|IL34|TMED6|ZFPM1|ADAD2|ZFP1|ADAMTS18|LDHD|FCSK|MLKL|ZNF778|ACSF3|CPNE2|ADGRG5|PRSS54|ADGRG3|TERB1|CES4A|EXOC3L1|NUDT7|CLEC18C|SNAI3|FAM92B|ATXN1L|PKD1L3|CLEC18A|CTU2|TEPP|C16orf86|C16orf47|PABPN1L|LOC400541|FENDRR|C16orf74|MIR138-2|MIR140|NPIPB15|CTRB2|MIR328|CLEC18B|KIAA0895L|LOC654780|SYCE1L|LINC01082|C16orf95|CKLF-CMTM1|LOC101927817|LOC101928417|LOC101928737	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	56368689 - 90141355			221345	223074
NM_020786.3(PDP2):c.890A>G (p.Asn297Ser)	PDP2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	66919077	16	66885174	161736	171576
NM_018430.3(TSNAXIP1):c.1594G>A (p.Ala532Thr)	TSNAXIP1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	67861243	16	67827340	161717	171577
NM_001793.5(CDH3):c.235G>A (p.Glu79Lys)	CDH3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	68710362	16	68676459	161583	171578
NM_004360.4(CDH1):c.781G>T (p.Glu261Ter)	CDH1	Breast cancer, lobular	Pathogenic(Last reviewed: Dec 15, 1995)	no assertion criteria provided	16	68844193	16	68810290	12234	27273
NM_004360.5(CDH1):c.1849G>A (p.Ala617Thr)	CDH1	Endometrial carcinoma|Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68856041	16	68822138	12232	27271
NM_004360.4(CDH1):c.2131C>G (p.Leu711Val)	CDH1	Endometrial carcinoma|Hereditary diffuse gastric cancer|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 23, 2018)	criteria provided, multiple submitters, no conflicts	16	68857496	16	68823593	12231	27270
NM_004360.5(CDH1):c.2512A>G (p.Ser838Gly)	CDH1	Hereditary diffuse gastric cancer|Neoplasm of ovary|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68867265	16	68833362	12233	27272
NM_005329.2(HAS3):c.141G>T (p.Leu47=)	HAS3	not provided	Uncertain significance	no assertion criteria provided	16	69143439	16	69109536	91963	97441
NM_000903.2(NQO1):c.559C>T (p.Pro187Ser)	NQO1	Lung cancer|Benzene toxicity, susceptibility to|Leukemia, post-chemotherapy, susceptibility to|Breast cancer, post-chemotherapy poor survival in|Alkylating Agents, anthracyclines and related substances, fluorouracil, and Platinum compounds response - Efficacy	drug response(Last reviewed: Oct 20, 2015)	reviewed by expert panel	16	69745145	16	69711242	16809	31848
NM_006927.3(ST3GAL2):c.341T>C (p.Met114Thr)	ST3GAL2	not provided	Uncertain significance	no assertion criteria provided	16	70429077	16	70395174	91971	97449
NM_012426.4(SF3B3):c.1501G>T (p.Gly501Trp)	SF3B3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	70588447	16	70554544	161663	171579
GRCh38/hg38 16q22.2(chr16:70855202-71067341)x1	HYDIN	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	70889105 - 71101244	16	70855202 - 71067341	221524	223253
NM_001270974.2(HYDIN):c.6449T>G (p.Val2150Gly)	HYDIN	not provided	Uncertain significance	no assertion criteria provided	16	70986406	16	70952503	100830	106690
GRCh37/hg19 16q22.2(chr16:71103288-72092204)x1	AP1G1|CALB2|DHODH|HP|TAT|ZNF19|ZNF23|IST1|CHST4|PHLPP2|HYDIN|ZNF821|CMTR2|MARVELD3|ATXN1L|PKD1L3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	71103288 - 72092204			221525	223254
GRCh38/hg38 16q22.2(chr16:72059151-72063259)x0	HP|HPR|TXNL4B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	72093050 - 72097158	16	72059151 - 72063259	221526	223255
GRCh37/hg19 16q22.2-24.3(chr16:72107834-90142285)x1	APRT|ZFHX3|GAS8-AS1|CA5A|CBFA2T3|CDH13|CDH15|COX4I1|CTRB1|CYBA|DPEP1|FANCA|FOXF1|FOXL1|FOXC2|GALNS|GAS8|GCSH|GLG1|HPR|HSBP1|HSD17B2|IRF8|KARS|MAF|MC1R|CHST6|MVD|CHMP1A|PLCG2|PSMD7|RPL13|SPG7|GAN|SLC7A5|CDK10|MBTPS1|TAF1C|USP10|BCAR1|VPS9D1|KIAA0513|PIEZO1|DHX38|ATP2C2|CLEC3A|MPHOSPH6|EMC8|TUBB3|CFDP1|PRDM7|GABARAPL2|MON1B|TCF25|ZCCHC14|GSE1|ATMIN|COTL1|MLYCD|ADAT1|CHST5|CPNE7|IL17C|ANKRD11|OSGIN1|GINS2|TRAPPC2L|WWOX|BCO1|TERF2IP|NECAB2|KLHDC4|DEF8|TXNL4B|BANP|RFWD3|ZDHHC7|CENPN|CMC2|JPH3|VAT1L|MEAK7|WFDC1|MTHFSD|DBNDD1|FA2H|TMEM231|WDR59|KLHL36|FBXO31|CMIP|CDT1|MAP1LC3B|PMFBP1|DYNLRB2|HSDL1|CRISPLD2|SPIRE2|ZNF469|ZNRF1|CNTNAP4|CENPBD1|ZNF276|KCNG4|SDR42E1|PKD1L2|RNF166|C16orf46|DNAAF1|SPATA2L|SPATA33|ZC3H18|CDYL2|TMEM170A|SLC38A8|SLC22A31|ZFPM1|ADAD2|ZFP1|ADAMTS18|LDHD|MLKL|ZNF778|ACSF3|NUDT7|SNAI3|FAM92B|CTU2|C16orf47|PABPN1L|FENDRR|C16orf74|NPIPB15|CTRB2|CLEC18B|LOC654780|SYCE1L|LINC01082|C16orf95|LOC101927817|LOC101928417|LOC101928737	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	16	72107834 - 90142285			221527	223256
NM_006885.3(ZFHX3):c.10142_10165del (p.Arg3381_Gln3388del)	ZFHX3	Prostate cancer, somatic	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	16	72822010 - 72822033	16	72788111 - 72788134	18167	33206
NM_001906.5(CTRB1):c.633C>T (p.Gly211=)	CTRB1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	75258605	16	75224707	161585	171580
NM_012091.4(ADAT1):c.674C>G (p.Pro225Arg)	ADAT1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	75646510	16	75612612	161660	171581
NM_199355.3(ADAMTS18):c.1453T>A (p.Phe485Ile)	ADAMTS18	not provided	Uncertain significance	no assertion criteria provided	16	77389844	16	77355947	100896	106756
NM_016373.3(WWOX):c.872T>C (p.Leu291Pro)	WWOX	Esophageal squamous cell carcinoma, somatic	Pathogenic(Last reviewed: Apr 15, 2002)	no assertion criteria provided	16	78466465	16	78432568	5203	20242
NM_002661.4(PLCG2):c.1993C>T (p.Arg665Trp)	PLCG2	Chronic lymphocytic leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	16	81946260	16	81912655	376213	363092
NM_002661.4(PLCG2):c.2535A>T (p.Leu845Phe)	PLCG2	Chronic lymphocytic leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	16	81962183	16	81928578	376215	363094
NM_002661.4(PLCG2):c.2535A>C (p.Leu845Phe)	PLCG2	Chronic lymphocytic leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	16	81962183	16	81928578	376214	363093
NM_079837.2(BANP):c.575A>G (p.Asn192Ser)	BANP	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	16	88052070	16	88018464	487782	480789
NM_001197181.1(TUBB3):c.1072G>C (p.Ala358Pro)	TUBB3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	16	90002147	16	89935739	219299	220988
NM_014853.2(SGSM2):c.1696G>A (p.Val566Met)	SGSM2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	2275690	17	2372396	219334	221023
NM_002663.4(PLD2):c.1657C>T (p.Arg553Trp)	PLD2	not provided	Uncertain significance	no assertion criteria provided	17	4720306	17	4817011	91944	97422
NM_033007.3(NLRP1):c.2818C>T (p.Arg940Ter)	NLRP1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	5442787	17	5539467	161786	171605
GRCh37/hg19 17p13.1(chr17:6934163-8217978)x1	ACADVL|ALOX12B|ALOX15B|ASGR1|ASGR2|ATP1B2|CD68|CHD3|CHRNB1|CLDN7|DLG4|DVL2|EFNB3|EIF4A1|EIF5A|FGF11|GPS2|GUCY2D|PER1|PFAS|POLR2A|SHBG|SLC2A4|SOX15|VAMP2|TP53|TRG-GCC2-6|TRK-TTT3-5|TRL-TAG1-1|TRQ-CTG1-5|TRR-TCT2-1|TNK1|TNFSF13|TNFSF12|KCNAB3|AURKB|FXR2|MPDU1|ACAP1|CLEC10A|GABARAP|ARHGEF15|KDM6B|CTDNEP1|ELP5|SENP3|RANGRF|YBX2|BORCS6|WRAP53|PLSCR3|NLGN2|ZBTB4|TRAPPC1|ALOXE3|PHF23|CTC1|TMEM107|NAA38|NEURL4|HES7|TMEM88|SAT2|CNTROB|CYB5D1|DNAH2|KCTD11|SLC16A11|SLC16A13|SPEM2|TMEM256|TMEM102|TMEM95|SPEM1|SLC25A35|TNFSF12-TNFSF13|SLC35G6	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	17	6934163 - 8217978			523158	513790
GRCh37/hg19 17p13.1(chr17:7120452-7165252)x3	ACADVL|CLDN7|DLG4|DVL2|GABARAP|CTDNEP1|ELP5|PHF23	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	17	7120452 - 7165252			221393	223122
GRCh37/hg19 17p13.1(chr17:7121580-7186623)x3	ACADVL|CLDN7|DLG4|DVL2|SLC2A4|GABARAP|CTDNEP1|ELP5|PHF23	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	17	7121580 - 7186623			221528	223257
GRCh38/hg38 17p13.1(chr17:7603519-7768486)x1	ATP1B2|EFNB3|SHBG|TP53|FXR2|WRAP53|SAT2|DNAH2	VEGF Inhibitors response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	17	7506837 - 7671804	17	7603519 - 7768486	523161	513793
NM_000546.5(TP53):c.1044_1051delGGAACTCA (p.Glu349Glyfs)	TP53	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	17	7573976 - 7573983	17	7670658 - 7670665	377386	364268
NM_000546.5(TP53):c.969G>A (p.Leu323=)	TP53	Hereditary cancer-predisposing syndrome|Sarcoma	Likely benign(Last reviewed: Feb 19, 2016)	criteria provided, single submitter	17	7576877	17	7673559	132974	136723
NM_000546.5(TP53):c.919+1G>T	TP53	Malignant Colorectal Neoplasm	Likely pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	17	7577018	17	7673700	495326	486821
NM_000546.5(TP53):c.916C>T (p.Arg306Ter)	TP53	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Colorectal Neoplasms|Head and Neck Neoplasms	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	17	7577022	17	7673704	142144	151858
NM_000546.5(TP53):c.887A>G (p.His296Arg)	TP53	not provided	Likely pathogenic	no assertion criteria provided	17	7577051	17	7673733	100816	106676
NM_000546.5(TP53):c.886C>T (p.His296Tyr)	TP53	Li-Fraumeni syndrome|not specified|Sarcoma	Uncertain significance(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	17	7577052	17	7673734	132973	136722
NM_000546.5(TP53):c.857A>C (p.Glu286Ala)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577081	17	7673763	376593	363472
NM_001126117.1(TP53):c.461A>T (p.Glu154Val)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577081	17	7673763	376592	363471
NM_000546.5(TP53):c.857A>G (p.Glu286Gly)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Uncertain significance(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	17	7577081	17	7673763	376590	363469
NM_001126117.1(TP53):c.460G>C (p.Glu154Gln)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577082	17	7673764	376591	363470
NM_000546.5(TP53):c.856G>A (p.Glu286Lys)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Acute myeloid leukemia|not provided|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Vulvar adenocarcinoma of mammary gland type	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	17	7577082	17	7673764	183752	185345
NM_000546.5(TP53):c.853G>A (p.Glu285Lys)	TP53	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|PARP Inhibitor response	Pathogenic/Likely pathogenic, drug response(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	17	7577085	17	7673767	420133	410258
NM_000546.5(TP53):c.845G>C (p.Arg282Pro)	TP53	Liver cancer|Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	7577093	17	7673775	376659	363538
NM_000546.5(TP53):c.845G>A (p.Arg282Gln)	TP53	Liver cancer|Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|not specified|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Conflicting interpretations of pathogenicity(Last reviewed: May 24, 2018)	criteria provided, conflicting interpretations	17	7577093	17	7673775	237956	242978
NM_000546.5(TP53):c.844C>G (p.Arg282Gly)	TP53	Liver cancer|Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	17	7577094	17	7673776	140821	150535
NM_000546.5(TP53):c.844C>T (p.Arg282Trp)	TP53	Liver cancer|Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Astrocytoma, anaplastic|Li-Fraumeni-like syndrome|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Pleomorphic xanthoastrocytoma	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	17	7577094	17	7673776	12364	27403
NM_000546.5(TP53):c.843C>A (p.Asp281Glu)	TP53	Carcinoma of colon|Li-Fraumeni syndrome|not provided	Uncertain significance(Last reviewed: Feb 28, 2018)	criteria provided, multiple submitters, no conflicts	17	7577095	17	7673777	406568	403007
NM_000546.5(TP53):c.843C>G (p.Asp281Glu)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Neuroblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	17	7577095	17	7673777	376587	363466
NM_001126117.1(TP53):c.446A>C (p.Asp149Ala)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Neuroblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577096	17	7673778	376589	363468
NM_000546.5(TP53):c.842A>T (p.Asp281Val)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Neuroblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	criteria provided, multiple submitters, no conflicts	17	7577096	17	7673778	182968	180995
NM_000546.5(TP53):c.842A>G (p.Asp281Gly)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Neuroblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	17	7577096	17	7673778	141141	150855
NM_001126115.1(TP53):c.445G>C (p.Asp149His)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Neuroblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577097	17	7673779	376588	363467
NM_001126116.1(TP53):c.445G>A (p.Asp149Asn)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Neuroblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577097	17	7673779	376586	363465
NM_001126116.1(TP53):c.445G>T (p.Asp149Tyr)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Neuroblastoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577097	17	7673779	376585	363464
NM_000546.5(TP53):c.839G>A (p.Arg280Lys)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Uterine cervical neoplasms|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	17	7577099	17	7673781	376657	363536
NM_001126115.1(TP53):c.443G>T (p.Arg148Ile)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Malignant tumor of prostate|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Uterine cervical neoplasms|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	17	7577099	17	7673781	161517	171613
NM_000546.5(TP53):c.839G>C (p.Arg280Thr)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Nasopharyngeal carcinoma|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Uterine cervical neoplasms|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	17	7577099	17	7673781	12368	27407
NM_000546.5(TP53):c.838A>G (p.Arg280Gly)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Uterine cervical neoplasms|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Conflicting interpretations of pathogenicity(Last reviewed: May 3, 2018)	criteria provided, conflicting interpretations	17	7577100	17	7673782	376658	363537
NM_000546.5(TP53):c.833C>A (p.Pro278His)	TP53	Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	17	7577105	17	7673787	376646	363525
NM_000546.5(TP53):c.833C>G (p.Pro278Arg)	TP53	Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Uncertain significance(Last reviewed: Jun 20, 2016)	criteria provided, multiple submitters, no conflicts	17	7577105	17	7673787	376644	363523
NM_000546.5(TP53):c.833C>T (p.Pro278Leu)	TP53	Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	17	7577105	17	7673787	232497	236459
NM_000546.5(TP53):c.832C>G (p.Pro278Ala)	TP53	Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	17	7577106	17	7673788	376645	363524
NM_000546.5(TP53):c.832C>A (p.Pro278Thr)	TP53	Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|PARP Inhibitor response	Likely pathogenic, drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	17	7577106	17	7673788	376643	363522
NM_000546.5(TP53):c.832C>T (p.Pro278Ser)	TP53	Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Conflicting interpretations of pathogenicity(Last reviewed: Feb 15, 2018)	criteria provided, conflicting interpretations	17	7577106	17	7673788	376642	363521
NM_000546.5(TP53):c.824G>C (p.Cys275Ser)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Ovarian Serous Cystadenocarcinoma	Uncertain significance(Last reviewed: Mar 11, 2017)	criteria provided, single submitter	17	7577114	17	7673796	376583	363462
NM_001126117.1(TP53):c.428G>T (p.Cys143Phe)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577114	17	7673796	376582	363461
NM_000546.5(TP53):c.824G>A (p.Cys275Tyr)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Ovarian Serous Cystadenocarcinoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	17	7577114	17	7673796	215997	213392
NM_001126112.2(TP53):c.823T>C (p.Cys275Arg)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577115	17	7673797	376584	363463
NM_001126113.2(TP53):c.821T>C (p.Val274Ala)	TP53	Liver cancer|Malignant melanoma of skin|Small cell lung cancer|Lung adenocarcinoma|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577117	17	7673799	376677	363556
NM_000546.5(TP53):c.821T>G (p.Val274Gly)	TP53	Liver cancer|Malignant melanoma of skin|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Conflicting interpretations of pathogenicity(Last reviewed: May 12, 2018)	criteria provided, conflicting interpretations	17	7577117	17	7673799	376676	363555
NM_001126116.1(TP53):c.425T>A (p.Val142Asp)	TP53	Liver cancer|Malignant melanoma of skin|Small cell lung cancer|Lung adenocarcinoma|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577117	17	7673799	376675	363554
NM_000546.5(TP53):c.820G>C (p.Val274Leu)	TP53	Liver cancer|Malignant melanoma of skin|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Uncertain significance(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	17	7577118	17	7673800	376678	363557
NM_001126116.1(TP53):c.424G>T (p.Val142Phe)	TP53	Liver cancer|Malignant melanoma of skin|Small cell lung cancer|Lung adenocarcinoma|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577118	17	7673800	376674	363553
NM_000546.5(TP53):c.818G>T (p.Arg273Leu)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Metastatic pancreatic neuroendocrine tumours	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	17	7577120	17	7673802	376655	363534
NM_000546.5(TP53):c.818G>C (p.Arg273Pro)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, multiple submitters, no conflicts	17	7577120	17	7673802	231060	236461
NM_000546.5(TP53):c.818G>A (p.Arg273His)	TP53	Adrenocortical carcinoma, hereditary|Familial cancer of breast|Glioma susceptibility 1|Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Osteosarcoma|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Nasopharyngeal carcinoma|Carcinoma of pancreas|Choroid plexus papilloma|Small cell lung cancer|Lung adenocarcinoma|Anaplastic thyroid carcinoma|Carcinoma of colon|Li-Fraumeni syndrome|Thyroid carcinoma, anaplastic, somatic|Squamous cell lung carcinoma|Acute myeloid leukemia|not specified|Basal cell carcinoma, susceptibility to, 7|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Neoplasm|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	17	7577120	17	7673802	12366	27405
NM_000546.5(TP53):c.817C>A (p.Arg273Ser)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	17	7577121	17	7673803	376656	363535
NM_000546.5(TP53):c.817C>T (p.Arg273Cys)	TP53	Liver cancer|Li-Fraumeni syndrome 1|Malignant tumor of prostate|Li-Fraumeni syndrome|Acute myeloid leukemia|not provided|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Neoplasm	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	17	7577121	17	7673803	43594	52763
NM_001126116.1(TP53):c.419T>A (p.Val140Glu)	TP53	Medulloblastoma|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577123	17	7673805	376673	363552
NM_000546.5(TP53):c.815T>G (p.Val272Gly)	TP53	Medulloblastoma|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Uncertain significance(Last reviewed: Aug 3, 2015)	criteria provided, single submitter	17	7577123	17	7673805	233323	236462
NM_000546.5(TP53):c.814G>A (p.Val272Met)	TP53	Medulloblastoma|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Uncertain significance(Last reviewed: Nov 10, 2017)	criteria provided, multiple submitters, no conflicts	17	7577124	17	7673806	185814	185350
NM_000546.5(TP53):c.814G>T (p.Val272Leu)	TP53	Medulloblastoma|Multiple myeloma|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	17	7577124	17	7673806	12358	27397
NM_001126117.1(TP53):c.414T>G (p.Phe138Leu)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577128	17	7673810	376595	363474
NM_001126114.2(TP53):c.809T>G (p.Phe270Cys)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577129	17	7673811	376597	363476
NM_000546.5(TP53):c.809T>C (p.Phe270Ser)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	17	7577129	17	7673811	376594	363473
NM_001126115.1(TP53):c.412T>G (p.Phe138Val)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577130	17	7673812	376598	363477
NM_001126113.2(TP53):c.808T>A (p.Phe270Ile)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577130	17	7673812	376596	363475
NM_000546.5(TP53):c.797G>T (p.Gly266Val)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	17	7577141	17	7673823	233303	236463
NM_001126115.1(TP53):c.401G>A (p.Gly134Glu)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Malignant tumor of prostate|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	7577141	17	7673823	161516	171614
NM_001126115.1(TP53):c.400G>C (p.Gly134Arg)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577142	17	7673824	376605	363484
NM_000546.5(TP53):c.764T>C (p.Ile255Thr)	TP53	Chronic lymphocytic leukemia|Lung adenocarcinoma|Li-Fraumeni syndrome|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Carcinoma of esophagus	Uncertain significance(Last reviewed: Oct 22, 2016)	criteria provided, single submitter	17	7577517	17	7674199	376623	363502
NM_001126117.1(TP53):c.368T>G (p.Ile123Ser)	TP53	Chronic lymphocytic leukemia|Lung adenocarcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Carcinoma of esophagus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577517	17	7674199	376622	363501
NM_000546.5(TP53):c.764T>A (p.Ile255Asn)	TP53	Chronic lymphocytic leukemia|Lung adenocarcinoma|Li-Fraumeni syndrome|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Carcinoma of esophagus	Uncertain significance(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	17	7577517	17	7674199	232289	236468
NM_001126114.2(TP53):c.763A>T (p.Ile255Phe)	TP53	Chronic lymphocytic leukemia|Lung adenocarcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Carcinoma of esophagus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577518	17	7674200	376621	363500
NM_000546.5(TP53):c.747G>T (p.Arg249Ser)	TP53	Carcinoma of cervix|Liver cancer|Li-Fraumeni syndrome|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 25, 2018)	criteria provided, conflicting interpretations	17	7577534	17	7674216	12352	27391
NM_000546.5(TP53):c.746G>T (p.Arg249Met)	TP53	Liver cancer|Medulloblastoma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	17	7577535	17	7674217	376653	363532
NM_001126112.2(TP53):c.746G>C (p.Arg249Thr)	TP53	Liver cancer|Medulloblastoma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577535	17	7674217	376015	362894
NM_000546.5(TP53):c.746G>A (p.Arg249Lys)	TP53	Liver cancer|Medulloblastoma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|not specified|not provided|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	17	7577535	17	7674217	142241	151955
NM_000546.5(TP53):c.745A>G (p.Arg249Gly)	TP53	Liver cancer|Medulloblastoma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not provided|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	17	7577536	17	7674218	376654	363533
NM_000546.5(TP53):c.745A>T (p.Arg249Trp)	TP53	Liver cancer|Medulloblastoma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Apr 11, 2014)	criteria provided, single submitter	17	7577536	17	7674218	141881	151595
NM_000546.5(TP53):c.743G>C (p.Arg248Pro)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	17	7577538	17	7674220	237954	242980
NM_000546.5(TP53):c.743G>T (p.Arg248Leu)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	17	7577538	17	7674220	230253	236469
NM_000546.5(TP53):c.743G>A (p.Arg248Gln)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Sarcoma|Neoplasm|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Malignant Colorectal Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	17	7577538	17	7674220	12356	27395
NM_001276761.1(TP53):c.625C>G (p.Arg209Gly)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Carcinoma of colon|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	17	7577539	17	7674221	376652	363531
NM_000546.5(TP53):c.742C>T (p.Arg248Trp)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Pectus excavatum|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Short stature|Cognitive impairment|Webbed neck|not provided|Pancytopenia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Abnormality of the tongue|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Neoplasm|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	7577539	17	7674221	12347	27386
NM_000546.5(TP53):c.736A>G (p.Met246Val)	TP53	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	17	7577545	17	7674227	100815	106675
NM_000546.5(TP53):c.734G>T (p.Gly245Val)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	17	7577547	17	7674229	376603	363482
NM_000546.5(TP53):c.734G>C (p.Gly245Ala)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	17	7577547	17	7674229	265357	260191
NM_000546.5(TP53):c.734G>A (p.Gly245Asp)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	17	7577547	17	7674229	12355	27394
NM_000546.5(TP53):c.733G>C (p.Gly245Arg)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	17	7577548	17	7674230	376604	363483
NM_000546.5(TP53):c.733G>A (p.Gly245Ser)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Astrocytoma, anaplastic|Li-Fraumeni-like syndrome|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Adenocarcinoma|Carcinoma of esophagus|Neoplasm|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Atypical teratoid/rhabdoid tumor	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	7577548	17	7674230	12365	27404
NM_000546.5(TP53):c.733G>T (p.Gly245Cys)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	17	7577548	17	7674230	12349	27388
NM_001126118.1(TP53):c.614G>T (p.Gly205Val)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Glioblastoma|Hepatocellular carcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577550	17	7674232	376601	363480
NM_000546.5(TP53):c.731G>A (p.Gly244Asp)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	17	7577550	17	7674232	372785	360335
NM_001126115.1(TP53):c.334G>C (p.Gly112Arg)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Glioblastoma|Hepatocellular carcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577551	17	7674233	376602	363481
NM_000546.5(TP53):c.730G>A (p.Gly244Ser)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	17	7577551	17	7674233	376600	363479
NM_000546.5(TP53):c.730G>T (p.Gly244Cys)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Glioblastoma|Hepatocellular carcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	17	7577551	17	7674233	376599	363478
NM_001126116.1(TP53):c.330C>G (p.Cys110Trp)	TP53	Liver cancer|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Adenocarcinoma of stomach|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577555	17	7674237	376580	363459
NM_000546.5(TP53):c.725G>T (p.Cys242Phe)	TP53	Liver cancer|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Adenocarcinoma of stomach|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	17	7577556	17	7674238	376578	363457
NM_000546.5(TP53):c.725G>A (p.Cys242Tyr)	TP53	Liver cancer|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni-like syndrome|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Adenocarcinoma of stomach|Uterine Carcinosarcoma	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	17	7577556	17	7674238	12354	27393
NM_000546.5(TP53):c.724T>G (p.Cys242Gly)	TP53	Liver cancer|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Adenocarcinoma of stomach|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	17	7577557	17	7674239	376581	363460
NM_000546.5(TP53):c.724T>A (p.Cys242Ser)	TP53	Liver cancer|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Adenocarcinoma of stomach|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	17	7577557	17	7674239	376579	363458
NM_001126117.1(TP53):c.326C>A (p.Ser109Tyr)	TP53	Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577559	17	7674241	376663	363542
NM_000546.5(TP53):c.722C>G (p.Ser241Cys)	TP53	Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Likely pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, multiple submitters, no conflicts	17	7577559	17	7674241	177791	176503
NM_000546.5(TP53):c.722C>T (p.Ser241Phe)	TP53	Non-Hodgkin lymphoma|Malignant melanoma of skin|Osteosarcoma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Hepatoblastoma|Li-Fraumeni syndrome|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Likely pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	17	7577559	17	7674241	12359	27398
NM_001126114.2(TP53):c.721T>G (p.Ser241Ala)	TP53	Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577560	17	7674242	376665	363544
NM_001126115.1(TP53):c.325T>C (p.Ser109Pro)	TP53	Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577560	17	7674242	376664	363543
NM_000546.5(TP53):c.716A>C (p.Asn239Thr)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Hepatocellular carcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	17	7577565	17	7674247	376638	363517
NM_000546.5(TP53):c.716A>G (p.Asn239Ser)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	17	7577565	17	7674247	376637	363516
NM_000546.5(TP53):c.715A>G (p.Asn239Asp)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Renal cell carcinoma, papillary, 1|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2017)	criteria provided, conflicting interpretations	17	7577566	17	7674248	234036	236471
NM_001126115.1(TP53):c.318T>G (p.Cys106Trp)	TP53	Malignant tumor of prostate|Li-Fraumeni syndrome	Pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	17	7577567	17	7674249	161515	171615
NM_000546.5(TP53):c.713G>C (p.Cys238Ser)	TP53	Liver cancer|Chronic lymphocytic leukemia|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577568	17	7674250	376575	363454
NM_000546.5(TP53):c.713G>T (p.Cys238Phe)	TP53	Liver cancer|Chronic lymphocytic leukemia|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Pathogenic(Last reviewed: May 20, 2018)	criteria provided, single submitter	17	7577568	17	7674250	376574	363453
NM_000546.5(TP53):c.713G>A (p.Cys238Tyr)	TP53	Liver cancer|Chronic lymphocytic leukemia|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	17	7577568	17	7674250	182935	181000
NM_001126115.1(TP53):c.316T>G (p.Cys106Gly)	TP53	Liver cancer|Chronic lymphocytic leukemia|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577569	17	7674251	376577	363456
NM_000546.5(TP53):c.712T>C (p.Cys238Arg)	TP53	Liver cancer|Chronic lymphocytic leukemia|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Jul 6, 2015)	criteria provided, single submitter	17	7577569	17	7674251	376576	363455
NM_000546.5(TP53):c.711G>A (p.Met237Ile)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not specified|Neoplasm of brain|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2018)	criteria provided, conflicting interpretations	17	7577570	17	7674252	142714	152428
NM_001126113.2(TP53):c.710T>A (p.Met237Lys)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Pancreatic adenocarcinoma|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577571	17	7674253	376636	363515
NM_000546.5(TP53):c.709A>G (p.Met237Val)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not specified|Neoplasm of brain|Neoplasm of the breast|Pancreatic adenocarcinoma|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Uncertain significance(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	17	7577572	17	7674254	182934	181001
NM_001126115.1(TP53):c.311A>G (p.Tyr104Cys)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577574	17	7674256	376693	363572
NM_000546.5(TP53):c.706T>A (p.Tyr236Asn)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Uncertain significance(Last reviewed: May 3, 2016)	criteria provided, multiple submitters, no conflicts	17	7577575	17	7674257	376694	363573
NM_000546.5(TP53):c.706T>G (p.Tyr236Asp)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Pathogenic(Last reviewed: Mar 2, 2013)	criteria provided, single submitter	17	7577575	17	7674257	142183	151897
NM_001126114.2(TP53):c.701A>C (p.Tyr234Ser)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577580	17	7674262	376690	363569
NM_000546.5(TP53):c.701A>G (p.Tyr234Cys)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not provided|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	17	7577580	17	7674262	127820	133277
NM_000546.5(TP53):c.700T>A (p.Tyr234Asn)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7577581	17	7674263	376692	363571
NM_000546.5(TP53):c.700T>C (p.Tyr234His)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2017)	criteria provided, conflicting interpretations	17	7577581	17	7674263	376691	363570
NM_000546.5(TP53):c.700T>G (p.Tyr234Asp)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2016)	criteria provided, conflicting interpretations	17	7577581	17	7674263	219759	222738
NM_000546.5(TP53):c.666G>T (p.Pro222=)	TP53	Li-Fraumeni syndrome 1|Neoplasm of ovary|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Dec 30, 2017)	criteria provided, multiple submitters, no conflicts	17	7578183	17	7674865	132972	136721
NM_000546.5(TP53):c.659A>G (p.Tyr220Cys)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	7578190	17	7674872	127819	133276
NM_000546.5(TP53):c.659A>C (p.Tyr220Ser)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	17	7578190	17	7674872	12383	27422
NM_000546.5(TP53):c.658T>G (p.Tyr220Asp)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578191	17	7674873	376689	363568
NM_000546.5(TP53):c.658T>A (p.Tyr220Asn)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	17	7578191	17	7674873	376688	363567
NM_000546.5(TP53):c.658T>C (p.Tyr220His)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	17	7578191	17	7674873	376687	363566
NM_001126116.1(TP53):c.251T>A (p.Val84Glu)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578202	17	7674884	376672	363551
NM_001126117.1(TP53):c.251T>G (p.Val84Gly)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578202	17	7674884	376671	363550
NM_001126117.1(TP53):c.250G>T (p.Val84Leu)	TP53	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578203	17	7674885	376670	363549
NM_000546.5(TP53):c.646G>A (p.Val216Met)	TP53	Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not specified|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Carcinoma of esophagus|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Conflicting interpretations of pathogenicity(Last reviewed: Jul 3, 2018)	criteria provided, conflicting interpretations	17	7578203	17	7674885	182965	181005
NM_000546.5(TP53):c.645T>G (p.Ser215Arg)	TP53	Liver cancer|Li-Fraumeni syndrome 1|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Acute myeloid leukemia|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Uncertain significance(Last reviewed: May 10, 2017)	criteria provided, multiple submitters, no conflicts	17	7578204	17	7674886	376661	363540
NM_000546.5(TP53):c.644G>A (p.Ser215Asn)	TP53	Liver cancer|Small cell lung cancer|Lung adenocarcinoma|Acute myeloid leukemia|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: Jan 8, 2013)	criteria provided, single submitter	17	7578205	17	7674887	376662	363541
NM_001126115.1(TP53):c.248G>T (p.Ser83Ile)	TP53	Liver cancer|Small cell lung cancer|Lung adenocarcinoma|Acute myeloid leukemia|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578205	17	7674887	376660	363539
NM_000546.5(TP53):c.643A>G (p.Ser215Gly)	TP53	Liver cancer|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Acute myeloid leukemia|not provided|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2018)	criteria provided, conflicting interpretations	17	7578206	17	7674888	265337	260192
NM_000546.5(TP53):c.641A>T (p.His214Leu)	TP53	Liver cancer|Chronic lymphocytic leukemia|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578208	17	7674890	376616	363495
NM_000546.5(TP53):c.641A>G (p.His214Arg)	TP53	Liver cancer|Chronic lymphocytic leukemia|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2017)	criteria provided, conflicting interpretations	17	7578208	17	7674890	376615	363494
NM_001126114.2(TP53):c.638G>T (p.Arg213Leu)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenoid cystic carcinoma|Nasopharyngeal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578211	17	7674893	376650	363529
NM_000546.5(TP53):c.638G>C (p.Arg213Pro)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|not specified|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenoid cystic carcinoma|Nasopharyngeal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2017)	criteria provided, multiple submitters, no conflicts	17	7578211	17	7674893	231214	236477
NM_000546.5(TP53):c.638G>A (p.Arg213Gln)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|not specified|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenoid cystic carcinoma|Nasopharyngeal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|PARP Inhibitor response	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, multiple submitters, no conflicts	17	7578211	17	7674893	135359	139098
NM_001126112.2(TP53):c.637C>G (p.Arg213Gly)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenoid cystic carcinoma|Nasopharyngeal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578212	17	7674894	376651	363530
NM_000546.5(TP53):c.636delT (p.Arg213Aspfs)	TP53	Acute megakaryoblastic leukemia|Mediastinal germ cell tumor	Pathogenic(Last reviewed: Oct 22, 2015)	no assertion criteria provided	17	7578213	17	7674895	218342	215053
NM_001126118.1(TP53):c.497A>C (p.Tyr166Ser)	TP53	Liver cancer|Non-Hodgkin lymphoma|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578235	17	7674917	376683	363562
NM_001126117.1(TP53):c.218A>T (p.Tyr73Phe)	TP53	Liver cancer|Non-Hodgkin lymphoma|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578235	17	7674917	376682	363561
NM_000546.5(TP53):c.614A>G (p.Tyr205Cys)	TP53	Liver cancer|Non-Hodgkin lymphoma|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	17	7578235	17	7674917	376681	363560
NM_000546.5(TP53):c.613T>G (p.Tyr205Asp)	TP53	Liver cancer|Non-Hodgkin lymphoma|Multiple myeloma|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	17	7578236	17	7674918	376686	363565
NM_000546.5(TP53):c.613T>C (p.Tyr205His)	TP53	Liver cancer|Non-Hodgkin lymphoma|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578236	17	7674918	376685	363564
NM_000546.5(TP53):c.613T>A (p.Tyr205Asn)	TP53	Liver cancer|Non-Hodgkin lymphoma|Multiple myeloma|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	17	7578236	17	7674918	376684	363563
NM_001126112.2(TP53):c.594_611del18 (p.Gly199_Glu204del)	TP53	Small cell carcinoma of the ovary, hypercalcemic type	Likely pathogenic(Last reviewed: Jun 1, 2018)	no assertion criteria provided	17	7578238 - 7578255	17	7674920 - 7674937	560921	552028
NM_000546.5(TP53):c.587G>C (p.Arg196Pro)	TP53	Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	17	7578262	17	7674944	231165	236479
NM_000546.5(TP53):c.587G>T (p.Arg196Leu)	TP53	not provided	Conflicting interpretations of pathogenicity	no assertion criteria provided	17	7578262	17	7674944	100814	106674
NM_000546.5(TP53):c.585C>G (p.Ile195Met)	TP53	Liver cancer|Chronic lymphocytic leukemia|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	17	7578264	17	7674946	376620	363499
NM_001126116.1(TP53):c.188T>G (p.Ile63Ser)	TP53	Liver cancer|Chronic lymphocytic leukemia|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578265	17	7674947	376619	363498
NM_000546.5(TP53):c.584T>A (p.Ile195Asn)	TP53	Liver cancer|Chronic lymphocytic leukemia|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: May 30, 2018)	criteria provided, single submitter	17	7578265	17	7674947	376618	363497
NM_000546.5(TP53):c.584T>C (p.Ile195Thr)	TP53	Liver cancer|Chronic lymphocytic leukemia|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	17	7578265	17	7674947	216077	213398
NM_001126115.1(TP53):c.187A>T (p.Ile63Phe)	TP53	Liver cancer|Chronic lymphocytic leukemia|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578266	17	7674948	376617	363496
NM_000546.5(TP53):c.581T>C (p.Leu194Pro)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Ovarian Serous Cystadenocarcinoma	Uncertain significance(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	17	7578268	17	7674950	376635	363514
NM_000546.5(TP53):c.581T>A (p.Leu194His)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Ovarian Serous Cystadenocarcinoma	Uncertain significance(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	17	7578268	17	7674950	376634	363513
NM_000546.5(TP53):c.581T>G (p.Leu194Arg)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Ovarian Serous Cystadenocarcinoma	Uncertain significance(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	17	7578268	17	7674950	376633	363512
NM_000546.5(TP53):c.580C>T (p.Leu194Phe)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Uterine cervical neoplasms|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: Nov 12, 2017)	criteria provided, single submitter	17	7578269	17	7674951	127817	133274
NM_001126115.1(TP53):c.182A>C (p.His61Pro)	TP53	Liver cancer|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578271	17	7674953	376612	363491
NM_000546.5(TP53):c.578A>T (p.His193Leu)	TP53	Liver cancer|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2018)	criteria provided, conflicting interpretations	17	7578271	17	7674953	185822	185366
NM_000546.5(TP53):c.578A>G (p.His193Arg)	TP53	Liver cancer|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|not provided|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	17	7578271	17	7674953	184979	185367
NM_001126113.2(TP53):c.577C>A (p.His193Asn)	TP53	Liver cancer|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578272	17	7674954	376614	363493
NM_000546.5(TP53):c.577C>G (p.His193Asp)	TP53	Liver cancer|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578272	17	7674954	376613	363492
NM_000546.5(TP53):c.577C>T (p.His193Tyr)	TP53	Liver cancer|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|not provided|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, multiple submitters, no conflicts	17	7578272	17	7674954	230256	236481
NM_001126117.1(TP53):c.141T>G (p.His47Gln)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578393	17	7675075	376607	363486
NM_001126117.1(TP53):c.140A>C (p.His47Pro)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578394	17	7675076	376611	363490
NM_000546.5(TP53):c.536A>T (p.His179Leu)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	17	7578394	17	7675076	376608	363487
NM_000546.5(TP53):c.536A>G (p.His179Arg)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Uncertain significance(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	17	7578394	17	7675076	376606	363485
NM_001126118.1(TP53):c.418C>G (p.His140Asp)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578395	17	7675077	376610	363489
NM_000546.5(TP53):c.535C>A (p.His179Asn)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Conflicting interpretations of pathogenicity(Last reviewed: Mar 2, 2018)	criteria provided, conflicting interpretations	17	7578395	17	7675077	376609	363488
NM_000546.5(TP53):c.535C>T (p.His179Tyr)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Pathogenic/Likely pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	17	7578395	17	7675077	127815	133272
NM_000546.5(TP53):c.528C>G (p.Cys176Trp)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Uncertain significance(Last reviewed: Apr 17, 2017)	criteria provided, multiple submitters, no conflicts	17	7578402	17	7675084	376572	363451
NM_001126114.2(TP53):c.527G>T (p.Cys176Phe)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578403	17	7675085	376569	363448
NM_000546.5(TP53):c.527G>A (p.Cys176Tyr)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2018)	criteria provided, conflicting interpretations	17	7578403	17	7675085	186451	185371
NM_001126117.1(TP53):c.130T>C (p.Cys44Arg)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578404	17	7675086	376573	363452
NM_001126117.1(TP53):c.130T>G (p.Cys44Gly)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578404	17	7675086	376571	363450
NM_000546.5(TP53):c.526T>A (p.Cys176Ser)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	17	7578404	17	7675086	376570	363449
NM_000546.5(TP53):c.524G>A (p.Arg175His)	TP53	Malignant tumor of esophagus|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Neoplasm	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	17	7578406	17	7675088	12374	27413
NM_000546.5(TP53):c.523C>G (p.Arg175Gly)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Carcinoma of gallbladder	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	17	7578407	17	7675089	376649	363528
NM_000546.5(TP53):c.523C>T (p.Arg175Cys)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not specified|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Carcinoma of gallbladder	Uncertain significance(Last reviewed: Mar 12, 2018)	criteria provided, multiple submitters, no conflicts	17	7578407	17	7675089	245851	245074
NM_000546.5(TP53):c.518T>A (p.Val173Glu)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|not specified|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	17	7578412	17	7675094	376669	363548
NM_001126113.2(TP53):c.518T>C (p.Val173Ala)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578412	17	7675094	376017	362896
NM_001126112.2(TP53):c.518T>G (p.Val173Gly)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Acute myeloid leukemia|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578412	17	7675094	376016	362895
NM_000546.5(TP53):c.517G>T (p.Val173Leu)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	17	7578413	17	7675095	376668	363547
NM_000546.5(TP53):c.517G>A (p.Val173Met)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|not provided|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2018)	criteria provided, multiple submitters, no conflicts	17	7578413	17	7675095	233951	232035
NM_000546.5(TP53):c.488A>G (p.Tyr163Cys)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	17	7578442	17	7675124	127814	133271
NM_001126112.2(TP53):c.487T>C (p.Tyr163His)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578443	17	7675125	376680	363559
NM_000546.5(TP53):c.487T>A (p.Tyr163Asn)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	17	7578443	17	7675125	376679	363558
NM_000546.5(TP53):c.487T>G (p.Tyr163Asp)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: Nov 5, 2014)	criteria provided, single submitter	17	7578443	17	7675125	187052	185375
NM_001126115.1(TP53):c.85G>A (p.Ala29Thr)	TP53	Malignant tumor of prostate|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2018)	criteria provided, conflicting interpretations	17	7578449	17	7675131	161518	171616
NM_000546.5(TP53):c.469G>T (p.Val157Phe)	TP53	Liver cancer|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	17	7578461	17	7675143	12353	27392
NM_000546.5(TP53):c.462C>T (p.Gly154=)	TP53	Neoplasm of ovary	not provided	no assertion provided	17	7578468	17	7675150	133285	137024
NM_000546.5(TP53):c.460G>A (p.Gly154Ser)	TP53	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Sarcoma	Uncertain significance(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	17	7578470	17	7675152	133284	137023
NM_000546.5(TP53):c.450_459delACCCCCGCCC (p.Pro151Alafs)	TP53	Sarcoma	not provided	no assertion provided	17	7578471 - 7578480	17	7675153 - 7675162	133283	137022
NM_000546.5(TP53):c.448_459delACACCCCCGCCC (p.Thr150_Pro153del)	TP53	Sarcoma	not provided	no assertion provided	17	7578471 - 7578482	17	7675153 - 7675164	133282	137021
NM_000546.5(TP53):c.452C>G (p.Pro151Arg)	TP53	Liver cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	17	7578478	17	7675160	376640	363519
NM_000546.5(TP53):c.452C>A (p.Pro151His)	TP53	Liver cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Nov 23, 2017)	criteria provided, single submitter	17	7578478	17	7675160	376639	363518
NM_000546.5(TP53):c.451C>G (p.Pro151Ala)	TP53	Liver cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	17	7578479	17	7675161	376641	363520
NM_000546.5(TP53):c.451C>T (p.Pro151Ser)	TP53	Liver cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Breast cancer, somatic|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Breast adenocarcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	7578479	17	7675161	12370	27409
NM_000546.5(TP53):c.451C>A (p.Pro151Thr)	TP53	Liver cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Breast cancer, somatic|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Breast adenocarcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 4, 2018)	criteria provided, multiple submitters, no conflicts	17	7578479	17	7675161	12369	27408
NM_001126118.1(TP53):c.315G>T (p.Gln105His)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578498	17	7675180	376648	363527
NM_001126112.2(TP53):c.431A>T (p.Gln144Leu)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Hepatocellular carcinoma|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578499	17	7675181	376647	363526
NM_000546.5(TP53):c.431A>C (p.Gln144Pro)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus	Uncertain significance(Last reviewed: Oct 3, 2014)	criteria provided, single submitter	17	7578499	17	7675181	186594	185384
NM_000546.5(TP53):c.423C>G (p.Cys141Trp)	TP53	Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2016)	criteria provided, conflicting interpretations	17	7578507	17	7675189	376564	363443
NM_001126114.2(TP53):c.422G>T (p.Cys141Phe)	TP53	Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578508	17	7675190	376568	363447
NM_000546.5(TP53):c.422G>A (p.Cys141Tyr)	TP53	Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	17	7578508	17	7675190	140801	150515
NM_000546.5(TP53):c.421T>A (p.Cys141Ser)	TP53	Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578509	17	7675191	376567	363446
NM_001126115.1(TP53):c.25T>G (p.Cys9Gly)	TP53	Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578509	17	7675191	376566	363445
NM_001126113.2(TP53):c.421T>C (p.Cys141Arg)	TP53	Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578509	17	7675191	376565	363444
NM_000546.5(TP53):c.413delC (p.Lys139Argfs)	TP53	Familial cancer of breast	not provided	no assertion provided	17	7578517	17	7675199	133281	137020
NM_000546.5(TP53):c.405C>G (p.Cys135Trp)	TP53	Liver cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not specified|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Uncertain significance(Last reviewed: Jan 27, 2018)	criteria provided, multiple submitters, no conflicts	17	7578525	17	7675207	376561	363440
NM_000546.5(TP53):c.404G>T (p.Cys135Phe)	TP53	Liver cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	17	7578526	17	7675208	376559	363438
NM_000546.5(TP53):c.404G>A (p.Cys135Tyr)	TP53	Liver cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	17	7578526	17	7675208	141762	151476
NM_000546.5(TP53):c.403T>G (p.Cys135Gly)	TP53	Liver cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Uncertain significance(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	17	7578527	17	7675209	376563	363442
NM_001126118.1(TP53):c.286T>A (p.Cys96Ser)	TP53	Liver cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578527	17	7675209	376562	363441
NM_001126116.1(TP53):c.7T>C (p.Cys3Arg)	TP53	Liver cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578527	17	7675209	376560	363439
NM_000546.5(TP53):c.396G>C (p.Lys132Asn)	TP53	Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	17	7578534	17	7675216	376624	363503
NM_000546.5(TP53):c.395A>T (p.Lys132Met)	TP53	Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	17	7578535	17	7675217	376629	363508
NM_001126112.2(TP53):c.395A>C (p.Lys132Thr)	TP53	Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578535	17	7675217	376627	363506
NM_000546.5(TP53):c.395A>G (p.Lys132Arg)	TP53	Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Uncertain significance(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	17	7578535	17	7675217	376625	363504
NM_001126112.2(TP53):c.394A>C (p.Lys132Gln)	TP53	Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7578536	17	7675218	376628	363507
NM_000546.5(TP53):c.394A>G (p.Lys132Glu)	TP53	Multiple myeloma|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma	Conflicting interpretations of pathogenicity(Last reviewed: Dec 20, 2016)	criteria provided, conflicting interpretations	17	7578536	17	7675218	376626	363505
NM_000546.5(TP53):c.386C>T (p.Ala129Val)	TP53	Familial cancer of breast	not provided	no assertion provided	17	7578544	17	7675226	133280	137019
NM_000546.5(TP53):c.374C>G (p.Thr125Arg)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Conflicting interpretations of pathogenicity(Last reviewed: Oct 18, 2017)	criteria provided, conflicting interpretations	17	7579313	17	7675995	376667	363546
NM_000546.5(TP53):c.374C>A (p.Thr125Lys)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	17	7579313	17	7675995	216465	213402
NM_000546.5(TP53):c.374C>T (p.Thr125Met)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	17	7579313	17	7675995	183748	185394
NM_000546.5(TP53):c.373A>C (p.Thr125Pro)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7579314	17	7675996	376666	363545
NM_001126113.2(TP53):c.332T>A (p.Leu111Gln)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Carcinoma of esophagus|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7579355	17	7676037	376632	363511
NM_001126112.2(TP53):c.332T>G (p.Leu111Arg)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Squamous cell lung carcinoma|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Carcinoma of esophagus|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	7579355	17	7676037	376631	363510
NM_000546.5(TP53):c.332T>C (p.Leu111Pro)	TP53	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not specified|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Carcinoma of esophagus|Adenocarcinoma of stomach	Uncertain significance(Last reviewed: Jun 23, 2016)	criteria provided, multiple submitters, no conflicts	17	7579355	17	7676037	376630	363509
NM_000546.5(TP53):c.105G>T (p.Leu35Phe)	TP53	Carcinoma of pancreas	Pathogenic(Last reviewed: May 14, 1993)	no assertion criteria provided	17	7579582	17	7676264	12371	27410
NM_018081.2(WRAP53):c.1510T>C (p.Ser504Pro)	WRAP53	not provided	Uncertain significance	no assertion criteria provided	17	7606667	17	7703349	100869	106729
GRCh37/hg19 17p13.1(chr17:7736464-7798352)x3	CHD3|KDM6B|NAA38|TMEM88|CYB5D1|DNAH2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	17	7736464 - 7798352			221529	223258
GRCh37/hg19 17p13.1(chr17:8017865-8135384)x3	PER1|VAMP2|TRG-GCC2-6|TRK-TTT3-5|TRL-TAG1-1|TRQ-CTG1-5|TRR-TCT2-1|AURKB|BORCS6|ALOXE3|CTC1|TMEM107|HES7	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	17	8017865 - 8135384			221394	223123
GRCh37/hg19 17p13.1(chr17:8020196-8157327)x3	PER1|PFAS|VAMP2|TRG-GCC2-6|TRK-TTT3-5|TRL-TAG1-1|TRQ-CTG1-5|TRR-TCT2-1|AURKB|BORCS6|ALOXE3|CTC1|TMEM107|HES7	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	17	8020196 - 8157327			221530	223259
NM_173728.3(ARHGEF15):c.1897C>T (p.Arg633Trp)	ARHGEF15	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	8222092	17	8318774	161833	171618
NM_004853.2(STX8):c.434A>C (p.Gln145Pro)	STX8	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	9408369	17	9505052	161626	171619
Single allele	ADORA2B|COX10|DNAH9|MYH1|MYH2|MYH3|MYH4|MYH8|PMP22|RCVRN|SCO1|MAP2K4|UBB|ZNF18|GAS7|MYH13|GLP2R|PIGL|NCOR1|ARHGAP44|HS3ST3B1|HS3ST3A1|TRIM16|TRPV2|TTC19|ADPRM|ZNF286A|ELAC2|TEKT3|MYOCD|USP43|ZSWIM7|CDRT15|DHRS7C|TVP23C|CENPV|CDRT4|TBC1D26|CDRT1|TMEM220|SHISA6|PIRT|TVP23C-CDRT4	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	17	9586165 - 16325968			221346	223075
GRCh38/hg38 17p13.1-12(chr17:9701182-11983353)x1	DNAH9|MYH1|MYH2|MYH3|MYH4|MYH8|RCVRN|SCO1|ZNF18|GAS7|MYH13|GLP2R|ADPRM|USP43|DHRS7C|TMEM220|SHISA6|GSG1L2|PIRT|MYHAS|TMEM238L|TMEM220-AS1|LOC108254670	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	17	9604499 - 11886670	17	9701182 - 11983353	221395	223124
NM_002472.2(MYH8):c.2339G>T (p.Arg780Ile)	MYH8|MYHAS	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	10309451	17	10406134	161597	171583
NM_002472.2(MYH8):c.398G>T (p.Trp133Leu)	MYH8|MYHAS	not provided	Uncertain significance	no assertion criteria provided	17	10322075	17	10418758	100840	106700
NM_017533.2(MYH4):c.4849A>G (p.Arg1617Gly)	MYH4|MYHAS	not provided	Uncertain significance	no assertion criteria provided	17	10351251	17	10447934	91994	97472
NM_002470.3(MYH3):c.118G>A (p.Val40Met)	MYH3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	10558264	17	10654947	161596	171584
NM_001372.3(DNAH9):c.3184A>G (p.Ile1062Val)	DNAH9	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	11572942	17	11669625	161580	171585
GRCh37/hg19 17p12(chr17:11887472-12044521)x3	MAP2K4|ZNF18	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	17	11887472 - 12044521			221531	223260
NM_001281435.1(MAP2K4):c.571C>G (p.Leu191Val)	MAP2K4	Neuroblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	17	12011131	17	12107814	438770	432406
NM_001146312.2(MYOCD):c.543C>T (p.Asp181=)	MYOCD	not provided	Uncertain significance	no assertion criteria provided	17	12639605	17	12736288	100828	106688
NM_153604.3(MYOCD):c.2533delA (p.Lys845Argfs)	MYOCD|LOC100128006	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	12666677	17	12763360	161824	171586
GRCh37/hg19 17p11.2(chr17:16052798-16062131)x4	NCOR1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	17	16052798 - 16062131			221532	223261
NM_020653.3(ZNF287):c.1093G>C (p.Glu365Gln)	ZNF287	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	16456363	17	16553049	161733	171587
NM_144997.5(FLCN):c.1333G>A (p.Ala445Thr)	FLCN	Multiple fibrofolliculomas|Carcinoma of colon|not specified|not provided|Hereditary cancer-predisposing syndrome|Spontaneous pneumothorax	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	17	17118598	17	17215284	3370	18409
NM_144997.5(FLCN):c.236C>G (p.Ser79Trp)	FLCN	Carcinoma of colon	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	17	17131216	17	17227902	3369	18408
GRCh37/hg19 17p11.2(chr17:17718204-17726877)x3	SREBF1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	17	17718204 - 17726877			221533	223262
NM_001082968.1(TOM1L2):c.144G>T (p.Lys48Asn)	TOM1L2	not provided	Uncertain significance	no assertion criteria provided	17	17801982	17	17898668	91927	97405
NM_014683.3(ULK2):c.514G>T (p.Ala172Ser)	ULK2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	19748646	17	19845333	161681	171588
GRCh37/hg19 17q11.1-11.2(chr17:25248166-30645676)x1	ALDOC|BLMH|CPD|CRYBA1|EVI2A|EVI2B|FLOT2|LGALS9|NF1|NOS2|OMG|RPL23A|SDF2|SLC6A4|SUPT6H|TNFAIP1|VTN|FOXN1|KSR1|SLC13A2|UNC119|TIAF1|GOSR1|TRAF4|KIAA0100|SPAG5|SARM1|SUZ12|POLDIP2|TBC1D29P|WSB1|ERAL1|TMEM97|GIT1|PIPOX|CRLF3|NLK|RHOT1|COPRS|FAM222B|ADAP2|UTP6|NUFIP2|TAOK1|PHF12|TEFM|ATAD5|RAB34|NSRP1|RNF135|RAB11FIP4|CORO6|SSH2|TP53I13|IFT20|PIGS|SLC46A1|LRRC37B|ABHD15|TLCD1|SEZ6|ANKRD13B|TMEM199|PROCA1|DHRS13|RHBDL3|LYRM9|NEK8|EFCAB5|TMIGD1|MYO18A|MIR144|MIR193A|MIR451A|SEBOX	MEK Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	17	25248166 - 30645676			523166	513798
NM_014680.3(KIAA0100):c.3387G>A (p.Trp1129Ter)	KIAA0100	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	26960645	17	28633627	161680	171589
NM_178170.3(NEK8):c.589G>C (p.Ala197Pro)	NEK8	Pancreatic Neoplasms	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	17	27062360	17	28735342	376707	363586
NM_001346765.1(MYO18A):c.40G>A (p.Gly14Arg)	MYO18A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	27493919	17	29166901	219335	221024
NM_032854.3(CORO6):c.1348G>A (p.Val450Met)	CORO6	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	17	27942821	17	29615803	221307	223036
NM_018404.2(ADAP2):c.1105C>T (p.Arg369Trp)	ADAP2	not provided	Uncertain significance	no assertion criteria provided	17	29283481	17	30956463	91999	97477
NG_009018.1(NF1):g.[134769_136954del2186;136931_139830del2900]	NF1	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 30, 2013)	no assertion criteria provided	17|17	29551763 - 29553948	17|17	31224745 - 31226930	267490	262762|262763
NM_000267.3(NF1):c.4021C>T (p.Gln1341Ter)	NF1	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 2, 2015)	criteria provided, single submitter	17	29576048	17	31249030	357	15396
NM_000267.3(NF1):c.4084C>T (p.Arg1362Ter)	NF1	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	17	29576111	17	31249093	344	15383
NM_032932.5(RAB11FIP4):c.1901A>T (p.Glu634Val)	RAB11FIP4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	29858737	17	31531719	161785	171590
NM_001094.4(ASIC2):c.976C>A (p.His326Asn)	ASIC2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	31355269	17	33028251	161511	171591
NM_145898.3(CCL23):c.181C>T (p.Arg61Ter)	CCL23	not provided	Uncertain significance	no assertion criteria provided	17	34340854	17	36013814	92029	97507
NM_004774.3(MED1):c.632T>G (p.Leu211Arg)	MED1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	37587385	17	39431132	161624	171592
NM_016507.3(CDK12):c.2636G>T (p.Gly879Val)	CDK12	Lung adenocarcinoma	Likely pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	17	37665984	17	39509731	431025	424553
NM_001005862.2(ERBB2):c.836G>C (p.Gly279Ala)	ERBB2	Neoplasm of the breast	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	17	37868205	17	39711952	376205	363084
NM_001289938.1(ERBB2):c.836G>A (p.Gly279Glu)	ERBB2	Lung adenocarcinoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	17	37868205	17	39711952	376138	363017
NM_001289938.1(ERBB2):c.839C>T (p.Ser280Phe)	ERBB2	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Neoplasm|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	37868208	17	39711955	376189	363068
NM_001289938.1(ERBB2):c.839C>A (p.Ser280Tyr)	ERBB2	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Neoplasm|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	37868208	17	39711955	376188	363067
NM_004448.3(ERBB2):c.2033G>A (p.Arg678Gln)	ERBB2	Neoplasm of the breast|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	37879658	17	39723405	376344	363223
NM_004448.3(ERBB2):c.2263T>A (p.Leu755Met)	ERBB2	Malignant melanoma of skin|Neoplasm of the breast|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	37880219	17	39723966	376404	363283
NM_001289936.1(ERBB2):c.2218_2232delTTGAGGGAAAACACA (p.Leu740_Thr744del)	ERBB2	Neoplasm of the breast	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	17	37880219 - 37880233	17	39723966 - 39723980	375990	362869
NM_001005862.2(ERBB2):c.2173_2174delTTinsCC (p.Leu725Pro)	ERBB2	Malignant melanoma of skin|Lung adenocarcinoma|Neoplasm of the breast|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	37880219 - 37880220	17	39723966 - 39723967	13877	28916
NM_004448.3(ERBB2):c.2264T>G (p.Leu755Trp)	ERBB2	Malignant melanoma of skin|Neoplasm of the breast|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	37880220	17	39723967	376343	363222
NM_004448.3(ERBB2):c.2264T>C (p.Leu755Ser)	ERBB2	Malignant melanoma of skin|Neoplasm of the breast|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Colorectal Neoplasms|Papillary renal cell carcinoma, sporadic|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	37880220	17	39723967	376035	362914
NM_004448.3(ERBB2):c.2305G>A (p.Asp769Asn)	ERBB2	Neoplasm of the breast|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Uterine cervical neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	37880261	17	39724008	376403	363282
NM_001005862.2(ERBB2):c.2215G>T (p.Asp739Tyr)	ERBB2	Neoplasm of the breast|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Uterine cervical neoplasms|Adenocarcinoma of stomach	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	37880261	17	39724008	375992	362871
NM_004448.3(ERBB2):c.2305G>C (p.Asp769His)	ERBB2	Neoplasm of the breast|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Uterine cervical neoplasms|Adenocarcinoma of stomach	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	37880261	17	39724008	375991	362870
NM_004448.3(ERBB2):c.2313_2324dupATACGTGATGGC (p.Ala775_Gly776insTyrValMetAla)	ERBB2	Lung adenocarcinoma|Non-small cell lung cancer	Likely pathogenic(Last reviewed: May 15, 2012)	criteria provided, single submitter	17	37880984 - 37880995	17	39724731 - 39724742	13875	28914
NM_004448.3(ERBB2):c.2314_2325dup (p.Ala775_Gly776insTyrValMetAla)	ERBB2	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Mar 11, 2011)	criteria provided, single submitter	17	37880985 - 37880996	17	39724732 - 39724743	44985	54152
NM_001005862.2(ERBB2):c.2230delA (p.Met744Trpfs)	ERBB2	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Nov 10, 2011)	criteria provided, single submitter	17	37880991	17	39724738	44986	54153
NM_001005862.2(ERBB2):c.2234_2235insCTCCGTGATGGC (p.Ala745_Gly746insSerValMetAla)	ERBB2	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	17	37880995 - 37880996	17	39724742 - 39724743	179590	176493
NM_001005862.2(ERBB2):c.2235_2236insTCCGTGATGGCT (p.Ala745_Gly746insSerValMetAla)	ERBB2	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Aug 19, 2013)	criteria provided, single submitter	17	37880996 - 37880997	17	39724743 - 39724744	163409	176631
NM_001005862.2(ERBB2):c.2236delGinsTTAT (p.Gly746delinsLeuCys)	ERBB2	Non-small cell lung cancer	Likely pathogenic(Last reviewed: May 19, 2011)	criteria provided, single submitter	17	37880997	17	39724744	44990	54157
NM_001005862.2(ERBB2):c.2236_2237insTTT (p.Gly746delinsValCys)	ERBB2	Non-small cell lung cancer	Likely pathogenic(Last reviewed: May 28, 2010)	criteria provided, single submitter	17	37880997 - 37880998	17	39724744 - 39724745	44989	54156
NM_001005862.2(ERBB2):c.2236_2237insTGT (p.Gly746delinsValCys)	ERBB2	Non-small cell lung cancer|Neoplasm of the breast	Likely pathogenic(Last reviewed: Jun 30, 2011)	criteria provided, single submitter	17	37880997 - 37880998	17	39724744 - 39724745	44988	54155
NM_001005862.2(ERBB2):c.2236_2237insTCT (p.Gly746delinsValCys)	ERBB2	not specified	Uncertain significance(Last reviewed: Dec 3, 2009)	no assertion criteria provided	17	37880997 - 37880998	17	39724744 - 39724745	44987	54154
NM_001005862.2(ERBB2):c.2236G>A (p.Gly746Ser)	ERBB2	Neoplasm of stomach|Neoplasm|Adenocarcinoma of stomach	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	17	37880997	17	39724744	13879	28918
NM_001005862.2(ERBB2):c.2237G>T (p.Gly746Val)	ERBB2	not specified	not provided(Last reviewed: Oct 18, 2012)	no assertion provided	17	37880998	17	39724745	163410	176494
NM_004448.3(ERBB2):c.2328_2336dupTGTGGGCTC (p.Ser779_Pro780insValGlySer)	ERBB2	Lung adenocarcinoma	Pathogenic(Last reviewed: Sep 30, 2004)	no assertion criteria provided	17	37880999 - 37881007	17	39724746 - 39724754	13876	28915
NM_001289936.1(ERBB2):c.2284G>A (p.Val762Met)	ERBB2	Neoplasm of the breast|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	37881000	17	39724747	376406	363285
NM_001289936.1(ERBB2):c.2284G>C (p.Val762Leu)	ERBB2	Neoplasm of the breast	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	17	37881000	17	39724747	376036	362915
NM_001005862.2(ERBB2):c.2239G>T (p.Val747Leu)	ERBB2	not specified|Neoplasm of the breast|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach	Uncertain significance(Last reviewed: Aug 17, 2010)	criteria provided, single submitter	17	37881000	17	39724747	44991	54158
NM_004448.3(ERBB2):c.2331_2339dup (p.Pro780_Tyr781insGlySerPro)	ERBB2	Non-small cell lung cancer	Pathogenic(Last reviewed: Jul 24, 2013)	criteria provided, single submitter	17	37881002 - 37881010	17	39724749 - 39724757	44992	54159
NM_001289936.1(ERBB2):c.2287_2288insGGCTCCCCA (p.Gly763_Ser764insLeuProSer)	ERBB2	Neoplasm of the breast	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	17	37881003 - 37881004	17	39724750 - 39724751	375993	362872
NM_004448.3(ERBB2):c.2332_2340dup (p.Pro780_Tyr781insGlySerPro)	ERBB2	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Mar 6, 2013)	criteria provided, single submitter	17	37881003 - 37881011	17	39724750 - 39724758	44993	54160
NM_001289936.1(ERBB2):c.2309T>C (p.Leu770Pro)	ERBB2	Neoplasm of the breast	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	17	37881025	17	39724772	376333	363212
NM_001005862.2(ERBB2):c.2404-3C>T	ERBB2	Familial cancer of breast	not provided	no assertion provided	17	37881299	17	39725046	132944	136693
NM_001005862.2(ERBB2):c.2416C>T (p.Leu806=)	ERBB2	Endometrial carcinoma	not provided	no assertion provided	17	37881314	17	39725061	132945	136694
NM_001005862.2(ERBB2):c.2430G>A (p.Arg810=)	ERBB2	Familial cancer of breast	not provided	no assertion provided	17	37881328	17	39725075	132946	136695
NM_004448.3(ERBB2):c.2524G>A (p.Val842Ile)	ERBB2	Neoplasm of the breast|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Carcinoma of gallbladder	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	37881332	17	39725079	375994	362873
NM_001005862.2(ERBB2):c.2445C>T (p.Asp815=)	ERBB2	Familial cancer of breast	not provided	no assertion provided	17	37881343	17	39725090	133279	137018
NM_001005862.2(ERBB2):c.2478C>T (p.Pro826=)	ERBB2	Familial cancer of breast	not provided	no assertion provided	17	37881376	17	39725123	132947	136696
NM_001005862.2(ERBB2):c.2480A>G (p.Asn827Ser)	ERBB2	Neoplasm of ovary|Ovarian Adenocarcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	17	37881378	17	39725125	13880	28919
NM_001005862.2(ERBB2):c.2515C>T (p.Leu839=)	ERBB2	Neoplasm of ovary	not provided	no assertion provided	17	37881413	17	39725160	132948	136697
NM_004448.3(ERBB2):c.2606T>G (p.Leu869Arg)	ERBB2	Lung adenocarcinoma	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	17	37881414	17	39725161	431024	424554
NM_004448.3(ERBB2):c.2686C>T (p.Arg896Cys)	ERBB2	Neoplasm of the breast	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	17	37881616	17	39725363	375995	362874
NM_004448.3(ERBB2):c.2706G>C (p.Gln902His)	ERBB2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	37881636	17	39725383	161622	171593
NM_001005862.2(ERBB2):c.2650G>A (p.Glu884Lys)	ERBB2	Glioma susceptibility 1	Pathogenic(Last reviewed: Sep 30, 2004)	no assertion criteria provided	17	37881974	17	39725721	13878	28917
NM_001005862.2(ERBB2):c.3056G>A (p.Ser1019Asn)	ERBB2	Familial cancer of breast	not provided	no assertion provided	17	37883243	17	39726990	132963	136712
NM_001303533.1(RAPGEFL1):c.398A>G (p.Gln133Arg)	RAPGEFL1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	38345135	17	40188883	219336	221025
NM_000964.3(RARA):c.826C>T (p.Arg276Trp)	RARA	all trans retinoic acid (ATRA) response	drug response(Last reviewed: Mar 1, 2015)	no assertion criteria provided	17	38510572	17	40354320	191350	189152
NM_000964.3(RARA):c.1225_1389del165 (p.Leu409_Ter463delinsProPro)	RARA	all trans retinoic acid (ATRA) response	drug response(Last reviewed: Mar 1, 2015)	no assertion criteria provided	17	38512314 - 38512478	17	40356062 - 40356226	191351	189153
NM_213656.3(KRT39):c.1461A>C (p.Arg487Ser)	KRT39	not provided	Uncertain significance	no assertion criteria provided	17	39114868	17	40958616	100899	106759
NM_004138.3(KRT33A):c.215A>G (p.Glu72Gly)	KRT33A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	39506805	17	41350553	161620	171594
NM_000226.3(KRT9):c.1141G>T (p.Glu381Ter)	KRT9	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	39724789	17	41568537	161462	171595
NM_003150.3(STAT3):c.1467T>A (p.Asn489Lys)	STAT3	Adenoid cystic carcinoma	Uncertain significance(Last reviewed: Feb 1, 2018)	no assertion criteria provided	17	40476862	17	42324844	495135	486685
NM_005177.3(ATP6V0A1):c.1023+1G>T	ATP6V0A1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	40639386	17	42487368	161630	171596
NM_173079.4(RUNDC1):c.866G>C (p.Gly289Ala)	RUNDC1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	41142343	17	42990326	219337	221026
NM_007294.3(BRCA1):c.5503C>T (p.Arg1835Ter)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41197784	17	43045767	55601	70268
NM_007294.3(BRCA1):c.5440delG (p.Ala1814Profs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41199687	17	43047670	55579	70246
NM_007294.3(BRCA1):c.5406+1_5406+3delGTA	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	17	41201135 - 41201137	17	43049118 - 43049120	55560	70227
NM_007294.3(BRCA1):c.5386dupT (p.Ser1796Phefs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41201158	17	43049141	55558	70225
NM_007294.3(BRCA1):c.5193+1G>C	BRCA1	Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, multiple submitters, no conflicts	17	41215349	17	43063332	55448	70115
NM_007294.3(BRCA1):c.5173G>T (p.Glu1725Ter)	BRCA1	Breast-ovarian cancer, familial 1|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41215370	17	43063353	55442	70109
NM_007294.3(BRCA1):c.5153-66T>A	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Jun 22, 1999)	no assertion criteria provided	17	41215456	17	43063439	125789	131327
NM_007294.3(BRCA1):c.5152+66G>A	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41215825	17	43063808	55428	70095
NM_007294.3(BRCA1):c.5074+284C>A	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41219341	17	43067324	127127	132630
NM_007294.3(BRCA1):c.5074+65G>A	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|not specified	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41219560	17	43067543	127126	132629
NM_007294.3(BRCA1):c.4903G>T (p.Glu1635Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41223028	17	43071011	55311	69978
NM_007294.3(BRCA1):c.4837A>G (p.Ser1613Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41223094	17	43071077	41827	50266
NM_007294.3(BRCA1):c.4755del (p.Glu1586Serfs)	BRCA1	Neoplasm of the breast	Pathogenic(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	17	41223176	17	43071159	224423	226194
NM_007294.3(BRCA1):c.4704C>T (p.Ile1568=)	BRCA1	Neoplasm of the breast	Uncertain significance(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	17	41223227	17	43071210	224435	226196
NM_007294.3(BRCA1):c.4696_4697insA (p.Ser1566Tyrfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41223234 - 41223235	17	43071217 - 43071218	125728	131266
NM_007294.3(BRCA1):c.4656C>G (p.Tyr1552Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41226367	17	43074350	55253	69920
NM_007294.3(BRCA1):c.4372C>T (p.Gln1458Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41228617	17	43076600	55183	69850
NM_007294.3(BRCA1):c.4308T>C (p.Ser1436=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41234470	17	43082453	125703	131241
NM_007294.3(BRCA1):c.4189A>C (p.Arg1397=)	BRCA1	Neoplasm of the breast	Uncertain significance(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	17	41234589	17	43082572	224434	226197
NM_007294.3(BRCA1):c.4097-141A>C	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|not specified	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41243190	17	43091173	125674	131212
NM_007294.3(BRCA1):c.4065_4068delTCAA (p.Asn1355Lysfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41243480 - 41243483	17	43091463 - 43091466	17674	32713
NM_007294.3(BRCA1):c.4050_4051insG (p.Leu1351Valfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41243497 - 41243498	17	43091480 - 43091481	125661	131199
NM_007294.3(BRCA1):c.3903T>A (p.Ser1301Arg)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Apr 16, 2016)	criteria provided, single submitter	17	41243645	17	43091628	55044	69711
NM_007294.3(BRCA1):c.3862delG (p.Glu1288Lysfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243686	17	43091669	55031	69698
NM_007294.3(BRCA1):c.3858_3861delTGAG (p.Ser1286Argfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243687 - 41243690	17	43091670 - 43091673	37553	46109
NM_007294.3(BRCA1):c.3839_3843delCTCAGinsAGGC (p.Ser1280Terfs)	BRCA1	Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41243705 - 41243709	17	43091688 - 43091692	55021	69688
NM_007294.3(BRCA1):c.3612delA (p.Ala1206Profs)	BRCA1	Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243936	17	43091919	37533	46089
NM_007294.3(BRCA1):c.3607C>G (p.Arg1203Gly)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: May 26, 2005)	no assertion criteria provided	17	41243941	17	43091924	54934	69601
NM_007294.3(BRCA1):c.3590delA (p.His1197Leufs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Aug 1, 2017)	no assertion criteria provided	17	41243958	17	43091941	433193	426756
NM_007294.3(BRCA1):c.3548_3549delAA (p.Lys1183Argfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243999 - 41244000	17	43091982 - 43091983	125636	131174
NM_007294.3(BRCA1):c.3508A>T (p.Ile1170Phe)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: May 26, 2005)	no assertion criteria provided	17	41244040	17	43092023	54905	69572
NM_007294.3(BRCA1):c.3432G>T (p.Gln1144His)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: May 29, 2002)	no assertion criteria provided	17	41244116	17	43092099	54884	69551
NM_007294.3(BRCA1):c.3342_3345delAGAA (p.Glu1115Terfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244203 - 41244206	17	43092186 - 43092189	54850	69517
NM_007294.3(BRCA1):c.3214delC (p.Leu1072Terfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244334	17	43092317	54798	69465
NM_007294.3(BRCA1):c.3113A>G (p.Glu1038Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Pancreatic cancer 4|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|FANCONI ANEMIA, COMPLEMENTATION GROUP S	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244435	17	43092418	41815	50254
NM_007294.3(BRCA1):c.3071G>C (p.Ser1024Thr)	BRCA1	Neoplasm of the breast	Uncertain significance(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	17	41244477	17	43092460	224431	226201
NM_007294.3(BRCA1):c.3026C>A (p.Ser1009Ter)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244522	17	43092505	54756	69423
NM_007294.3(BRCA1):c.2899A>T (p.Thr967Ser)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: May 26, 2005)	no assertion criteria provided	17	41244649	17	43092632	54711	69378
NM_007294.3(BRCA1):c.2635G>T (p.Glu879Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244913	17	43092896	37478	46034
NM_007294.3(BRCA1):c.2612C>T (p.Pro871Leu)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244936	17	43092919	41812	50251
NM_007294.3(BRCA1):c.2601_2604dupGTCA (p.Phe869Valfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244944 - 41244947	17	43092927 - 43092930	254415	249128
NM_007294.3(BRCA1):c.2566T>C (p.Tyr856His)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244982	17	43092965	54604	69271
NM_007294.3(BRCA1):c.2428A>T (p.Asn810Tyr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245120	17	43093103	54567	69234
NM_007294.3(BRCA1):c.2420C>A (p.Ala807Glu)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: May 26, 2005)	no assertion criteria provided	17	41245128	17	43093111	54566	69233
NM_007294.3(BRCA1):c.2356C>T (p.Leu786=)	BRCA1	Breast-ovarian cancer, familial 1	Benign(Last reviewed: Feb 20, 2013)	no assertion criteria provided	17	41245192	17	43093175	125557	131095
NM_007294.3(BRCA1):c.2311T>C (p.Leu771=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Pancreatic cancer 4|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|FANCONI ANEMIA, COMPLEMENTATION GROUP S	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41245237	17	43093220	125554	131092
NM_007294.3(BRCA1):c.2216_2217delAA (p.Lys739Serfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245331 - 41245332	17	43093314 - 43093315	54504	69171
NM_007294.3(BRCA1):c.2158G>A (p.Glu720Lys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 21, 2014)	criteria provided, single submitter	17	41245390	17	43093373	54479	69146
NM_007294.3(BRCA1):c.2098_2099insA (p.Leu700Hisfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245449 - 41245450	17	43093432 - 43093433	125539	131077
NM_007294.3(BRCA1):c.2082C>T (p.Ser694=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41245466	17	43093449	125536	131074
NM_007294.3(BRCA1):c.2077G>A (p.Asp693Asn)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245471	17	43093454	41808	50247
NM_007294.3(BRCA1):c.1961dupA (p.Tyr655Valfs)	BRCA1	Breast-ovarian cancer, familial 1|Ovarian cancer|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41245587	17	43093570	54417	69084
NM_007294.3(BRCA1):c.1648_1860del213 (p.Asn550_Ile620del)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Jun 22, 1999)	no assertion criteria provided	17	41245688 - 41245900	17	43093671 - 43093883	54317	68984
NM_007294.3(BRCA1):c.1504_1508delTTAAA (p.Leu502Alafs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Dysgerminoma|DYSGERMINOMA	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41246040 - 41246044	17	43094023 - 43094027	37417	45973
NM_007294.3(BRCA1):c.1116G>A (p.Trp372Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246432	17	43094415	54135	68802
NM_007294.3(BRCA1):c.1011dupA (p.Val340Glyfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246532	17	43094515	54102	68769
NM_007294.3(BRCA1):c.1016delA (p.Lys339Argfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246532	17	43094515	37386	45942
NM_007294.3(BRCA1):c.981_982delAT (p.Cys328Terfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41246566 - 41246567	17	43094549 - 43094550	55772	70439
NM_007294.3(BRCA1):c.959_960delGA (p.Arg320Metfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246588 - 41246589	17	43094571 - 43094572	55764	70431
NM_007294.3(BRCA1):c.671-248_671-246dupAGG	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41247123 - 41247125	17	43095106 - 43095108	127125	132628
NM_007294.3(BRCA1):c.470_471delCT (p.Ser157Terfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41251868 - 41251869	17	43099851 - 43099852	37608	46164
NM_007294.3(BRCA1):c.470delC (p.Ser157Leufs)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Feb 20, 2013)	no assertion criteria provided	17	41251869	17	43099852	125877	131415
NM_007294.3(BRCA1):c.442_444delCAG (p.Gln148del)	BRCA1	Breast-ovarian cancer, familial 1|not specified	Uncertain significance(Last reviewed: Jan 31, 2014)	no assertion criteria provided	17	41251895 - 41251897	17	43099878 - 43099880	55198	69865
NM_007294.3(BRCA1):c.213-1G>A	BRCA1	Breast-ovarian cancer, familial 1|Neoplasm of the breast	Pathogenic(Last reviewed: Nov 1, 2015)	criteria provided, multiple submitters, no conflicts	17	41256974	17	43104957	54472	69139
NM_007294.3(BRCA1):c.212+1G>T	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	17	41258472	17	43106455	54465	69132
NM_007294.3(BRCA1):c.211A>G (p.Arg71Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41258474	17	43106457	17693	32732
NM_007294.3(BRCA1):c.181T>G (p.Cys61Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast carcinoma	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41258504	17	43106487	17661	32700
NM_007294.3(BRCA1):c.70_71insTGTC (p.Cys24Leufs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41276043 - 41276044	17	43124026 - 43124027	125512	131050
NM_007294.3(BRCA1):c.32_33insC (p.Gln12Thrfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41276081 - 41276082	17	43124064 - 43124065	54829	69496
NM_007294.3(BRCA1):c.-2A>T	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: May 26, 2005)	no assertion criteria provided	17	41276115	17	43124098	125485	131023
NM_007294.3(BRCA1):c.-3G>C	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Jun 22, 1998)	no assertion criteria provided	17	41276116	17	43124099	125484	131022
NM_001076683.1(UBTF):c.2053G>T (p.Asp685Tyr)	UBTF	not provided	Conflicting interpretations of pathogenicity	no assertion criteria provided	17	42284827	17	44207459	100822	106682
NM_002087.3(GRN):c.1626C>T (p.Ala542=)	GRN	not provided	Uncertain significance	no assertion criteria provided	17	42429921	17	44352553	91940	97418
NM_000419.4(ITGA2B):c.798G>A (p.Trp266Ter)	ITGA2B	not provided	Uncertain significance	no assertion criteria provided	17	42462317	17	44384949	100811	106671
chr17:45008570..45994044 complex variant	CDC27|ITGB3|KPNB1|MYL4|SP2|NPEPPS|GOSR2|TBKBP1|TBX21|SP6|LRRC46|SCRN2|OSBPL7|EFCAB13|MRPL10|RPRML	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	17	45008570 - 45994044			221347	223076
NM_016835.4(MAPT):c.69G>C (p.Arg23Ser)	MAPT	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	44039772	17	45962406	161704	171597
NM_016835.4(MAPT):c.100G>T (p.Asp34Tyr)	MAPT	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	44039803	17	45962437	161703	171598
NM_016835.4(MAPT):c.834G>C (p.Glu278Asp)	MAPT	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	44061004	17	45983638	161705	171599
NM_001007228.1(SPOP):c.399C>G (p.Phe133Leu)	SPOP	Malignant tumor of prostate|Adenocarcinoma of prostate	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696424	17	49619062	161487	171600
NM_001007226.1(SPOP):c.398T>C (p.Phe133Ser)	SPOP	Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696425	17	49619063	376547	363426
NM_001007226.1(SPOP):c.398T>G (p.Phe133Cys)	SPOP	Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696425	17	49619063	376546	363425
NM_001007226.1(SPOP):c.397T>A (p.Phe133Ile)	SPOP	Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696426	17	49619064	376548	363427
NM_001007226.1(SPOP):c.397T>G (p.Phe133Val)	SPOP	Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696426	17	49619064	376545	363424
NM_001007226.1(SPOP):c.393G>T (p.Trp131Cys)	SPOP	Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696430	17	49619068	376552	363431
NM_001007226.1(SPOP):c.392G>C (p.Trp131Ser)	SPOP	Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696431	17	49619069	376550	363429
NM_001007226.1(SPOP):c.391T>A (p.Trp131Arg)	SPOP	Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696432	17	49619070	376551	363430
NM_001007226.1(SPOP):c.391T>G (p.Trp131Gly)	SPOP	Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696432	17	49619070	376549	363428
NM_001007226.1(SPOP):c.306C>G (p.Phe102Leu)	SPOP	Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696642	17	49619280	376544	363423
NM_001007228.1(SPOP):c.305T>G (p.Phe102Cys)	SPOP	Malignant tumor of prostate|Adenocarcinoma of prostate	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696643	17	49619281	161486	171601
NM_001007226.1(SPOP):c.304T>G (p.Phe102Val)	SPOP	Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696644	17	49619282	376543	363422
NM_001007226.1(SPOP):c.260A>G (p.Tyr87Cys)	SPOP	Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696688	17	49619326	376555	363434
NM_001007226.1(SPOP):c.260A>C (p.Tyr87Ser)	SPOP	Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696688	17	49619326	376553	363432
NM_001007226.1(SPOP):c.259T>A (p.Tyr87Asn)	SPOP	Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	17	47696689	17	49619327	376554	363433
NM_007067.4(KAT7):c.1687C>T (p.Gln563Ter)	KAT7	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	47904114	17	49826752	161655	171602
NM_000088.3(COL1A1):c.3277C>T (p.Arg1093Cys)	COL1A1	Osteogenesis imperfecta type I|Malignant tumor of prostate	Uncertain significance(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	17	48265329	17	50187968	161457	171603
NM_002126.4(HLF):c.436_437insA (p.Ser146Lysfs)	HLF	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	53345432	17	55268071	161590	171604
NM_001242902.1(AKAP1):c.239A>G (p.Lys80Arg)	AKAP1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	55183064	17	57105703	161577	171606
NM_003488.3(AKAP1):c.926_946del21 (p.Gly323_Glu329del)	AKAP1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	17	55183751 - 55183771	17	57106390 - 57106410	221331	223060
NM_198393.3(TEX14):c.3263C>T (p.Ser1088Leu)	TEX14	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	56659000	17	58581639	161852	171607
NM_030938.4(VMP1):c.331_332delCT (p.Leu111Phefs)	VMP1	Monoclonal B-Cell Lymphocytosis	Uncertain significance(Last reviewed: Dec 15, 2015)	no assertion criteria provided	17	57816225 - 57816226	17	59738864 - 59738865	222959	224687
NM_199340.4(LRRC37A3):c.3859delG (p.Ala1287Leufs)	LRRC37A3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	62856405	17	64860287	161856	171608
NM_004655.3(AXIN2):c.2116G>T (p.Glu706Ter)	AXIN2	Carcinoma of colon	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	17	63532463	17	65536345	5879	20918
NM_004655.3(AXIN2):c.1994delG (p.Gly665Alafs)	AXIN2	Oligodontia-colorectal cancer syndrome|Carcinoma of colon	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	17	63532585	17	65536467	5880	20919
NM_001033571.1(AMZ2):c.521C>A (p.Thr174Lys)	AMZ2	Monoclonal B-Cell Lymphocytosis	Uncertain significance(Last reviewed: Dec 15, 2015)	no assertion criteria provided	17	66247254	17	68251113	222960	224688
NM_002734.4(PRKAR1A):c.329C>T (p.Ala110Val)	PRKAR1A	Carney complex, type 1|Medulloblastoma	Uncertain significance(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	17	66519048	17	68522907	438784	432415
NM_002734.4(PRKAR1A):c.892-1G>A	PRKAR1A	Adrenocortical tumor, somatic	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	17	66526060	17	68529919	12673	27712
NM_000346.3(SOX9):c.61G>A (p.Ala21Thr)	SOX9|LOC108021846	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	70117593	17	72121452	161465	171609
NM_001159770.1(SLC39A11):c.616G>T (p.Val206Phe)	SLC39A11	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	17	70845779	17	72849640	487809	480816
NM_018714.2(COG1):c.1348C>T (p.Gln450Ter)	COG1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	71197314	17	73201175	161722	171610
NM_018714.2(COG1):c.2125G>A (p.Val709Ile)	COG1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	71199190	17	73203051	161723	171611
NM_017941.5(C17orf80):c.973C>T (p.Arg325Trp)	C17orf80	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	71232594	17	73236455	219338	221027
NM_014738.5(TMEM94):c.953A>G (p.Gln318Arg)	TMEM94	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	73485742	17	75489661	161682	171612
NM_003003.3(SEC14L1):c.100C>G (p.Pro34Ala)	SEC14L1	Monoclonal B-Cell Lymphocytosis	Uncertain significance(Last reviewed: Dec 15, 2015)	no assertion criteria provided	17	75186921	17	77190839	222961	224689
NM_003258.4(TK1):c.596G>T (p.Gly199Val)	TK1	not provided	Uncertain significance	no assertion criteria provided	17	76170949	17	78174868	91947	97425
NM_178543.4(ENPP7):c.68C>T (p.Pro23Leu)	ENPP7	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	17	77704969	17	79731207	161838	171617
NM_001256071.2(RNF213):c.12841C>T (p.Arg4281Trp)	RNF213|LOC100294362	Anaplastic ependymoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	17	78346864	17	80373064	438786	432417
NM_005559.3(LAMA1):c.2488A>C (p.Arg830=)	LAMA1	not provided	Uncertain significance	no assertion criteria provided	18	7024380	18	7024381	91966	97444
NM_015208.4(ANKRD12):c.2593G>T (p.Asp865Tyr)	ANKRD12	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	18	9255858	18	9255860	219339	221028
GRCh37/hg19 18p11.21-q11.1(chr18:14748529-18690826)x3	ROCK1|ANKRD30B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	18	14748529 - 18690826			221534	223263
NM_005406.2(ROCK1):c.3577C>T (p.Pro1193Ser)	ROCK1	Lung cancer|Neoplasm of the breast	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	18	18535142	18	20955181	376704	363583
NM_005257.5(GATA6):c.712G>T (p.Gly238Ter)	GATA6	Pancreatic agenesis and congenital heart disease|Abnormality of cardiovascular system morphology|Congenital diaphragmatic hernia	Pathogenic(Last reviewed: Jan 24, 2014)	criteria provided, single submitter	18	19751817	18	22171856	156010	165814
NM_002894.2(RBBP8):c.1009A>G (p.Lys337Glu)	RBBP8	Microcephaly with mental retardation and digital anomalies|Seckel syndrome|Carcinoma of pancreas	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	18	20572799	18	22992836	5824	20863
GRCh37/hg19 18q12.2(chr18:33611007-33722860)x4	SLC39A6|RPRD1A|ELP2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	18	33611007 - 33722860			221535	223264
NM_015559.3(SETBP1):c.2608G>A (p.Gly870Ser)	SETBP1	Chronic myelogenous leukemia|Schinzel-Giedion syndrome	Pathogenic(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	18	42531913	18	44951948	1035	16074
NM_144612.6(LOXHD1):c.2813G>A (p.Arg938Lys)	LOXHD1	not provided	Uncertain significance	no assertion criteria provided	18	44140294	18	46560331	92027	97505
NM_016427.2(ELOA2):c.367T>C (p.Ser123Pro)	ELOA2|KATNAL2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	18	44561269	18	47034898	161702	171620
NM_017653.4(DYM):c.1614C>G (p.Ile538Met)	DYM	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	18	46645246	18	49118876	161709	171621
NM_005359.5(SMAD4):c.989A>C (p.Glu330Ala)	SMAD4	Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	18	48591826	18	51065456	375996	362875
NM_005359.5(SMAD4):c.1051G>C (p.Asp351His)	SMAD4	Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	18	48591888	18	51065518	375998	362877
NM_005359.5(SMAD4):c.1051G>A (p.Asp351Asn)	SMAD4	Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	18	48591888	18	51065518	375997	362876
NM_005359.5(SMAD4):c.1065C>A (p.Asp355Glu)	SMAD4	Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	18	48591902	18	51065532	375999	362878
NM_005359.5(SMAD4):c.1072G>T (p.Gly358Ter)	SMAD4	Carcinoma of pancreas	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	18	48591909	18	51065539	8536	23575
NM_005359.5(SMAD4):c.1081C>G (p.Arg361Gly)	SMAD4	Juvenile polyposis syndrome|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|JP and JP/HHT|Neoplasm of the breast|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	18	48591918	18	51065548	24830	36171
NM_005359.5(SMAD4):c.1081C>A (p.Arg361Ser)	SMAD4	Juvenile polyposis syndrome|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	18	48591918	18	51065548	24822	36163
NM_005359.5(SMAD4):c.1081C>T (p.Arg361Cys)	SMAD4	Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|JP, JP/HHT, and HHT|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	18	48591918	18	51065548	8543	23582
NM_005359.5(SMAD4):c.1082G>C (p.Arg361Pro)	SMAD4	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	18	48591919	18	51065549	376541	363420
NM_005359.5(SMAD4):c.1082G>A (p.Arg361His)	SMAD4	Juvenile polyposis syndrome|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|JP and JP/HHT|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	18	48591919	18	51065549	24832	36173
NM_005359.5(SMAD4):c.1156G>T (p.Gly386Cys)	SMAD4	Lung adenocarcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	18	48593405	18	51067035	376539	363418
NM_005359.5(SMAD4):c.1156G>A (p.Gly386Ser)	SMAD4	Lung adenocarcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	18	48593405	18	51067035	376538	363417
NM_005359.5(SMAD4):c.1157G>C (p.Gly386Ala)	SMAD4	Lung adenocarcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	18	48593406	18	51067036	376540	363419
NM_005359.5(SMAD4):c.1157G>T (p.Gly386Val)	SMAD4	Lung adenocarcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	18	48593406	18	51067036	376537	363416
NM_005359.5(SMAD4):c.1157G>A (p.Gly386Asp)	SMAD4	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Lung adenocarcinoma|JP and JP/HHT|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	18	48593406	18	51067036	8545	23584
NM_005359.5(SMAD4):c.1236C>G (p.Tyr412Ter)	SMAD4	Juvenile polyposis syndrome|Carcinoma of pancreas	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48593485	18	51067115	24845	36186
NM_005359.5(SMAD4):c.1477G>C (p.Asp493His)	SMAD4	Carcinoma of pancreas	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	18	48604655	18	51078285	8538	23577
NM_005359.5(SMAD4):c.1543A>T (p.Arg515Ter)	SMAD4	Carcinoma of pancreas	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	18	48604721	18	51078351	8539	23578
NM_005359.5(SMAD4):c.1609G>T (p.Asp537Tyr)	SMAD4	Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	18	48604787	18	51078417	376000	362879
NM_005359.5(SMAD4):c.1610A>G (p.Asp537Gly)	SMAD4	Colorectal cancer	Likely pathogenic(Last reviewed: Nov 27, 2017)	no assertion criteria provided	18	48604788	18	51078418	523175	513785
NM_005215.3(DCC):c.503T>C (p.Met168Thr)	DCC	Esophageal carcinoma, somatic	Pathogenic(Last reviewed: Jun 1, 1994)	no assertion criteria provided	18	50432504	18	52906134	17075	32114
NM_005215.3(DCC):c.4124C>A (p.Pro1375His)	DCC	Carcinoma of colon	Pathogenic(Last reviewed: Feb 1, 1994)	no assertion criteria provided	18	51052999	18	53526629	17074	32113
Single allele	CDH7|SERPINB2|SERPINB8|SERPINB10|SERPINB7|SERPINB11|HMSD	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	18	61387312 - 63489378			221348	223077
NM_020854.3(RELCH):c.1735C>A (p.Gln579Lys)	RELCH	not provided	Uncertain significance	no assertion criteria provided	18	59919898	18	62252665	92009	97487
NM_012397.3(SERPINB13):c.893C>T (p.Ala298Val)	SERPINB13	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	18	61264314	18	63597080	219298	220987
NM_002974.3(SERPINB4):c.476T>A (p.Ile159Asn)	SERPINB4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	18	61307004	18	63639770	161604	171622
NM_000455.4(STK11):c.108C>A (p.Tyr36Ter)	STK11	Carcinoma of pancreas	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	19	1207020	19	1207021	7452	22491
NM_000455.4(STK11):c.109C>T (p.Gln37Ter)	STK11	Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, multiple submitters, no conflicts	19	1207021	19	1207022	376334	363213
NM_000455.4(STK11):c.145T>G (p.Tyr49Asp)	STK11	Cutaneous malignant melanoma 1	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	19	1207057	19	1207058	7456	22495
NM_000455.4(STK11):c.200T>C (p.Leu67Pro)	STK11	Peutz-Jeghers syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, multiple submitters, no conflicts	19	1207112	19	1207113	7445	22484
NM_000455.4(STK11):c.256C>G (p.Arg86Gly)	STK11	Squamous cell lung carcinoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	1207168	19	1207169	376742	363621
NM_000455.4(STK11):c.323A>G (p.Lys108Arg)	STK11	Peutz-Jeghers syndrome	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	1218448	19	1218449	376743	363622
NM_000455.4(STK11):c.368A>G (p.Gln123Arg)	STK11	Squamous cell lung carcinoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	1218493	19	1218494	376709	363588
NM_000455.4(STK11):c.403G>C (p.Gly135Arg)	STK11	Cutaneous malignant melanoma 1	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	19	1219351	19	1219352	7457	22496
NM_000455.4(STK11):c.487G>T (p.Gly163Cys)	STK11	Squamous cell lung carcinoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	1220394	19	1220395	376710	363589
NM_000455.4(STK11):c.488G>A (p.Gly163Asp)	STK11	Malignant tumor of testis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	19	1220395	19	1220396	7448	22487
NM_000455.4(STK11):c.508C>T (p.Gln170Ter)	STK11	Cutaneous malignant melanoma 1|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	19	1220415	19	1220416	7455	22494
NM_000455.4(STK11):c.526G>A (p.Asp176Asn)	STK11	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	19	1220433	19	1220434	182907	181057
NM_000455.4(STK11):c.530T>A (p.Ile177Asn)	STK11	Peutz-Jeghers syndrome	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	1220437	19	1220438	376744	363623
NM_000455.4(STK11):c.580G>A (p.Asp194Asn)	STK11	Peutz-Jeghers syndrome|Lung adenocarcinoma|not provided|Hereditary cancer-predisposing syndrome|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	19	1220487	19	1220488	188348	186283
NM_000455.4(STK11):c.580G>T (p.Asp194Tyr)	STK11	Cutaneous malignant melanoma 1|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	1220487	19	1220488	7450	22489
NM_000455.4(STK11):c.581A>T (p.Asp194Val)	STK11	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	19	1220488	19	1220489	376335	363214
NM_000455.4(STK11):c.582C>G (p.Asp194Glu)	STK11	Pancreatic Neoplasms	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	19	1220489	19	1220490	376187	363066
NM_000455.4(STK11):c.582C>A (p.Asp194Glu)	STK11	not provided|Hereditary cancer-predisposing syndrome|Pancreatic Neoplasms	Likely pathogenic(Last reviewed: Jun 25, 2014)	criteria provided, single submitter	19	1220489	19	1220490	185384	185491
NM_000455.4(STK11):c.587G>T (p.Gly196Val)	STK11	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	19	1220494	19	1220495	376336	363215
NM_000455.4(STK11):c.595G>T (p.Glu199Ter)	STK11	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	19	1220502	19	1220503	376338	363217
NM_000455.4(STK11):c.595G>A (p.Glu199Lys)	STK11	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	19	1220502	19	1220503	376337	363216
NM_000455.4(STK11):c.644G>A (p.Gly215Asp)	STK11	Peutz-Jeghers syndrome	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	1220626	19	1220627	376741	363620
NM_000455.4(STK11):c.647C>T (p.Ser216Phe)	STK11	Lung adenocarcinoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	1220629	19	1220630	376708	363587
NM_000455.4(STK11):c.650delC (p.Pro217Argfs)	STK11	Carcinoma of pancreas	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	19	1220632	19	1220633	7453	22492
NM_000455.4(STK11):c.717G>C (p.Trp239Cys)	STK11	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 26, 2016)	criteria provided, single submitter	19	1220699	19	1220700	7458	22497
NM_000455.4(STK11):c.842C>T (p.Pro281Leu)	STK11	Peutz-Jeghers syndrome|not specified|Hereditary cancer-predisposing syndrome|Neoplasm	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	19	1221319	19	1221320	142115	151829
NM_000455.4(STK11):c.910C>T (p.Arg304Trp)	STK11	Peutz-Jeghers syndrome|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	19	1221995	19	1221996	183802	185520
NM_000455.4(STK11):c.924G>C (p.Trp308Cys)	STK11	Peutz-Jeghers syndrome	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	1222987	19	1222988	376745	363624
NM_000455.4(STK11):c.936delA (p.Lys312Asnfs)	STK11	Carcinoma of pancreas	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	19	1222999	19	1223000	7454	22493
NM_000455.4(STK11):c.971C>T (p.Pro324Leu)	STK11	Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	19	1223034	19	1223035	135931	139643
NM_000455.4(STK11):c.996G>A (p.Trp332Ter)	STK11	Neoplasm	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	19	1223059	19	1223060	376339	363218
NM_000455.4(STK11):c.1060T>C (p.Phe354Leu)	STK11	Squamous cell lung carcinoma	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	1223123	19	1223124	376711	363590
NM_000455.4(STK11):c.1088C>T (p.Thr363Ile)	STK11	Peutz-Jeghers syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2017)	criteria provided, conflicting interpretations	19	1223151	19	1223152	135277	139016
GRCh37/hg19 19p13.3(chr19:1236038-1272435)x3	ATP5F1D|CIRBP|MIDN|CBARP	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	1236038 - 1272435			221536	223265
NM_018959.3(DAZAP1):c.1213T>C (p.Tyr405His)	DAZAP1	Monoclonal B-Cell Lymphocytosis	Uncertain significance(Last reviewed: Dec 15, 2015)	no assertion criteria provided	19	1434900	19	1434901	222962	224690
GRCh38/hg38 19p13.3(chr19:1453072-1481984)x1	APC2|PCSK4|C19orf25	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	1453071 - 1481983	19	1453072 - 1481984	221537	223266
GRCh38/hg38 19p13.3(chr19:1508508-1510400)x0	ADAMTSL5	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	1508506 - 1510398	19	1508508 - 1510400	221396	223125
GRCh37/hg19 19p13.3(chr19:1997403-2076912)x3	MKNK2|BTBD2|MOB3A	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	1997403 - 2076912			221538	223267
NM_002067.4(GNA11):c.547C>T (p.Arg183Cys)	GNA11	Lobular capillary hemangiomas	Likely pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	19	3115012	19	3115014	548668	539160
NM_002067.4(GNA11):c.626A>T (p.Gln209Leu)	GNA11	Malignant melanoma of skin|Intraocular melanoma|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	19	3118942	19	3118944	376002	362881
NM_002067.4(GNA11):c.626A>C (p.Gln209Pro)	GNA11	Intraocular melanoma|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	19	3118942	19	3118944	376001	362880
NM_002067.4(GNA11):c.943G>A (p.Asp315Asn)	GNA11	not provided	Uncertain significance	no assertion criteria provided	19	3121040	19	3121042	91939	97417
NM_030662.3(MAP2K2):c.376A>G (p.Asn126Asp)	MAP2K2	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	19	4110581	19	4110583	376176	363055
NM_030662.3(MAP2K2):c.373T>A (p.Cys125Ser)	MAP2K2	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	19	4110584	19	4110586	376177	363056
NM_030662.3(MAP2K2):c.179A>C (p.Gln60Pro)	MAP2K2	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	19	4117541	19	4117543	376178	363057
NM_030662.3(MAP2K2):c.171T>G (p.Phe57Leu)	MAP2K2	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Pancreatic adenocarcinoma|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	19	4117549	19	4117551	376449	363328
NM_030662.3(MAP2K2):c.169T>G (p.Phe57Val)	MAP2K2	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Cardiofaciocutaneous syndrome 4|Pancreatic adenocarcinoma|Cardio-facio-cutaneous syndrome|Adenocarcinoma of stomach	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	19	4117551	19	4117553	8273	23312
NM_030662.3(MAP2K2):c.136C>T (p.Leu46Phe)	MAP2K2	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	19	4117584	19	4117586	376179	363058
NM_030662.3(MAP2K2):c.103G>A (p.Val35Met)	MAP2K2	Cutaneous melanoma	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	19	4117617	19	4117619	376180	363059
NM_014649.2(SAFB2):c.1367C>T (p.Ser456Leu)	SAFB2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	5604877	19	5604866	161679	171643
GRCh37/hg19 19p13.3(chr19:5679382-5694843)x3	LONP1|RPL36|MICOS13|HSD11B1L	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	5679382 - 5694843			221539	223268
NM_001130955.1(ARHGEF18):c.1409C>A (p.Ala470Glu)	ARHGEF18	not provided	Uncertain significance	no assertion criteria provided	19	7518470	19	7453584	91931	97409
GRCh37/hg19 19p13.2(chr19:7682488-7698319)x3	XAB2|CAMSAP3|PCP2|PET100	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	7682488 - 7698319			221540	223269
NM_145185.3(MAP2K7):c.752T>C (p.Leu251Pro)	MAP2K7	Neuroblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	19	7975941	19	7911056	438771	432407
NM_005968.4(HNRNPM):c.2129G>A (p.Arg710Gln)	HNRNPM	not provided	Uncertain significance	no assertion criteria provided	19	8553674	19	8488790	100852	106712
GRCh37/hg19 19p13.2(chr19:8661944-10104083)x1	PIN1|ZNF121|ZNF177|ZNF266|OR7E24|COL5A3|ZNF562|FBXL12|ZNF317|UBL5|ZNF426|ADAMTS10|ZNF559|MBD3L1|ZNF561|OLFM2|MUC16|OR7D4|OR7G1|OR1M1|ZNF560|ZNF558|ZNF846|OR7D2|ACTL9|OR2Z1|ZNF699|OR7G2|OR7G3|ZNF559-ZNF177	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	8661944 - 10104083			221397	223126
NM_001004699.2(OR2Z1):c.878G>T (p.Arg293Met)	OR2Z1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	8842268	19	8731906	161481	171649
Single allele	PIN1|ZNF121|ZNF177|ZNF266|OR7E24|COL5A3|ZNF562|FBXL12|ZNF317|UBL5|ZNF426|ZNF559|ZNF561|OLFM2|MUC16|OR7D4|OR7G1|OR1M1|ZNF560|ZNF846|OR7D2|ZNF699|OR7G2|OR7G3|ZNF559-ZNF177	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	9001833 - 10085054			221349	223078
NM_152476.2(ZNF560):c.1096C>A (p.His366Asn)	ZNF560	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	9578527	19	9467851	161815	171650
NM_001128849.1(SMARCA4):c.2729C>T (p.Thr910Met)	SMARCA4	Medulloblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	19	11132513	19	11021837	438790	432419
NM_003437.4(ZNF136):c.883T>G (p.Leu295Val)	ZNF136	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	12298076	19	12187261	161614	171623
NM_004317.3(ASNA1):c.224C>G (p.Pro75Arg)	ASNA1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	12849387	19	12738573	219340	221029
NM_004343.3(CALR):c.1092_1143del52 (p.Leu367Thrfs)	CALR	Essential thrombocythemia|Myelofibrosis	Pathogenic(Last reviewed: Dec 19, 2013)	no assertion criteria provided	19	13054565 - 13054616	19	12943751 - 12943802	97006	102915
NM_002730.3(PRKACA):c.617T>G (p.Leu206Arg)	PRKACA	not provided|Pigmented nodular adrenocortical disease, primary, 4	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	19	14208416	19	14097604	91945	97423
NM_002730.3(PRKACA):c.597_599dup (p.Leu199_Cys200insTrp)	PRKACA	Pigmented nodular adrenocortical disease, primary, 4	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	19	14208434 - 14208436	19	14097622 - 14097624	162471	172145
NM_000435.2(NOTCH3):c.5161T>A (p.Trp1721Arg)	NOTCH3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	15280935	19	15170124	221308	223037
NM_000435.2(NOTCH3):c.146G>T (p.Cys49Phe)	NOTCH3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	15308362	19	15197551	161467	171624
NM_022904.2(RASAL3):c.-5C>G	RASAL3	Acute megakaryoblastic leukemia|Mediastinal germ cell tumor	Uncertain significance(Last reviewed: Oct 22, 2015)	no assertion criteria provided	19	15575174	19	15464363	218343	215054
NM_000896.2(CYP4F3):c.824G>A (p.Arg275His)	CYP4F3	not provided	Uncertain significance	no assertion criteria provided	19	15760899	19	15650089	100817	106677
NM_001007525.4(NWD1):c.3668A>G (p.Asn1223Ser)	NWD1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	16910905	19	16800094	161488	171625
NM_015692.4(CPAMD8):c.4015G>A (p.Ala1339Thr)	CPAMD8	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	17017774	19	16906964	221309	223038
NM_001304547.1(MVB12A):c.-406-60_-406-59insGGGCCTGAGTCTGGGGGCG	BST2|MVB12A|BISPR	Human immunodeficiency virus type 1, rapid progression to AIDS	association	no assertion criteria provided	19	17516826 - 17516827	19	17406017 - 17406018	523645	514293
NM_000215.3(JAK3):c.2164G>A (p.Val722Ile)	JAK3	Lymphoblastic leukemia, acute, with lymphomatous features|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative|Acute megakaryoblastic leukemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2018)	criteria provided, conflicting interpretations	19	17945696	19	17834887	134573	138312
NM_000215.3(JAK3):c.2143G>A (p.Val715Ile)	JAK3	Severe combined immunodeficiency disease	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	17945717	19	17834908	376714	363593
NM_000215.3(JAK3):c.1970G>A (p.Arg657Gln)	JAK3	Acute megakaryoblastic leukemia|Leukemoid Reaction	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	17945969	19	17835160	376113	362992
NM_000215.3(JAK3):c.1765G>A (p.Gly589Ser)	JAK3	not provided|Adenoid cystic carcinoma	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	19	17947959	19	17837150	265205	260213
NM_000215.3(JAK3):c.1715C>T (p.Ala572Val)	JAK3	Acute megakaryoblastic leukemia|Myeloproliferative Neoplasm	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	17948009	19	17837200	376037	362916
NM_000215.3(JAK3):c.1503G>C (p.Gln501His)	JAK3	Acute megakaryoblastic leukemia	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	19	17949138	19	17838329	376115	362994
NM_000215.3(JAK3):c.1503G>T (p.Gln501His)	JAK3	Acute megakaryoblastic leukemia|Leukemoid Reaction	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	17949138	19	17838329	376114	362993
NM_000215.3(JAK3):c.394C>A (p.Pro132Thr)	JAK3	Lymphoblastic leukemia, acute, with lymphomatous features|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative|Acute megakaryoblastic leukemia|not specified|Severe Combined Immune Deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jul 11, 2017)	criteria provided, conflicting interpretations	19	17954215	19	17843406	134580	138319
NM_000215.3(JAK3):c.260T>C (p.Ile87Thr)	JAK3	Acute megakaryoblastic leukemia|Leukemoid Reaction	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	19	17954634	19	17843825	376116	362995
NM_005027.3(PIK3R2):c.1681A>G (p.Asn561Asp)	PIK3R2	Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	19	18278061	19	18167251	376165	363044
NM_017712.3(PGPEP1):c.434G>A (p.Gly145Asp)	PGPEP1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	18468422	19	18357612	161710	171626
chr19:19230868-24115369 complex variant	NCAN|ZNF14|ZNF708|ZNF43|ZNF85|ZNF90|ZNF91|ZNF99|ZNF208|RFXANK|LPAR2|MAU2|NDUFA13|GMIP|TM6SF2|GATAD2A|TMEM161A|ZNF253|ATP13A1|ZNF492|SUGP1|ZNF430|PBX4|ZNF93|TSSK6|ZNF486|ZNF682|ZNF101|ZNF257|NR2C2AP|CILP2|ZNF98|ZNF714|ZNF681|ZNF676|ZNF100|ZNF431|ZNF675|ZNF626|ZNF493|ZNF429|YJEFN3|ZNF728|HAPLN4|ZNF506|BORCS8|ZNF726|ZNF730|ZNF737|MEF2B|ZNF729	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	19230868 - 24115369			221350	223079
NM_133473.3(ZNF431):c.1021G>A (p.Glu341Lys)	ZNF431	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	21366127	19	21183324	161801	171627
NM_173531.3(ZNF100):c.407delG (p.Gly136Glufs)	ZNF100	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	21910707	19	21727905	161828	171628
NM_020856.3(TSHZ3):c.1181C>T (p.Ser394Leu)	TSHZ3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	31769518	19	31278612	161739	171629
NM_004364.4(CEBPA):c.935_991dup (p.Gln330_Leu331insGlnLysValLeuGluLeuThrSerAspAsnAspArgLeuArgLysArgValGluGln)	CEBPA	Acute myeloid leukemia	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	19	33792330 - 33792386	19	33301424 - 33301480	17569	32608
NM_004364.4(CEBPA):c.925_951dup (p.Leu317_Thr318insGluThrGlnGlnLysValLeuGluLeu)	CEBPA	Acute myeloid leukemia	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	19	33792370 - 33792396	19	33301464 - 33301490	17570	32609
NM_004364.4(CEBPA):c.251A>T (p.His84Leu)	CEBPA	Acute myeloid leukemia	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	19	33793070	19	33302164	17568	32607
NM_004364.4(CEBPA):c.211_214dupGCCG (p.Ala72Glyfs)	CEBPA	Acute myeloid leukemia	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	19	33793107 - 33793110	19	33302201 - 33302204	17571	32610
NM_004364.4(CEBPA):c.148G>T (p.Glu50Ter)	CEBPA	Acute myeloid leukemia	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	19	33793173	19	33302267	17567	32606
NM_004364.4(CEBPA):c.115_121delCCCGCGC (p.Pro39Serfs)	CEBPA	Acute myeloid leukemia	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	19	33793200 - 33793206	19	33302294 - 33302300	17566	32605
NM_014164.5(FXYD5):c.280A>G (p.Ser94Gly)	FXYD5	not provided	Uncertain significance	no assertion criteria provided	19	35651692	19	35160789	91979	97457
NM_003367.3(USF2):c.497G>A (p.Arg166Gln)	USF2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	35761417	19	35270514	161613	171630
GRCh37/hg19 19q13.12(chr19:35516999-35990896)x3	CD22|FFAR1|FFAR3|GPR42|FFAR2|HPN|MAG|FXYD1|FXYD3|SCN1B|USF2|LSR|FXYD7|FXYD5|GRAMD1A|HAMP|DMKN|FAM187B|LGI4|KRTDAP	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	35516999 - 35990896			221398	223127
NM_014364.4(GAPDHS):c.1129G>A (p.Asp377Asn)	GAPDHS|TMEM147-AS1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	36035883	19	35544981	161676	171631
GRCh38/hg38 19q13.12(chr19:35778321-35862983)x1	NPHS1|PRODH2|KIRREL2|ARHGAP33|LINC01529	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	36269222 - 36353884	19	35778321 - 35862983	221400	223129
NM_199180.3(KIRREL2):c.343G>A (p.Ala115Thr)	KIRREL2	not provided	Uncertain significance	no assertion criteria provided	19	36349441	19	35858539	92039	97517
GRCh37/hg19 19q13.12(chr19:36227660-36250792)x3	KMT2B|PSENEN|LIN37|IGFLR1|HSPB6|PROSER3|U2AF1L4	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	36227660 - 36250792			221541	223270
GRCh37/hg19 19q13.12(chr19:36227660-36268769)x3	KMT2B|PSENEN|LIN37|IGFLR1|ARHGAP33|HSPB6|PROSER3|U2AF1L4	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	36227660 - 36268769			221399	223128
chr19:36674305-38652962 complex variant	ZNF146|ZFP30|SIPA1L3|ZNF345|ZNF571|ZFP14|ZNF529|WDR87|ZNF527|ZNF607|ZNF382|ZNF566|ZNF461|ZNF585B|ZNF573|ZNF420|ZNF565|ZNF569|ZNF570|ZNF567|ZNF383|ZNF781|ZNF540|ZNF585A|ZFP82|ZNF875|ZNF260|ZNF850|ZNF829|ZNF568|ZNF790|ZNF793	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	36674305 - 38652962			221351	223080
GRCh37/hg19 19q13.12-13.2(chr19:36685995-38708166)x1	ZNF146|DPF1|ZFP30|SIPA1L3|ZNF345|ZNF571|ZFP14|ZNF529|WDR87|ZNF527|ZNF607|ZNF382|ZNF566|ZNF461|ZNF585B|ZNF573|ZNF420|ZNF565|ZNF569|ZNF570|ZNF567|ZNF383|ZNF781|ZNF540|ZNF585A|ZFP82|ZNF875|ZNF260|ZNF850|ZNF829|ZNF568|ZNF790|ZNF793	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	36685995 - 38708166			221401	223130
NM_001329517.1(ZNF420):c.149A>G (p.Asn50Ser)	ZNF420	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	37618255	19	37127353	221310	223039
NM_015073.2(SIPA1L3):c.4035C>G (p.Gly1345=)	SIPA1L3	not provided	Uncertain significance	no assertion criteria provided	19	38655373	19	38164733	91987	97465
NM_001014831.2(PAK4):c.1504G>C (p.Gly502Arg)	PAK4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	39668333	19	39177693	161494	171632
GRCh37/hg19 19q13.2(chr19:39879621-39944079)x3	RPS16|SUPT5H|ZFP36|PAF1|MED29|PLEKHG2	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	39879621 - 39944079			221542	223271
NM_001626.5(AKT2):c.1112G>A (p.Arg371His)	AKT2	Non-small cell lung cancer	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	19	40741860	19	40235953	376038	362917
NM_001626.5(AKT2):c.904A>G (p.Ser302Gly)	AKT2	Neoplasm of the large intestine|Colorectal Neoplasms	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	19	40742220	19	40236313	376039	362918
NM_144685.4(HIPK4):c.1279G>A (p.Asp427Asn)	HIPK4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	40886619	19	40380712	161807	171633
NM_006297.2(XRCC1):c.580C>T (p.Arg194Trp)	XRCC1	Non-small cell lung cancer	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	19	44057574	19	43553422	376355	363234
NM_001007561.2(IRGQ):c.1795G>A (p.Gly599Ser)	IRGQ	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	44096255	19	43592103	161489	171634
NM_013398.3(ZNF224):c.1354G>A (p.Gly452Arg)	ZNF224|LOC100379224	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	44611667	19	44107514	161669	171635
NM_001083335.1(ZNF112):c.1387A>G (p.Ile463Val)	ZNF112	not provided	Uncertain significance	no assertion criteria provided	19	44832941	19	44328788	91928	97406
GRCh37/hg19 19q13.31(chr19:44466919-45029206)x1	ZNF221|ZNF222|ZNF155|ZNF180|ZNF223|ZNF224|ZNF225|ZNF226|ZNF227|ZNF112|ZNF229|ZNF230|ZNF235|ZNF234|ZNF285|CEACAM20|ZNF284|ZNF233	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	44466919 - 45029206			221402	223131
chr19:44501518-45322744 complex variant	BCL3|BCAM|PVR|ZNF222|ZNF155|ZNF180|ZNF223|ZNF224|ZNF225|ZNF226|ZNF227|ZNF112|ZNF229|ZNF230|ZNF235|ZNF234|CBLC|ZNF285|CEACAM19|CEACAM20|IGSF23|ZNF284|ZNF233|CEACAM16	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	44501518 - 45322744			221352	223081
NM_000041.3(APOE):c.364C>A (p.Leu122Met)	APOE	Major depressive disorder	not provided(Last reviewed: Oct 28, 2013)	no assertion provided	19	45411917	19	44908660	88639	94228
NM_000041.3(APOE):c.451C>A (p.Leu151Met)	APOE	Major depressive disorder	not provided(Last reviewed: Oct 28, 2013)	no assertion provided	19	45412004	19	44908747	88640	94229
NM_000400.3(ERCC2):c.2251A>C (p.Lys751Gln)	ERCC2	Osteosarcoma|Xeroderma pigmentosum|Non-small cell lung cancer|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	45854919	19	45351661	134105	137844
NM_004491.4(ARHGAP35):c.1959_1960delGCinsAA (p.Pro654Thr)	ARHGAP35	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	47423891 - 47423892	19	46920634 - 46920635	221320	223049
NM_001277075.1(ZNF541):c.1608G>A (p.Pro536=)	ZNF541	not provided	Uncertain significance	no assertion criteria provided	19	48048178	19	47544921	91934	97412
NM_000554.5(CRX):c.107C>A (p.Pro36His)	CRX	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	48339506	19	47836249	161470	171636
NM_031485.3(GRWD1):c.593G>A (p.Arg198Gln)	GRWD1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	48953694	19	48450437	161778	171637
NM_001161354.1(PLEKHA4):c.20_28delGCAGCAGCC (p.Arg7_Ser9del)	PLEKHA4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	49370850 - 49370858	19	48867593 - 48867601	161541	171638
NM_014475.3(DHDH):c.611A>T (p.His204Leu)	DHDH	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	49442950	19	48939693	219306	220995
NM_138761.3(BAX):c.115_121delGGGGGGG (p.Gly39Argfs)	BAX	T-cell acute lymphoblastic leukemia|Leukemia, T-cell acute lymphoblastic, somatic	Pathogenic(Last reviewed: Apr 15, 1998)	no assertion criteria provided	19	49458972 - 49458978	19	48955715 - 48955721	9514	24553
NM_138761.3(BAX):c.121delG (p.Glu41Argfs)	BAX	Carcinoma of colon	Pathogenic(Last reviewed: Feb 14, 1997)	no assertion criteria provided	19	49458978	19	48955721	9512	24551
NM_138761.3(BAX):c.121dupG (p.Glu41Glyfs)	BAX	Carcinoma of colon	Pathogenic(Last reviewed: Feb 14, 1997)	no assertion criteria provided	19	49458978	19	48955721	9511	24550
NM_138761.3(BAX):c.199G>A (p.Gly67Arg)	BAX	T-cell acute lymphoblastic leukemia|Leukemia, T-cell acute lymphoblastic, somatic	Pathogenic(Last reviewed: Apr 15, 1998)	no assertion criteria provided	19	49459056	19	48955799	9513	24552
NM_001282517.1(BCL2L12):c.52C>T (p.Arg18Trp)	IRF3|BCL2L12	Malignant melanoma of skin|Squamous cell carcinoma of the skin	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	19	50169132	19	49665875	376373	363252
NM_015428.3(ZNF473):c.2359A>T (p.Arg787Ter)	ZNF473	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	50550059	19	50046802	221311	223040
NM_001077186.1(MYH14):c.3369-3C>T	MYH14	Deafness, autosomal dominant 4|not specified|Nonsyndromic Hearing Loss, Dominant	Benign/Likely benign(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	19	50779245	19	50275988	44066	53234
NM_001245.6(SIGLEC6):c.883G>T (p.Ala295Ser)	SIGLEC6	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	52033107	19	51529853	219341	221030
NM_001193306.1(FPR1):c.772C>T (p.Gln258Ter)	FPR1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	52249476	19	51746223	161561	171639
NM_014225.5(PPP2R1A):c.536C>G (p.Pro179Arg)	PPP2R1A	Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	19	52715971	19	52212718	376504	363383
NM_014225.5(PPP2R1A):c.536C>T (p.Pro179Leu)	PPP2R1A	not provided|Mental retardation, autosomal dominant 36|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	19	52715971	19	52212718	190313	188142
NM_014225.5(PPP2R1A):c.547C>G (p.Arg183Gly)	PPP2R1A	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	19	52715982	19	52212729	376507	363386
NM_014225.5(PPP2R1A):c.547C>T (p.Arg183Trp)	PPP2R1A	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	19	52715982	19	52212729	376505	363384
NM_014225.5(PPP2R1A):c.548G>A (p.Arg183Gln)	PPP2R1A	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|not provided|Neoplasm of the breast|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	19	52715983	19	52212730	376506	363385
NM_001143939.2(ZNF534):c.13C>A (p.Gln5Lys)	ZNF534	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	52934740	19	52431487	161531	171640
GRCh37/hg19 19q13.42(chr19:54647215-54705417)x3	CNOT3|RPS9|TSEN34|MBOAT7|LENG1|TMC4	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	54647215 - 54705417			221403	223132
GRCh37/hg19 19q13.42(chr19:54710237-55648526)x1	FCAR|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|LAIR1|LAIR2|RPS9|TNNT1|NCR1|LILRB2|LILRB1|LILRB5|LILRB4|LILRA1|LILRB3|LILRA3|LILRA2|LILRA4|GP6|PPP1R12C|EPS8L1|NLRP2|TTYH1|LILRA6|LENG9|RDH13|LENG8|KIR3DL3|CDC42EP5|NLRP7|LILRA5	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	54710237 - 55648526			221404	223133
NM_015868.2(KIR2DL3):c.71-4C>T	KIR2DL3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	55253422	19	54741976	161697	171641
chr19:54754752-55624113 complex variant	FCAR|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|LAIR1|LAIR2|NCR1|LILRB2|LILRB1|LILRB5|LILRB4|LILRA1|LILRA3|LILRA2|LILRA4|GP6|PPP1R12C|EPS8L1|NLRP2|TTYH1|LENG9|RDH13|LENG8|KIR3DL3|CDC42EP5|NLRP7|LILRA5	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	54754752 - 55624113			221353	223082
NM_013289.2(KIR3DL1):c.809G>A (p.Arg270His)	KIR3DL1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	55333173	19	54821718	161666	171642
chr19:55143156-55294969 complex variant	KIR2DL1|KIR2DL3|LILRB1|LILRB4|KIR3DL3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	55143156 - 55294969			221370	223099
chr19:56133299..57648277 complex variant	PEG3|U2AF2|ZIM2|CCDC106|EPN1|ZNF580|ZNF581|ZNF444|ZNF471|USP29|ZNF71|ZNF667|ZSCAN5A|GALP|ZNF835|ZIM3|NLRP13|NLRP8|NLRP5|ZNF787|ZFP28|SMIM17|ZNF784|NLRP4|ZNF582|ZNF583|NLRP11|NLRP9|RFPL4A|ZSCAN5B|ZNF470|RFPL4AL1|ZIM2-AS1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	56133299 - 57648277			221354	223083
GRCh37/hg19 19q13.42-13.43(chr19:56200298-57654005)x1	PEG3|ZIM2|EPN1|ZNF444|ZNF471|USP29|ZNF71|ZNF667|ZSCAN5A|GALP|ZNF835|ZIM3|NLRP13|NLRP8|NLRP5|ZNF787|ZFP28|SMIM17|NLRP4|ZNF582|ZNF583|NLRP11|NLRP9|RFPL4A|ZSCAN5B|ZNF470|RFPL4AL1|ZIM2-AS1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	19	56200298 - 57654005			221405	223134
NM_020657.3(ZNF304):c.1400T>A (p.Ile467Lys)	ZNF304	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	57868637	19	57357269	161734	171644
NM_001024596.2(ZNF772):c.10_11insGGC (p.Ala4delinsGlyPro)	ZNF772	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	57988667 - 57988668	19	57477299 - 57477300	161496	171645
NM_001098494.1(ZNF419):c.76G>T (p.Gly26Cys)	ZNF419	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	58002839	19	57491471	161512	171646
NM_173632.3(ZNF776):c.574A>C (p.Asn192His)	ZNF776	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	58265072	19	57753704	161832	171647
NM_025027.4(ZNF606):c.2099G>C (p.Arg700Thr)	ZNF606	not provided	Uncertain significance	no assertion criteria provided	19	58489949	19	57978581	92015	97493
NM_005762.2(TRIM28):c.1216+23C>T	TRIM28	Familial colorectal cancer	not provided	no assertion provided	19	59059798	19	58548431	91860	97337
NM_005762.2(TRIM28):c.2193+3G>T	TRIM28	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	19	59061405	19	58550038	161641	171648
NM_080739.2(C20orf141):c.265G>A (p.Ala89Thr)	C20orf141	not provided	Uncertain significance	no assertion criteria provided	20	2796188	20	2815542	92024	97502
GRCh38/hg38 20p13(chr20:3672811-3673618)x1	ADAM33	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	20	3653457 - 3654264	20	3672811 - 3673618	221543	223272
NM_001009924.1(TMEM230):c.152T>C (p.Val51Ala)	TMEM230	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	5086904	20	5106258	161490	171658
NM_144773.3(PROKR2):c.742C>T (p.Arg248Trp)	PROKR2	not provided	Uncertain significance	no assertion criteria provided	20	5283099	20	5302453	100889	106749
NM_001819.2(CHGB):c.1308A>C (p.Glu436Asp)	CHGB	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	5904098	20	5923452	161584	171659
NM_017545.2(HAO1):c.*697T>C	HAO1	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	20	7863543	20	7882896	126880	132392
NM_017545.2(HAO1):c.814-2945A>G	HAO1	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	20	7869456	20	7888809	126881	132393
NM_017545.2(HAO1):c.814-4211G>A	HAO1	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	20	7870722	20	7890075	126882	132394
NM_017545.2(HAO1):c.721+1617G>C	HAO1	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	20	7885184	20	7904537	126883	132395
NM_017545.2(HAO1):c.545+1171T>C	HAO1	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	20	7893640	20	7912993	126884	132396
NM_017545.2(HAO1):c.290-1983G>A	HAO1	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	20	7897049	20	7916402	126885	132397
NM_017545.2(HAO1):c.290-4862A>G	HAO1	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	20	7899928	20	7919281	126886	132398
NM_017545.2(HAO1):c.289+8188C>T	HAO1	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	20	7906943	20	7926296	126887	132399
NM_017545.2(HAO1):c.289+5965C>T	HAO1	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	20	7909166	20	7928519	126888	132400
NM_017545.2(HAO1):c.289+2189G>C	HAO1	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	20	7912942	20	7932295	126889	132401
NM_017545.2(HAO1):c.137+329T>C	HAO1	Calcium oxalate urolithiasis	association(Last reviewed: Mar 1, 2014)	no assertion criteria provided	20	7920604	20	7939957	126890	132402
NM_001172646.1(PLCB4):c.408C>A (p.Phe136Leu)	PLCB4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	9343581	20	9362934	161550	171664
GRCh37/hg19 20p12.1(chr20:13714429-13789519)x3	ESF1|NDUFAF5	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	20	13714429 - 13789519			221544	223273
NM_001199866.1(KIF16B):c.1979G>A (p.Arg660His)	KIF16B	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	16360668	20	16380023	161567	171651
NM_001199866.1(KIF16B):c.1588G>A (p.Val530Met)	KIF16B	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	16407773	20	16427128	161566	171652
GRCh37/hg19 20p11.23(chr20:19662569-20003113)x3	NAA20|RIN2|SLC24A3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	20	19662569 - 20003113			221545	223274
NM_001278625.1(CRNKL1):c.347C>T (p.Ser116Phe)	CRNKL1	Malignant melanoma of skin|Squamous cell carcinoma of the skin	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	20	20033087	20	20052443	376389	363268
NM_022080.2(NAPB):c.786+2T>C	NAPB	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	23360080	20	23379443	161755	171653
GRCh37/hg19 20p11.21(chr20:25284225-25371245)x3	ABHD12	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	20	25284225 - 25371245			221546	223275
NM_015600.4(ABHD12):c.935T>G (p.Phe312Cys)	ABHD12	not provided	Uncertain significance	no assertion criteria provided	20	25287484	20	25306848	100864	106724
NM_015338.5(ASXL1):c.2100T>A (p.Tyr700Ter)	ASXL1	Myelodysplasia	Pathogenic	criteria provided, single submitter	20	31022615	20	32434812	548120	538607
NM_005225.2(E2F1):c.497G>A (p.Arg166His)	E2F1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	32267636	20	33679830	219310	220999
NM_178468.5(FAM83C):c.863G>A (p.Arg288His)	FAM83C	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	33875719	20	35287916	161837	171654
NM_005417.4(SRC):c.1200C>G (p.Asn400Lys)	SRC	not provided	Uncertain significance	no assertion criteria provided	20	36030921	20	37402518	100851	106711
NM_198291.2(SRC):c.1591C>T (p.Gln531Ter)	SRC	Colon cancer, advanced|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	20	36031762	20	37403359	12573	27612
NM_001029864.1(KIAA1755):c.3089G>T (p.Gly1030Val)	KIAA1755	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	36841958	20	38213556	161499	171655
NM_015035.3(ZHX3):c.496G>T (p.Gly166Cys)	ZHX3	not provided	Uncertain significance	no assertion criteria provided	20	39833061	20	41204421	91985	97463
GRCh37/hg19 20q13.12(chr20:43955980-44053178)x3	SDC4|TP53TG5|PIGT|DBNDD2|SYS1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	20	43955980 - 44053178			221547	223276
NM_022829.5(SLC13A3):c.1637G>A (p.Arg546Gln)	SLC13A3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	45188833	20	46560194	161765	171656
NM_080829.3(RIPOR3):c.55G>A (p.Val19Met)	RIPOR3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	49247330	20	50630793	161799	171657
NM_003610.3(RAE1):c.408C>G (p.Ile136Met)	RAE1	not provided	Uncertain significance	no assertion criteria provided	20	55941895	20	57366839	91952	97430
GRCh37/hg19 20q13.33(chr20:58444946-58533817)x3	PPP1R3D|SYCP2|CDH26|FAM217B	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	20	58444946 - 58533817			221548	223277
NM_000516.5(GNAS):c.601C>G (p.Arg201Gly)	GNAS	McCune-Albright syndrome	Pathogenic(Last reviewed: Jan 7, 2015)	no assertion criteria provided	20	57484420	20	58909365	15945	30984
NM_000516.5(GNAS):c.601C>A (p.Arg201Ser)	GNAS	Cushing's syndrome|McCune-Albright syndrome|Polyostotic fibrous dysplasia, somatic, mosaic|PITUITARY TUMOR 3, GROWTH HORMONE-SECRETING, SOMATIC	Pathogenic(Last reviewed: Jan 7, 2015)	no assertion criteria provided	20	57484420	20	58909365	15937	30976
NM_000516.5(GNAS):c.601C>T (p.Arg201Cys)	GNAS	Cushing's syndrome|Liver cancer|McCune-Albright syndrome|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Sex cord-stromal tumor|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Neoplasm|Colorectal Neoplasms|Uterine cervical neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|PITUITARY ADENOMA 3, MULTIPLE TYPES	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	20	57484420	20	58909365	15933	30972
NM_000516.5(GNAS):c.602G>T (p.Arg201Leu)	GNAS	Liver cancer|McCune-Albright syndrome|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Neoplasm|Colorectal Neoplasms|Uterine cervical neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	20	57484421	20	58909366	210045	206650
NM_000516.5(GNAS):c.602G>A (p.Arg201His)	GNAS	Cushing's syndrome|Liver cancer|McCune-Albright syndrome|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Sex cord-stromal tumor|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Neoplasm|Colorectal Neoplasms|Uterine cervical neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|PITUITARY ADENOMA 3, MULTIPLE TYPES	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	20	57484421	20	58909366	15934	30973
NM_000516.5(GNAS):c.680A>T (p.Gln227Leu)	GNAS	McCune-Albright syndrome|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	20	57484596	20	58909541	210047	206652
NM_000516.5(GNAS):c.680A>G (p.Gln227Arg)	GNAS	McCune-Albright syndrome|PITUITARY ADENOMA 3, MULTIPLE TYPES	Pathogenic(Last reviewed: Jan 7, 2015)	no assertion criteria provided	20	57484596	20	58909541	15935	30974
NM_001077488.3(GNAS):c.684G>C (p.Gln228His)	GNAS	PITUITARY ADENOMA 3, MULTIPLE TYPES	Pathogenic(Last reviewed: Feb 1, 1995)	no assertion criteria provided	20	57484597	20	58909542	15936	30975
NM_014258.3(SYCP2):c.2365-8T>C	SYCP2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	58461897	20	59886842	161672	171660
GRCh37/hg19 20q13.33(chr20:60882468-62045494)x1	CHRNA4|COL9A3|KCNQ2|LAMA5|NTSR1|RPS21|TCFL5|ADRM1|OGFR|DIDO1|SLCO4A1|YTHDF1|GID8|MRGBP|ARFGAP1|COL20A1|SLC17A9|BIRC7|CABLES2|BHLHE23|NKAIN4|MIR1-1HG|GATA5|RBBP8NL|MIR1-1|MIR133A2|HAR1A|HAR1B|DPH3P1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	20	60882468 - 62045494			221406	223135
chr20:60885242-61929348 complex variant	COL9A3|LAMA5|NTSR1|RPS21|TCFL5|OGFR|DIDO1|SLCO4A1|YTHDF1|GID8|MRGBP|ARFGAP1|COL20A1|SLC17A9|BIRC7|CABLES2|BHLHE23|NKAIN4|MIR1-1HG|GATA5|RBBP8NL|MIR1-1|MIR133A2|HAR1A|HAR1B|DPH3P1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	20	60885242 - 61929348			221355	223084
chr20:61880169-61908597 complex variant	ARFGAP1|NKAIN4	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	20	61880169 - 61908597			221371	223100
NM_007002.3(ADRM1):c.653C>A (p.Pro218Gln)	ADRM1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	60882681	20	62307625	161653	171661
NM_005560.4(LAMA5):c.2479C>T (p.Arg827Cys)	LAMA5	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	60910080	20	62335024	161636	171662
GRCh38/hg38 20q13.33(chr20:63239482-63415015)x1	CHRNA4|KCNQ2|ARFGAP1|COL20A1|BIRC7|NKAIN4|LOC100130587|FLJ16779|MIR4326	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	20	61870834 - 62046368	20	63239482 - 63415015	221549	223278
NM_000744.6(CHRNA4):c.1711G>A (p.Val571Ile)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Tobacco use disorder	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2018)	criteria provided, conflicting interpretations	20	61981052	20	63349700	98323	104216
NM_000744.6(CHRNA4):c.1662G>A (p.Pro554=)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Seizures|Tobacco use disorder	Benign/Likely benign(Last reviewed: Dec 8, 2017)	criteria provided, multiple submitters, no conflicts	20	61981101	20	63349749	98322	104215
NM_000744.6(CHRNA4):c.1635G>A (p.Thr545=)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|not provided|Tobacco use disorder	Conflicting interpretations of pathogenicity(Last reviewed: Oct 24, 2017)	criteria provided, conflicting interpretations	20	61981128	20	63349776	98321	104214
NM_000744.6(CHRNA4):c.1634C>T (p.Thr545Met)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|not provided|Tobacco use disorder	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2017)	criteria provided, conflicting interpretations	20	61981129	20	63349777	98320	104213
NM_000744.6(CHRNA4):c.1625C>T (p.Pro542Leu)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981138	20	63349786	98319	104212
NM_000744.6(CHRNA4):c.1460G>A (p.Arg487Gln)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Seizures|Tobacco use disorder	Benign/Likely benign(Last reviewed: Nov 19, 2017)	criteria provided, multiple submitters, no conflicts	20	61981303	20	63349951	98318	104211
NM_000744.6(CHRNA4):c.1425C>T (p.Gly475=)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|Tobacco use disorder	Uncertain significance(Last reviewed: May 3, 2018)	criteria provided, single submitter	20	61981338	20	63349986	98317	104210
NM_000744.6(CHRNA4):c.1402G>A (p.Val468Ile)	CHRNA4	not specified|Tobacco use disorder	Uncertain significance(Last reviewed: Jun 3, 2016)	criteria provided, single submitter	20	61981361	20	63350009	98316	104209
NM_000744.6(CHRNA4):c.1373C>T (p.Pro458Leu)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Tobacco use disorder	Uncertain significance(Last reviewed: Sep 11, 2017)	criteria provided, multiple submitters, no conflicts	20	61981390	20	63350038	98315	104208
NM_000744.6(CHRNA4):c.1359C>T (p.His453=)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Tobacco use disorder	Benign/Likely benign(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	20	61981404	20	63350052	98314	104207
NM_000744.6(CHRNA4):c.1311T>C (p.Ala437=)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981452	20	63350100	98313	104206
NM_000744.6(CHRNA4):c.1266C>T (p.Cys422=)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Tobacco use disorder	Uncertain significance(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	20	61981497	20	63350145	98312	104205
NM_000744.6(CHRNA4):c.1265G>A (p.Cys422Tyr)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|Tobacco use disorder	Uncertain significance(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	20	61981498	20	63350146	98311	104204
NM_000744.6(CHRNA4):c.1228G>A (p.Val410Ile)	CHRNA4	not specified|Seizures|Tobacco use disorder	Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2017)	criteria provided, conflicting interpretations	20	61981535	20	63350183	98310	104203
NM_000744.6(CHRNA4):c.1224C>T (p.Phe408=)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981539	20	63350187	98309	104202
NM_000744.6(CHRNA4):c.1200C>T (p.Ser400=)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981563	20	63350211	98308	104201
NM_000744.6(CHRNA4):c.1184C>T (p.Thr395Met)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981579	20	63350227	98307	104200
NM_000744.6(CHRNA4):c.1169G>A (p.Gly390Glu)	CHRNA4	not specified|Tobacco use disorder	Likely benign(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	20	61981594	20	63350242	98306	104199
NM_000744.6(CHRNA4):c.1109G>A (p.Arg370Gln)	CHRNA4	not specified|Tobacco use disorder	Likely benign(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	20	61981654	20	63350302	98305	104198
NM_000744.6(CHRNA4):c.1087G>A (p.Val363Met)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Tobacco use disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	20	61981676	20	63350324	98304	104197
NM_000744.6(CHRNA4):c.1066C>T (p.Leu356Phe)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981697	20	63350345	98303	104196
NM_000744.6(CHRNA4):c.1054G>A (p.Val352Met)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981709	20	63350357	98302	104195
NM_000744.6(CHRNA4):c.1002G>A (p.Ser334=)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981761	20	63350409	98301	104194
NM_000744.6(CHRNA4):c.1001C>T (p.Ser334Leu)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981762	20	63350410	98300	104193
NM_000744.6(CHRNA4):c.963C>T (p.Ile321=)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981800	20	63350448	72824	83715
NM_000744.6(CHRNA4):c.953C>T (p.Thr318Ile)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981810	20	63350458	98341	104234
NM_000744.6(CHRNA4):c.948C>T (p.Phe316=)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|Tobacco use disorder	Benign(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	20	61981815	20	63350463	98340	104233
NM_000744.6(CHRNA4):c.915C>T (p.Leu305=)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981848	20	63350496	98339	104232
NM_000744.6(CHRNA4):c.858C>T (p.Thr286=)	CHRNA4	not specified|not provided|Tobacco use disorder	Benign/Likely benign(Last reviewed: Sep 25, 2017)	criteria provided, multiple submitters, no conflicts	20	61981905	20	63350553	98338	104231
NM_000744.6(CHRNA4):c.799C>T (p.Leu267=)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981964	20	63350612	98337	104230
NM_000744.6(CHRNA4):c.775T>C (p.Cys259Arg)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61981988	20	63350636	98336	104229
NM_000744.6(CHRNA4):c.753C>T (p.Ile251=)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61982010	20	63350658	98335	104228
NM_000744.6(CHRNA4):c.729G>A (p.Pro243=)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|not provided|Tobacco use disorder	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2018)	criteria provided, conflicting interpretations	20	61982034	20	63350682	98334	104227
NM_000744.6(CHRNA4):c.707C>T (p.Ala236Val)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61982056	20	63350704	98333	104226
NM_000744.6(CHRNA4):c.705T>C (p.Tyr235=)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61982058	20	63350706	98332	104225
NM_000744.6(CHRNA4):c.693G>A (p.Pro231=)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61982070	20	63350718	98331	104224
NM_000744.6(CHRNA4):c.617G>C (p.Ser206Thr)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61982146	20	63350794	98330	104223
NM_000744.6(CHRNA4):c.585C>G (p.His195Gln)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61982178	20	63350826	98329	104222
NM_000744.6(CHRNA4):c.510C>T (p.Phe170=)	CHRNA4	not specified|Tobacco use disorder	Benign(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	20	61982253	20	63350901	98328	104221
NM_000744.6(CHRNA4):c.504C>T (p.Phe168=)	CHRNA4	Tobacco use disorder	not provided	no assertion provided	20	61982259	20	63350907	98327	104220
NM_000744.6(CHRNA4):c.462G>A (p.Pro154=)	CHRNA4	not specified|Tobacco use disorder	Benign(Last reviewed: Jul 9, 2015)	criteria provided, single submitter	20	61982301	20	63350949	98326	104219
NM_000744.6(CHRNA4):c.461C>T (p.Pro154Leu)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|not provided|Tobacco use disorder	Uncertain significance(Last reviewed: Nov 17, 2017)	criteria provided, multiple submitters, no conflicts	20	61982302	20	63350950	98325	104218
NM_000744.6(CHRNA4):c.442C>T (p.Arg148Trp)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Tobacco use disorder|Inborn genetic diseases	Uncertain significance(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	20	61982321	20	63350969	98324	104217
NM_020062.3(SLC2A4RG):c.1060C>A (p.Arg354Ser)	SLC2A4RG	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	20	62374239	20	63742886	161728	171663
NM_020706.2(SCAF4):c.1518C>T (p.Cys506=)	SCAF4	not provided	Uncertain significance	no assertion criteria provided	21	33064758	21	31692445	92007	97485
NM_003895.3(SYNJ1):c.3752C>A (p.Ala1251Glu)	SYNJ1	not provided	Uncertain significance	no assertion criteria provided	21	34012043	21	32639733	91955	97433
NM_001754.4(RUNX1):c.601C>T (p.Arg201Ter)	RUNX1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	21	36231783	21	34859486	376018	362897
NM_001754.4(RUNX1):c.486G>C (p.Arg162Ser)	RUNX1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	21	36252876	21	34880579	376020	362899
NM_001754.4(RUNX1):c.486G>T (p.Arg162Ser)	RUNX1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	21	36252876	21	34880579	376019	362898
NM_001754.4(RUNX1):c.485G>A (p.Arg162Lys)	RUNX1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	21	36252877	21	34880580	376021	362900
NM_001754.4(RUNX1):c.484A>G (p.Arg162Gly)	RUNX1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	21	36252878	21	34880581	376022	362901
NM_005441.2(CHAF1B):c.862A>G (p.Thr288Ala)	CHAF1B	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	21	37781706	21	36409408	161635	171665
NM_001135099.1(TMPRSS2):c.1333_1334delCA (p.Gln445Glufs)	TMPRSS2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	21	42840414 - 42840415	21	41468487 - 41468488	161524	171666
NM_001199528.2(UMODL1):c.3439G>A (p.Val1147Ile)	UMODL1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	21	43547906	21	42127796	219342	221031
NM_002606.2(PDE9A):c.1085+1G>A	PDE9A	not provided	Uncertain significance	no assertion criteria provided	21	44181018	21	42760908	91942	97420
NM_001025203.1(U2AF1):c.470A>C (p.Gln157Pro)	U2AF1	Acute myeloid leukemia|Myelodysplastic syndrome	Likely pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	21	44514777	21	43094667	376024	362903
NM_001025203.1(U2AF1):c.470A>G (p.Gln157Arg)	U2AF1	Acute myeloid leukemia	Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	21	44514777	21	43094667	376023	362902
NM_001025203.1(U2AF1):c.101C>A (p.Ser34Tyr)	U2AF1	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	21	44524456	21	43104346	376026	362905
NM_006758.2(U2AF1):c.101C>T (p.Ser34Phe)	U2AF1	Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	21	44524456	21	43104346	376025	362904
NM_003683.5(RRP1):c.340C>T (p.Arg114Cys)	RRP1	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	21	45213265	21	43793384	221321	223050
NM_003274.4(TRAPPC10):c.2929A>G (p.Ser977Gly)	TRAPPC10	not provided	Uncertain significance	no assertion criteria provided	21	45511862	21	44091981	91948	97426
GRCh38/hg38 21q22.3(chr21:45850091-46137287)x1	COL6A1|COL6A2|FTCD|PCBP3|LOC101928796	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	21	47270005 - 47557201	21	45850091 - 46137287	221407	223136
chr21:45970718..47545826 complex variant	ADARB1|PTTG1IP|COL6A1|COL6A2|ITGB2|SLC19A1|SUMO3|UBE2G2|POFUT2|PCBP3|TSPEAR|COL18A1|FAM207A|LINC00334|LINC00315|KRTAP12-2|KRTAP12-1|KRTAP10-10|KRTAP10-4|KRTAP10-6|KRTAP10-7|KRTAP10-9|KRTAP10-11|KRTAP10-2|KRTAP10-5|KRTAP10-8|KRTAP10-3|KRTAP12-3|KRTAP12-4|KRTAP10-12|LINC00163	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	21	45970718 - 47545826			221356	223085
NM_006031.5(PCNT):c.2167C>G (p.Leu723Val)	PCNT	not provided	Uncertain significance	no assertion criteria provided	21	47783407	21	46363492	100853	106713
NM_003325.3(HIRA):c.820G>A (p.Val274Met)	HIRA	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	19381867	22	19394344	161612	171667
NM_006440.4(TXNRD2):c.1432G>C (p.Ala478Pro)	TXNRD2	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	22	19865626	22	19878103	487801	480808
NM_013373.3(ZDHHC8):c.1022C>A (p.Ala341Asp)	ZDHHC8	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	20128950	22	20141427	161668	171668
NM_033257.3(DGCR6L):c.608C>T (p.Pro203Leu)	DGCR6L	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	20302253	22	20314730	161788	171669
NM_002745.4(MAPK1):c.964G>A (p.Glu322Lys)	MAPK1	Squamous cell carcinoma of the head and neck|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	22	22127164	22	21772875	376450	363329
NM_003073.4(SMARCB1):c.110G>C (p.Arg37Pro)	SMARCB1	Adenoid cystic carcinoma	Uncertain significance(Last reviewed: Feb 1, 2018)	no assertion criteria provided	22	24133959	22	23791772	495134	486686
NM_003073.4(SMARCB1):c.544C>T (p.Gln182Ter)	SMARCB1	Schwannomatosis 1, somatic	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	22	24145525	22	23803338	8027	23066
NM_003073.4(SMARCB1):c.951delA (p.Gln318Serfs)	SMARCB1	Malignant rhabdoid tumor, somatic	Pathogenic(Last reviewed: Jul 9, 1998)	no assertion criteria provided	22	24167567	22	23825380	8022	23061
NM_001201429.1(CABIN1):c.3757G>A (p.Glu1253Lys)	CABIN1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	24492014	22	24096051	161568	171670
NM_001145468.3(SPECC1L):c.464G>T (p.Arg155Leu)	SPECC1L|SPECC1L-ADORA2A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	24717412	22	24321444	161536	171671
NM_001184774.1(SEZ6L):c.778G>T (p.Glu260Ter)	SEZ6L	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	26689055	22	26293089	161554	171672
NM_001184774.1(SEZ6L):c.1515-5G>A	SEZ6L	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	26706631	22	26310665	161553	171673
NM_002430.2(MN1):c.927_929delGCA (p.Gln309del)	MN1	Hepatoblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	22	28195603 - 28195605	22	27799615 - 27799617	438776	432388
NM_007194.4(CHEK2):c.1183G>T (p.Val395Phe)	CHEK2	Neoplasm of the breast	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	22	29091774	22	28695786	376746	363625
NM_007194.3(CHEK2):c.1100delC (p.Thr367Metfs)	CHEK2	Familial cancer of breast|Li-Fraumeni syndrome 2|Osteosarcoma|Malignant tumor of prostate|Breast cancer, susceptibility to|Breast and colorectal cancer, susceptibility to|Li-Fraumeni syndrome|Colitis|not provided|Neoplasm of the breast|Astrocytoma|Hereditary cancer-predisposing syndrome|Inflammation of the large intestine|Hematochezia|Leiomyosarcoma|Thrombocytopenia|Breast cancer|CHEK2-Related Cancer Susceptibility|Hereditary cancer	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	22	29091857	22	28695869	128042	133499
NM_007194.4(CHEK2):c.1067C>T (p.Ser356Leu)	CHEK2	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	22	29092917	22	28696929	126907	132420
NM_007194.4(CHEK2):c.1040A>C (p.Asp347Ala)	CHEK2	Neoplasm of the breast	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	22	29092944	22	28696956	376747	363626
NM_007194.4(CHEK2):c.715G>A (p.Glu239Lys)	CHEK2	Familial cancer of breast|Prostate cancer, somatic|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 7, 2018)	criteria provided, multiple submitters, no conflicts	22	29107974	22	28711986	5600	20639
NM_007194.3(CHEK2):c.715G>T (p.Glu239Ter)	CHEK2	Familial cancer of breast|Prostate cancer, somatic|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	22	29107974	22	28711986	5599	20638
NM_007194.4(CHEK2):c.542G>A (p.Arg181His)	CHEK2	Familial cancer of breast|Prostate cancer, somatic|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	22	29121015	22	28725027	5598	20637
NM_007194.4(CHEK2):c.541C>T (p.Arg181Cys)	CHEK2	Familial cancer of breast|Prostate cancer, somatic|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	22	29121016	22	28725028	5597	20636
NM_007194.4(CHEK2):c.539G>A (p.Arg180His)	CHEK2	Familial cancer of breast|Prostate cancer, somatic|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	22	29121018	22	28725030	5596	20635
NM_007194.4(CHEK2):c.254C>T (p.Pro85Leu)	CHEK2	Familial cancer of breast|Osteosarcoma|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	22	29130456	22	28734468	5594	20633
NM_007194.4(CHEK2):c.49G>T (p.Ala17Ser)	CHEK2	Osteosarcoma	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	22	29130661	22	28734673	5595	20634
NM_000268.3(NF2):c.125_126insG (p.Gly43Argfs)	NF2	Schwannomatosis 1	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	22	30032750 - 30032751	22	29636761 - 29636762	3299	18338
NM_000268.3(NF2):c.169C>T (p.Arg57Ter)	NF2	Neurofibromatosis, type 2|Meningioma|not provided	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	22	30032794	22	29636805	3285	18324
NM_000268.3(NF2):c.205_211delAAGGACA (p.Lys69Glnfs)	NF2	Schwannomatosis 1	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	22	30032830 - 30032836	22	29636841 - 29636847	3300	18339
NM_000268.3(NF2):c.551G>A (p.Trp184Ter)	NF2	Ependymoma	Likely pathogenic(Last reviewed: Dec 29, 2017)	no assertion criteria provided	22	30051617	22	29655628	487796	480803
NM_000268.3(NF2):c.575A>G (p.Tyr192Cys)	NF2	Choroid plexus carcinoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	22	30051641	22	29655652	438777	432410
NM_000268.3(NF2):c.583_589delCACCGAG (p.His195Alafs)	NF2	Spindle cell sarcoma	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	22	30051649 - 30051655	22	29655660 - 29655666	585330	576379
NC_000022.10:g.[30057723_30063344del;30063345_30067790del]	NF2	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 21, 2014)	no assertion criteria provided	22|22	30057723 - 30063344	22|22	29661734 - 29667355	267491	262764|262765
NM_000268.3(NF2):c.995delA (p.Lys332Serfs)	NF2	Meningioma	Pathogenic(Last reviewed: Feb 1, 1994)	no assertion criteria provided	22	30064431	22	29668442	3284	18323
NM_032050.1(PATZ1):c.562G>T (p.Asp188Tyr)	PATZ1	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	22	31741027	22	31345041	487786	480793
NM_001242897.1(DEPDC5):c.2705G>A (p.Trp902Ter)	DEPDC5	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	22	32241141	22	31845155	487789	480796
NM_001135774.1(SYN3):c.1247C>T (p.Ala416Val)	SYN3	not provided	Uncertain significance	no assertion criteria provided	22	32923973	22	32527986	100827	106687
NM_006078.4(CACNG2):c.541T>C (p.Tyr181His)	CACNG2	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	22	36960829	22	36564782	487807	480814
NM_002872.4(RAC2):c.225+1G>A	RAC2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	37628840	22	37232800	161602	171674
NM_001039141.2(TRIOBP):c.815C>A (p.Thr272Lys)	TRIOBP	Deafness, autosomal recessive 28|not provided	Uncertain significance(Last reviewed: Dec 9, 2014)	criteria provided, single submitter	22	38119378	22	37723371	156028	165838
NM_152868.2(KCNJ4):c.586C>T (p.Arg196Cys)	KCNJ4	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	38823552	22	38427547	161819	171675
NM_015373.3(CBY1):c.346C>G (p.Leu116Val)	CBY1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	39069206	22	38673201	161693	171676
NM_175709.4(CBX7):c.227C>G (p.Pro76Arg)	CBX7	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	39534660	22	39138655	161834	171677
NM_145738.2(SYNGR1):c.487-3C>T	SYNGR1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	39773600	22	39377595	161810	171678
NM_001429.3(EP300):c.1738C>T (p.Arg580Ter)	EP300	Carcinoma of colon	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	22	41533772	22	41137768	6880	21919
NM_001429.3(EP300):c.4195G>T (p.Asp1399Tyr)	EP300	Medulloblastoma|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Uterine cervical neoplasms	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	22	41565529	22	41169525	376402	363281
NM_001429.3(EP300):c.4195G>A (p.Asp1399Asn)	EP300	Medulloblastoma|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Transitional cell carcinoma of the bladder|Carcinoma of esophagus|Uterine cervical neoplasms	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	22	41565529	22	41169525	376401	363280
NM_001429.3(EP300):c.6662C>A (p.Pro2221Gln)	EP300	Carcinoma of colon	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	22	41574377	22	41178373	6881	21920
NM_022785.3(EFCAB6):c.314C>T (p.Pro105Leu)	EFCAB6	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	44168809	22	43772929	161763	171679
GRCh37/hg19 22q13.33(chr22:50318056-50437748)x3	CRELD2|IL17REL|PIM3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	22	50318056 - 50437748			221550	223279
GRCh37/hg19 22q13.33(chr22:50318056-50356682)x4	CRELD2|PIM3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	22	50318056 - 50356682			221408	223137
NM_001242898.1(PPP6R2):c.2350C>T (p.Arg784Trp)	PPP6R2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	22	50878454	22	50440025	161576	171680
GRCh37/hg19 22q13.33(chr22:50964500-51016275)x3	CPT1B|TYMP|SCO2|KLHDC7B|ODF3B|SYCE3	Ductal breast carcinoma	Uncertain significance(Last reviewed: Jul 20, 2015)	no assertion criteria provided	22	50964500 - 51016275			221551	223280
NC_000022.11:g.(29668447_29671826)_(29681601_?)del	NF2	Schwannomatosis 1	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided			22	29668447 - 29681601	3298	18337
NM_022148.3(CRLF2):c.695T>G (p.Phe232Cys)	CRLF2	Lymphoblastic leukemia, acute, with lymphomatous features	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	X	1314966	X	1196852	376003	362882
NM_015419.3(MXRA5):c.5788G>A (p.Ala1930Thr)	MXRA5	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	3235934	X	3317893	161694	171687
NM_015691.3(WWC3):c.2089C>A (p.Leu697Met)	WWC3	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	10094329	X	10126289	161696	171681
NM_001830.3(CLCN4):c.2183C>T (p.Thr728Met)	CLCN4	not provided	Conflicting interpretations of pathogenicity	no assertion criteria provided	X	10188908	X	10220868	100836	106696
NM_013427.2(ARHGAP6):c.1675G>T (p.Gly559Ter)	ARHGAP6	not provided	Uncertain significance	no assertion criteria provided	X	11187759	X	11169639	100858	106718
NM_182680.1(AMELX):c.171G>C (p.Gln57His)	AMELX|ARHGAP6	Amelogenesis imperfecta, hypoplastic/hypomaturation, X-linked 2	not provided	no assertion provided	X	11316382	X	11298262	96976	102879
NM_182680.1(AMELX):c.173G>A (p.Ser58Asn)	AMELX|ARHGAP6	Amelogenesis imperfecta, hypoplastic/hypomaturation, X-linked 2	not provided	no assertion provided	X	11316384	X	11298264	96977	102880
NM_182680.1(AMELX):c.174C>A (p.Ser58Arg)	AMELX|ARHGAP6	Amelogenesis imperfecta, hypoplastic/hypomaturation, X-linked 2	not provided	no assertion provided	X	11316385	X	11298265	96978	102881
NM_002641.3(PIGA):c.1355_1356insAATTGAGATGGATGACTCCAGATTCTATCATTGA (p.Asp452Glufs)	PIGA	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	X	15339727 - 15339728	X	15321605 - 15321606	9966	25005
NM_002641.3(PIGA):c.1323_1324delCT (p.Leu442Glufs)	PIGA	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	X	15339759 - 15339760	X	15321637 - 15321638	9964	25003
NM_002641.3(PIGA):c.1188+2delT	PIGA	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: May 21, 1993)	no assertion criteria provided	X	15342785	X	15324663	9957	24996
NM_002641.3(PIGA):c.1115delC (p.Pro372Glnfs)	PIGA	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	X	15342860	X	15324738	9960	24999
NM_002641.3(PIGA):c.459_460insA (p.His154Thrfs)	PIGA	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	X	15349593 - 15349594	X	15331471 - 15331472	9959	24998
NM_002641.3(PIGA):c.431delC (p.Thr144Lysfs)	PIGA	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	X	15349622	X	15331500	9963	25002
NM_002641.3(PIGA):c.294C>A (p.Tyr98Ter)	PIGA	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: Apr 27, 1999)	no assertion criteria provided	X	15349759	X	15331637	9958	24997
NM_002641.3(PIGA):c.249_250insGT (p.Thr84Valfs)	PIGA	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	X	15349803 - 15349804	X	15331681 - 15331682	9962	25001
NM_002641.3(PIGA):c.163C>T (p.Gln55Ter)	PIGA	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: Dec 15, 1995)	no assertion criteria provided	X	15349890	X	15331768	9961	25000
NM_198270.3(NHS):c.1048G>T (p.Val350Phe)	NHS	not provided	Uncertain significance	no assertion criteria provided	X	17742421	X	17724301	100895	106755
NM_198270.3(NHS):c.2141G>A (p.Arg714His)	NHS	Malignant tumor of prostate|History of neurodevelopmental disorder	Likely benign(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	X	17744430	X	17726310	161851	171686
NM_000284.3(PDHA1):c.265G>A (p.Gly89Ser)	PDHA1	Pyruvate dehydrogenase E1-alpha deficiency	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	X	19368202	X	19350084	561077	552254
NM_031892.2(SH3KBP1):c.1258A>G (p.Arg420Gly)	SH3KBP1	not provided	Uncertain significance	no assertion criteria provided	X	19606801	X	19588683	100879	106739
NM_173495.2(PTCHD1):c.1230C>A (p.Ile410=)	PTCHD1	not provided	Uncertain significance	no assertion criteria provided	X	23410865	X	23392748	100892	106752
NM_000397.3(CYBB):c.90_92delCCGinsGGT (p.Tyr30Ter)	CYBB	Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	X	37641385 - 37641387	X	37782132 - 37782134	10940	25979
NM_001123385.1(BCOR):c.4787_4802del16 (p.Gly1596Valfs)	BCOR	Adenoid cystic carcinoma	Likely pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	X	39913526 - 39913541	X	40054273 - 40054288	495132	486687
NM_017745.5(BCOR):c.3961G>T (p.Glu1321Ter)	BCOR	Adenoid cystic carcinoma	Likely pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	X	39922109	X	40062856	495127	486688
NM_001123383.1(BCOR):c.3781_3782delAG (p.Leu1262Phefs)	BCOR	not provided|Glioblastoma	Pathogenic(Last reviewed: Nov 18, 2015)	criteria provided, single submitter	X	39922288 - 39922289	X	40063035 - 40063036	284290	268527
NM_017745.5(BCOR):c.398_399insAC (p.Ala134Argfs)	BCOR	Adenoid cystic carcinoma	Likely pathogenic(Last reviewed: Feb 1, 2018)	no assertion criteria provided	X	39934200 - 39934201	X	40074947 - 40074948	495125	486689
NM_001356.4(DDX3X):c.107_108insGC (p.Tyr38Alafs)	DDX3X	PARP Inhibitor response	drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	X	41198292 - 41198293	X	41339039 - 41339040	523172	513786
NM_001356.4(DDX3X):c.1033G>C (p.Val345Leu)	DDX3X	Medulloblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	X	41204440	X	41345187	438761	432399
NM_001356.4(DDX3X):c.1588G>T (p.Gly530Cys)	DDX3X	Medulloblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	X	41205848	X	41346595	438759	432397
NM_001356.4(DDX3X):c.1592G>A (p.Arg531His)	DDX3X	Medulloblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	X	41205852	X	41346599	438760	432398
NM_080817.4(GPR82):c.482G>T (p.Gly161Val)	CASK|GPR82	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	41586761	X	41727508	161798	171688
NM_021140.3(KDM6A):c.452dupA (p.Ala152Serfs)	KDM6A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	44879863	X	45020618	161745	171689
NM_021140.3(KDM6A):c.4034delC (p.Thr1345Ilefs)	KDM6A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	44969352	X	45110107	161744	171690
NM_001654.4(ARAF):c.640T>G (p.Ser214Ala)	ARAF	Malignant melanoma of skin|Lung adenocarcinoma|Papillary renal cell carcinoma, sporadic	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	X	47426120	X	47566721	376367	363246
NM_001654.4(ARAF):c.641C>T (p.Ser214Phe)	ARAF	Malignant melanoma of skin|Lung adenocarcinoma|Papillary renal cell carcinoma, sporadic	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	X	47426121	X	47566722	376366	363245
NM_001654.4(ARAF):c.641C>G (p.Ser214Cys)	ARAF	Malignant melanoma of skin|Lung adenocarcinoma|Non-small cell lung cancer|Papillary renal cell carcinoma, sporadic	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	X	47426121	X	47566722	376137	363016
NM_000377.2(WAS):c.1A>T (p.Met1Leu)	WAS	Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	X	48542243	X	48683854	11120	26159
NM_003173.3(SUV39H1):c.415C>T (p.Arg139Cys)	SUV39H1	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	X	48558731	X	48700340	487783	480790
NM_002049.3(GATA1):c.154_173dup20 (p.Ala59Glnfs)	GATA1	Acute megakaryoblastic leukemia	Pathogenic(Last reviewed: Apr 15, 2004)	no assertion criteria provided	X	48649670 - 48649689	X	48791263 - 48791282	10429	25468
NM_002049.3(GATA1):c.187_188insTACT (p.Tyr63Leufs)	GATA1	Leukemia, megakaryoblastic, of Down syndrome	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	X	48649700 - 48649703	X	48791293 - 48791296	10426	25465
NM_001042498.2(SLC35A2):c.991G>A (p.Val331Ile)	SLC35A2	not provided|CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm	Likely pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	X	48762195	X	48904918	50364	59489
NM_005660.2(SLC35A2):c.245G>T (p.Cys82Phe)	SLC35A2	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm	Uncertain significance(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	X	48767120	X	48909843	453301	446897
SLC35A2:c.15_91+48delinsA	SLC35A2	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm	Pathogenic(Last reviewed: Nov 14, 2013)	no assertion criteria provided	X	48768775 - 48768899	X	48911498 - 48911622	50363	59488
NM_017602.3(OTUD5):c.1702C>A (p.Pro568Thr)	OTUD5	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	X	48780465	X	48923188	487794	480801
NM_004187.3(KDM5C):c.4231G>A (p.Val1411Met)	KDM5C	not provided	Uncertain significance	no assertion criteria provided	X	53222705	X	53193523	91959	97437
NM_015107.2(PHF8):c.1142-1G>A	PHF8	not provided	Uncertain significance	no assertion criteria provided	X	54026395	X	53999962	91988	97466
NM_015185.2(ARHGEF9):c.1045C>A (p.Leu349Ile)	ARHGEF9	not provided	Uncertain significance	no assertion criteria provided	X	62885777	X	63665897	100861	106721
NM_017677.3(MTMR8):c.1493G>A (p.Gly498Glu)	MTMR8	not provided	Uncertain significance	no assertion criteria provided	X	63490942	X	64271062	91997	97475
NM_000044.4(AR):c.1943G>A (p.Ser648Asn)	AR	Prostate cancer, somatic	Pathogenic(Last reviewed: May 25, 1995)	no assertion criteria provided	X	66931301	X	67711459	9809	24848
NM_000044.4(AR):c.2105T>A (p.Leu702His)	AR	Malignant tumor of prostate	Likely pathogenic	no assertion criteria provided	X	66931463	X	67711621	219296	220985
NM_000044.4(AR):c.2164G>A (p.Ala722Thr)	AR	Prostate cancer, somatic	Pathogenic(Last reviewed: May 25, 1995)	no assertion criteria provided	X	66931522	X	67711680	9836	24875
NM_000044.4(AR):c.2191G>A (p.Val731Met)	AR	Prostate cancer, somatic	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	X	66937337	X	67717495	9817	24856
NM_000044.4(AR):c.2623C>T (p.His875Tyr)	AR	Prostate cancer, somatic	Pathogenic(Last reviewed: May 25, 1995)	no assertion criteria provided	X	66943543	X	67723701	9834	24873
NM_000044.4(AR):c.2629T>C (p.Phe877Leu)	AR	Prostate neoplasm	not provided(Last reviewed: Mar 10, 2016)	no assertion provided	X	66943549	X	67723707	376347	363226
NM_000044.4(AR):c.2632A>G (p.Thr878Ala)	AR	Prostate cancer, somatic	Pathogenic(Last reviewed: Jun 1, 1994)	no assertion criteria provided	X	66943552	X	67723710	9831	24870
NM_000044.4(AR):c.2633C>G (p.Thr878Ser)	AR	Prostate cancer, somatic	Pathogenic(Last reviewed: May 25, 1995)	no assertion criteria provided	X	66943553	X	67723711	9833	24872
NM_000044.4(AR):c.2708A>G (p.Gln903Arg)	AR	Prostate cancer, somatic	Pathogenic(Last reviewed: May 25, 1995)	no assertion criteria provided	X	66943628	X	67723786	9835	24874
NM_198512.2(DGAT2L6):c.769C>A (p.Leu257Met)	DGAT2L6	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	69424276	X	70204426	161853	171691
NM_005120.2(MED12):c.100-8T>A	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339215	X	71119365	92199	97589
NM_005120.2(MED12):c.100-2_141del44insAG	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339221 - 70339264	X	71119371 - 71119414	92198	97588
NM_005120.2(MED12):c.100-1_139del41	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339222 - 70339262	X	71119372 - 71119412	92197	97587
NM_005120.2(MED12):c.103_138del36 (p.Glu35_Asn46del)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339226 - 70339261	X	71119376 - 71119411	92200	97590
NM_005120.2(MED12):c.107_111delTGACGinsGC (p.Leu36_Thr37delinsArg)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339230 - 70339234	X	71119380 - 71119384	92202	97592
NM_005120.2(MED12):c.107T>G (p.Leu36Arg)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339230	X	71119380	92201	97591
NM_005120.2(MED12):c.111_155del45 (p.Ala38_Ser52del)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339234 - 70339278	X	71119384 - 71119428	92203	97593
NM_005120.2(MED12):c.113_121delCCTTGAATG (p.Ala38_Asn40del)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339236 - 70339244	X	71119386 - 71119394	92204	97594
NM_005120.2(MED12):c.117_122delGAATGT (p.Asn40_Val41del)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339240 - 70339245	X	71119390 - 71119395	92205	97595
NM_005120.2(MED12):c.118_146del29insTT (p.Asn40_Pro49delinsPhe)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339241 - 70339269	X	71119391 - 71119419	92208	97598
NM_005120.2(MED12):c.118_134del17insTA (p.Asn40_Phe45delinsTyr)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339241 - 70339257	X	71119391 - 71119407	92207	97597
NM_005120.2(MED12):c.118_132delAATGTAAAACAAGGT (p.Asn40_Gly44del)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339241 - 70339255	X	71119391 - 71119405	92206	97596
NM_005120.2(MED12):c.122_163del42 (p.Val41_Asp54del)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339245 - 70339286	X	71119395 - 71119436	92210	97600
NM_005120.2(MED12):c.122_148del27 (p.Val41_Pro49del)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339245 - 70339271	X	71119395 - 71119421	92209	97599
NM_005120.2(MED12):c.123_152del30 (p.Lys42_Val51del)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339246 - 70339275	X	71119396 - 71119425	92211	97601
NM_005120.2(MED12):c.126_140delACAAGGTTTCAATAA (p.Lys42_Asn46del)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339249 - 70339263	X	71119399 - 71119413	92213	97603
NM_005120.2(MED12):c.126_131delACAAGG (p.Lys42_Gly44delinsAsn)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339249 - 70339254	X	71119399 - 71119404	92212	97602
NM_005120.2(MED12):c.128A>C (p.Gln43Pro)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339251	X	71119401	92214	97604
NM_005120.2(MED12):c.129_143delAGGTTTCAATAACCA (p.Gly44_Gln48del)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339252 - 70339266	X	71119402 - 71119416	92216	97606
NM_005120.2(MED12):c.129_137delAGGTTTCAA (p.Gln43_Asn46delinsHis)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339252 - 70339260	X	71119402 - 71119410	92215	97605
NM_005120.2(MED12):c.130G>T (p.Gly44Cys)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339253	X	71119403	92219	97609
NM_005120.2(MED12):c.130G>C (p.Gly44Arg)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339253	X	71119403	92218	97608
NM_005120.2(MED12):c.130G>A (p.Gly44Ser)	MED12	Uterine leiomyoma|Angiosarcoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	X	70339253	X	71119403	92217	97607
NM_005120.2(MED12):c.131G>T (p.Gly44Val)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339254	X	71119404	92222	97612
NM_005120.2(MED12):c.131G>C (p.Gly44Ala)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339254	X	71119404	92221	97611
NM_005120.2(MED12):c.131G>A (p.Gly44Asp)	MED12	Uterine leiomyoma|Wilms Tumor	other(Last reviewed: May 1, 2016)	no assertion criteria provided	X	70339254	X	71119404	92220	97610
NM_005120.2(MED12):c.133_144delTTCAATAACCAG (p.Phe45_Gln48del)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339256 - 70339267	X	71119406 - 71119417	92223	97613
NM_005120.2(MED12):c.149_163delCTGTCTCTGGGGATG (p.Ala50_Asp54del)	MED12	Uterine leiomyoma	not provided	no assertion provided	X	70339272 - 70339286	X	71119422 - 71119436	92224	97614
NM_005120.2(MED12):c.3670C>G (p.Leu1224Val)	MED12	Squamous cell lung carcinoma|Neoplasm of the breast|Pancreatic adenocarcinoma|Adenocarcinoma of stomach|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	X	70349258	X	71129408	376452	363331
NM_005120.2(MED12):c.3670C>T (p.Leu1224Phe)	MED12	Squamous cell lung carcinoma|Neoplasm of the breast|Pancreatic adenocarcinoma|Adenocarcinoma of stomach|Adenocarcinoma of prostate	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	X	70349258	X	71129408	376451	363330
NM_005120.2(MED12):c.5980C>T (p.Arg1994Trp)	MED12	Glioblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	X	70357729	X	71137879	438772	432408
NM_001145408.1(NONO):c.725_726insA (p.Asn244Lysfs)	NONO	Medulloblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	X	70516490	X	71296639 - 71296640	438778	432390
NM_002637.3(PHKA1):c.79A>C (p.Asn27His)	PHKA1	not provided	Uncertain significance	no assertion criteria provided	X	71932779	X	72712937	91943	97421
NM_001039840.3(CHIC1):c.331C>T (p.Pro111Ser)	CHIC1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	72797277	X	73577441	219349	221038
NM_006517.4(SLC16A2):c.1451G>T (p.Gly484Val)	SLC16A2	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	73751219	X	74531384	161647	171692
NM_183353.2(RLIM):c.260delA (p.Asp87Alafs)	RLIM	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	73812890	X	74593055	161848	171693
NM_000489.4(ATRX):c.6631G>T (p.Glu2211Ter)	ATRX	not provided	Uncertain significance	no assertion criteria provided	X	76812990	X	77557519	91912	97390
NM_000489.4(ATRX):c.1558G>T (p.Val520Phe)	ATRX	Metastatic pancreatic neuroendocrine tumours	Likely pathogenic(Last reviewed: Nov 1, 2017)	no assertion criteria provided	X	76939190	X	77683698	446275	439681
NM_000489.5(ATRX):c.236C>G (p.Ser79Ter)	ATRX	Acquired hemoglobin H disease	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	X	76953077	X	77697589	11741	26780
NM_000489.4(ATRX):c.20+1G>A	ATRX	Acquired hemoglobin H disease	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	X	77041467	X	77785981	11740	26779
NM_006639.3(CYSLTR1):c.68delA (p.Asn23Ilefs)	CYSLTR1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	77529176	X	78273679	161649	171694
NM_000307.4(POU3F4):c.1013C>T (p.Pro338Leu)	POU3F4	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	X	82764345	X	83509337	487785	480792
NM_001184880.1(PCDH19):c.919G>A (p.Glu307Lys)	PCDH19	Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	X	99662677	X	100407679	561074	552237
NM_024885.3(TAF7L):c.213C>T (p.Ala71=)	TAF7L	not provided	Uncertain significance	no assertion criteria provided	X	100547821	X	101292833	100877	106737
NM_000061.2(BTK):c.1442G>C (p.Cys481Ser)	BTK	Neoplasm of the breast	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	X	100611164	X	101356176	376203	363082
NM_000061.2(BTK):c.1441T>A (p.Cys481Ser)	BTK	Chronic lymphocytic leukemia|Neoplasm of the breast	Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	X	100611165	X	101356177	376204	363083
NM_000061.2(BTK):c.121G>A (p.Glu41Lys)	BTK	Agammaglobulinemia	Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	X	100630152	X	101375164	376751	363630
NM_017752.2(TBC1D8B):c.528T>C (p.Gly176=)	TBC1D8B	not provided	Uncertain significance	no assertion criteria provided	X	106065374	X	106822144	100867	106727
NM_014289.3(CAPN6):c.1757G>A (p.Arg586Gln)	CAPN6	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	110489974	X	111246746	161673	171682
NM_000868.3(HTR2C):c.502C>T (p.Arg168Trp)	HTR2C	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	114082718	X	114848155	161473	171683
NM_019045.4(WDR44):c.1837C>T (p.Leu613Phe)	WDR44	not provided	Uncertain significance	no assertion criteria provided	X	117566843	X	118432880	100873	106733
NM_080632.2(UPF3B):c.772G>C (p.Glu258Gln)	UPF3B	not provided	Uncertain significance	no assertion criteria provided	X	118975074	X	119841111	100888	106748
NM_006978.2(RNF113A):c.247T>A (p.Leu83Met)	RNF113A	not provided	Uncertain significance	no assertion criteria provided	X	119005330	X	119871367	91972	97450
NM_152692.4(C1GALT1C1):c.577T>C (p.Ser193Pro)	C1GALT1C1	Polyagglutinable erythrocyte syndrome	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	X	119760445	X	120626590	39573	48172
NM_152692.4(C1GALT1C1):c.454G>A (p.Glu152Lys)	C1GALT1C1	Polyagglutinable erythrocyte syndrome	Pathogenic(Last reviewed: Oct 27, 2005)	no assertion criteria provided	X	119760568	X	120626713	10793	25832
NM_152692.4(C1GALT1C1):c.393T>A (p.Asp131Glu)	C1GALT1C1	Polyagglutinable erythrocyte syndrome	Pathogenic(Last reviewed: Oct 27, 2005)	no assertion criteria provided	X	119760629	X	120626774	10792	25831
NM_152692.4(C1GALT1C1):c.202C>T (p.Arg68Ter)	C1GALT1C1	Polyagglutinable erythrocyte syndrome	Pathogenic(Last reviewed: Oct 27, 2005)	no assertion criteria provided	X	119760820	X	120626965	10791	25830
NM_152692.4(C1GALT1C1):c.3G>C (p.Met1Ile)	C1GALT1C1	Polyagglutinable erythrocyte syndrome	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	X	119761019	X	120627164	39574	48173
NM_001081550.1(THOC2):c.278T>C (p.Ile93Thr)	THOC2	not provided	Uncertain significance	no assertion criteria provided	X	122831598	X	123697748	100824	106684
NM_003399.5(XPNPEP2):c.399G>A (p.Lys133=)	XPNPEP2	not provided	Uncertain significance	no assertion criteria provided	X	128880312	X	129746336	91949	97427
NM_145812.2(AIFM1):c.485C>T (p.Pro162Leu)	AIFM1|RAB33A	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	129281576	X	130147601	161811	171684
NM_004484.3(GPC3):c.1705G>A (p.Ala569Thr)	GPC3	Wilms tumor 1	Pathogenic(Last reviewed: Jun 17, 2002)	no assertion criteria provided	X	132670190	X	133536162	11691	26730
NM_004484.3(GPC3):c.361C>T (p.His121Tyr)	GPC3	Wilms tumor 1	Pathogenic(Last reviewed: Jun 17, 2002)	no assertion criteria provided	X	132888180	X	133754153	11690	26729
NM_001015877.1(PHF6):c.119C>A (p.Ala40Glu)	PHF6	Neuroblastoma	other(Last reviewed: May 1, 2016)	no assertion criteria provided	X	133511766	X	134377736	438782	432413
NC_000023.10:g.135533330_136123779dup	BRS3|CD40LG|ARHGEF6|RBMX|HTATSF1|VGLL1|GPR101	Chromosome Xq26.3 duplication syndrome	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	X	135533330 - 136123779			374411	361297
NC_000023.10:g.135549274_136126345dup	BRS3|CD40LG|ARHGEF6|RBMX|HTATSF1|VGLL1|GPR101	Chromosome Xq26.3 duplication syndrome	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	X	135549274 - 136126345			374409	361295
NC_000023.10:g.135596446_136254970dup	CD40LG|ARHGEF6|RBMX|VGLL1|GPR101	Chromosome Xq26.3 duplication syndrome	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	X	135596446 - 136254970			374412	361298
NC_000023.10:g.135622314_136191699dup	CD40LG|ARHGEF6|RBMX|VGLL1|GPR101	Chromosome Xq26.3 duplication syndrome	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	X	135622314 - 136191699			374410	361296
NM_054021.1(GPR101):c.1156A>C (p.Asn386His)	GPR101	not provided	Uncertain significance	no assertion criteria provided	X	136112678	X	137030519	92023	97501
NM_001009613.2(SPANXN4):c.169A>G (p.Arg57Gly)	SPANXN4	not provided	Uncertain significance	no assertion criteria provided	X	142121901	X	143034115	100820	106680
NM_001177465.2(MAMLD1):c.1916G>T (p.Ser639Ile)	MAMLD1	Malignant tumor of prostate	Uncertain significance	no assertion criteria provided	X	149678305	X	150510035	161551	171685
NM_004961.3(GABRE):c.975C>A (p.Thr325=)	GABRE	not provided	Uncertain significance	no assertion criteria provided	X	151124002	X	151955530	100849	106709
NM_021949.3(ATP2B3):c.1272_1277delGCTGGT (p.Leu425_Val426del)	ATP2B3	Aldosterone Producing Adrenal Cortex Adenoma	Pathogenic(Last reviewed: Feb 17, 2013)	no assertion criteria provided	X	152814246 - 152814251	X	153548788 - 153548793	162467	172142
NM_021949.3(ATP2B3):c.1273_1278delCTGGTC (p.Leu425_Val426del)	ATP2B3	Aldosterone Producing Adrenal Cortex Adenoma	Pathogenic(Last reviewed: Feb 17, 2013)	no assertion criteria provided	X	152814247 - 152814252	X	153548789 - 153548794	162469	172143
NM_021949.3(ATP2B3):c.1277_1282delTCGTGG (p.Val426_Val427del)	ATP2B3	Aldosterone Producing Adrenal Cortex Adenoma	Pathogenic(Last reviewed: Feb 17, 2013)	no assertion criteria provided	X	152814251 - 152814256	X	153548793 - 153548798	162470	172144
NM_001363.4(DKC1):c.1147G>A (p.Gly383Ser)	DKC1	not provided	Uncertain significance	no assertion criteria provided	X	154001516	X	154773241	100833	106693
NM_003372.6(VBP1):c.331C>A (p.Leu111Met)	VBP1	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	X	154456711	X	155228429	487792	480799
NM_005840.2(SPRY3):c.55C>T (p.Arg19Cys)	SPRY3	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	X	155003588	X	155773926	487791	480798
m.1555A>G	MT-CO1|MT-RNR1	Aminoglycoside-induced deafness|Deafness, nonsyndromic sensorineural, mitochondrial|Cardiomyopathy, restrictive|not provided|Gentamicin response|aminoglycoside antibacterials response - Toxicity/ADR|amikacin response - Toxicity/ADR|gentamicin response - Toxicity/ADR|kanamycin response - Toxicity/ADR|neomycin response - Toxicity/ADR|streptomycin response - Toxicity/ADR|tobramycin response - Toxicity/ADR	drug response(Last reviewed: Mar 19, 2018)	reviewed by expert panel	MT	1555	MT	1555	9628	24667
m.3242G>A	MT-TL1	Myelodysplastic syndrome	Pathogenic(Last reviewed: Jun 11, 2010)	no assertion criteria provided	MT	3242	MT	3242	9600	24639
NC_012920.1:m.3243A>G	MT-TL1	3-Methylglutaconic aciduria type 1|Cyclical vomiting syndrome|Diabetes-deafness syndrome maternally transmitted|Age-related macular degeneration 2|Myoclonus with epilepsy with ragged red fibers|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leigh syndrome|Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency|Sensorineural hearing loss|Mitochondrial diseases|MERRF/MELAS overlap syndrome|Muscle stiffness, painful|Short stature|Stroke|not provided|Glucose intolerance|Stroke	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, multiple submitters, no conflicts	MT	3243	MT	3243	9589	24628
m.5874T>C	MT-TY	Exercise intolerance and complex III deficiency, somatic|not provided	Pathogenic(Last reviewed: Oct 24, 2000)	no assertion criteria provided	MT	5874	MT	5874	9550	24589
m.5877C>T	MT-TY	Kearns Sayre syndrome	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	MT	5877	MT	5877	9552	24591
m.5888delT	MT-TY	Kearns Sayre syndrome	Pathogenic(Last reviewed: Dec 26, 2001)	no assertion criteria provided	MT	5888	MT	5888	9551	24590
NC_012920.1:m.11032delA	MT-ND4	Ependymoma	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	MT	11032	MT	11032	487804	480811
NC_012920.1:m.14372C>A	MT-ND6	Acute megakaryoblastic leukemia|Mediastinal germ cell tumor	Uncertain significance(Last reviewed: Oct 22, 2015)	no assertion criteria provided	MT	14372	MT	14372	218344	215055
